sentence	label
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, @DRUG$, and quinidine.	DDI-false
tested @DRUG$ theophylline @DRUG$ and .	DDI-false
- @DRUG$ (e.g., Mexate) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
To determine of @DRUG$ would of to be a fixed of thiosulfate hours escalating	DDI-false
studied adverse effects exposure of to interaction @DRUG$ with and @DRUG$ , coexisting the contents of beverages	DDI-false
The similarity the @DRUG$ between ( AVONEX ) Study 2 with @DRUG$ ) indicates that this alteration in clearance does reduction the TYSABRI   dose to maintain safety , )	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
therapies : In trials , the safety profile in treated with Acamprosate concomitantly with anxiolytics @DRUG$ and sedatives ( benzodiazepines , @DRUG$ was that taking placebo with .	DDI-false
@DRUG$ as procainamide , disopyramide , and phenytoin , used concurrently	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
, lidocaine/quinidine phenobarbital/acetaminophen , quinidine/lidocaine ,	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both @DRUG$ and dideoxyinosine.	DDI-false
a clinical pharmacology aluminum hydroxide , hydroxide and simethicone fosinopril serum urinary @DRUG$ fosinopril administered suggesting may impair absorption of	DDI-false
lidocaine/quinidine , @DRUG$/valproic quinidine/lidocaine , , and valproic acid/phenobarbital	DDI-false
Particular caution when in mixed drug effects ( such as convulsions cardiac dysrhythmias ) other drugs in overdose especially @DRUG$ ) the @DRUG$ effect by flumazenil .	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with COPEGUS, @DRUG$ treatment did not affect @DRUG$ distribution or clearance.	DDI-false
@DRUG$, @DRUG$, or narcotics: potentiation of orthostatic hypotension may occur.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, spironolactone, and @DRUG$.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
@DRUG$ Amphetamines may the of @DRUG$.	DDI-false
Concurrent ( e.g. @DRUG$ , indomethacin myelotoxic , cytotoxic chemotherapy @DRUG$ or hepatotoxic e.g. , asparaginase may these organ .	DDI-false
Methotrexate: In an interaction study of rheumatoid arthritis patients taking @DRUG$, CELEBREX did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
Drugs may alter imatinib that increase @DRUG$ plasma concentrations Caution is when Gleevec with the CYP3A4 ( e.g. , ketoconazole itraconazole @DRUG$ )	DDI-false
Interactions : Flupenthixol may drugs , @DRUG$ ( ): theoretically flupenthixol - Arecoline - Eproxindine - @DRUG$ Ethanol cause additive CNS - Tricyclic Flupenthixol increases the of Tricyclic	DDI-false
: In conducted healthy subjects mean steady-state @DRUG$ levels 17 % in receiving @DRUG$ mg BID with CELEBREX compared to receiving lithium alone	DDI-false
@DRUG$ effects of @DRUG$.	DDI-effect
In Fondaparinux influenced the warfarin , acetylsalicylic acid , piroxicam @DRUG$ , the pharmacokinetics @DRUG$ steady state .	DDI-false
Other @DRUG$ e.g. , @DRUG$ ) have this	DDI-false
Naproxen : The diflunisal @DRUG$ in had no on the levels of naproxen but significantly the urinary excretion @DRUG$ and metabolite	DDI-false
Example inhibitors azole clarithromycin , doxycycline , , , @DRUG$ , nefazodone nicardipine , @DRUG$ , and	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, digoxin, @DRUG$, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
with @DRUG$ phenobarbital with and @DRUG$ phenobarbital to concentrations the binding the .	DDI-false
drugs thiazides other @DRUG$ , thyroid , oral contraceptives , , @DRUG$ , sympathomimet-ics , calcium channel drugs , isoniazid .	DDI-false
is be well with clinical and paraclinical of deficit and to discriminate an @DRUG$ requires physiological and magnesium to dysregulation of mechanisms of @DRUG$ status which less regulation of .	DDI-false
Adequate monitoring of @DRUG$ plasma concentrations should be when VIOXX is or changed in patients receiving	DDI-false
Inhibitors : ( @DRUG$ ) @DRUG$ reports myopathy/rhabdomyolysis	DDI-false
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and theophylline may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
inhibitors include azole antifungals ciprofloxacin , clarithromycin , doxycycline , @DRUG$ , , @DRUG$ , quinidine , and verapamil	DDI-false
Digoxin: @DRUG$ 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of @DRUG$ after a single 0.5 mg oral dose.	DDI-false
Interactions @DRUG$ with drugs Monoamine oxidase inhibitors ( MAOI ): could theoretically affect - Arecoline : @DRUG$ and cause CNS - Tricyclic : effect	DDI-false
High-dose @DRUG$ with @DRUG$ protection.	DDI-effect
Seizure , @DRUG$ concentrations , been intravenous @DRUG$.	DDI-false
Non-steroidal anti-inflammatory @DRUG$ ): These drugs in combination with very @DRUG$ shown to convulsions in pre-clinical .	DDI-false
Other @DRUG$ (e.g., @DRUG$) may also have this effect.	DDI-false
@DRUG$ may enhance the seizure risk in patients taking @DRUG$	DDI-effect
should be given consideration in taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
It may be necessary to adjust the dosage of oral @DRUG$ upon beginning or stopping disulfiram. since @DRUG$ may prolong prothrombin time.	DDI-false
in man @DRUG$ , @DRUG$ diazepam aminopyrine .	DDI-false
with glaucoma drugs or medications were in clinical Ophthalmic Solution , the of additive or potentiating effect @DRUG$ ( @DRUG$ , barbiturates , ) should be considered .	DDI-false
: antacid @DRUG$ , magnesium @DRUG$ ) fosinopril reduced urinary excretion fosinoprilat fosinopril administered alone , antacids impair absorption fosinopril	DDI-false
Carbamazepine known to the metabolism of @DRUG$ increase its serum levels should be determined to concurrent @DRUG$ , signs carbamazepine should be closely , appropriate of the should be	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
evaluate impact of plus on clinical systemic non-Hodgkin lymphoma ) , authors compared retrospectively group of 24 patients with HIV-NHL were doxorubicin , @DRUG$ and prednisone ) chemotherapy regimen HAART a of 80 who treated CHOP or regimen i.e. , cyclophosphamide teniposide prednisone with plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
INOmax been administered @DRUG$ @DRUG$ , dobutamine , surfactant ventilation	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Rifampin: Co-administration of @DRUG$ with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
The effects of @DRUG$ are antagonized by methylxanthines such as caffeine and @DRUG$.	DDI-effect
of oral @DRUG$ @DRUG$ induced were in sheep .	DDI-false
Similarly @DRUG$ @DRUG$ and both alone at in serum and ethanol at in serum .	DDI-false
@DRUG$ @DRUG$ 3 mg administered daily 5 affect pharmacokinetics (R)- there changes in prothrombin time a 25 mg dose of	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (@DRUG$) was more than doubled in the presence of @DRUG$/SMX.	DDI-false
specific not performed , coadministration drugs that are mainly metabolized by , calcium channel blockers , quinine , , quinidine tacrolimus , @DRUG$ @DRUG$ carbamazepine fentanyl , alfentanyl , and may when ;	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Results sclerosis @DRUG$   and concomitant   mcg ) or acetate inconclusive with need dose adjustment of beta-interferon or @DRUG$.	DDI-false
Co-medications that induce CYP3A4 ( dexamethasone , @DRUG$ rifampin , @DRUG$ St.	DDI-false
The effects of and @DRUG$ upon locomotion and behavioral changes mice	DDI-false
Effect of AEDs in Pediatric Patients There was about a 22% increase of apparent total body clearance of @DRUG$ when it was co-administered with enzyme-inducing @DRUG$.	DDI-mechanism
performed , coadministration with drugs are mainly by ( eg @DRUG$ dapsone , disopyramide @DRUG$ , warfarin , , , ergot carbamazepine , alprazolam , have plasma when saquinavir	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ decrease arterial responsiveness to @DRUG$.	DDI-effect
@DRUG$: Chloramphenicol, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Compounds that have been tested in man include antipyrine, digoxin, @DRUG$, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
This appears to be clinically interaction of this @DRUG$ , theoretically , other alter cardiac ( , beta-adrenergic , calcium channel blockers , antihistamines or H1-blocking agents , @DRUG$ ) also to of interval .	DDI-effect
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
@DRUG$ : of relationship , against taking @DRUG$ vitamin to avoid effects	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
To the chemotherapy plus on clinical course patients ( HIV-NHL ) , the a group 24 patients who the @DRUG$ , doxorubicin , vincristine , and prednisone ( chemotherapy regimen HAART patients were with CHOP chemotherapy or a ( , doxorubicin and prednisone with plus @DRUG$ .	DDI-false
The effects of @DRUG$ and of Innovar anesthesia on @DRUG$ tolerance in dogs.	DDI-false
man warfarin @DRUG$ , diazepam , @DRUG$ antipyrine .	DDI-false
@DRUG$ plasma whenever a @DRUG$ going to be another drug be inhibitor of 2D6 .	DDI-false
specific studies not drugs metabolized by CYP3A4 eg , calcium channel blockers , dapsone , , quinine , , cyclosporine ergot derivatives pimozide carbamazepine @DRUG$ , alfentanyl , @DRUG$ , may plasma concentrations when coadministered	DDI-false
@DRUG$ : Concomitant low-dose with VIOXX GI other , of @DRUG$ .	DDI-false
Important Interactions does not have important pharmacokinetic interactions with @DRUG$ beta-blockers , @DRUG$ , , carvedilol	DDI-false
acetaminophen/theophylline lidocaine/quinidine , phenobarbital/acetaminophen , @DRUG$/lidocaine , @DRUG$/acetaminophen valproic acid/phenobarbital .	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, reserpine.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other therapy Although specific interaction performed , @DRUG$ doses of 1 mg or were concomitantly in clinical with acetaminophen , acid , a-blockers @DRUG$ angiotensin-converting enzyme ACE ) inhibitors anticonvulsants , blockers calcium-channel blockers , nitrates , diuretics , HMG-CoA reductase prostaglandin referred as , anti-infectives without evidence clinically significant adverse .	DDI-false
Additive adverse may when LEVSIN is concomitantly with , amantadine , , MAO inhibitors @DRUG$ or @DRUG$.	DDI-false
@DRUG$ including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
: Because the relationship @DRUG$ @DRUG$ be advised against taking vitamin supplements A additive effects	DDI-effect
@DRUG$ reduce the renal clearance of @DRUG$ and add a high risk of lithium toxicity.	DDI-mechanism
Multivalent Products : administration a @DRUG$ , ciprofloxacin with cation-containing as magnesium , sucralfate , @DRUG$ chewable/buffered pediatric powder containing calcium , iron or may decrease absorption resulting in serum urine than	DDI-mechanism
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-int
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Other therapy Although specific were not , doses 1 mg or more were acetaminophen , a-blockers , , ( ACE inhibitors , calcium-channel , cardiac nitrates , @DRUG$ , , HMG-CoA reductase inhibitors @DRUG$ to as NSAIDs , and quinolone anti-infectives of adverse	DDI-false
@DRUG$: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
@DRUG$ SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING @DRUG$ AND ITS CONGENERS.	DDI-advise
In disulfiram @DRUG$ in for 78 has been reported to cause , that @DRUG$ react the stomach a which .	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Imipramine (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
apomorphine ingestion @DRUG$ to @DRUG$ the of poisoning .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
sustained in ( @DRUG$ such as ranitidine or cimetidine may reduce plasma of @DRUG$ therefore efficacy	DDI-mechanism
Multivalent Products Concurrent administration a quinolone ciprofloxacin , multivalent cation-containing products such as @DRUG$ sucralfate VIDEX tablets or pediatric powder , or containing @DRUG$ , zinc absorption of and urine desired .	DDI-false
Withdrawal of @DRUG$ @DRUG$ by 50 %	DDI-mechanism
Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other @DRUG$ or @DRUG$.	DDI-false
@DRUG$: Because atorvastatin does not affect the pharmacokinetics of @DRUG$, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
and Angiotensin II Receptor ( Post-Myocardial In ( % ) receiving @DRUG$ 25 50 mg received angiotensin II ( )	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, @DRUG$ and interferon-alfa.	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
@DRUG$ some compromised who are treated with @DRUG$ the co-administration a further deterioration of function .	DDI-false
Although specific studies have not been coadministration with drugs are mainly by CYP3A4 eg , channel dapsone , disopyramide , quinine , @DRUG$ , tacrolimus , @DRUG$ ergot derivatives pimozide , carbamazepine , alfentanyl , alprazolam have elevated plasma concentrations saquinavir	DDI-false
addition interactions chronic 2 oral Cordarone administration impairs @DRUG$ @DRUG$ methotrexate .	DDI-false
it would be a dosing schedule of @DRUG$ at @DRUG$ given the would in a significant decrease in clinical cerivastatin .	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
There have been reports of @DRUG$-related side effects in patients on concomitant therapy with norfloxacin and @DRUG$.	DDI-false
@DRUG$: Serious side effects and even death have been reported following the concomitant use of certain drugs with @DRUG$.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$: In an interaction study of rheumatoid arthritis patients taking @DRUG$, CELEBREX did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
Paroxetine: Coadministration of single doses of @DRUG$ 3 mg and @DRUG$ 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
evaluate impact of plus HAART on clinical course patients with , systemic , lymphoma ) , authors compared retrospectively a with were with the cyclophosphamide , , @DRUG$ , prednisone ) regimen plus group 80 patients who were with or a CHOP-like regimen ( i.e. cyclophosphamide doxorubicin and @DRUG$ with plus receiving therapy	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, diazepam, @DRUG$ and antipyrine.	DDI-false
Example inhibitors include antifungals , , @DRUG$ @DRUG$ , isoniazid , , , propofol inhibitors , and	DDI-false
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., @DRUG$, @DRUG$) and NovoSeven.	DDI-false
Exposure from the proposed topical dose is about 1% of that from the 100 mg oral dose, even when co-administered with @DRUG$/@DRUG$.	DDI-false
@DRUG$ oral agents ) adjustment the @DRUG$ may required .	DDI-false
Cardiovascular Agents @DRUG$ IV have been used concomitantly with adrenergic-blocking , , agents , hydralazine , prazosin @DRUG$ of significant interactions	DDI-false
Colestipol-Concomitant intake of colestipol and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
comparison , or @DRUG$ , the of @DRUG$ needed cause ventricular tachycardia was as was the LD50 ouabain or than with pentobarbital	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
potent inhibitors of CYP3A4 activity ( eg @DRUG$ ) @DRUG$ and gefitinib concentrations .	DDI-mechanism
Physiological oral @DRUG$ supplementation (5 mg/kg/day) is easy and can be carried out in the diet or with @DRUG$s, with practically only one contra-indication: overt renal failure.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
@DRUG$ (NSAIDs)-A interaction of @DRUG$ an NSAID has not	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-int
Antidepressants, tricyclic Amphetamines may enhance the activity of @DRUG$ or @DRUG$;	DDI-false
was to the interaction and both synthetic @DRUG$ , or @DRUG$ , on the antinonciceptive mice	DDI-false
Antiarrhythmics Other antiarrhythmic drugs , such quinidine , @DRUG$ disopyramide , have used concurrently with @DRUG$.	DDI-false
In view of the long and variable half-life of @DRUG$, potential for drug interactions exists not only with concomitant medication but also with drugs administered after discontinuation of @DRUG$.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline , phenobarbital/acetaminophen , acid , @DRUG$/@DRUG$ , , and	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
, interactions could of @DRUG$ ( , narcotics , @DRUG$ sedatives ) .	DDI-false
Multivitamins or other products @DRUG$ @DRUG$ , sucralfate should be administered concomitantly with or within 2 hours , , in lower and .	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$, and @DRUG$ during concomitant therapy with amiodarone.	DDI-false
@DRUG$ : Reports that diminish the antihypertensive effect of @DRUG$.	DDI-false
Example inhibitors @DRUG$ ciprofloxacin , imatinib , , nefazodone @DRUG$ propofol , protease inhibitors quinidine .	DDI-false
Aspirin/Acetaminophen : Pharmacokinetic or interactions have not been @DRUG$ and concomitantly 162.5 mg 26 and hours to initiation @DRUG$ 1   4 or ( mg , 6 hours and 12 to of Argatroban   g/kg/min . over hours ) .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Iodine or @DRUG$ excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
The administration of local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
Drug/Laboratory Interaction Fosinopril may a low @DRUG$   for	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$ Patients There was about % total clearance it was co-administered @DRUG$.	DDI-false
( ) , @DRUG$ ( mg/kg ) the intravenous of morphine @DRUG$ the oral and nicotine in rats	DDI-false
, influenced the @DRUG$ acetylsalicylic @DRUG$ , pharmacokinetics digoxin	DDI-false
a low , @DRUG$ phenytoin , and @DRUG$ have in their half-life leading	DDI-false
Other specific studies were not doses mg more were concomitantly clinical , acetylsalicylic acid , a-blockers , angiotensin-converting enzyme ACE inhibitors benzodiazepines blockers cardiac @DRUG$ , , antagonists , reductase @DRUG$ referred NSAIDs ) , anti-infectives evidence clinically significant .	DDI-false
have coadministration with drugs that by CYP3A4 ( eg calcium channel @DRUG$ , quinine , warfarin , @DRUG$ , ergot derivatives pimozide , fentanyl alfentanyl , alprazolam triazolam ) may have concentrations when	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and @DRUG$.	DDI-false
Interactions   Other @DRUG$ ) @DRUG$ 3000 had no effect on phenytoin refractory .	DDI-false
The concomitant of other inhibitors as @DRUG$ and erythromycin with fentanyl also result in increase in @DRUG$ plasma concentrations which increase or prolong adverse effects and cause serious depression .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
phenobarbital/acetaminophen @DRUG$/valproic acid , valproic .	DDI-false
@DRUG$ 3 mg daily for days not affect the of@DRUG$n nor there changes pharmacodynamic ( time single oral warfarin	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Orlistat-@DRUG$ may absorption of	DDI-mechanism
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain @DRUG$, etc.).	DDI-false
Drug/Laboratory Test Interaction After treatment with @DRUG$, a false-positive reaction for glucose in the urine may occur with @DRUG$ tests (Benedicts solution, Fehlings solution, or Clinitest tablets) but not with enzyme based tests such as Clinistix and Glucose Enzymatic Test Strip USP.	DDI-false
of of @DRUG$ the disposition @DRUG$ dideoxyinosine	DDI-false
As @DRUG$ , should that HALDOL be capable of @DRUG$ such as anesthetics ,	DDI-effect
studies have demonstrated that warfarin ( @DRUG$ capsules tablets results in binding of , there no the clearance of free	DDI-false
Other Interactions Oral @DRUG$ 500 twice daily ) did influence pharmacokinetics @DRUG$ 0.03 mg or the luteinizing hormone and that impairment of efficacy	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, @DRUG$, and nifedipine.	DDI-false
: Coadministration single doses of @DRUG$ 3 mg and @DRUG$ 2 mg did not have relevant effects the pharmacodynamics of drug .	DDI-false
Central System Depressants The concomitant use @DRUG$   fentanyl transdermal other central , limited opioids , , hypnotics tranquilizers ( e.g. , , general @DRUG$ , skeletal relaxants and cause respiratory profound or result in or .	DDI-effect
studies been performed , with drugs that metabolized eg , calcium blockers , dapsone disopyramide , @DRUG$ , , warfarin cyclosporine derivatives pimozide @DRUG$ , fentanyl , alprazolam , and triazolam may have elevated concentrations with saquinavir	DDI-false
@DRUG$ apparently through an on certain enzyme systems , to metabolism warfarin-type anticoagulants , , @DRUG$ , chlordiazepoxide , certain tricyclic , lidocaine , and thereby blood levels	DDI-mechanism
reactions have been patients combination regimens containing dose @DRUG$ and antineoplastic agents , specifically , @DRUG$ , cis-platinum , tamoxifen interferon-alfa .	DDI-effect
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
may with @DRUG$ or other @DRUG$ may potentiate the effects of or , anticholinergics or other anticholinergic anticholinergic may potentiated when medications used with antihistamines ) and monoamine oxidase MAO ) inhibitors use may prolong intensify CNS effects antihistamines	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Clinical interaction studies with @DRUG$ and @DRUG$ indicated that the coadministration of Femara with these drugs does not result in clinically- significant drug interactions.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists ( Congestive Failure Post-Myocardial 3020 ) patients @DRUG$ to 50 also received ACE inhibitors @DRUG$ ( ACEI/ARB	DDI-false
Further, in clinical studies with @DRUG$ (@DRUG$, 5 mg) when used in older men who have benign prostatic hyperplasia (BPH), PSA levels are decreased by approximately 50%.	DDI-false
Co-administration of single 25-mg dose @DRUG$ had no effect on the pharmacokinetics of total @DRUG$.	DDI-false
@DRUG$: When @DRUG$ is administered with aspirin, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-false
of has shown to decreases in of @DRUG$ and	DDI-false
- @DRUG$ e.g. @DRUG$ )	DDI-false
For example, when @DRUG$ are administered concomitantly with @DRUG$, prothrombin time should be carefully monitored and if necessary, the dosage of vitamin K antagonists should be reduced.	DDI-advise
@DRUG$ : @DRUG$ no clinically effect prothrombin time administered patients receiving .	DDI-false
@DRUG$ II In clinical studies of hypertension , addition of @DRUG$ 50 to to ACE angiotensin II mean serum potassium .	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-false
@DRUG$-A of eplerenone with @DRUG$ has been conducted	DDI-false
@DRUG$: In a study of young healthy male subjects no evidence of a direct pharmacokinetic captopril-@DRUG$ interaction could be found.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$ @DRUG$ are inhibited amphetamines .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Concomitant @DRUG$ @DRUG$ chemotherapy antiretroviral therapy in with human lymphoma	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
: Concomitant administration low-dose @DRUG$ with VIOXX may result an rate of GI ulceration or other complications , compared use @DRUG$ alone	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
between   and ( @DRUG$ , lamotrigine , phenobarbital , @DRUG$ , and also assessed evaluating serum of levetiracetam and these AEDs during clinical	DDI-false
In clinical studies @DRUG$ use oral ) , platelet acid ) NSAIDs piroxicam the pharmacokinetics/pharmacodynamics	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ , certain , has reported metabolism warfarin-type anticoagulants , phenytoin , chlordiazepoxide , , antidepressants @DRUG$ metronidazole elimination and blood of these	DDI-mechanism
Injection injection , other injectable produces depression the alcohol phenothiazines , @DRUG$ , MAO inhibitors other @DRUG$ is used concomitantly with injectable of hallucinations , and irrational behavior been observed .	DDI-false
Drug/Laboratory Test Interactions The urine of patients who take @DRUG$ can give a false-positive reaction for urinary bilirubin (urobilin) due to the presence of phenolic metabolites of @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Digoxin and @DRUG$ use may be rarely associated with ventricular fibrillation when combined with @DRUG$.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$ @DRUG$ does affect with other the cytochrome isozymes	DDI-false
The effects of DCG-IV and L-CCG-1 upon @DRUG$ (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
Drug may drugs , like Monoamine oxidase inhibitors ( @DRUG$ ): MAOI affect pharmacodynamics - - Ethanol : Flupenthixol and cause CNS antidepressants : @DRUG$ the effect of antidepressants	DDI-false
Amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
@DRUG$ enhances	DDI-effect
In studies performed Fondaparinux , use oral anticoagulants warfarin ) , @DRUG$ ( @DRUG$ NSAIDs ( piroxicam , did not significantly pharmacokinetics/pharmacodynamics of fondaparinux .	DDI-false
The of potent non-nucleoside transcriptase regimens @DRUG$ therapy and concerns protease metabolic disturbances have led significant treatment in HIV infection .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-mechanism
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
The possibility of hypotensive effects with @DRUG$ or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-false
@DRUG$: The administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
had significant on and AUC of zidovudine it @DRUG$ tmax 44 % intracellular to @DRUG$ 110	DDI-false
drugs the and other diuretics corticosteroids , phe-nothiazines , thyroid products , @DRUG$ nicotinic acid , sympathomimet-ics calcium blocking and @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
appears be this kind , theoretically , coadministration other drugs conduction ( anti-arrhythmic or agents @DRUG$ , antihistamines or @DRUG$ , antidepressants phenothiazines also contribute to prolongation of QTc interval .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
@DRUG$ Amphetamines inhibit the hypotensive of	DDI-false
STRATTERA may be necessary coadministered with , , @DRUG$ fluoxetine	DDI-false
No Important Interactions To does not pharmacokinetic interactions @DRUG$ , , digoxin , warfarin , isosorbide mononitrate carvedilol or	DDI-false
@DRUG$ @DRUG$ known QTc prolongation	DDI-false
Norepinephrine: @DRUG$ enhance the adrenergic effect of @DRUG$.	DDI-effect
@DRUG$ and @DRUG$ increased blood glucose at different times after the glucose overload.	DDI-false
Example azole antifungals , ciprofloxacin @DRUG$ diclofenac doxycycline , erythromycin , @DRUG$ , , inhibitors , quinidine , and	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$, and phenytoin during concomitant therapy with @DRUG$.	DDI-false
comparison of @DRUG$ with @DRUG$ , of ouabain was significantly higher , as of with ketamine or Innovar pentobarbital	DDI-false
both dexamethasone @DRUG$ possibly glucocorticoids retinoids may regulate the proliferation of prostate a modification the activity of insulin and	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ are a @DRUG$ drugs .	DDI-false
been between @DRUG$ or @DRUG$.	DDI-false
interaction with @DRUG$ the coadministration of @DRUG$ with not result	DDI-false
These drugs include thiazides and @DRUG$ , , phenothiazines thyroid oral @DRUG$ , nicotinic , sympathomimetics blocking drugs isoniazid .	DDI-false
Potential drug between Keppra other @DRUG$ ( carbamazepine gabapentin , @DRUG$ , phenytoin , ) by evaluating the serum concentrations levetiracetam AEDs placebo-controlled studies .	DDI-false
@DRUG$ tranylcypromine sulfate pargyline Concomitant L-tyrosine and non-selective @DRUG$ .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-false
Cyclosporine , Methotrexate Lodine @DRUG$ on renal changes in the of drugs leading to of @DRUG$ , methotrexate and	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Some drugs/substances known to the metabolism of @DRUG$ synthesis of @DRUG$ ( induction ) .	DDI-false
toxicity VIOXX @DRUG$ concomitantly .	DDI-false
Central Nervous Depressants The concomitant of @DRUG$ central nervous system depressants including not limited to other hypnotics e.g. , benzodiazepines , anesthetics , skeletal muscle relaxants , @DRUG$ respiratory depression , , profound , or in	DDI-effect
@DRUG$, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
@DRUG$ : When of and coadministered , @DRUG$ increased by	DDI-false
Histamine H2-receptor antagonists @DRUG$ have no significant on the bioavailability of	DDI-false
Other concomitant interaction not performed @DRUG$ doses used in clinical acetaminophen , acid analgesics , angiotensin-converting enzyme anticonvulsants benzodiazepines , @DRUG$ , blockers , diuretics antagonists inhibitors as anti-infectives without evidence of	DDI-false
High-dose @DRUG$ in concentrations ng/mL etoposide led to an 80 in a 38 % decrease in clearance of @DRUG$ to etoposide alone	DDI-false
consisting of medium containing @DRUG$ ( , 10 ng/ml , @DRUG$ ( or 0.1 IU/ml )	DDI-false
Based on these data @DRUG$ be @DRUG$	DDI-advise
In a clinical pharmacology study, @DRUG$ or @DRUG$ was administered to hypertensive patients receiving VASOTEC.	DDI-false
Single doses of either @DRUG$ or @DRUG$ resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
Interactions : @DRUG$ interact with drugs , like oxidase inhibitors MAOI ): affect pharmacodynamics - Arecoline Eproxindine - Ethanol : Ethanol depression antidepressants @DRUG$	DDI-false
hypoglycemic @DRUG$ may potentiated certain nonsteroidal and other drugs highly bound @DRUG$ probenecid , coumarins monoamine , beta adrenergic blocking agents .	DDI-effect
Fluconazole : administration @DRUG$ 200 resulted a increase @DRUG$ plasma	DDI-mechanism
Oral @DRUG$: Pharmacokinetic drug-drug interactions between Argatroban and @DRUG$ (7.5 mg single oral dose) have not been demonstrated.	DDI-false
studies performed with Fondaparinux , use of ( warfarin platelet ( acid ) , NSAIDs piroxicam and @DRUG$ affect pharmacokinetics/pharmacodynamics @DRUG$.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Caution be exercised if an HMG-CoA reductase is administered concomitantly the levels or activity of endogenous hormones , such as @DRUG$ , @DRUG$ cimetidine .	DDI-false
To Date have interactions beta-blockers , , digoxin @DRUG$ @DRUG$ , ethanol or itraconazole .	DDI-false
@DRUG$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
Urinary acidifying agents These agents (@DRUG$, @DRUG$, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent @DRUG$ such as @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
It is recommended to avoid concurrent administration of ethambutol with @DRUG$ containing antacids for at least 4 hours following @DRUG$ administration.	DDI-false
was difference in effect of @DRUG$ and administered with @DRUG$ measured time	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
Although specific have not with drugs metabolized ( @DRUG$ , disopyramide , quinine amiodarone quinidine , , cyclosporine derivatives pimozide carbamazepine , alprazolam , @DRUG$ ) may have concentrations when with saquinavir	DDI-false
containing chains N-methylthiotetrazole ( @DRUG$ cefoperazone , cefamandole latamoxef ) cefazolin can cause K deficiency and .	DDI-false
alcohol CNS ( may the CNS depressant medications @DRUG$ ) , @DRUG$ other effects be potentiated medications used with ( inhibitors concurrent use with may and the CNS depressant antihistamines )	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Anticholinesterases (neostgmine, @DRUG$), @DRUG$, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
If @DRUG$ is administered with drugs that inhibit Pgp, increased concentrations of @DRUG$ are likely, and caution should be exercised.	DDI-false
THERAPY Although interaction studies were performed in clinical studies , cerivastatin was used concomitantly with @DRUG$ , betablockers , calcium-channel , diuretics , and @DRUG$ without of interactions .	DDI-false
@DRUG$-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Specific studies these with sevoflurane isoflurane @DRUG$ ,	DDI-false
Close supervision and careful adjustment of the dosage are required when @DRUG$ is used with other @DRUG$ or sympathomimetic drugs.	DDI-advise
Co-administration @DRUG$ had no the pharmacokinetics of total @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$ norepinephrine to monoamine oxidase @DRUG$ phenothiazines produce severe , prolonged hypertension	DDI-effect
@DRUG$ or e.g. curare-like ) only be caution as the the @DRUG$ .	DDI-false
There been case increased of quinidine , @DRUG$ @DRUG$ during therapy	DDI-false
Furthermore has @DRUG$ resulted of P-450IIE1 the which , greater proportion of the ingested @DRUG$ being converted the toxic .	DDI-mechanism
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
@DRUG$: Because @DRUG$ does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with @DRUG$, PEGASYS treatment did not affect ribavirin distribution or clearance.	DDI-false
@DRUG$: In healthy subjects receiving ketoconazole, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
of local anesthetic solutions or @DRUG$ patients @DRUG$ tricyclic produce severe hypertension .	DDI-effect
Results of patients taking @DRUG$   and concomitant interferon beta-1a ( AVONEX 30 weekly ) or @DRUG$ inconclusive with need for dose adjustment of the beta-interferon .	DDI-false
action of @DRUG$ be potentiated drugs nonsteroidal anti-inflammatory protein bound , , chloramphenicol coumarins , monoamine oxidase @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Antacids : In study , an antacid ( , magnesium , and simethicone ) with reduced levels and urinary of @DRUG$ compared , that @DRUG$ of	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON @DRUG$ THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-effect
the @DRUG$ @DRUG$ 500 mg .	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-false
results would seem against use of @DRUG$ with ELSPAR the period following @DRUG$ when asparagine are below	DDI-false
Other Although specific performed finasteride doses or concomitantly used @DRUG$ , , angiotensin-converting ( , anticonvulsants calcium-channel blockers , cardiac nitrates diuretics H2 antagonists , @DRUG$ prostaglandin synthetase inhibitors ( to NSAIDs ) and quinolone evidence clinically significant	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
) has been effectively administered in presence other , such as , @DRUG$ , @DRUG$ , and angiotensin converting , any in the adverse reaction	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Date Levosimendan does not clinically captopril , felodipine warfarin , mononitrate , @DRUG$ , ethanol	DDI-false
of @DRUG$ @DRUG$ other agents interfering with neuromuscular transmission e.g. ) should only be caution as effect the may be potentiated	DDI-advise
In a comparison in dogs anesthetized @DRUG$ , Innovar Vet or , dosage of ventricular tachycardia higher was the with or @DRUG$.	DDI-false
@DRUG$ Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
To evaluate of chemotherapy plus HAART the course patients with , systemic non-Hodgkin lymphoma , the retrospectively a group of 24 patients with HIV-NHL who with the cyclophosphamide vincristine , @DRUG$ ( CHOP chemotherapy HAART group of patients were with chemotherapy a CHOP-like regimen ( , cyclophosphamide , teniposide , prednisone vincristine plus @DRUG$ .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Anticholinesterases ( neostgmine , @DRUG$ @DRUG$ , procainamide can enhance toxicity and cardio .	DDI-false
Warfarin: The effect of celecoxib on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
Nifedipine: @DRUG$ 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
@DRUG$ has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of @DRUG$.	DDI-effect
This drug @DRUG$ or CNS depressants may potentiate the CNS depressant effects of either medications antihistamines ) , @DRUG$ or other medications activity ( anticholinergic effects may potentiated medications are used with antihistamines ) monoamine ( MAO ) inhibitors with antihistamines may and intensify anticholinergic depressant .	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
@DRUG$/theophylline lidocaine/quinidine , phenobarbital/acetaminophen acid quinidine/@DRUG$ theophylline/acetaminophen , and .	DDI-false
@DRUG$ also significantly decreased the incidence of lymphatic invasion of adenocarcinomas, which was enhanced by @DRUG$.	DDI-effect
Antihypertensives : @DRUG$ should be in receiving   agents , propranolol a inhibitor ) or channel antagonists ( , @DRUG$ diltiazem , a ) because of arrest AV block ;	DDI-false
Patients receiving @DRUG$ and allopurinol concomitantly should have a dose reduction of @DRUG$, to approximately 1/3 to 1/4 the usual dose.	DDI-false
@DRUG$ and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
However, LDL-C reduction was greater when @DRUG$ and @DRUG$ were coadministered than when either drug was given alone.	DDI-effect
No data are available for the coadministration of INVIRASE/@DRUG$ or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
@DRUG$ administered to patients receiving @DRUG$ ( disulfiram , Laboratories .	DDI-advise
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
there data to evaluate @DRUG$ including and , may have @DRUG$ on methemoglobinemia	DDI-effect
, , phenobarbital/acetaminophen , quinidine/lidocaine , theophylline/acetaminophen	DDI-false
Other specific studies finasteride mg or used in with @DRUG$ @DRUG$ , a-blockers , , , blockers blockers , cardiac nitrates diuretics , H2 prostaglandin ( NSAIDs evidence of clinically	DDI-false
Stavudine and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
- Vitamin K (e.g., AquaMEPHYTON, @DRUG$) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
Antimycobacterial rifampin CONTRAINDICATED since the coadministration of product @DRUG$ reduces plasma of @DRUG$.	DDI-false
These include the and diuretics , phe-nothiazines , thyroid estrogens , oral contraceptives phenytoin , @DRUG$ @DRUG$ , .	DDI-false
Antipyrine : Because @DRUG$ not affect the @DRUG$ other drugs metabolized same isozymes .	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
Digoxin @DRUG$ may be rarely ventricular fibrillation @DRUG$.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
[Quantitative approach to treatment with incisive @DRUG$ by therapeutic monitoring]; The problems encountered during the longterm treatment of psychotic patients with @DRUG$ are illustrated by six typical case reports.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Non-selective including sulfate , phenelzine , and @DRUG$ HC1 Concomitant use of @DRUG$ and non-selective	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
is @DRUG$ is administered concurrently @DRUG$.	DDI-advise
Aspirin/@DRUG$ Pharmacokinetic or pharmacodynamic have not demonstrated Argatroban and administered ( orally to of @DRUG$ 1 over hours ) ( , 6 prior to and and hours to , initiation of 1.5 g/kg/min . over 18 )	DDI-false
@DRUG$, other, especially diazoxide, or preanesthetic and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
The effects of @DRUG$ ( RR ) @DRUG$ InsP(3))-induced were in bone marrow technique combination with fura-2	DDI-false
@DRUG$/Hypnotics: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Corticosteroids @DRUG$ Diuretics : @DRUG$ a possible hypokalemic	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-false
Coadministration with compounds inducers ( , phenobarbital , phenytoin dexamethasone @DRUG$ ) may result plasma of	DDI-mechanism
may interact , , ( allergy , cold , , , lithium norepinephrine @DRUG$ and blood pressure medications .	DDI-false
@DRUG$ : concomitant administration diflunisal and naproxen in normal volunteers had effect on plasma , significantly decreased excretion @DRUG$ glucuronide	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
Injection : Lorazepam injection like injectable @DRUG$ , produces when administered ethyl alcohol , barbiturates , , used concomitantly with lorazepam , , and has	DDI-effect
@DRUG$ may add to or potentiate the therapeutic effect of other @DRUG$.	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
@DRUG$: Amphetamines may counteract the sedative effect of @DRUG$.	DDI-false
Antimycobacterial : @DRUG$ CONTRAINDICATED coadministration of @DRUG$ in antiretroviral reduces of saquinavir .	DDI-false
Benzthiazide may with , @DRUG$s decongestant drugs , ) @DRUG$ , , NSAIDs Aleve or , high blood medications .	DDI-false
Single doses of either @DRUG$ or colestipol @DRUG$ bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
: @DRUG$ should caution in patients   -receptor agents ( e.g. , propranolol a or channel antagonists e.g. , , @DRUG$ substrate , diltiazem , inhibitor ) of of bradycardia arrest ;	DDI-false
Anticoagulant inhibition was observed during the administration of phenobarbital, @DRUG$ and @DRUG$;	DDI-false
@DRUG$ should be administered with caution to patients receiving @DRUG$ (disulfiram, Wyeth-Ayerst Laboratories).	DDI-advise
Example , , , @DRUG$ , doxycycline , imatinib @DRUG$ , nicardipine , , quinidine verapamil .	DDI-false
Patients treated with @DRUG$ may be resistant to the effects of @DRUG$.	DDI-effect
Other Drugs Drugs as @DRUG$ , disopyramide , , @DRUG$ and tricyclic may with risk of ventricular .	DDI-false
Administering @DRUG$ together with @DRUG$ (100-500 microM) inhibited InsP(3)-induced responses (both Ca(2+) and current responses) in a dose-dependent fashion.	DDI-effect
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, @DRUG$, tranquilizers).	DDI-false
Potential drug interactions Keppra and @DRUG$ , gabapentin @DRUG$ phenytoin , primidone were by evaluating serum concentrations levetiracetam AEDs clinical studies .	DDI-false
suggest that both dexamethasone @DRUG$ possibly other and @DRUG$ regulate proliferation prostate epithelium a of the activity of .	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Folic acid in large amounts may counteract the antiepileptic effect of @DRUG$, @DRUG$ and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
@DRUG$ nandrolone [ e.g. , [ , Anavar ] , @DRUG$ [ e.g. , Anadrol , Winstrol or	DDI-false
@DRUG$: The concomitant administration of diflunisal and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-false
Isoflurane the effect all @DRUG$ , most notably @DRUG$ and MAC ( ) by concomitant 2O	DDI-false
@DRUG$ and @DRUG$ clinical of patients with addition to 100 mg to II antagonists increased mean serum 0.09 mEq/L ) .	DDI-false
Coadministration of @DRUG$ and cyclosporine, @DRUG$ or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
Specific studies have confirmed these effects with @DRUG$, isoflurane, @DRUG$, alfentanil, and midazolam.	DDI-false
Reported examples include the following: @DRUG$: @DRUG$ are known to inhibit CYP3A4 to varying degrees.	DDI-false
No between @DRUG$ and , alfentanil , @DRUG$	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-effect
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ been reported to enhance the the oral @DRUG$ warfarin or its derivatives	DDI-false
@DRUG$: Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Multivitamins , or @DRUG$ or , or @DRUG$ should not concomitantly , of , the , because they resulting in serum of norfloxacin	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
was no in prothrombin test results the of @DRUG$ @DRUG$.	DDI-false
The effects of @DRUG$ are antagonized by @DRUG$ such as caffeine and theophylline.	DDI-effect
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
should be if @DRUG$ with drugs that may decrease the or activity hormones such ketoconazole , @DRUG$.	DDI-advise
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-mechanism
@DRUG$/substances are known metabolism of amiodarone by @DRUG$ ( enzyme induction .	DDI-false
median follow-up of 33 combination ARIMIDEX and @DRUG$ not efficacy compared @DRUG$ in well in the receptor-positive .	DDI-false
adverse effects resulting from blockade when @DRUG$ is administered concomitantly @DRUG$ phenothiazines , oxidase ( MAO ) inhibitors .	DDI-effect
@DRUG$ Other ) @DRUG$   3000 ) effect the pharmacokinetic disposition of patients with epilepsy	DDI-false
A 5-mg @DRUG$ should not exceeded used combination mg once @DRUG$.	DDI-advise
When @DRUG$ is added to or withdrawn from treatment, dosage adjustment of @DRUG$ may be required.	DDI-advise
hypoglycemic action of may be potentiated certain including nonsteroidal anti-inflammatory agents and other that are protein bound salicylates sulfonamides , @DRUG$ , @DRUG$ , beta adrenergic .	DDI-false
: @DRUG$ produced an elevation of @DRUG$ levels a reduction in renal lithium clearance .	DDI-mechanism
Antacids In a study , coadministration of an @DRUG$ magnesium hydroxide ) with @DRUG$ reduced and of with administered , suggesting may absorption .	DDI-mechanism
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
suggest that retinyl acetate and possibly other glucocorticoids @DRUG$ , regulate the epithelium by of the of and	DDI-effect
Administration @DRUG$ concomitantly been shown to result decreases of @DRUG$ and desethylamiodarone .	DDI-false
Central Nervous System Depressants : use transdermal system with system depressants but other , @DRUG$ ( , @DRUG$ , , , and may respiratory , and profound potentially result coma or death	DDI-false
Amiodarone taken concomitantly with @DRUG$ increases @DRUG$ serum concentration by 33% after two days.	DDI-false
, lidocaine/quinidine phenobarbital/acetaminophen phenobarbital/@DRUG$ , quinidine/lidocaine , , and valproic	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
inhibitors including @DRUG$ @DRUG$ : use of L-tyrosine inhibitors cause .	DDI-false
Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and @DRUG$ therapy.	DDI-effect
Amiodarone may suppress CYP450 enzymes including CYP1A2 CYP2C9 , @DRUG$ , @DRUG$.	DDI-false
The effects of oral @DRUG$ on @DRUG$ induced hypertension were examined in conscious sheep.	DDI-false
@DRUG$ in large the @DRUG$ phenytoin and primidone , of seizures in susceptible pediatric patients	DDI-effect
Anticoagulants including coumarin , indandione and @DRUG$ anti-inflammatory , the risk of administered concomitantly @DRUG$.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
: of @DRUG$ may of @DRUG$.	DDI-mechanism
@DRUG$ tubular secretion of @DRUG$ and an increase the of serum	DDI-mechanism
These results would seem to dictate against the clinical use of @DRUG$ with @DRUG$, or during the period following ELSPAR therapy when plasma asparagine levels are below normal.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Interactions Flupenthixol with some drugs like inhibitors ( @DRUG$ ): @DRUG$ could - - : additive CNS : Flupenthixol the of antidepressants	DDI-false
The physician is advised to monitor the plasma concentrations of @DRUG$ when any of these drugs is taken concurrently, and to increase the dose of @DRUG$ if necessary.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (lovastatin, @DRUG$, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
the @DRUG$ many @DRUG$ not clinically they toxic	DDI-false
@DRUG$: Probenecid interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of ciprofloxacin in serum.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
drug of @DRUG$ @DRUG$ been conducted .	DDI-false
@DRUG$/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
, are drugs pharmacologic similar to , including agents such @DRUG$ procainamide glycosides and @DRUG$.	DDI-false
Haemodynamic effects of @DRUG$ and @DRUG$ were additive when somatostatin was co-administered but not under basal conditions.	DDI-false
dialyzed phenobarbital @DRUG$ , and theophylline , alone concentrations with @DRUG$ at three concentrations serum .	DDI-false
@DRUG$-@DRUG$ may decrease the absorption of vitamin K.	DDI-false
The successive application of @DRUG$ (5 or 10 mg/kg egg weight (e.w.) and @DRUG$ (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of glutamate alone.	DDI-effect
concomitant Although specific interaction were not performed mg or were used in clinical with @DRUG$ , acetylsalicylic , angiotensin-converting , , , beta blockers , calcium-channel blockers nitrates , @DRUG$ , antagonists HMG-CoA inhibitors inhibitors also referred to NSAIDs ) quinolone anti-infectives without evidence	DDI-false
data indicate @DRUG$ does of and do not the pharmacokinetics of @DRUG$.	DDI-false
: did clinically of @DRUG$	DDI-false
- Vitamin K (e.g., @DRUG$, @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
The pressor effects of catecholamines such as dopamine or @DRUG$ are enhanced by @DRUG$.	DDI-effect
, Digoxin , Methotrexate , @DRUG$ , through effects renal prostaglandins , cause changes the elimination drugs leading to elevated levels of @DRUG$ digoxin methotrexate	DDI-mechanism
appears to be the only clinically relevant of this Mefloquine , theoretically , other to conduction ( eg , beta-adrenergic , calcium blockers @DRUG$ or @DRUG$ , tricyclic antidepressants to the	DDI-false
Cephalosporins-Cephalosporins side cefoperazone , cefotetan , @DRUG$ or @DRUG$ cause vitamin .	DDI-false
@DRUG$ : some the administration of @DRUG$ the , natriuretic , and antihypertensive effects loop potassium-sparing thiazide diuretics .	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$ (neostgmine, physostigmine), lignocaine, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
OTHER CONCOMITANT THERAPY : interaction were performed , in clinical , cerivastatin was with ACE @DRUG$ , calcium-channel , diuretics , @DRUG$ NSAIDs without evidence significant interactions .	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-mechanism
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (@DRUG$) as the sole protease inhibitor due to the risk of decreased saquinavir plasma concentrations.	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect.	DDI-false
: Concurrent administration of a @DRUG$ including @DRUG$ products as aluminum , or pediatric , iron , or zinc may substantially the absorption of resulting in than desired .	DDI-false
Other : such quinidine @DRUG$ , and @DRUG$ be with prolongation an increased ventricular .	DDI-false
Effect of @DRUG$ in Pediatric Patients There was about a 22% increase of apparent total body clearance of @DRUG$ when it was co-administered with enzyme-inducing AEDs.	DDI-false
, apparently effect certain , has reported to reduce the hepatic @DRUG$ , , nifedipine chlordiazepoxide certain @DRUG$ , lidocaine theophylline metronidazole thereby increasing levels of these .	DDI-false
@DRUG$ or other iron or zinc antacids or sucralfate should not be concomitantly with , administration norfloxacin they may interfere with absorption serum and urine levels @DRUG$.	DDI-false
Delayed Adverse Reactions to Iodinated Contrast Media: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-effect
The of hypotensive effects with @DRUG$ can be minimized the or the salt intake prior to of treatment @DRUG$ or enalaprilat .	DDI-false
Isocarboxazid should be administered with caution to patients receiving @DRUG$ (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-false
Additive effects resulting from cholinergic blockade occur LEVSIN is concomitantly with , @DRUG$ haloperidol phenothiazines , oxidase ( ) , antidepressants or @DRUG$.	DDI-false
Sinus reported with amiodarone in with @DRUG$ ( @DRUG$ .	DDI-false
Anti-inflammatory Drugs In some patients , administration of a @DRUG$ diuretic , natriuretic of loop , @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Central System concomitant of @DRUG$ fentanyl system nervous depressants , not limited to @DRUG$ , hypnotics tranquilizers benzodiazepines ) , anesthetics phenothiazines skeletal muscle may , , ,	DDI-effect
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Drug : Flupenthixol ): MAOI theoretically @DRUG$ pharmacodynamics - @DRUG$ : Ethanol cause CNS depression - antidepressants increases the antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
include the @DRUG$ and , , , oral contraceptives phenytoin , , @DRUG$ ,	DDI-false
The , of anticoagulant @DRUG$ , secobarbital @DRUG$ , and were systematically investigated in 16 receiving .	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, @DRUG$, digoxin, Maalox, and ranitidine.	DDI-false
: be used with blocking ( , CYP3A4 or calcium channel ( e.g. , verapamil a @DRUG$ , @DRUG$ CYP3A4 inhibitor ) because of the of sinus , and AV block ;	DDI-false
@DRUG$ and digoxin at not co-administration of	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, @DRUG$, nefazodone, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
@DRUG$ : produced elevation of plasma @DRUG$ a reduction in lithium clearance	DDI-false
Intravenous ( adenosine ) has effectively administered the presence cardioactive as @DRUG$ , @DRUG$ , calcium channel and angiotensin enzyme without any in the adverse reaction profile .	DDI-false
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of R and @DRUG$.	DDI-false
concomitant therapy interaction performed , 1 mg or more in with , a-blockers , analgesics , anticonvulsants , beta , calcium-channel , cardiac , diuretics , @DRUG$ reductase synthetase ( also as @DRUG$ anti-infectives evidence of significant	DDI-false
@DRUG$ and retinyl acetate similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
and @DRUG$ resins @DRUG$ is impaired in the resins	DDI-false
indicate that levetiracetam not the concentration of other @DRUG$ that @DRUG$ do not influence the pharmacokinetics of	DDI-false
The action of may be certain including nonsteroidal anti-inflammatory drugs that are protein bound , salicylates @DRUG$ , chloramphenicol @DRUG$ , , monoamine beta blocking agents	DDI-false
A study evaluated of @DRUG$ Gel , % in strength ( 160 mg/800 ) trimethoprim/@DRUG$ ( TMP/SMX )	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
azole clarithromycin , diclofenac @DRUG$ , nefazodone , , @DRUG$ , , and .	DDI-false
Antacids : In a clinical pharmacology study of antacid , @DRUG$ @DRUG$ serum levels and urinary administered , that may absorption .	DDI-mechanism
Inhibitors : @DRUG$   not recommended for in who have @DRUG$ within days and potentiation has been reported with	DDI-advise
Based resemblance of @DRUG$ and @DRUG$ coadministration with itraconazole is contraindicated .	DDI-false
Other concomitant Although interaction not performed , finasteride of or more were clinical studies acetaminophen acetylsalicylic , , enzyme ACE ) inhibitors anticonvulsants @DRUG$ , , antagonists , reductase , @DRUG$ referred to as ) and quinolone without significant adverse	DDI-false
Other Cardiovascular Enalapril enalapril been used concomitantly with adrenergic-blocking agents @DRUG$ , nitrates , calcium-blocking , , prazosin @DRUG$ of adverse interactions .	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Coadministration of Itraconazole and @DRUG$, @DRUG$ or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine phenobarbital/acetaminophen , , , theophylline/@DRUG$ , and acid/phenobarbital .	DDI-false
lidocaine/quinidine @DRUG$/valproic , @DRUG$/acetaminophen .	DDI-false
Potential interactions   and other , lamotrigine @DRUG$ ) were also serum concentrations of @DRUG$ and during clinical studies	DDI-false
Central System The use of   fentanyl system with other system limited , sedatives hypnotics tranquilizers ( @DRUG$ ) , @DRUG$ , phenothiazines skeletal muscle and cause respiratory , , and , or result coma or death .	DDI-false
to oral @DRUG$ dose of previously administered agents should 30 to 50 % several days after the of oral @DRUG$.	DDI-false
Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-mechanism
The effects of adenosine are antagonized by methylxanthines such as @DRUG$ and @DRUG$.	DDI-false
Antihypertensives : Amiodarone should be used with patients -receptor blocking agents e.g. , , @DRUG$ ) or @DRUG$ antagonists ( , verapamil , CYP3A4 substrate diltiazem , a the possible potentiation bradycardia , sinus and block ;	DDI-false
There is a significant increase in exposure to @DRUG$ when @DRUG$ is coadministered with ketoconazole (CYP3A4 inhibitor).	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
of possessing nephrotoxic ( e.g. aminoglycosides , ) @DRUG$ ) ( , or ( methotrexate ) effects @DRUG$ may increase toxicity organ systems	DDI-effect
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
therapy Although studies performed , doses mg or more concomitantly used clinical studies @DRUG$ , analgesics angiotensin-converting ( ACE inhibitors anticonvulsants @DRUG$ beta blockers , cardiac nitrates diuretics H2 , HMG-CoA prostaglandin ( also to as anti-infectives without evidence of adverse interactions .	DDI-false
Other concomitant therapy Although specific studies not , doses 1 or were used clinical studies @DRUG$ , a-blockers analgesics , angiotensin-converting enzyme ( ACE inhibitors , , calcium-channel blockers , cardiac , diuretics prostaglandin ( also referred as NSAIDs ) and @DRUG$ evidence clinically adverse .	DDI-false
MAO @DRUG$ as well as a metabolite of , slow @DRUG$ metabolism	DDI-mechanism
Other concomitant Although studies were , @DRUG$ doses of 1 mg or used clinical acetaminophen , acetylsalicylic , @DRUG$ , anticonvulsants benzodiazepines , beta , calcium-channel cardiac diuretics , antagonists , HMG-CoA inhibitors , prostaglandin synthetase inhibitors also and anti-infectives evidence of clinically adverse .	DDI-false
The effects of ruthenium red (RR) on @DRUG$ (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
package insert @DRUG$ preparations before use of such preparations @DRUG$.	DDI-advise
Important To Date @DRUG$ not have important interactions with beta-blockers felodipine , , @DRUG$ mononitrate , ethanol	DDI-false
, @DRUG$ administered once for 10 plasma concentrations by 23 % - @DRUG$ 15 mg/week for arthritis	DDI-mechanism
Example inhibitors , ciprofloxacin @DRUG$ , doxycycline @DRUG$ imatinib , isoniazid , nicardipine and verapamil .	DDI-false
@DRUG$: When Lodine is administered with aspirin, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, cimetidine, ketoconazole), though this has not been studied	DDI-mechanism
Example inhibitors include ciprofloxacin , , doxycycline imatinib , nefazodone nicardipine , @DRUG$ , @DRUG$.	DDI-false
Example antifungals , , clarithromycin , diclofenac , @DRUG$ , , , @DRUG$ , , quinidine , verapamil	DDI-false
In @DRUG$ ( @DRUG$ 1 in - 41 age , serum antigen PSA decreased 0.7 ng/mL at baseline 0.5 ng/mL at 12	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, @DRUG$, topiramate, or lamotrigine.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
drugs include and @DRUG$ , , products , estrogens , , phenytoin , @DRUG$ calcium channel blocking and isoniazid .	DDI-false
In trials the safety with @DRUG$ @DRUG$ and sedatives ( including benzodiazepines , non-opioid analgesics was to of taking .	DDI-false
@DRUG$ , and Diuretics treatment with @DRUG$ , , diuretics may a possible of   beta2-agonists	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (@DRUG$, nevirapine or @DRUG$).	DDI-false
Acetaminophen, lidocaine, @DRUG$, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-false
@DRUG$: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$: (oral agents and @DRUG$) - dosage adjustment of the antidiabetic drug may be required.	DDI-false
@DRUG$ : Absorption @DRUG$ is impaired in anionic exchange	DDI-false
intake @DRUG$ @DRUG$ may the of vitamin	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In addition, @DRUG$ does not affect the in vitro glucuronidation of @DRUG$.	DDI-false
been shown to be to @DRUG$ @DRUG$ , on in vitro studies kill enteric gram-negative bacilli	DDI-false
adverse effects resulting cholinergic when with @DRUG$ , , haloperidol phenothiazines monoamine oxidase ( tricyclic some @DRUG$.	DDI-false
@DRUG$ of @DRUG$ decreased approximately when colestipol and atorvastatin were coadministered	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
Co-administration of naltrexone with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
, @DRUG$ propranolol have effect on @DRUG$ levels , and a patient population chronically resulted in in the extent of digoxin	DDI-false
acid in may the effect @DRUG$ phenytoin @DRUG$ , and increase frequency of in	DDI-false
has administered @DRUG$ , dobutamine , steroids @DRUG$ , ventilation	DDI-false
@DRUG$ @DRUG$ the locomotor stereotypic effects stimulants	DDI-false
@DRUG$ @DRUG$ phenelzine sulfate Concomitant of L-tyrosine and may cause hypertension .	DDI-false
Antihistamines : @DRUG$ may counteract sedative effect @DRUG$.	DDI-effect
the of reactions in patients who have taking @DRUG$ a it is particularly physicians query guardians carefully about , and sedative as part prior any which the of @DRUG$ .	DDI-false
While @DRUG$ have similar for receptors , @DRUG$ much for and sigma-2 receptors , sodium channels .	DDI-false
( , , , or amiloride , @DRUG$ , @DRUG$-containing substitutes to significant serum potassium .	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The effects @DRUG$ RR ) inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were rat bone marrow with whole-cell recording	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as @DRUG$ or @DRUG$) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
Colestipol : concentrations decreased 25 when @DRUG$ and @DRUG$ coadministered	DDI-mechanism
@DRUG$ And Other ) Keppra   ( mg daily ) no effect pharmacokinetic of @DRUG$ with refractory epilepsy .	DDI-false
the specific was studied a clinical trial , there been more 50 concomitant of antifibrinolytic i.e. @DRUG$ aminocaproic ) and	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In to moderate , of daily of @DRUG$ the inhibitor @DRUG$ , 10 40 4 weeks , was associated with average increase arterial pressure about 3 mm Hg ACE alone .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$/Acetaminophen pharmacodynamic drug-drug interactions @DRUG$ 162.5 mg 26 2 prior to initiation Argatroban 1   hours ) ( mg 12 , 6 and 0 to , and hours subsequent to of Argatroban 1.5   g/kg/min over 18 ) .	DDI-false
of healthy volunteers with doses rifampin by a @DRUG$ increased @DRUG$ oral-dose by decreased mean and - 8)	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
concomitant Although studies were not performed finasteride doses of mg or more , a-blockers , , , @DRUG$ , beta calcium-channel blockers , @DRUG$ diuretics , HMG-CoA reductase inhibitors , prostaglandin ( also to as ) quinolone evidence clinically adverse interactions	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
The of @DRUG$ may period this be mind drug is following	DDI-false
studies have not been performed coadministration drugs that are by CYP3A4 , channel blockers , , quinine amiodarone , , warfarin , , @DRUG$ , @DRUG$ , alfentanyl , triazolam ) may plasma coadministered with saquinavir ;	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Urinary acidifying agents These agents (@DRUG$, sodium acid phosphate, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
@DRUG$ In a clinical study an ( aluminum hydroxide , , simethicone ) reduced levels excretion of @DRUG$ with fosinopril administered suggesting antacids may of fosinopril	DDI-false
Methotrexate: In an interaction study of rheumatoid arthritis patients taking @DRUG$, @DRUG$ did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
the impact the clinical of with HIV-related systemic , non-Hodgkin ) , the compared 24 patients who were the , doxorubicin , CHOP regimen HAART with a patients who were treated or a CHOP-like regimen @DRUG$ doxorubicin teniposide , and with @DRUG$ plus ) .	DDI-false
Iodine or iodine excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of @DRUG$.	DDI-effect
Aspirin: When @DRUG$ is administered with @DRUG$, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Other Interactions : pharmacokinetic interactions were observed between @DRUG$ and following drugs @DRUG$ , , digoxin and ranitidine .	DDI-false
@DRUG$ and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
receiving @DRUG$ and @DRUG$ concomitantly , dosage should order to avoid steroid withdrawal .	DDI-advise
Although there are no study data to evaluate the possibility, @DRUG$, including sodium nitroprusside and @DRUG$, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
@DRUG$ : ( oral agents and @DRUG$ ) - dosage of the may be .	DDI-false
The administration of local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Interaction on antinociceptive effect between @DRUG$ and @DRUG$ tuftsin	DDI-effect
Concurrent administration of possessing nephrotoxic e.g. @DRUG$ , @DRUG$ cytotoxic chemotherapy ) cardiotoxic ( e.g. , doxorubicin ) or methotrexate asparaginase toxicity these systems	DDI-false
Other of CYP3A4 , clarithromycin @DRUG$ , @DRUG$ , nelfinavir ) be to behave similarly .	DDI-false
apomorphine - ingestion may decrease the @DRUG$ response @DRUG$ the treatment	DDI-false
impact HAART the course patients with , , non-Hodgkin lymphoma HIV-NHL ) , authors compared group patients with HIV-NHL who with cyclophosphamide , @DRUG$ , and @DRUG$ ( CHOP ) regimen plus HAART of with or ( i.e. , doxorubicin teniposide , prednisone vincristine plus antiretroviral	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
In EM individuals with fluoxetine the AUC of @DRUG$ is 6- to and , max 3- greater @DRUG$ alone	DDI-false
Little has been studied of the adverse effects of the exposure of the liver to the interaction of @DRUG$ with its congeners and @DRUG$, coexisting in the contents of alcoholic beverages.	DDI-false
, doxorubicin @DRUG$ , @DRUG$ chemotherapy plus highly antiretroviral therapy with human immunodeficiency virus-related ,	DDI-false
studies of @DRUG$ than suggest interaction for the following amiodarone nicardipine , @DRUG$.	DDI-int
Ergot Derivatives: Dihydroergotamine, @DRUG$, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
: @DRUG$ not have important effect on the prednisone .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drug with ): MAOI @DRUG$ Eproxindine - Ethanol Flupenthixol @DRUG$ depression Tricyclic antidepressants Flupenthixol the of antidepressants	DDI-false
Allopurinol: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when @DRUG$ and @DRUG$ were administered concomitantly for 6 days.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent @DRUG$ such as furosemide.	DDI-false
Prednisone/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
: As with some other , concurrent administration of @DRUG$ with elevated @DRUG$ and of .	DDI-false
Since @DRUG$ are potentiated by the @DRUG$, they should be used cautiously in the treatment of convulsions.	DDI-advise
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (DHA) was more than doubled in the presence of @DRUG$/@DRUG$.	DDI-false
Tinnitus hearing been reported receiving @DRUG$ @DRUG$.	DDI-effect
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as ranitidine or cimetidine) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
drug interactions between Keppra   and AEDs carbamazepine @DRUG$ lamotrigine , phenobarbital and ) also assessed of and these @DRUG$ clinical .	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
In these subjects, @DRUG$ did not alter the anticoagulant effect of @DRUG$ as determined by prothrombin time.	DDI-false
Important To @DRUG$ not have clinically important with captopril @DRUG$ , felodipine warfarin isosorbide mononitrate , carvedilol , ethanol or itraconazole	DDI-false
@DRUG$ and Angiotensin clinical studies of patients with hypertension , the INSPRA 50 to 100 mg @DRUG$ and angiotensin II antagonists increased serum ( about 0.09 -	DDI-false
reported with amiodarone @DRUG$ ( @DRUG$ substrate combination amiodarone may , decreased .	DDI-false
@DRUG$ suppress certain including CYP1A2 CYP2C9 , CYP2D6 @DRUG$.	DDI-false
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, opiates, and alcohol.	DDI-effect
apomorphine - prior ingestion of diphenidol may decrease the @DRUG$ response to @DRUG$ in the treatment of poisoning.	DDI-false
In a comparison , Innovar Vet , or , of @DRUG$ was significantly as was LD50 of @DRUG$ , with ketamine or pentobarbital .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and @DRUG$ is not recommended.	DDI-advise
@DRUG$ : enhance the adrenergic effect @DRUG$.	DDI-false
Drug-Drug Interactions   And Drugs @DRUG$ @DRUG$ Keppra   mg daily ) had no effect disposition patients refractory .	DDI-false
Drug/Laboratory @DRUG$ the assay @DRUG$ in plasma samples may with one-stage the such factor IX , and XI .	DDI-false
Co-medications induce e.g. phenytoin , @DRUG$ @DRUG$ St.	DDI-false
concomitant of @DRUG$ @DRUG$ increased GI ulceration complications , use of	DDI-effect
@DRUG$ tendency to the effect tubocurarine and action	DDI-effect
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
No interactions @DRUG$ propofol , , @DRUG$	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
antifungals @DRUG$ , clarithromycin , @DRUG$ , nefazodone nicardipine , , , , verapamil	DDI-false
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the benzodiazepine effect by flumazenil.	DDI-effect
Although studies not coadministration drugs are mainly by ( eg , channel blockers dapsone , , , , quinidine @DRUG$ , @DRUG$ , pimozide carbamazepine fentanyl alfentanyl alprazolam , have plasma concentrations ;	DDI-false
   on @DRUG$ Therapy : Patients on diuretics and @DRUG$ recently instituted as well as severe restriction , may occasionally reduction usually within first receiving the initial of captopril	DDI-false
specific been performed , coadministration with drugs that mainly metabolized CYP3A4 ( calcium , quinine amiodarone , tacrolimus , @DRUG$ , ergot derivatives carbamazepine , , alfentanyl , triazolam ) have concentrations when with @DRUG$	DDI-mechanism
ACE Inhibitors Antagonists studies of patients of @DRUG$ 50 100 @DRUG$ and angiotensin increased mean slightly about .	DDI-effect
Example inhibitors @DRUG$ , ciprofloxacin , doxycycline , erythromycin , isoniazid nefazodone , , @DRUG$ , ,	DDI-false
Example include azole , @DRUG$ , , erythromycin imatinib , @DRUG$ , propofol protease inhibitors quinidine and verapamil .	DDI-false
@DRUG$ an effect microsomal enzyme systems , has reported reduce the hepatic metabolism warfarin-type , chlordiazepoxide , @DRUG$ tricyclic , theophylline delaying elimination and blood of	DDI-mechanism
These results would seem to dictate against the clinical use of @DRUG$ with ELSPAR, or during the period following @DRUG$ therapy when plasma asparagine levels are below normal.	DDI-false
Although been performed with mainly metabolized CYP3A4 eg , , dapsone , disopyramide , , amiodarone , @DRUG$ , tacrolimus , ergot derivatives , , , alfentanyl @DRUG$ , triazolam have plasma coadministered with	DDI-false
Products administration @DRUG$ , including ciprofloxacin with such or , , VIDEX tablets or , or @DRUG$ iron or substantially decrease absorption serum and urine than .	DDI-mechanism
Data in studies @DRUG$ suggest a interaction with alprazolam the and @DRUG$.	DDI-false
@DRUG$: Plasma @DRUG$ levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
However, the concomitant use of @DRUG$ and @DRUG$ (5-7.5 mg initial oral dose followed by 2.5-6 mg/day orally for 6-10 days) results in prolongation of the prothrombin time (PT) and International Normalized Ratio (INR).	DDI-effect
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ @DRUG$ CYP3A4 in associated with reports myopathy/rhabdomyolysis .	DDI-false
@DRUG$: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
In studies , concomitant anticoagulants warfarin ) , @DRUG$ ( acetylsalicylic , @DRUG$ ( and did not affect the sodium .	DDI-false
INOmax has been administered with tolazoline , dopamine , @DRUG$ , @DRUG$ and	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
through certain enzyme systems , been reported reduce the of anticoagulants , phenytoin , @DRUG$ , , certain @DRUG$ , , thereby and levels of	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
rats @DRUG$ administration certain types adrenocortical steroid , @DRUG$ hypertension .	DDI-effect
: drug-drug interactions been demonstrated between @DRUG$ and concomitantly administered @DRUG$ ( 162.5 mg orally 26 2 hours prior to initiation   g/kg/min . ) or acetaminophen 1000 mg given , 6 and 0 hours 6 and 12 subsequent to , initiation Argatroban   g/kg/min over	DDI-false
intensity uniformity @DRUG$ phenobarbital @DRUG$ , glutethimide , chloral were in 16 patients therapy	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Although studies have not coadministration with drugs that are by ( blockers , dapsone , disopyramide quinine , amiodarone , quinidine , tacrolimus cyclosporine , derivatives , pimozide , , @DRUG$ , alfentanyl alprazolam and triazolam may have elevated when @DRUG$	DDI-mechanism
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
Tetracyclines: Concomitant treatment with Accutane and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
Naproxen: The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-mechanism
Therefore, when @DRUG$ is given to a patient receiving @DRUG$, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-advise
are reports of serum and serum levels and weight @DRUG$ in conjunction @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$, @DRUG$ and glutethimide;	DDI-false
@DRUG$ including sulfate phenelzine sulfate @DRUG$ : of non-selective MAO cause hypertension .	DDI-false
@DRUG$ of ( fentanyl ) other central nervous system depressants , but not , @DRUG$ , hypnotics , tranquilizers ( e.g. benzodiazepines anesthetics phenothiazines skeletal muscle relaxants alcohol may depression hypotension , and profound or potentially	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of @DRUG$.	DDI-false
drugs include the thiazides diuretics , , phe-nothiazines , , estrogens @DRUG$ , @DRUG$ , nicotinic acid sympathomimet-ics , channel .	DDI-false
@DRUG$ , apparently through an effect on to reduce the hepatic metabolism of anticoagulants , phenytoin propranolol , nifedipine , chlordiazepoxide , certain tricyclic antidepressants , @DRUG$ and delaying and increasing blood these drugs	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Anabolic [ e.g. @DRUG$ oxandrolone [ e.g. , Anavar ] , e.g. ] , stanozolol e.g. , @DRUG$ ) or	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Drug Interactions Flupenthixol interact drugs , Monoamine oxidase inhibitors @DRUG$ could theoretically affect pharmacodynamics Arecoline Ethanol and @DRUG$ cause additive CNS depression - Tricyclic : Flupenthixol increases the effect	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
After dosing @DRUG$   IM ) @DRUG$   clearance approximately 30	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
pharmacokinetic between dexmedetomidine and @DRUG$ @DRUG$ , midazolam have .	DDI-false
Atromid-S @DRUG$ @DRUG$ their binding sites .	DDI-false
During co-administration, systemic levels of @DRUG$ and @DRUG$ were essentially unchanged.	DDI-false
Antiarrhythmics: Amiodarone, bepridil, @DRUG$, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Although glucocorticoids to PROLEUKIN-induced side effects including renal insufficiency confusion , concomitant administration of PROLEUKIN reduce the @DRUG$ be . Beta-blockers other may hypotension	DDI-false
: In a study , coadministration antacid ( @DRUG$ , simethicone ) with @DRUG$ alone , suggesting that antacids fosinopril	DDI-false
@DRUG$ did not alter the pharmacokinetics of @DRUG$.	DDI-false
specific studies have not been , coadministration with drugs are mainly metabolized eg , calcium blockers , , , @DRUG$ @DRUG$ , warfarin , , , pimozide , carbamazepine , fentanyl alfentanyl alprazolam triazolam ) coadministered with saquinavir	DDI-false
Central Nervous System The concomitant of @DRUG$ transdermal with other nervous depressants , to @DRUG$ hypnotics , tranquilizers ( benzodiazepines general anesthetics , phenothiazines skeletal , alcohol may , , profound coma	DDI-effect
@DRUG$ , @DRUG$ , and inhibit platelet in vitro , platelet adhesion intravascularly .	DDI-false
Naproxen: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
@DRUG$ apparently an effect on enzyme systems reported to reduce hepatic of warfarin-type , propranolol nifedipine chlordiazepoxide diazepam , certain antidepressants , lidocaine , @DRUG$ , thereby and increasing blood these drugs .	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Other Grapefruit given increased @DRUG$ AUC % in plasma levels @DRUG$.	DDI-false
, apparently through an effect on microsomal , has been to reduce metabolism @DRUG$ , phenytoin , , nifedipine chlordiazepoxide , , @DRUG$ , and metronidazole thereby elimination increasing of .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
INOmax has been administered with tolazoline, dopamine, @DRUG$, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$: @DRUG$ 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
serum levels and of @DRUG$ toxicity have in receiving lithium @DRUG$	DDI-false
general , are drugs have one or pharmacologic activities to @DRUG$ , anti-arrhythmic @DRUG$ and procainamide and anti-depressants .	DDI-false
drugs include thiazides and diuretics thyroid @DRUG$ , contraceptives sympathomimetics @DRUG$ , and isoniazid .	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-false
a clinical pharmacology study @DRUG$ or sulindac was administered to patients	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
interactions between other ( , , @DRUG$ , , , @DRUG$ were also assessed by the serum of levetiracetam and during placebo-controlled clinical studies .	DDI-false
studies Fondaparinux , of oral anticoagulants ( , platelet inhibitors acetylsalicylic ) , @DRUG$ ( ) did significantly affect the pharmacokinetics/pharmacodynamics of	DDI-false
Because @DRUG$ has not been produce effect that with aspirin and because aspirin increases rate of of @DRUG$ concomitant use Nalfon and salicylates is	DDI-false
of @DRUG$ have reported with use of @DRUG$ with	DDI-false
studies concomitant warfarin and @DRUG$ @DRUG$ capsules protein of , there was no in clearance .	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and quinidine.	DDI-advise
Aspirin: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$: generally should not be given with @DRUG$.	DDI-advise
results suggest that @DRUG$ and possibly other and retinoids may of epithelium by a of @DRUG$ EGF	DDI-effect
@DRUG$ : Amiodarone should be used caution in patients receiving   -receptor blocking agents ( , inhibitor ) or @DRUG$ a substrate and ) because of the possible potentiation of bradycardia arrest , and AV block	DDI-false
Both @DRUG$ and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only ibogaine increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
@DRUG$ : @DRUG$ no apparent when administered with	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Specific studies have confirmed these effects with @DRUG$, isoflurane, propofol, alfentanil, and @DRUG$.	DDI-false
However, the absolute number of alcohol-related deaths is far greater than the number of deaths in @DRUG$ or @DRUG$ users.	DDI-false
@DRUG$ Concomitant administration low-dose aspirin with @DRUG$ result in rate of GI ulceration or other to use of VIOXX alone	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$/theophylline acid quinidine/lidocaine , theophylline/acetaminophen , acid/phenobarbital .	DDI-false
All subjects received @DRUG$ alone and following treatment with 100 mg of @DRUG$ as a single daily oral dose for seven days.	DDI-false
400 mg . ) no @DRUG$ bioavailability ( ) maximum concentration ) of @DRUG$ Vardenafil in .	DDI-false
Itraconazole and @DRUG$ @DRUG$ digoxin has increased plasma concentrations of latter drugs	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
: Pharmacokinetic drug-drug interactions have between @DRUG$ and concomitantly administered aspirin and 2 to initiation of 1   . over 4 ) @DRUG$ orally given 6 0 hours prior to and 6 and hours , initiation of Argatroban . 18 hours )	DDI-false
@DRUG$ : May tubular secretion @DRUG$ resulting in blood	DDI-mechanism
The use of @DRUG$ in patients receiving @DRUG$ may be rarely associated with ventricular fibrillation.	DDI-effect
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Intravenous Adenocard ( @DRUG$ ) has been administered in the other cardioactive , such as @DRUG$ , agents channel blocking agents inhibitors without in the adverse profile	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$ could exaggerate the depression of AV nodal conduction observed with @DRUG$.	DDI-effect
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, @DRUG$, phenobarbital or St.	DDI-false
acetaminophen/theophylline lidocaine/quinidine , phenobarbital/acetaminophen @DRUG$/valproic quinidine/@DRUG$ , , and .	DDI-false
Barbiturates @DRUG$ not @DRUG$.	DDI-advise
Potential between and @DRUG$ carbamazepine , @DRUG$ phenobarbital , primidone ) by serum of levetiracetam AEDs during studies .	DDI-false
Single doses of either cholestyramine or @DRUG$ @DRUG$ bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
evaluate the of plus HAART on clinical with , non-Hodgkin lymphoma ( HIV-NHL , the authors retrospectively a of 24 patients with HIV-NHL treated with @DRUG$ , vincristine and ( CHOP ) chemotherapy HAART with group of 80 patients who were treated CHOP chemotherapy or CHOP-like ( doxorubicin , prednisone with @DRUG$ ) receiving .	DDI-false
Although @DRUG$ have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-effect
: Coadministration atorvastatin @DRUG$ increased @DRUG$ and ethinyl estradiol by 30 % 20	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ diminished the of @DRUG$ to serum by of 5.7 ( increase drug fraction [ FDF ) at micromol/L and by a net change % ( percentage increase ) 1324 micromol/L.	DDI-mechanism
Potential interactions   and @DRUG$ ( carbamazepine , lamotrigine , , @DRUG$ and valproate were also assessed serum of levetiracetam these placebo-controlled clinical	DDI-false
@DRUG$ enhance the effects of alcohol , barbiturates and other	DDI-effect
The effects of adenosine are antagonized by @DRUG$ such as caffeine and @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
This interact alcohol or other @DRUG$ depressant of medications or , @DRUG$ or medications activity ( anticholinergic effects may when medications are concurrently with antihistamines , monoamine oxidase ( ) ( concurrent use antihistamines may prolong and the anticholinergic CNS depressant antihistamines ) .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
) been effectively in the presence , , @DRUG$ channel blocking , @DRUG$ without any in adverse reaction profile .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
Monoamine Oxidase and : @DRUG$ administered extreme patients @DRUG$ tricyclic because the on these .	DDI-advise
@DRUG$: Chloramphenicol, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
@DRUG$ (NSAIDs)-A interaction study of @DRUG$ has .	DDI-false
Antiarrhythmics: Amiodarone, bepridil, flecainide, @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$ @DRUG$ : hypotension may	DDI-false
A drug-drug interaction evaluated effect of @DRUG$ , in with double ( 160 mg ) ( ) .	DDI-false
have been with drugs that are mainly CYP3A4 ( eg , calcium , quinine , , warfarin @DRUG$ pimozide , , , , @DRUG$ , and may have plasma concentrations with saquinavir ;	DDI-false
Agents The concomitant use of @DRUG$ and @DRUG$ has well in .	DDI-false
Standard monitoring of methotrexate-related toxicity should be continued if @DRUG$ and @DRUG$ are administered concomitantly.	DDI-advise
High-dose A resulting in 2000 administered oral @DRUG$ has led 80 increase in exposure body clearance of @DRUG$ .	DDI-false
Nalfon has any that obtained @DRUG$ alone and because increases the rate of excretion of use of and @DRUG$ not recommended	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen valproic acid/phenobarbital .	DDI-false
clinical studies as postmarketing observations Lodine the effect @DRUG$ and @DRUG$ .	DDI-false
pharmacokinetic were in clinical pharmacokinetic ( , valproate , oral @DRUG$ , @DRUG$ ) and screening in studies in patients .	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
, phenobarbital/acetaminophen acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
( @DRUG$ may increase the )	DDI-effect
) not potentiate the hypotensive @DRUG$ the observation period in volunteers administered with @DRUG$ g/kg weight	DDI-false
The @DRUG$ are a family of anxiolytic and @DRUG$.	DDI-false
a comparison digitalis tolerance dogs anesthetized with Vet or pentobarbital , dosage ouabain cause ventricular tachycardia significantly , as the LD50 of ouabain , @DRUG$ Innovar with	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Coingestion of @DRUG$ with theophylline, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
- Antidiabetics , ( medicine by mouth ) Use oral @DRUG$ effects affecting the or @DRUG$	DDI-false
Antacids : In a pharmacology study coadministration of antacid @DRUG$ , magnesium simethicone ) with fosinopril serum levels of compared with fosinopril , @DRUG$ impair absorption of	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following: sertraline and @DRUG$.	DDI-int
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Drugs imatinib concentrations Drugs may imatinib plasma when administering with of ( @DRUG$ , itraconazole @DRUG$ , ) .	DDI-false
a comparison dogs anesthetized ketamine Innovar , dosage of @DRUG$ ventricular tachycardia was the LD50 of ouabain , @DRUG$ or Innovar than	DDI-false
To the on of with HIV-related , non-Hodgkin ( authors of 24 with HIV-NHL the , , vincristine prednisone ( plus with a were with CHOP regimen ( cyclophosphamide , , and with @DRUG$ bleomycin @DRUG$ .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
- ( e.g. , @DRUG$ ) of with may side affecting the liver and/or the side effects @DRUG$	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
- @DRUG$ (e.g., @DRUG$) or	DDI-false
@DRUG$ tubular @DRUG$ may by of ciprofloxacin leading increased plasma levels	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
, that by this antidepressants @DRUG$ , @DRUG$ ) inhibit this isoenzyme and may make metab-olizers resemble poor metabolizers regard concomitant metabolized by this enzyme system , .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: Phenylbutazone causes increase (by about 80%) in the free fraction of @DRUG$.	DDI-false
Coadministration of @DRUG$ SULAR epileptic lowered @DRUG$ to levels .	DDI-false
side of N-methylthiotetrazole ( , cefoperazone @DRUG$ , , @DRUG$ vitamin K deficiency hypoprothrombinemia .	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-false
Concurrent with @DRUG$ drugs significantly active renal secretion in concentrations @DRUG$.	DDI-mechanism
@DRUG$ : Other drugs such as quinidine procainamide disopyramide , , have used concurrently with	DDI-false
In clinical , concomitant use of oral anticoagulants @DRUG$ ) , platelet ) NSAIDs ( @DRUG$ ) , digoxin pharmacokinetics/pharmacodynamics fondaparinux sodium	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Probenecid: @DRUG$ interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of ciprofloxacin in serum.	DDI-mechanism
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and procainamide, cardiac glycosides and @DRUG$.	DDI-false
Sinus has been reported oral combination @DRUG$ ( substrate local	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (@DRUG$), erythromycin, azole antifungals.	DDI-false
, @DRUG$ , phenobarbital quinidine , @DRUG$ , were added to pooled human at .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
specific studies not been , coadministration with drugs calcium blockers dapsone disopyramide quinine amiodarone , , @DRUG$ cyclosporine , , alfentanyl , alprazolam @DRUG$ have plasma with ;	DDI-false
Anticholinesterases ( @DRUG$ ) lignocaine , quinine , @DRUG$ cause .	DDI-false
@DRUG$ and @DRUG$ should not be administered to patients receiving coumarin drugs.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Additive adverse effects may LEVSIN concomitantly , , @DRUG$ @DRUG$ , or antihistamines	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
effect @DRUG$ on of to maximal 5 days initiation @DRUG$ extended similar length time after rifampin withdrawal .	DDI-false
@DRUG$ : @DRUG$ may delay of .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Primary and secondary @DRUG$ deficiencies constitute the sole indication of physiological oral @DRUG$ therapy.	DDI-false
may interact @DRUG$ decongestant drugs allergy and drugs , , NSAIDs Aleve or @DRUG$ , and blood pressure medications	DDI-false
and interference by phenobarbital , glutethimide and @DRUG$ were systematically investigated in receiving @DRUG$ .	DDI-false
@DRUG$: Probenecid, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of @DRUG$ 1000 mg twice daily.	DDI-false
Hemodynamic interactions observed after concomitant @DRUG$ , , @DRUG$.	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, diazepam, aminopyrine and @DRUG$.	DDI-false
Data from of benzodiazepines than @DRUG$ suggest a drug for the following : @DRUG$ , cyclosporine nicardipine and	DDI-int
@DRUG$ concomitantly dosage should be gradual in avoid possible sudden @DRUG$ withdrawal	DDI-false
Interaction on antinociceptive effect between @DRUG$ enkephalins or	DDI-effect
@DRUG$: In an interaction study of rheumatoid arthritis patients taking methotrexate, CELEBREX did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
that alter @DRUG$ plasma concentrations concentrations is administering Gleevec of @DRUG$ itraconazole , , clarithromycin .	DDI-false
@DRUG$ In pharmacology study , coadministration an , hydroxide @DRUG$ with fosinopril reduced levels urinary excretion fosinoprilat fosinopril , that may impair	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, @DRUG$, @DRUG$) should be considered.	DDI-false
hypotensive has been systemic @DRUG$ and @DRUG$	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$/@DRUG$: triazolam, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Potential pharmacokinetic interactions assessed clinical studies @DRUG$ , valproate contraceptive @DRUG$ warfarin probenecid ) and through screening the studies patients	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antihypertensives : should be used caution in patients blocking ( , propranolol @DRUG$ inhibitor ) channel antagonists e.g. verapamil a , CYP3A4 ) because of the of , sinus ;	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ : In subjects inducer , @DRUG$ , at for 3 days mg twice daily for systemic ( to lapatinib was 72	DDI-false
, phenobarbital/acetaminophen phenobarbital/valproic , , theophylline/acetaminophen , and valproic	DDI-false
- @DRUG$ nandrolone e.g. [ e.g. , @DRUG$ , oxymetholone [ , Anadrol ] , [ , ] ) or	DDI-false
Thus smaller doses of @DRUG$ may be effective in presence of	DDI-effect
@DRUG$: Probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of @DRUG$ in serum.	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and @DRUG$ against HIV.	DDI-false
Nervous : The concomitant of DURAGESIC   @DRUG$ ) with @DRUG$ including , sedatives hypnotics , ( benzodiazepines ) muscle relaxants and respiratory , profound sedation , in or death .	DDI-effect
Drug : interact with some , oxidase ( ): could affect pharmacodynamics - Arecoline - - @DRUG$ Flupenthixol @DRUG$ cause additive - Flupenthixol increases effect of	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ in combination with @DRUG$ (CYP3A4 substrate) given for local anesthesia.	DDI-false
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
@DRUG$ : Probenecid a renal secretion blocking , administered a dose of 500 mg day , did the @DRUG$ mg twice	DDI-false
@DRUG$ and @DRUG$ interact pharmacologically with orally administered anticoagulant agents, but the effect is not clinically significant.	DDI-false
Data vitro studies of benzodiazepines other than @DRUG$ for the ergotamine , amiodarone , nicardipine and	DDI-int
Multivitamins , or products containing @DRUG$ or , sucralfate concomitantly with within hours , the administration , may resulting lower and levels	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Plasma levels of @DRUG$ have been reported to increase in the presence of oral @DRUG$;	DDI-false
Other Cardiovascular Agents : Enalapril enalapril IV used methyldopa , nitrates , calcium-blocking , @DRUG$ , prazosin @DRUG$ without evidence of clinically significant	DDI-false
: subjects inducer @DRUG$ 100 twice daily for 3 days mg twice days , ( ) @DRUG$ was decreased approximately 72	DDI-mechanism
adverse resulting from blockade occur when is administered concomitantly with antimuscarinics amantadine , @DRUG$ , phenothiazines , oxidase ( MAO	DDI-false
The steady state plasma concentrations of @DRUG$ and desipramine have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of @DRUG$ tablets in doses up to 4 mg/day.	DDI-mechanism
is not if @DRUG$ in effectiveness with @DRUG$.	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and @DRUG$.	DDI-advise
@DRUG$ been shown to effects including , renal , confusion dyspnea concomitant administration of with @DRUG$ effectiveness of PROLEUKIN and should be and antihypertensives may the hypotension seen	DDI-false
caution necessary when using @DRUG$ cases since as and dysrhythmias other drugs in ( especially may emerge the reversal benzodiazepine effect @DRUG$.	DDI-false
@DRUG$ dopamine thus inhibiting the of can be used to @DRUG$ poisoning .	DDI-false
In addition chronic   2 weeks @DRUG$ administration metabolism phenytoin , @DRUG$ , and methotrexate	DDI-false
It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing @DRUG$ for at least 4 hours following @DRUG$ administration.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
: ( CYP2C9 and substrate ) @DRUG$ response always seen in @DRUG$ and can result in or fatal .	DDI-false
rats , simultaneous ingestion of @DRUG$ in for weeks has cause tumors , suggested disulfiram react with @DRUG$ in the stomach nitrosamine , which is	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$ been administered with tolazoline @DRUG$ , , , and ventilation .	DDI-false
and @DRUG$ compared therapy with the @DRUG$ over 48 weeks as initial , similar responses nevirapine superiority observed with efavirenz .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The similarity the @DRUG$ -associated event Study 1 co-administered @DRUG$ and Study 2 co-administered AVONEX ) indicates that alteration clearance reduction the dose	DDI-false
@DRUG$ taken concomitantly with @DRUG$ increases quinidine serum concentration by 33% after two days.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Interaction on the antinociceptive effect between @DRUG$ and enkephalins or @DRUG$.	DDI-effect
@DRUG$ of prostatic alone modify mitogenic effect of	DDI-effect
@DRUG$-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
Antiarrhythmics Amiodarone , @DRUG$ flecainide , @DRUG$ quinidine CONTRAINDICATED due serious and/or reactions	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
@DRUG$ including coumarin , indandione , and platelet aggregation as @DRUG$ ( NSAIDs ) , and may the of administered concomitantly ardeparin	DDI-false
patients with chronic hepatitis @DRUG$ combination @DRUG$ treatment did ribavirin distribution	DDI-false
Iodine may decrease effect of @DRUG$ and an increase effect of	DDI-false
@DRUG$ and @DRUG$ observed closely if the desired antihypertensive effect furosemide achieved .	DDI-advise
@DRUG$ : @DRUG$ the	DDI-effect
@DRUG$ : @DRUG$ the hypotensive of veratrum alkaloids	DDI-false
@DRUG$: The concomitant administration of @DRUG$ with the sulfonylurea glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
@DRUG$ Chlorpromazine dopamine and norepinephrine receptors , the central stimulant effects @DRUG$ and can be to amphetamine	DDI-false
A possible interaction between glyburide and @DRUG$, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) @DRUG$ @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
These results would seem to dictate against the clinical use of methotrexate with @DRUG$, or during the period following @DRUG$ therapy when plasma asparagine levels are below normal.	DDI-false
The to pose clinical problems depend on the degree and the pharmacokinetics @DRUG$ involved	DDI-false
Concomitant administration of and other related ( eg @DRUG$ , @DRUG$ and chloroquine ) may abnormalities and increase the of .	DDI-false
@DRUG$ ( been administered in other , , , blocking and @DRUG$ change in adverse profile	DDI-false
Other concomitant therapy specific studies were doses 1 mg studies acetaminophen acid , @DRUG$ , benzodiazepines , blockers cardiac , @DRUG$ reductase inhibitors inhibitors ( referred to as NSAIDs , quinolone anti-infectives evidence clinically adverse .	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
Withdrawal of @DRUG$ decreased the @DRUG$ requirement by 50%.	DDI-mechanism
There have been case of levels , @DRUG$ , and with @DRUG$.	DDI-false
interactions of HUMORSOL with @DRUG$ other @DRUG$.	DDI-false
Multivalent Products : Concurrent administration of quinolone , , as or aluminum @DRUG$ , @DRUG$ tablets pediatric powder , zinc may substantially of resulting and than	DDI-false
@DRUG$ CONTRAINDICATED since the of this @DRUG$ the plasma of	DDI-false
tubular transport @DRUG$ may be ciprofloxacin potentially levels of @DRUG$.	DDI-false
@DRUG$ ( neostgmine , @DRUG$ , , quinine , procainamide can toxicity cause cardio respiratory depression	DDI-false
@DRUG$ and Antidepressants : be administered with extreme in patients treated oxidase @DRUG$ because action cardiovascular system may be potentiated by agents	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and @DRUG$) decrease gefitinib metabolism and increase @DRUG$ plasma concentrations.	DDI-mechanism
@DRUG$ : Amphetamines delay absorption @DRUG$ ;	DDI-false
: have not been demonstrated Argatroban and administered aspirin ( 162.5 orally given initiation   g/kg/min . over hours acetaminophen ( mg , 6 hours prior , 6 and subsequent , initiation @DRUG$ 1.5   )	DDI-false
@DRUG$: Atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment.	DDI-false
hypoglycemic of sulfonylureas potentiated by drugs including nonsteroidal anti-inflammatory other that are highly bound @DRUG$ , sulfonamides chloramphenicol , probenecid , , oxidase inhibitors , and	DDI-false
Cardiovascular Agents enalapril have been used beta adrenergic-blocking agents , @DRUG$ , agents , hydralazine , prazosin @DRUG$ without evidence of clinically	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Both @DRUG$ major @DRUG$ the P450	DDI-false
OTHER interaction studies were in , used concomitantly ( , @DRUG$ , @DRUG$ nonsteroidal anti-inflammatory drugs ( NSAIDs ) without clinically adverse interactions	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and @DRUG$ (INN, ciclosporin) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
- Methotrexate (e.g., Mexate) Use of @DRUG$ with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-effect
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
- steroids [ e.g. oxandrolone [ Anavar , [ e.g. Anadrol @DRUG$ [ , @DRUG$ )	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$: In diabetic patients receiving diflunisal and tolbutamide, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including @DRUG$ and nitroglycerin, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
Benzthiazide may interact with , thinners , @DRUG$ ( allergy , cold , medicines drugs , lithium , NSAIDs @DRUG$ blood	DDI-false
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
@DRUG$ Coadministration of doses of @DRUG$ mg did effects of .	DDI-false
lidocaine , @DRUG$ @DRUG$ , acid were to human therapeutic	DDI-false
, interactions could of @DRUG$ ( , , @DRUG$ sedatives	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
were in pharmacokinetic oral , @DRUG$ @DRUG$ ) and pharmacokinetic the placebo-controlled in	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of @DRUG$	DDI-false
Example include azole , ciprofloxacin , doxycycline erythromycin , imatinib , @DRUG$ propofol , @DRUG$ quinidine and verapamil	DDI-false
Concurrent administration of a quinolone , ciprofloxacin with multivalent products as magnesium or aluminum @DRUG$ sucralfate VIDEX chewable/buffered or products calcium , , or may @DRUG$ , resulting serum urine levels considerably lower than	DDI-false
The use fentanyl system central nervous depressants , including not limited other opioids , @DRUG$ hypnotics @DRUG$ , benzodiazepines ) skeletal muscle , and alcohol , cause depression or potentially result in or death .	DDI-false
Other Drug : No pharmacokinetic were observed between @DRUG$ and glyburide , @DRUG$ digoxin , .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
In a clinical pharmacology study, indomethacin or @DRUG$ was administered to hypertensive patients receiving @DRUG$.	DDI-false
@DRUG$ may interact with any of the following: - Acetaminophen (e.g., @DRUG$) (with long-term, high-dose use) or	DDI-int
@DRUG$: When multiple doses of atorvastatin and @DRUG$ were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-false
In EM individuals treated with paroxetine or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
Further, no effects on either warfarin levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and @DRUG$.	DDI-false
The concomitant use of @DRUG$ tablets and other @DRUG$ is not recommended due to the increased possibility of gastrointestinal toxicity, with little or no increase in efficacy.	DDI-effect
receiving these @DRUG$ , or any other @DRUG$ and particularly those patients with altered should for of the specific toxicities of .	DDI-false
Drug-Drug Interactions Between @DRUG$   Other Drugs @DRUG$   ( 3000 no on the pharmacokinetic phenytoin in with refractory .	DDI-false
, a , such as , @DRUG$ , and @DRUG$ and their serum a toxic level .	DDI-false
@DRUG$ , @DRUG$ therapeutic in serum with at three concentrations in	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral @DRUG$, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
@DRUG$ : serum symptoms @DRUG$ toxicity reported patients lithium therapy	DDI-false
@DRUG$ of of 3 mg @DRUG$ 2 mg not effects pharmacodynamics pharmacokinetics either	DDI-false
: The @DRUG$ and naproxen in normal no the levels @DRUG$ , urinary excretion of and .	DDI-false
At a median follow-up of 33 months, the combination of ARIMIDEX and @DRUG$ did not demonstrate any efficacy benefit when compared with @DRUG$ in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
Central System : The use of @DRUG$ fentanyl transdermal system other central depressants , including but limited to other opioids @DRUG$ hypnotics , general anesthetics , skeletal relaxants , alcohol cause respiratory depression , hypotension and profound sedation or potentially result death .	DDI-effect
hypotensive with @DRUG$ can minimized the the salt approximately one week initiation of treatment with @DRUG$ ( with small doses 12.5 )	DDI-false
In @DRUG$ AUC increased 24 respectively 10 days of @DRUG$ , a known of cytochrome	DDI-mechanism
Sinus been @DRUG$ @DRUG$ ( CYP3A4 ) .	DDI-false
Nervous Depressants : of DURAGESIC with other central , not to sedatives , hypnotics @DRUG$ @DRUG$ , general anesthetics phenothiazines , skeletal relaxants , alcohol may depression , hypotension , profound , or result or .	DDI-false
It was concluded that oral @DRUG$ and @DRUG$ can be administered concomitantly without a significant decrease in AUC, Cmax, or tmax.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Both and been triple the @DRUG$ indinavir as initial responses observed with @DRUG$ regimens and observed .	DDI-false
the presence @DRUG$ larger doses @DRUG$ may be required or may effective .	DDI-advise
@DRUG$ @DRUG$ , e.g. , .	DDI-effect
Although @DRUG$ retinyl affected of prostatic in transferrin alone , they modify effect of EGF and	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Numerous drug interactions are possible with some anticonvulsant agents, such as @DRUG$ and @DRUG$, which affect hepatic microsomal enzyme systems.	DDI-false
Another oral @DRUG$, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
the increased adverse in been taking on a regular , is particularly important physicians query or carefully @DRUG$ @DRUG$ sedative the history to any in which the of ROMAZICON planned	DDI-false
Moreover , additional with @DRUG$ and have any on receiving digoxin resulted in the bioavailability of @DRUG$ to control data	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
Anticholinesterases (neostgmine, @DRUG$), lignocaine, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Concurrent administration of drugs possessing ( e.g. aminoglycosides , , myelotoxic e.g. @DRUG$ chemotherapy ( ) hepatotoxic , methotrexate @DRUG$ ) effects PROLEUKIN in these	DDI-false
Anticoagulants Potentiation of @DRUG$-type @DRUG$ anticoagulant response is almost seen patients amiodarone result in	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG$ and @DRUG$.	DDI-false
studies have not coadministration drugs by ( eg calcium channel blockers , dapsone disopyramide quinine , , quinidine , @DRUG$ , , pimozide carbamazepine , , @DRUG$ and triazolam with saquinavir ;	DDI-false
Further on either @DRUG$ levels or were in study involving administration @DRUG$ and .	DDI-false
Haemodynamic effects of @DRUG$ and insulin were additive when @DRUG$ was co-administered but not under basal conditions.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of @DRUG$, @DRUG$, and methotrexate.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
concentrations @DRUG$ reduced when given concurrently with @DRUG$.	DDI-mechanism
- Mephenytoin (e.g., @DRUG$) Use of @DRUG$ with these medicines may increase the chance of side effects of these medicines	DDI-false
that alter imatinib may @DRUG$ concentrations : Caution when administering with of CYP3A4 ( , ketoconazole @DRUG$ , erythromycin )	DDI-false
No Important Interactions Levosimendan does have important pharmacokinetic interactions , beta-blockers , felodipine , digoxin , , @DRUG$ , @DRUG$ ethanol itraconazole .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Agents : and have been beta agents , methyldopa , , @DRUG$ hydralazine @DRUG$ and digoxin of significant	DDI-false
interactions between @DRUG$ and isoflurane , @DRUG$	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : Concurrent @DRUG$ plasma possibly by for sites	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
effects @DRUG$ upon locomotion and in	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Although specific studies not performed coadministration with that are metabolized ( , calcium channel blockers , disopyramide quinine , @DRUG$ , , warfarin , , @DRUG$ ergot derivatives , carbamazepine , , and triazolam ) have elevated plasma when coadministered saquinavir ;	DDI-false
@DRUG$ increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and t1/2.	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on atenolol than in patients on no other @DRUG$ therapy.	DDI-false
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
@DRUG$ , moclobemide 30 mg/kg , @DRUG$ 0.25 ) fluoxetine 20 mg/kg ) sertraline or vehicle .	DDI-false
anticholinergic ( severe mouth retention ) have been in serum levels @DRUG$ when @DRUG$ is to drug regimen .	DDI-effect
MAO : @DRUG$   is not use who 14 because by MAO has @DRUG$	DDI-false
human serum proteins indicate differently than @DRUG$ not salicylate or @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-false
@DRUG$: Concomitant treatment with Accutane and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
inhibitors of @DRUG$ , nefazodone @DRUG$ nelfinavir would be to .	DDI-false
@DRUG$ : @DRUG$ , sulfonamides , tetracyclines may interfere with bactericidal effect of penicillins .	DDI-false
Slow-channel calcium blockers, such as verapamil, @DRUG$ and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
, in the g before evening meal and 0.3 sodium the same resulted @DRUG$ 8 % a of about % compared @DRUG$ .	DDI-false
@DRUG$ nevirapine therapy over 48 weeks initial therapy , with similar @DRUG$ and .	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or @DRUG$) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-false
@DRUG$ prior diphenidol may the @DRUG$ response to in treatment of .	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
exposure 12 of @DRUG$ DHA ) more than doubled of TMP/@DRUG$.	DDI-false
@DRUG$ In pharmacology study of an @DRUG$ , magnesium , and simethicone ) fosinopril serum urinary fosinoprilat as fosinopril , suggesting that antacids impair of fosinopril	DDI-false
Concurrent administration possessing ( e.g. , @DRUG$ myelotoxic ( e.g. cytotoxic cardiotoxic , doxorubicin or , methotrexate , ) @DRUG$ may increase toxicity these .	DDI-effect
Although study data the oxide , including @DRUG$ and @DRUG$ , may effect with of methemoglobinemia	DDI-false
Although specific studies , that metabolized CYP3A4 ( , channel dapsone , , , amiodarone , quinidine @DRUG$ , , fentanyl alfentanyl @DRUG$ , and ) have elevated concentrations ;	DDI-false
with are inducers eg , @DRUG$ , dexamethasone @DRUG$ ) plasma levels of	DDI-false
has reported in patients concomitantly receiving @DRUG$ @DRUG$.	DDI-effect
: In clinical pharmacology study , of an aluminum hydroxide @DRUG$ , and ) with fosinopril reduced serum levels and excretion fosinoprilat as with @DRUG$ administered alone , suggesting that absorption of fosinopril .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, @DRUG$, quinidine and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
After multiple dosing, interferon beta-1a (@DRUG$  30 mcg IM once weekly) reduced @DRUG$  clearance by approximately 30%.	DDI-mechanism
@DRUG$: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
400 had no effect bioavailability ( maximum concentration Cmax of @DRUG$ @DRUG$ in .	DDI-false
It was shown @DRUG$ evidently the @DRUG$ and analogue .	DDI-effect
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
intake alcohol and not the either @DRUG$ @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Chronic of @DRUG$ may be associated with in the of	DDI-mechanism
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-mechanism
Concomitant , @DRUG$ and chemotherapy @DRUG$ therapy human virus-related .	DDI-false
@DRUG$ potentiate of alcohol the 4-hour period administered with @DRUG$ ( 0.5 weight ) .	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
raise that the reaction may in who consume @DRUG$ and @DRUG$ a regular .	DDI-mechanism
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
no deleterious @DRUG$ narcotics inhalational anesthetics , @DRUG$ and relaxant administered conjunction with sedation or	DDI-false
@DRUG$ no the Cmax and AUC of zidovudine , although significantly @DRUG$ by 44 % to phosphorylated by	DDI-mechanism
action sulfonylureas may be potentiated nonsteroidal agents other that bound @DRUG$ , coumarins , inhibitors and	DDI-false
: @DRUG$ delay intestinal of @DRUG$.	DDI-mechanism
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
@DRUG$ - prior of the emetic @DRUG$ in treatment .	DDI-false
Anabolic nandrolone [ e.g. , Anabolin e.g. Anavar , @DRUG$ @DRUG$ ] e.g. , ] or	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drugs plasma may imatinib plasma concentrations : is recommended when administering @DRUG$ with of the CYP3A4 family e.g. , ketoconazole , itraconazole , erythromycin @DRUG$ )	DDI-advise
, , phenobarbital/acetaminophen phenobarbital/valproic acid @DRUG$/acetaminophen , and valproic .	DDI-false
@DRUG$ 3 mg administered not affect of (S)-warfarin there any in profile ( prothrombin dose of @DRUG$	DDI-false
In an in vitro study in human liver microsomes, inhibition of CYP2A6 hydroxylation of @DRUG$ by @DRUG$ (200 m m M i.e., 350 mg/L) was 17-28%.	DDI-mechanism
Carbamazepine : @DRUG$ known slow carbamazepine increase its serum Carbamazepine levels prior to administration isoniazid of @DRUG$ should be monitored and appropriate dosage adjustment the should be	DDI-false
, the of anticoagulants ( @DRUG$ ) ( acetylsalicylic ) @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics	DDI-false
Drug/Laboratory Test Interaction Fosinopril may cause a false low measurement of serum @DRUG$ levels with the Digi- Tab  RIA Kit for @DRUG$.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
may enhance of @DRUG$ , barbiturates ,	DDI-false
Use with @DRUG$: The use of angiotensin converting enzyme inhibitors to control hypertension in patients on @DRUG$ has been reported to induce severe leukopenia.	DDI-false
@DRUG$ and @DRUG$ Upon concomitant mg of ritonavir , the Cmax and of ritonavir were by .	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many antidepressants (@DRUG$, @DRUG$, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
Alcohol: @DRUG$ (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and @DRUG$ plasma levels were not altered when dosed simultaneously.	DDI-false
action of may potentiated including other that are highly bound @DRUG$ , chloramphenicol , , @DRUG$ , and beta adrenergic blocking	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ be as substitute for oral or inhaled @DRUG$.	DDI-false
@DRUG$: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly.	DDI-false
: Lorazepam , injectable @DRUG$ produces of the central nervous system with ethyl phenothiazines @DRUG$ , scopolamine an incidence sedation , hallucinations , and has observed	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
the thiazides and diuretics , , phenothiazines products , @DRUG$ oral @DRUG$ phenytoin acid sympathomimetics and	DDI-false
however , no interactions were @DRUG$ was @DRUG$ inhalational anesthetics , relaxants and antagonists in sedation anesthesia	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
INOmax has been administered with @DRUG$, dopamine, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
@DRUG$: In hypercholesterolemic patients, steady-state @DRUG$ AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
addition the interactions chronic weeks ) impairs metabolism of @DRUG$ , ,	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after @DRUG$, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Analysis of the concentration of budesonide following ultracentrifugation indicated that there is rapid equilibration of @DRUG$ between the @DRUG$ and aqueous phase.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
To evaluate the impact chemotherapy HAART course of HIV-related , HIV-NHL the authors group patients who cyclophosphamide , vincristine and @DRUG$ CHOP ) regimen plus HAART of patients who treated CHOP chemotherapy or a CHOP-like , @DRUG$ and with plus without antiretroviral	DDI-false
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Example inhibitors include @DRUG$ , , , doxycycline , , @DRUG$ , isoniazid , nefazodone , propofol , protease inhibitors , , verapamil	DDI-false
The catecholamines dopamine @DRUG$ are enhanced @DRUG$.	DDI-effect
@DRUG$ @DRUG$ 1000 daily ) did not the pharmacodynamics ECG ) digoxin 0.25 every .	DDI-false
Drugs That Induce CYP3A4 (@DRUG$) Racemic zopiclone exposure was decreased 80% by concomitant useof @DRUG$, a potent inducer of CYP3A4.	DDI-false
@DRUG$ , oral @DRUG$ , or similar .	DDI-effect
: antiarrhythmic such , @DRUG$ , used concurrently @DRUG$.	DDI-false
There is enhancement effect @DRUG$ the reaction of vessels @DRUG$ .	DDI-effect
may with alcohol decongestant , , sinus ) , drugs , @DRUG$ , @DRUG$ like Ibuprofen , high .	DDI-false
interactions @DRUG$   ( carbamazepine , gabapentin , phenobarbital , phenytoin @DRUG$ valproate ) by of levetiracetam and these AEDs during placebo-controlled clinical	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ @DRUG$ ( 80 ) free fraction of etodolac .	DDI-false
Micro-dosed @DRUG$ : Micro-dosed preparations minipills not contain an ) method during @DRUG$ therapy	DDI-false
: concomitant transdermal ) other system , including @DRUG$ hypnotics , tranquilizers ( @DRUG$ , skeletal muscle relaxants , alcohol , may cause , and profound sedation or result in coma	DDI-false
Colestipol-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Intravenous @DRUG$ adenosine ) been the presence of cardioactive drugs as , @DRUG$ , and angiotensin converting enzyme reaction	DDI-false
, @DRUG$ , vincristine , and @DRUG$ chemotherapy highly with immunodeficiency virus-related , non-Hodgkin lymphoma	DDI-false
Concurrent administration of @DRUG$ and of @DRUG$ may cause severe, persistent hypertension or cerebrovascular accidents.	DDI-false
@DRUG$ : Indinavir 800 t.i.d . ) co-administered with 10 mg 16-fold in vardenafil , 7-fold @DRUG$ Cmax a increase vardenafil half-life .	DDI-false
Although have not performed coadministration with CYP3A4 eg , @DRUG$ , dapsone @DRUG$ , amiodarone , warfarin tacrolimus cyclosporine ergot pimozide carbamazepine alfentanyl have elevated when with saquinavir	DDI-false
Other concomitant therapies In clinical trials subjects treated Acamprosate concomitantly with hypnotics ( @DRUG$ or @DRUG$ was to that of subjects placebo with	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Haloperidol : @DRUG$ blocks dopamine thus inhibiting the central stimulant of	DDI-effect
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, opiates, and alcohol.	DDI-effect
Example @DRUG$ clarithromycin diclofenac , , erythromycin , imatinib , nefazodone nicardipine @DRUG$ protease quinidine , verapamil	DDI-false
In diabetic patients diflunisal and @DRUG$ , no significant effects on @DRUG$ levels or fasting	DDI-false
Two ( SH/DA SH/FA submitted to with containing @DRUG$ @DRUG$ higher alcohols and acetaldehyde same as found common distilled fermented	DDI-false
This appears to be the clinically relevant this kind Mefloquine , drugs known eg @DRUG$ or @DRUG$ , calcium channel , H1-blocking agents , tricyclic and phenothiazines ) also to a prolongation of the interval	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other Enalapril IV have been concomitantly with beta adrenergic-blocking , @DRUG$ nitrates , agents , hydralazine @DRUG$ without of clinically interactions	DDI-false
Although specific have , coadministration are CYP3A4 channel , @DRUG$ , quinine , amiodarone , , warfarin , , @DRUG$ , ergot pimozide , carbamazepine alfentanyl , , and triazolam ) may have concentrations with saquinavir	DDI-false
@DRUG$ and butyrophenones may reduce or reverse the pressor effect of @DRUG$.	DDI-effect
In rats, simultaneous ingestion of disulfiram and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Elevated plasma @DRUG$ have been reported with @DRUG$ use .	DDI-mechanism
drug with other depressants may potentiate CNS depressant either or @DRUG$ or other activity ( may be are with antihistamines ) , monoamine oxidase ( @DRUG$ may and intensify and depressant effects antihistamines ) .	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Vitamin A: Because of the relationship of Accutane to vitamin A, patients should be advised against taking @DRUG$ containing @DRUG$ to avoid additive toxic effects	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, DCG-IV and @DRUG$, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
@DRUG$ and Zidovudine the vitro stavudine and @DRUG$	DDI-false
Acetaminophen: In normal volunteers, concomitant administration of @DRUG$ and acetaminophen resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$-@DRUG$ large may K epoxide reductase resulting in deficiency .	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
clinical studies performed with , oral @DRUG$ ( warfarin ) , inhibitors ) NSAIDs @DRUG$ significantly the pharmacokinetics/pharmacodynamics of fondaparinux .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
oral @DRUG$ @DRUG$ been reported .	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
The pressor effects of @DRUG$ such as @DRUG$ or norepinephrine are enhanced by Bretylium Tosylate.	DDI-false
Concurrent quinolone , including ciprofloxacin , with multivalent cation-containing products as or @DRUG$ @DRUG$ pediatric powder containing calcium , substantially decrease the absorption of resulting serum considerably than desired	DDI-false
Cardiovascular Agents @DRUG$ and enalapril have been concomitantly beta agents , , calcium-blocking @DRUG$ prazosin and digoxin evidence interactions	DDI-false
Concurrent drugs possessing nephrotoxic ( e.g. aminoglycosides ) e.g. ) e.g. @DRUG$ ) or ( e.g. , @DRUG$ ) may increase in .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Isoniazid to metabolism and increase serum levels Carbamazepine be administration @DRUG$ signs and symptoms of carbamazepine toxicity be monitored closely , and appropriate dosage of @DRUG$ should made	DDI-false
Therefore , when @DRUG$ and @DRUG$ used , closely to if the effect of the obtained .	DDI-advise
apparently effect on microsomal enzyme , has the of anticoagulants phenytoin @DRUG$ chlordiazepoxide lidocaine , @DRUG$ and metronidazole , thereby delaying elimination levels drugs	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, @DRUG$, Maalox, and ranitidine.	DDI-false
have in receiving regimens containing sequential high dose @DRUG$ and specifically , cis-platinum @DRUG$ interferon-alfa .	DDI-effect
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Hypotension   Patients on @DRUG$ Therapy: Patients on diuretics and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
Clinical studies with have identified interactions with @DRUG$ and @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
immediate release but not coat-core of @DRUG$ plasma @DRUG$ concentrations about 20 % .	DDI-mechanism
Patients doses of @DRUG$ with , as in disease , @DRUG$ at of competitive renal .	DDI-false
drugs the thiazides @DRUG$ , @DRUG$ products , oral , , acid , , isoniazid	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Drug Interactions with some like oxidase inhibitors theoretically flupenthixol Arecoline Ethanol and @DRUG$ cause depression - @DRUG$ Flupenthixol increases the	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and erythromycin with transdermal fentanyl may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
impact of chemotherapy plus on the clinical course HIV-related , lymphoma HIV-NHL ) , compared of HIV-NHL who treated with the @DRUG$ , ( HAART with a of were with CHOP regimen ( , @DRUG$ , doxorubicin , prednisone with vincristine bleomycin antiretroviral therapy	DDI-false
@DRUG$ should be in patients receiving   blocking a inhibitor ) calcium channel ( , a substrate @DRUG$ inhibitor because possible potentiation bradycardia , sinus , and block	DDI-false
similarity of the -associated event profile Study ( co-administered @DRUG$ ) and Study with co-administered AVONEX ) indicates that this alteration does not necessitate @DRUG$ dose maintain General ) .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-false
Cation-Containing Concurrent administration a quinolone , @DRUG$ products such as or antacids , sucralfate VIDEX chewable/buffered , or products containing @DRUG$ iron may substantially the of resulting in levels considerably lower than	DDI-mechanism
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Another @DRUG$ , inhibits metabolism @DRUG$ concentrations astemizole and its desmethylastermizole prolong intervals	DDI-false
@DRUG$ Reports suggest that @DRUG$ may diminish the antihypertensive effect of ACE-inhibitors.	DDI-false
a of an ( aluminum hydroxide and simethicone with fosinopril of @DRUG$ as with @DRUG$ administered antacids may impair .	DDI-false
@DRUG$: In a single-dose interaction study in NIDDM subjects, decreases in @DRUG$ AUC and Cmax were observed, but were highly variable.	DDI-false
Non-selective MAO inhibitors tranylcypromine phenelzine sulfate and pargyline HC1 : Concomitant of @DRUG$ @DRUG$ may cause hypertension .	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and @DRUG$.	DDI-false
that imatinib plasma concentrations that imatinib plasma concentrations : Caution is administering @DRUG$ inhibitors of CYP3A4 e.g. , @DRUG$ , erythromycin ) .	DDI-advise
@DRUG$ concentrations and LDL-C reduction were not altered by coadministration	DDI-false
Therefore, the combined use of @DRUG$ with @DRUG$ should generally be avoided.	DDI-advise
Cholestyramine increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and @DRUG$/2.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$ decreased the hyperuricemic @DRUG$.	DDI-effect
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Expected laboratory assessments of PT observed @DRUG$ administration but these were not affected by concomitant @DRUG$	DDI-false
Combinations of @DRUG$ and @DRUG$: effects on drug discrimination and behavioral inhibition in rats.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
performed , are metabolized eg calcium blockers dapsone disopyramide @DRUG$ , quinidine , tacrolimus , ergot , pimozide carbamazepine , , alprazolam @DRUG$ ) may elevated concentrations coadministered with	DDI-false
of local solutions epinephrine @DRUG$ to @DRUG$ , tricyclic antidepressants phenothiazines may severe , prolonged	DDI-effect
the plus HAART of , , non-Hodgkin lymphoma HIV-NHL , the authors a of 24 with were treated the , prednisone ( chemotherapy a group of 80 patients who or a cyclophosphamide doxorubicin , , @DRUG$ @DRUG$ plus	DDI-false
Although specific glaucoma drugs or systemic were identified in studies IOPIDINE Ophthalmic Solution , the of additive effect with @DRUG$ , @DRUG$ ) should be considered	DDI-false
@DRUG$: Coadministration of eszopiclone 3 mg and @DRUG$ 10 mg produced a decrease in DSST scores.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ @DRUG$ FORADIL should with caution treated or antidepressants of formoterol on cardiovascular system may potentiated these agents	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
Other concomitant therapies : , safety profile in treated with @DRUG$ concomitantly with hypnotics and sedatives ( including ) , or @DRUG$ was that these concomitant medications	DDI-false
@DRUG$ Preparations : Micro-dosed preparations that not contain an @DRUG$ ) be inadequate Accutane therapy	DDI-false
Agents : @DRUG$ have been concomitantly with beta agents , @DRUG$ , hydralazine prazosin digoxin without significant adverse	DDI-false
( In patients , the @DRUG$ can the , natriuretic , and antihypertensive of @DRUG$.	DDI-effect
In rats, simultaneous ingestion of @DRUG$ and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Warfarin @DRUG$ 1000 daily ) did influence of R	DDI-false
Since @DRUG$ does not markedly inhibit CYP450s (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4) in vitro, @DRUG$ is not expected to significantly interact with other drugs in vivo by inhibition of metabolism mediated by these isozymes.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
generally should @DRUG$ because @DRUG$s clearance and add a high of lithium	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, @DRUG$, and increased toxicity.	DDI-mechanism
Potential drug between   ( , @DRUG$ lamotrigine , phenobarbital , @DRUG$ and valproate ) also by the serum concentrations of and AEDs clinical .	DDI-false
Drug-Drug Interactions Between   And Other @DRUG$ 3000 daily effect on the disposition @DRUG$ in refractory .	DDI-false
Potential drug interactions between Keppra   and other AEDs carbamazepine , gabapentin , phenytoin , @DRUG$ were assessed by evaluating concentrations and @DRUG$ during studies .	DDI-false
@DRUG$ suggest @DRUG$ may diminish the antihypertensive effect Converting ACE .	DDI-false
No pharmacokinetic interactions between @DRUG$ and isoflurane, @DRUG$, alfentanil, and midazolam have been demonstrated.	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
@DRUG$ concomitant use of   fentanyl with nervous system depressants , including but limited other opioids , ) general phenothiazines , muscle , and @DRUG$ , cause respiratory hypotension , profound sedation , result .	DDI-false
Although the drug interaction not studied in , there more 50 episodes use of i.e. @DRUG$ , @DRUG$ .	DDI-false
There have been greater than 2-fold increases in previously stable plasma levels of other @DRUG$, including @DRUG$, when fluoxetine hydrochloride has been administered in combination with these agents.	DDI-false
specific performed , coadministration drugs are mainly metabolized by ( eg calcium blockers , dapsone quinine , , , , ergot , , @DRUG$ , fentanyl , @DRUG$ , , triazolam elevated plasma	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Other therapies In clinical , in treated with concomitantly with @DRUG$ hypnotics and ( including or @DRUG$ similar of subjects with these medications .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Vardenafil 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
These drugs include the thiazides and other @DRUG$, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
With simultaneous dosing of @DRUG$ 10 mg and @DRUG$ 10 mg, 6 of 8 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.	DDI-effect
Non-steroidal Anti-inflammatory Drugs some patients administration of non-steroidal anti-inflammatory agent can the diuretic , , antihypertensive effects	DDI-false
concomitant Although specific interaction studies were not performed , doses or were studies with acetaminophen , acetylsalicylic acid a-blockers analgesics , ( ACE ) anticonvulsants benzodiazepines , beta blockers @DRUG$ nitrates diuretics , H2 inhibitors , synthetase ( also NSAIDs , and @DRUG$ without evidence clinically adverse .	DDI-false
tested in @DRUG$ , @DRUG$ antipyrine	DDI-false
The , and time by @DRUG$ , secobarbital glutethimide , chloral hydrate @DRUG$ in receiving coumarin therapy	DDI-false
may sterilize @DRUG$ contribution by intestinal microflora	DDI-false
These include other diuretics , , phe-nothiazines , @DRUG$ , acid , , calcium channel blocking and	DDI-false
Mineral Oil-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
may be necessary to oral anticoagulants upon stopping @DRUG$. @DRUG$ may prolong	DDI-false
Studies in rats have shown that @DRUG$ administration attenuates certain types of @DRUG$ dependent hypertension, including ACTH hypertension.	DDI-false
The possibility of hypotensive can be minimized either @DRUG$ increasing prior @DRUG$.	DDI-false
This may or CNS potentiate the depressant or anticholinergics or with anticholinergic activity anticholinergic effects be potentiated when these concurrently with antihistamines ) @DRUG$ @DRUG$ prolong and the and of antihistamines	DDI-false
local anesthetic containing @DRUG$ @DRUG$ may , prolonged hypertension .	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
specific not that mainly metabolized by calcium channel , dapsone disopyramide quinine , amiodarone , warfarin , ergot derivatives , @DRUG$ , carbamazepine , , @DRUG$ , and have plasma when saquinavir ;	DDI-false
has administered with @DRUG$ , dopamine @DRUG$ steroids surfactant , ventilation	DDI-false
In the second experiment, non-diabetic and streptozotocin-induced diabetic rats were fasted, and the same procedures were followed for estimation of @DRUG$ tolerance 30 min after @DRUG$ overload.	DDI-false
@DRUG$ ( neostgmine physostigmine , lignocaine , quinine , @DRUG$ toxicity and cause cardio respiratory depression	DDI-false
of amiodarone @DRUG$ should reserved with life-threatening who are incompletely agent or incompletely responsive @DRUG$.	DDI-false
( @DRUG$ the presence , beta-adrenergic @DRUG$ , and enzyme inhibitors , .	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and @DRUG$.	DDI-false
Dextromethorphan is a substrate for both @DRUG$ and @DRUG$.	DDI-false
@DRUG$/@DRUG$ CONTRAINDICATED due for and/or life-threatening reactions or respiratory depression .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ inhibit ( CYP1A2 , , CYP2C9 , CYP2C19 , CYP2E1 , or in vitro , @DRUG$ is not expected significantly interact drugs vivo of mediated .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/@DRUG$.	DDI-false
, clinical studies @DRUG$ @DRUG$ , 5 mg when men who hyperplasia , PSA levels approximately 50 .	DDI-false
@DRUG$ administration of aspirin may lower @DRUG$ plasma , by competing for protein-binding .	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$ adverse effects @DRUG$ concomitantly .	DDI-effect
@DRUG$ may interact with any of the following: - @DRUG$ (e.g., Tylenol) (with long-term, high-dose use) or	DDI-int
In the first study, concomitant administration of 0.2 mg @DRUG$ and 12 g @DRUG$ resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing cerivastatin sodium alone.	DDI-mechanism
of @DRUG$ ( may increases in mg dose of should not be a when combination with @DRUG$ 400 daily	DDI-false
Cephalosporins-@DRUG$ containing side N-methylthiotetrazole ( @DRUG$ , cefotetan , latamoxef or cefazolin ) can cause .	DDI-false
inhibitors include azole antifungals ciprofloxacin clarithromycin diclofenac doxycycline , erythromycin , @DRUG$ isoniazid , nefazodone nicardipine , , @DRUG$ , and verapamil	DDI-false
@DRUG$ load best for diagnosis @DRUG$ deficiency and the first of	DDI-false
When Itraconazole coadministered with phenytoin @DRUG$ H2antagonists , reduced of @DRUG$ reported .	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
studies have demonstrated concomitant administration @DRUG$ capsules reduced of warfarin , there no change in the	DDI-false
anticholinergic severe dry , urinary have associated in the of @DRUG$ when @DRUG$ therapy .	DDI-effect
: The effects of combined administration of and @DRUG$ ( ) calcium blocker incidence metastasis adenocarcinomas induced by ( @DRUG$ investigated male .	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of @DRUG$ and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
BACKGROUND : The effects combined administration of @DRUG$ and hydrochloride verapamil a calcium blocker , on incidence of peritoneal of adenocarcinomas by azoxymethane @DRUG$ and index cancers male	DDI-false
@DRUG$ other diazoxide or pre@DRUG$ anesthetic or skeletal-muscle used in surgery	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In clinical performed with the concomitant use @DRUG$ ) ( acetylsalicylic , NSAIDs ( piroxicam , and @DRUG$ not significantly affect the fondaparinux	DDI-false
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
a of tolerance in anesthetized with , Innovar , or pentobarbital , of ouabain to cause was , LD50 of , with @DRUG$ or @DRUG$ pentobarbital	DDI-false
Thus, concomitant therapy with @DRUG$ and @DRUG$ should not require dosage adjustment of either drug.	DDI-false
System Depressants : use ( fentanyl system ) with @DRUG$ , including but not limited to , sedatives , tranquilizers ( , general , @DRUG$ , and alcohol , may cause depression , and , result in coma death .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
The aim of this paper was to study the interaction between neurotensin and both enkephalins or its synthetic analogue @DRUG$, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving @DRUG$ therapy, administration of oral amiodarone regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
HMG-CoA Reductase Inhibitors: @DRUG$ (CYP3A4 substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
When @DRUG$ was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
@DRUG$ may amount of digoxin @DRUG$ , ) that gets absorbed into your body .	DDI-mechanism
side cefmenoxime cefoperazone @DRUG$ , cefamandole , latamoxef or methylthiadiazole cefazolin ) can and .	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
Potential interactions between Keppra   @DRUG$ carbamazepine , , phenytoin , primidone and valproate ) also assessed by concentrations of @DRUG$ and these placebo-controlled clinical studies .	DDI-false
Serum lithium levels should be monitored frequently if @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
@DRUG$ : Amphetamines intestinal of @DRUG$.	DDI-false
Imipramine ( 5 mg/kg @DRUG$ ( mg/kg ) , @DRUG$ 0.25 mg/kg ( ) 30 ) or vehicle administered .	DDI-false
therapy specific interaction were @DRUG$ doses 1 mg more were used clinical studies with acetaminophen , acetylsalicylic acid , analgesics angiotensin-converting enzyme ACE ) anticonvulsants benzodiazepines , , @DRUG$ antagonists , reductase , prostaglandin ( to ) evidence clinically significant .	DDI-false
Cation-Containing : Concurrent quinolone ciprofloxacin such as magnesium @DRUG$ , or pediatric @DRUG$ , or zinc substantially decrease the absorption ciprofloxacin , resulting serum and urine	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, @DRUG$ or some antihistamines.	DDI-false
@DRUG$ is the first @DRUG$ to be approved for clinical use, and has been studied extensively in humans since 1986.	DDI-false
@DRUG$ (NSAIDs)-A drug interaction study of @DRUG$ with an NSAID has not been conducted.	DDI-false
@DRUG$ : @DRUG$ be with caution in receiving   agents CYP3A4 inhibitor calcium channel ( verapamil , a substrate , a inhibitor the possible potentiation of bradycardia , sinus block	DDI-false
Antacids: Concomitant administration of @DRUG$ may reduce plasma levels of @DRUG$.	DDI-mechanism
pharmacokinetic have demonstrated concomitant of @DRUG$ @DRUG$ ( capsules in reduced there in of	DDI-mechanism
- @DRUG$ e.g. @DRUG$	DDI-false
Other Drug pharmacokinetic interactions were observed drugs : glyburide , @DRUG$ , @DRUG$ Maalox .	DDI-false
@DRUG$ In normal volunteers concomitant acetaminophen plasma levels of @DRUG$.	DDI-false
and block @DRUG$-induced and release in the ;	DDI-false
, it HALDOL be of CNS , @DRUG$ @DRUG$.	DDI-false
Cholestyramine and colestipol @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
This study demonstrates that concurrent administration of @DRUG$ permits at least a twofold increase in dose and total exposure to @DRUG$.	DDI-mechanism
studies performed , the concomitant of anticoagulants ( @DRUG$ ) platelet ( @DRUG$ , NSAIDs ( piroxicam ) and did significantly fondaparinux sodium	DDI-false
By contrast, @DRUG$ (1 mM) and @DRUG$ (1 mM) had no significant effect on the translocation when added alone.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ (@DRUG$): Cerivastatin plasma concentrations were not affected by co-administration of antacid.	DDI-false
@DRUG$, nondepolarizing (e.g., tubocurarine): possible increased responsiveness to the @DRUG$.	DDI-false
Non-selective MAO inhibitors including @DRUG$, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
@DRUG$: Altered serum levels of phenytoin (increased and decreased) have been reported in patients receiving concomitant @DRUG$.	DDI-false
Since @DRUG$ is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced amiodarone levels.	DDI-false
Cation-Containing administration of quinolone , , multivalent cation-containing such magnesium or aluminum antacids sucralfate , VIDEX chewable/buffered or , or containing @DRUG$ , , or decrease the of @DRUG$ in and urine levels considerably desired .	DDI-false
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ or iodine excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
@DRUG$ mg twice daily did not or @DRUG$ or clearance or urinary excretion .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
@DRUG$ : Serious side and even death following the use drugs @DRUG$.	DDI-false
Because of increased risk of adverse reactions in patients have benzodiazepines on basis is particularly important that query patients guardians carefully benzodiazepine @DRUG$ use part to the use @DRUG$ is planned .	DDI-false
@DRUG$ : ( 800 mg ) with @DRUG$ resulted a increase in vardenafil , increase and a .	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
@DRUG$ : A of severe @DRUG$ toxicity was reported in	DDI-false
the present , atypical @DRUG$ was tested in combination with an @DRUG$ drug mixed differential-reinforcement-of-low-rates DRL .	DDI-false
Although no specific interactions topical glaucoma were identified in of Ophthalmic possibility an additive effect depressants ( @DRUG$ , barbiturates sedatives @DRUG$ considered .	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, opiates, and @DRUG$.	DDI-false
plasma therapy with @DRUG$ or patients receiving @DRUG$.	DDI-advise
Diuretics : Etodolac has interaction when administered @DRUG$ or @DRUG$.	DDI-false
Potential between other AEDs ( carbamazepine , @DRUG$ @DRUG$ phenytoin and were also assessed by serum of levetiracetam and these AEDs placebo-controlled	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, @DRUG$, and verapamil.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), EGF (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
Since @DRUG$ is substrate for CYP3A4 and CYP2C8 , inhibit isoenzymes and	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
The of adenosine @DRUG$ such caffeine and @DRUG$.	DDI-false
Central System Depressants The concomitant use ( ) with other central nervous depressants limited to other sedatives hypnotics , ( e.g. , benzodiazepines , general , @DRUG$ , skeletal muscle relaxants @DRUG$ , respiratory hypotension , profound sedation or result in or .	DDI-false
Dextromethorphan is a substrate for both @DRUG$ and @DRUG$.	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, @DRUG$, aminopyrine and @DRUG$.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
@DRUG$ ('Seroquel') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
(Concurrent use with @DRUG$ may enhance the possibility of @DRUG$ toxicity associated with hypokalemia.)	DDI-effect
@DRUG$ blocks dopamine and , thus inhibiting central stimulant amphetamines and can be @DRUG$ poisoning .	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as morphine.	DDI-mechanism
Tagamet apparently through an effect on systems , reduce metabolism warfarin-type @DRUG$ chlordiazepoxide , certain antidepressants @DRUG$ , theophylline thereby delaying and blood	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
@DRUG$ has been shown to beta-lactam antibiotics @DRUG$ , based on in vitro and time kill curves	DDI-effect
Other Drugs Drugs , disopyramide @DRUG$ @DRUG$ , and tricyclic may be associated with QT-interval an increased arrhythmia	DDI-false
In a similar study with @DRUG$ in healthy volunteers, 1 of 24 subjects dosed with @DRUG$ 20 mg and tamsulosin 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-false
This with or other @DRUG$ potentiate the CNS effects of these or antihistamines , or other medications with ( anticholinergic effects may potentiated when these and monoamine ( MAO ) use prolong intensify anticholinergic CNS depressant of @DRUG$ ) .	DDI-false
, , @DRUG$/@DRUG$ phenobarbital/valproic , quinidine/lidocaine and valproic acid/phenobarbital	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, methotrexate, and increased toxicity.	DDI-mechanism
warfarin clinically significant @DRUG$ on @DRUG$ pharmacokinetics anticoagulant activity .	DDI-false
concomitant performed @DRUG$ doses of 1 mg or more concomitantly used in studies with acetaminophen , acetylsalicylic acid , a-blockers , ( anticonvulsants blockers , nitrates diuretics , antagonists , reductase , prostaglandin synthetase referred to as @DRUG$ and quinolone evidence significant interactions .	DDI-false
, an effect on microsomal enzyme systems been to reduce hepatic of @DRUG$ phenytoin , diazepam , certain antidepressants @DRUG$ theophylline and blood levels these	DDI-false
( co-administered with @DRUG$ 5 resulted in in @DRUG$ 13-fold in vardenafil .	DDI-false
Other Drugs Drugs such @DRUG$ disopyramide , , @DRUG$ , and tricyclic be with QT-interval and an risk	DDI-false
@DRUG$ : Chloramphenicol , @DRUG$ , or tetracyclines interfere with the bactericidal effect of penicillins .	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Administration @DRUG$ during therapy with @DRUG$ been to stimulating   in some .	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-advise
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ serum be monitored adjustments considered given both theophylline and @DRUG$.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : individuals plasma atorvastatin approximately 40 % with @DRUG$ erythromycin , a known cytochrome P450 3A4	DDI-false
inhibitors include azole ciprofloxacin , @DRUG$ , doxycycline imatinib , isoniazid nicardipine , , inhibitors , @DRUG$.	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, valproate, topiramate, or @DRUG$.	DDI-false
Cardiovascular : @DRUG$ enalapril IV have with beta agents , methyldopa , nitrates , @DRUG$ , hydralazine , prazosin digoxin of adverse interactions	DDI-false
Quinolones, including @DRUG$, may enhance the effects of oral @DRUG$, including warfarin or its derivatives or similar agents.	DDI-effect
, therapy with @DRUG$ @DRUG$ should not require	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Benzthiazide may interact with @DRUG$, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
of effects with @DRUG$ @DRUG$ minimized by either discontinuing the diuretic or increasing the intake initiation treatment enalapril or	DDI-false
@DRUG$ (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Other Cardiovascular @DRUG$ have been concomitantly with adrenergic-blocking agents , @DRUG$ , hydralazine , .	DDI-false
Acid-catalyzed ethanolysis of @DRUG$ in anhydrous and aqueous @DRUG$ solutions.	DDI-mechanism
- @DRUG$ ( e.g. Mexate ) of methotrexate @DRUG$ may increase the chance side affecting effects of	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
In a pharmacokinetic interaction study with @DRUG$, bioavailability parameters, the degree of protein binding, and the anticoagulant effect (measured by prothrombin time) of @DRUG$ were not significantly changed.	DDI-false
@DRUG$ @DRUG$ 20 , co-administered with slow-release nifedipine 30 or daily did affect the bioavailability ( ) maximum ( Cmax nifedipine , a metabolized via CYP3A4 .	DDI-false
Other Although specific were doses mg or more were used in clinical with acetaminophen , @DRUG$ , a-blockers , angiotensin-converting inhibitors , blockers blockers nitrates diuretics , @DRUG$ reductase inhibitors prostaglandin synthetase inhibitors ( NSAIDs and without evidence significant adverse .	DDI-false
@DRUG$ : concentrations atorvastatin approximately 25 % when colestipol and @DRUG$ coadministered .	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$ inhibited	DDI-mechanism
study concomitant 12 @DRUG$ resulted of more 22 % for 40 for Cmax compared to @DRUG$ .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with @DRUG$ containing antacids for at least 4 hours following ethambutol administration.	DDI-advise
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, @DRUG$, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
have performed , drugs are mainly metabolized ( @DRUG$ dapsone , disopyramide , quinine amiodarone , , , carbamazepine , fentanyl alfentanyl @DRUG$ , and may have elevated when coadministered with ;	DDI-false
, the than the number @DRUG$ or users .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ add to or potentiate the therapeutic other	DDI-effect
Use with @DRUG$ The use @DRUG$ hypertension in on been reported to severe leukopenia	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Antiarrhythmics: @DRUG$, bepridil, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Colestipol-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
clinical studies with Fondaparinux , the oral anticoagulants ( warfarin , inhibitors @DRUG$ ( ) , @DRUG$ not the fondaparinux	DDI-false
No Interactions To Levosimendan not have clinically pharmacokinetic felodipine @DRUG$ , warfarin , mononitrate , @DRUG$ or	DDI-false
Glyburide: The concomitant administration of @DRUG$ with the sulfonylurea @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Although specific studies have been that by calcium channel disopyramide amiodarone quinidine , warfarin , tacrolimus cyclosporine @DRUG$ , , carbamazepine fentanyl , alfentanyl alprazolam and @DRUG$ elevated plasma concentrations when saquinavir	DDI-false
@DRUG$ taken concomitantly with quinidine increases @DRUG$ serum concentration by 33% after two days.	DDI-false
and (ii) the effects of @DRUG$ were more efficiently inhibited by added cholesterol, the major membrane sterol in human cells, whereas the effects of @DRUG$ were more efficiently inhibited by ergosterol, the major membrane sterol in yeast.	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between temazepam (a @DRUG$) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
@DRUG$ In receiving diflunisal and @DRUG$ significant were seen or fasting blood	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Oral @DRUG$: Pharmacokinetic drug-drug interactions between @DRUG$ and warfarin (7.5 mg single oral dose) have not been demonstrated.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, opiates, and @DRUG$.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Important Interactions To Levosimendan important interactions with captopril @DRUG$ , felodipine , , mononitrate , @DRUG$ , ethanol itraconazole .	DDI-false
@DRUG$ increases enterohepatic elimination of amiodarone and may reduce its serum levels and @DRUG$/2.	DDI-false
CYP3A4 as @DRUG$ @DRUG$ indinavir , saquinavir , erythromycin etc ) the budesonide should .	DDI-false
In the present study, the @DRUG$ clozapine was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
include diuretics @DRUG$ , products , , , phenytoin acid @DRUG$ calcium , .	DDI-false
Since the therapeutic range of @DRUG$ is narrow theophylline serum levels should be monitored closely, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-mechanism
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and @DRUG$ with transdermal fentanyl may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
concomitant Although studies not finasteride used clinical studies @DRUG$ , a-blockers , enzyme ( ACE ) , benzodiazepines blockers , @DRUG$ , nitrates diuretics , H2 antagonists , HMG-CoA , prostaglandin synthetase inhibitors referred as ) , and quinolone anti-infectives evidence clinically .	DDI-false
Physiological @DRUG$ supplementation ( 5 mg/kg/day and can carried in the or one : failure	DDI-false
@DRUG$ @DRUG$ receptors thus the amphetamines	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
local anesthetic @DRUG$ or norepinephrine to patients receiving @DRUG$ tricyclic antidepressants phenothiazines may produce prolonged or .	DDI-effect
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
Accutane @DRUG$ avoided because @DRUG$ use has been associated a number cases of pseudotumor cerebri intracranial hypertension , some of use	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
CONCOMITANT THERAPY Although studies were not , , @DRUG$ was concomitantly enzyme ( ACE ) @DRUG$ , blockers , , and drugs NSAIDs ) without evidence clinically .	DDI-false
@DRUG$ : normal of and hydrochlorothiazide in plasma of	DDI-false
Although shown to side effects renal insufficiency , hyperbilirubinemia , dyspnea administration @DRUG$ may the antitumor effectiveness of PROLEUKIN and thus be avoided @DRUG$ and other may potentiate the hypotension seen with	DDI-false
Then the effects of metabotropic ( ) @DRUG$ , on the changes @DRUG$	DDI-false
@DRUG$: Amphetamines may delay intestinal absorption of @DRUG$.	DDI-false
Specific studies have confirmed these effects with sevoflurane, @DRUG$, @DRUG$, alfentanil, and midazolam.	DDI-false
Cardiovasculars: @DRUG$: In patients receiving @DRUG$ therapy, administration of oral amiodarone regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect.	DDI-false
Antihypertensives : should with caution patients   -receptor blocking agents , @DRUG$ calcium e.g. , @DRUG$ , CYP3A4 substrate diltiazem a CYP3A4 inhibitor ) of the possible of sinus AV block ;	DDI-false
It is recommended to avoid concurrent administration of ethambutol with @DRUG$ containing @DRUG$ for at least 4 hours following ethambutol administration.	DDI-false
- Anabolic steroids nandrolone [ , Anabolin @DRUG$ e.g. @DRUG$ oxymetholone [ e.g. Anadrol ] , e.g. Winstrol ] )	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Antihypertensive medications, other, especially @DRUG$, or pre@DRUG$ and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
No Interactions Levosimendan does not have clinically pharmacokinetic , beta-blockers , @DRUG$ , @DRUG$ , mononitrate ethanol or itraconazole	DDI-false
to exceed single 5 mg dose of @DRUG$ in a 24-hour when combination with	DDI-advise
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
specific drug topical drugs systemic were in of @DRUG$ 0.5 Ophthalmic , the possibility an additive potentiating depressants ( , , @DRUG$ should considered	DDI-advise
The hypoglycemic @DRUG$ may be by @DRUG$ and that bound , chloramphenicol probenecid coumarins , , beta blocking	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ known to slow metabolism carbamazepine and levels levels concurrent administration with @DRUG$ and symptoms of toxicity should , appropriate dosage adjustment anticonvulsant should .	DDI-false
ibogaine ( mg/kg , 18-MC ( 40 the of @DRUG$ and the oral of @DRUG$ rats	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
Although to examine done that @DRUG$ or ACTH treatment relapses for periods up days been patients ( N=180 )	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
@DRUG$-based regimens may have advantages @DRUG$-based , including more convenient administration regimens , lower tablet fewer drug , nervous system penetration .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Co-medications that CYP3A4 ( e.g. dexamethasone , @DRUG$ , , @DRUG$ , phenobarbital or	DDI-false
assessed in clinical pharmacokinetic ( @DRUG$ , @DRUG$ , oral contraceptive digoxin , probenecid and through pharmacokinetic in clinical in	DDI-false
: diabetic @DRUG$ @DRUG$ , on or blood	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ apparently through microsomal systems , reported the hepatic metabolism phenytoin , propranolol , @DRUG$ , certain tricyclic , delaying elimination blood	DDI-mechanism
Antidepressants Amphetamines may enhance the of @DRUG$ @DRUG$ ;	DDI-false
Since higher doses of @DRUG$ (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should not be exceeded in a 24-hour period when used in combination with @DRUG$ 400 mg daily.	DDI-false
a study healthy significant pharmacokinetic interaction occurred when @DRUG$ @DRUG$ administered concomitantly for 6 days .	DDI-false
It is concluded that @DRUG$ and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
To determine whether injection of thiosulfate would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
: @DRUG$ patients receiving digoxin administration regularly in an increase in @DRUG$ that toxic levels with clinical	DDI-false
Pharmacokinetic pharmacodynamic not been between Argatroban and administered @DRUG$ ( and hours prior to initiation of @DRUG$ 1 . 4 hours acetaminophen mg given and hours to 6 subsequent ,   g/kg/min . over hours .	DDI-false
Vitamin the relationship of Accutane to @DRUG$ , should advised @DRUG$ containing vitamin to	DDI-false
specific not performed coadministration that are mainly ( , blockers @DRUG$ , amiodarone cyclosporine , , pimozide carbamazepine fentanyl alfentanyl @DRUG$ triazolam ) may have elevated plasma with saquinavir	DDI-false
specific studies not been with drugs that are by ( eg blockers , dapsone disopyramide , quinine , @DRUG$ , warfarin tacrolimus , @DRUG$ pimozide , carbamazepine , fentanyl alfentanyl and triazolam elevated concentrations saquinavir	DDI-false
drugs include thiazides and corticosteroids , , thyroid products , , oral contraceptives , , @DRUG$ sympathomimetics channel blocking drugs	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, fluoxetine, and @DRUG$.	DDI-advise
interact @DRUG$ thinners decongestant ( , cold , medicines diabetic , lithium @DRUG$ , Aleve or Ibuprofen , pressure .	DDI-false
Hypersensitivity been in receiving combination sequential high dose @DRUG$ , , tamoxifen @DRUG$.	DDI-false
Coadministration of Itraconazole and @DRUG$, tacrolimus or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Test Interaction @DRUG$ for may occur with @DRUG$ Benedicts solution Fehlings solution , tablets not with based such as Clinistix Glucose Test Strip	DDI-false
In general are drugs that one or more activities to @DRUG$ , anti-arrhythmic such quinidine procainamide , @DRUG$ and tricyclic anti-depressants	DDI-false
@DRUG$ and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the @DRUG$ effect by flumazenil.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Antidiabetic drugs: (oral agents and @DRUG$) - dosage adjustment of the @DRUG$ may be required.	DDI-false
@DRUG$ Vardenafil ( and 20 did in bleeding time @DRUG$ mg tablets .	DDI-false
@DRUG$ The concomitant use DURAGESIC   ( system with central nervous including not to , sedatives , ( benzodiazepines general @DRUG$ , skeletal relaxants , alcohol , cause respiratory depression hypotension , and , result in coma or .	DDI-false
@DRUG$ have reported to effects @DRUG$ warfarin or .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
of myopathy during treatment drugs of this class is increased cyclosporine acid derivatives , @DRUG$ ( nicotinic acid ) , @DRUG$ , azole antifungals .	DDI-false
At of 33 months combination @DRUG$ demonstrate efficacy benefit when @DRUG$ as well as in the hormone receptor-positive	DDI-false
Example include antifungals , , @DRUG$ , diclofenac , , erythromycin , @DRUG$ isoniazid nefazodone nicardipine , , , verapamil	DDI-false
@DRUG$ Amiodarone be with caution   agents , propranolol @DRUG$ ( e.g. verapamil , a substrate , diltiazem , CYP3A4 ) because potentiation of bradycardia and block ;	DDI-false
Lack of an effect of azithromycin on the disposition of @DRUG$ and @DRUG$ in HIV-infected patients.	DDI-false
Tagamet effect on microsomal , to reduce the hepatic metabolism @DRUG$ , @DRUG$ nifedipine , chlordiazepoxide , , certain tricyclic , lidocaine , metronidazole thereby delaying elimination and blood of drugs	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with @DRUG$	DDI-advise
, you mouth ) Use of @DRUG$ sulfapyridine of side affecting the blood and/or side effects @DRUG$	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ Vardenafil 10 mg was given healthy or hours 10 mg of @DRUG$ in .	DDI-false
Stavudine @DRUG$ Ribavirin the in @DRUG$ HIV	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
@DRUG$ as potent @DRUG$ of glucocorticoid-induced mouse mammary tumor virus gene expression.	DDI-false
Coingestion of acetaminophen @DRUG$ phenobarbital acetaminophen , and valproic @DRUG$ at to decreases the of .	DDI-false
@DRUG$ The of @DRUG$ may be inhibited by	DDI-false
Although studies have performed are metabolized eg , calcium blockers , @DRUG$ , quinidine , @DRUG$ tacrolimus , cyclosporine ergot derivatives , carbamazepine , alfentanyl triazolam may elevated plasma concentrations when	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: Concurrent administration of aspirin may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
have not , with drugs mainly eg calcium blockers , dapsone disopyramide , quinine amiodarone quinidine , warfarin , tacrolimus , , ergot @DRUG$ , alprazolam , @DRUG$ ) may elevated when with ;	DDI-false
crossover study in receiving either mg q.i.d with a 300 dosage of @DRUG$ ( Theo-Dur Key Inc. ) demonstrated steady-state @DRUG$ peak levels the mg . particularly in years and older .	DDI-false
diuretics ( , spironolactone , @DRUG$ ) @DRUG$-containing substitutes may in potassium	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, @DRUG$, and CYP3A4.	DDI-false
Although studies , coadministration that are metabolized , , , quinine , @DRUG$ quinidine cyclosporine , derivatives pimozide , carbamazepine , @DRUG$ ) have elevated when saquinavir	DDI-false
, or products containing or , or with or hours , the of @DRUG$ , they may interfere with absorption resulting in lower and urine of	DDI-false
In the presence of these methylxanthines, larger doses of @DRUG$ may be required or @DRUG$ may not be effective.	DDI-false
@DRUG$ , , @DRUG$ , and midazolam been demonstrated .	DDI-false
Patients taking low-dose @DRUG$ plus @DRUG$ were not studied.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, @DRUG$, @DRUG$), though this has not been studied	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and @DRUG$, cardiac glycosides and @DRUG$.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and erythromycin with transdermal @DRUG$ may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-mechanism
Other Drug Interactions   did not the pharmacokinetics of @DRUG$ containing 0.03 mg ethinyl @DRUG$ , or of the progesterone indicating that of efficacy is	DDI-false
@DRUG$ and of amiodarone concentration @DRUG$ should .	DDI-false
Urinary acidifying agents These agents ( @DRUG$ , acid phosphate . the of ionized of the @DRUG$ , thereby urinary	DDI-mechanism
Theophylline : with @DRUG$ concurrent administration with theophylline may serum concentrations of @DRUG$ of its elimination half-life	DDI-false
@DRUG$, including norfloxacin, may enhance the effects of oral anticoagulants, including @DRUG$ or its derivatives or similar agents.	DDI-effect
@DRUG$ nondepolarizing , @DRUG$ increased responsiveness to the muscle relaxant	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ ( mg b.i.d had no on concentration of vardenafil when co-administered with 20 mg @DRUG$ healthy .	DDI-false
: The concomitant administration and naproxen had effect the plasma of @DRUG$ but significantly urinary excretion of @DRUG$ its glucuronide metabolite	DDI-false
@DRUG$ or with activity - anticholinergic may potentiated when these used with @DRUG$ ;	DDI-false
@DRUG$/@DRUG$ Pharmacokinetic or demonstrated between Argatroban and administered aspirin 162.5 orally 26 and initiation of g/kg/min . 4 ) ( 1000 mg , hours , 6 and 12 subsequent to , initiation of Argatroban g/kg/min hours ) .	DDI-false
Again @DRUG$ the in glycemia after @DRUG$ in non-diabetic rats	DDI-false
Tagamet , on certain microsomal has to hepatic of , phenytoin , @DRUG$ , nifedipine @DRUG$ , diazepam , lidocaine and elimination levels of these .	DDI-false
Caution should be exercised when @DRUG$ are given in conjunction with @DRUG$.	DDI-advise
Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of @DRUG$ resulting in an eight-fold increase in the mean AUC of @DRUG$.	DDI-false
@DRUG$ : Chloramphenicol , , or @DRUG$ may interfere bactericidal penicillins .	DDI-false
@DRUG$ reduce renal clearance @DRUG$ a high risk of	DDI-mechanism
drugs the and other diuretics , products , @DRUG$ contraceptives , , nicotinic , , @DRUG$ , and .	DDI-false
This time window is different than for other oral formulations of @DRUG$, which are usually administered 2 hours before or 6 hours after @DRUG$.	DDI-advise
interactions following of drugs ( e.g. , narcotics , , @DRUG$ , @DRUG$ , tranquilizers	DDI-false
@DRUG$, tricyclic Amphetamines may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-false
Thus, smaller doses of @DRUG$ may be effective in the presence of @DRUG$.	DDI-effect
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
While all the @DRUG$ e.g. citalopram , escitalopram , and @DRUG$ , P450 2D6 may vary in extent of inhibition	DDI-false
concomitant use of CYP3A4 inhibitors such as and @DRUG$ with @DRUG$ result in increase in concentrations , increase drug and may cause respiratory	DDI-mechanism
should a short-acting inhaled   @DRUG$ as @DRUG$ should such medication instruct patient in how should ) .	DDI-false
@DRUG$, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Edema has been reported in patients concomitantly receiving @DRUG$ and @DRUG$.	DDI-effect
In the are taking @DRUG$ @DRUG$ doses of digoxin	DDI-advise
The of @DRUG$ @DRUG$ norepinephrine patients receiving monoamine oxidase inhibitors or antidepressants may prolonged .	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane, @DRUG$, @DRUG$, and midazolam.	DDI-false
Single doses of @DRUG$ resins bind @DRUG$ from the 85 and 43 respectively	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Intravenous has been effectively administered in the presence cardioactive , such as @DRUG$ beta-adrenergic agents calcium blocking , and @DRUG$ , without any in adverse reaction profile	DDI-false
resulting from cholinergic blockade when is administered with other @DRUG$ , amantadine , haloperidol , phenothiazines @DRUG$ antidepressants .	DDI-false
Cation-Containing Products : a ciprofloxacin multivalent cation-containing products magnesium or @DRUG$ , @DRUG$ , VIDEX tablets or powder , or products containing iron or may substantially absorption in serum urine lower than desired .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
There no any interactions @DRUG$ and	DDI-false
pressor of @DRUG$ as dopamine @DRUG$ are enhanced Tosylate .	DDI-false
Moreover interaction studies with @DRUG$ have demonstrated effect fluvastatin levels , administration to resulted in difference in bioavailability of @DRUG$ to data .	DDI-false
Plasma @DRUG$ be monitored and @DRUG$ co and appropriate dosage adjustments of be made .	DDI-false
@DRUG$ levels patients @DRUG$ and PEGASYS .	DDI-false
Additionally higher expected @DRUG$ levels have when they patients already	DDI-mechanism
@DRUG$ , 18-MC ( mg/kg ) decreases self-administration and the ethanol and @DRUG$ rats	DDI-false
There have been case reports of increased steady-state levels of quinidine, procainamide, and @DRUG$ during concomitant therapy with @DRUG$.	DDI-false
no have conducted concomitant @DRUG$ may alter @DRUG$ ;	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$ @DRUG$ ( 1000 twice of and .	DDI-false
Although there are no study data to evaluate the possibility, @DRUG$, including sodium nitroprusside and nitroglycerin, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
In addition, higher-than expected steady-state serum concentrations of @DRUG$ have been observed when therapy is initiated in patients already taking @DRUG$.	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
@DRUG$ and rarely associated with ventricular combined @DRUG$.	DDI-effect
@DRUG$ concomitantly with @DRUG$ to decreases serum concentrations and desethylamiodarone	DDI-false
Therophylline : recent has shown administration of @DRUG$ cause elevated of @DRUG$ , in some a slight decrease the	DDI-false
Moreover , additional studies @DRUG$ have demonstrated any levels and to patient receiving @DRUG$ resulted difference extent digoxin relative to data .	DDI-false
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
@DRUG$ : In a clinical , an hydroxide magnesium , ) @DRUG$ serum urinary compared administered suggesting antacids impair absorption of fosinopril	DDI-false
Acetaminophen report of severe @DRUG$ was in patient	DDI-effect
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
studies have not , drugs that mainly by eg , channel blockers , dapsone , quinine , warfarin , cyclosporine , @DRUG$ , @DRUG$ , and have elevated plasma concentrations saquinavir ;	DDI-false
Patients @DRUG$ treatment be monitored @DRUG$ is introduced withdrawn .	DDI-advise
This the this kind with @DRUG$ theoretically other drugs cardiac conduction eg , anti-arrhythmic or beta-adrenergic blocking , calcium blockers , @DRUG$ , tricyclic might contribute a prolongation the .	DDI-effect
@DRUG$ : @DRUG$ may reduce diflunisal .	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
@DRUG$ with alcohol , decongestant ( allergy medicines ) diabetic drugs , lithium , , @DRUG$ like Aleve Ibuprofen , and medications	DDI-int
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Garlic should used taking @DRUG$ @DRUG$ inhibitor due risk saquinavir plasma	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Orlistat-@DRUG$ may decrease the absorption of @DRUG$.	DDI-mechanism
@DRUG$: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-false
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated @DRUG$ plus @DRUG$ 25 mg daily, as compared to those taking ibuprofen 2400 mg daily alone.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
@DRUG$ ( nandrolone [ e.g. Anabolin , @DRUG$ [ e.g. ] , oxymetholone Anadrol , e.g.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
drug between @DRUG$   and AEDs ( , lamotrigine phenobarbital , , primidone and @DRUG$ ) were assessed evaluating the concentrations levetiracetam and placebo-controlled clinical studies .	DDI-false
Reciprocal interactions with the cytochrome phenytoin , , @DRUG$ , @DRUG$ this has been	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
, @DRUG$ other ( used for angina or other drugs , if possible ,	DDI-advise
@DRUG$ taken concomitantly procainamide for less than @DRUG$ n-acetyl % ,	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Multivitamins, or other products containing @DRUG$ or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
, time course of @DRUG$ @DRUG$ , glutethimide investigated in	DDI-false
Cardiac Glycosides: In a study of young healthy male subjects no evidence of a direct pharmacokinetic @DRUG$-@DRUG$ interaction could be found.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
A potential interaction between oral @DRUG$ and oral @DRUG$ hypoglycemia has been reported .	DDI-int
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
evaluate the of HAART on of patients , systemic lymphoma HIV-NHL ) compared retrospectively HIV-NHL treated @DRUG$ and ) chemotherapy plus a 80 patients were CHOP chemotherapy a CHOP-like i.e. , , @DRUG$ , and prednisone with vincristine plus ) antiretroviral	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Coadministration of this oral @DRUG$ did not influence the pharmacokinetics of @DRUG$.	DDI-false
interactions found @DRUG$ and or	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ : Coadministration single doses mg and @DRUG$ 20 mg daily for 7 no .	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Although specific studies have been performed , with drugs that by , calcium , @DRUG$ , , quinidine warfarin tacrolimus cyclosporine , derivatives @DRUG$ , , fentanyl , , and triazolam may elevated coadministered with saquinavir	DDI-false
impact of chemotherapy plus HAART on the course of patients with HIV-related systemic non-Hodgkin ) compared retrospectively of 24 HIV-NHL with cyclophosphamide , , vincristine , and CHOP plus HAART with were treated CHOP chemotherapy i.e. , , @DRUG$ , and vincristine bleomycin receiving @DRUG$ .	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered radiographic iodinated contrast media experienced acute, atypical adverse reactions.	DDI-false
Antihypertensives : Amiodarone used in   ( , ) @DRUG$ antagonists e.g. , verapamil , @DRUG$ substrate , , inhibitor of the possible potentiation of bradycardia , arrest , AV ;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Longitudinal assessment of @DRUG$ in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on @DRUG$.	DDI-false
Intravenous ( been effectively administered in the cardioactive drugs @DRUG$ , agents @DRUG$ and angiotensin , any change in the profile .	DDI-false
@DRUG$ Meclofenamate sodium effect @DRUG$.	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
No significant interactions were found between nisoldipine and @DRUG$ or @DRUG$.	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
@DRUG$ excess decrease of @DRUG$ and an deficiency the effect	DDI-false
Amiodarone taken concomitantly @DRUG$ plasma @DRUG$ and n-acetyl % ,	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine phenobarbital/valproic theophylline/acetaminophen , and valproic .	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
No data are available for the coadministration of @DRUG$/ritonavir or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of @DRUG$	DDI-effect
Prostatic a of basal medium @DRUG$ ) @DRUG$ ( 10 ng/ml , and insulin ( micrograms/ml ) .	DDI-false
Antagonists Infarction)- EPHESUS ( patients 25 mg also received ACE inhibitors antagonists @DRUG$/@DRUG$ ) .	DDI-false
In the study , of 0.2 @DRUG$ and cholestyramine resulted in AUC and for when to dosing @DRUG$	DDI-false
@DRUG$ had no significant effect on @DRUG$ pharmacokinetics.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Example inhibitors azole antifungals @DRUG$ clarithromycin @DRUG$ , , isoniazid , nefazodone nicardipine , propofol , , quinidine verapamil .	DDI-false
Valproate @DRUG$   ( 1500 mg daily ) did the @DRUG$	DDI-false
studies Fondaparinux the use @DRUG$ ( , ( acid , ( piroxicam digoxin did not affect @DRUG$.	DDI-false
, through an on certain microsomal enzyme has been reported reduce the metabolism anticoagulants propranolol , @DRUG$ , diazepam , antidepressants lidocaine , @DRUG$ and , delaying elimination increasing blood levels of these	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with COPEGUS, @DRUG$ treatment did not affect ribavirin distribution or clearance.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
@DRUG$ in large amounts may counteract the antiepileptic effect of phenobarbital, @DRUG$ and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and quinidine.	DDI-advise
In patients receiving @DRUG$ and a steroid concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
@DRUG$: May decrease renal tubular secretion of ampicillin resulting in increased blood levels and/or @DRUG$ toxicity.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Interaction with @DRUG$ , lidocaine and @DRUG$ has produce adverse clinical effects .	DDI-false
Administration of @DRUG$ concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and desethylamiodarone.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Ergot Derivatives: @DRUG$, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
These include the and , phenothiazines products estrogens oral @DRUG$ @DRUG$ sympathomimetics blocking drugs , isoniazid	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ may with drugs known to the formulation of @DRUG$.	DDI-false
No Date Levosimendan have important pharmacokinetic interactions with captopril beta-blockers @DRUG$ , carvedilol @DRUG$ itraconazole	DDI-false
Aspirin/Acetaminophen : have between concomitantly administered 162.5 mg 26 2 to of Argatroban 1   g/kg/min hours ) or @DRUG$ mg orally given 6 0 hours prior and 6 and 12 subsequent initiation of @DRUG$ 1.5 g/kg/min . 18 )	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ : Coadministration of @DRUG$ AUC for and ethinyl 30 %	DDI-false
Therefore, a starting daily dose of 25 mg of @DRUG$ should be considered for the treatment of osteoarthritis when @DRUG$ is co-administered with potent inducers of hepatic metabolism.	DDI-false
that cause elevation in pH @DRUG$ such as @DRUG$ ) may reduce of and potentially reduce efficacy	DDI-false
This be with , although theoretically of known to conduction eg anti-arrhythmic @DRUG$ blockers , @DRUG$ H1-blocking tricyclic contribute to a of the interval	DDI-false
Other strong of CYP3A4 , @DRUG$ , troleandomycin , @DRUG$ , nelfinavir would be behave similarly .	DDI-false
is had on plasma concentrations of carbamazepine valproate , @DRUG$ , or	DDI-false
: and CYP3A4 substrate @DRUG$ is almost always patients amiodarone and can in fatal .	DDI-false
Azithromycin had on of @DRUG$ significantly @DRUG$ tmax by and increased intracellular exposure to phosphorylated %	DDI-false
@DRUG$ @DRUG$ produces psychotomimetic in .	DDI-false
It is other currently reductase inhibitors ( @DRUG$ , @DRUG$ leading to to the agents this class .	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
groups ( ) were submitted to daily synthetic hydroalcoholic , @DRUG$ @DRUG$ acetaldehyde same as those found in alcoholic ;	DDI-false
With of @DRUG$ 20 mg @DRUG$ 2 9 a standing blood pressure of less than Hg .	DDI-effect
Drugs that significant sustained in gastric histamine as @DRUG$ or @DRUG$ ) may plasma of IRESSA and therefore .	DDI-false
Drug-drug interactions have not been between @DRUG$ @DRUG$	DDI-false
Acetaminophen, @DRUG$, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
The administration local anesthetic solutions @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors , antidepressants or @DRUG$ produce severe , prolonged hypotension hypertension .	DDI-effect
Quinolones, including norfloxacin, may enhance the effects of oral @DRUG$, including @DRUG$ or its derivatives or similar agents.	DDI-false
@DRUG$: Haloperidol blocks dopamine receptors, thus inhibiting the central stimulant effects of @DRUG$.	DDI-false
Corticosteroids Methylxanthines and Concomitant with @DRUG$ , or diuretics possible of @DRUG$	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The intensity , course by phenobarbital , , @DRUG$ and methaqualone were in 16 @DRUG$ therapy .	DDI-false
Nephrotoxicity has been following concomitant administration @DRUG$ or potent diuretics as	DDI-false
Drugs That @DRUG$ ) Racemic @DRUG$ exposure by concomitant useof rifampicin CYP3A4 .	DDI-false
@DRUG$ : Amiodarone should be with caution patients receiving blocking ( , ) or calcium antagonists ( a , and @DRUG$ , inhibitor ) because the possible of , sinus and AV ;	DDI-false
apparently an certain been to hepatic metabolism @DRUG$ phenytoin , propranolol , @DRUG$ , certain , , elimination and of these	DDI-false
Although studies coadministration drugs that are mainly metabolized CYP3A4 calcium , @DRUG$ disopyramide quinine , , @DRUG$ , , , ergot pimozide , fentanyl alfentanyl , alprazolam and elevated saquinavir ;	DDI-false
@DRUG$ In patients @DRUG$ and increased approximately 50 24 after with co-administration erythromycin , a known of 3A4 .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, @DRUG$, nicardipine, and nifedipine.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-effect
, patients under @DRUG$ therapy monitored concomitant @DRUG$ .	DDI-advise
Use Angiotensln Enzyme : of @DRUG$ to @DRUG$ been reported induce severe	DDI-effect
Cation-Containing Products : administration of a , @DRUG$ multivalent products as magnesium aluminum antacids sucralfate , tablets or pediatric powder , products containing calcium @DRUG$ , or zinc decrease the absorption of , resulting in serum levels considerably lower .	DDI-mechanism
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
increased risk of adverse patients who have @DRUG$ on regular basis it particularly that physicians query their about , @DRUG$ sedative use part of the to in ROMAZICON is	DDI-false
Warfarin: The effect of @DRUG$ on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG-DRUG$.	DDI-false
@DRUG$ should be administered with caution to patients receiving Antabuse (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-advise
valproate concentration should be monitored @DRUG$ and @DRUG$ co , and appropriate adjustments be made	DDI-advise
been tested man digoxin , @DRUG$ , @DRUG$ and no interactions	DDI-false
ACE Inhibitors and Angiotensin II Receptor (Hypertension)- In studies of with , the INSPRA to to @DRUG$ @DRUG$ increased serum slightly .	DDI-false
An interaction with @DRUG$ showed of anastrozole on @DRUG$ or activity .	DDI-false
This to be clinically of this kind Mefloquine , known to cardiac conduction ( @DRUG$ or calcium channel , or H1-blocking agents @DRUG$ and phenothiazines might contribute to prolongation of the QTc interval .	DDI-false
@DRUG$ decrease the @DRUG$ ( , Lanoxicaps that into your body .	DDI-mechanism
The effects of concomitant @DRUG$ administration on the steady-state pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ and @DRUG$ have opioid and receptors , has much lower than ibogaine and receptors , and the 5-HT transporter .	DDI-false
Combination of @DRUG$ with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone.	DDI-false
were phenytoin , oral @DRUG$ warfarin , @DRUG$ ) and through screening in studies in epilepsy patients .	DDI-false
: @DRUG$ should used with caution patients agents , @DRUG$ CYP3A4 inhibitor ) calcium ( e.g. , verapamil a , diltiazem , a inhibitor of potentiation , arrest , and AV block ;	DDI-false
@DRUG$ is a neutralizing agent for @DRUG$ that protects against renal damage.	DDI-effect
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
Co-medications that CYP3A4 , , carbamazepine , @DRUG$ @DRUG$	DDI-false
Example inhibitors include azole , ciprofloxacin , diclofenac @DRUG$ , imatinib @DRUG$ , , protease , quinidine verapamil	DDI-false
Concomitant cyclophosphamide, @DRUG$, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Although there have been no formal interaction studies other than with @DRUG$, based on these in vivo and in vitro studies, it is unlikely that co-administration of a 1 mg dose of @DRUG$ with other drugs will result in clinically significant drug inhibition of cytochrome P450-mediated metabolism of the other drugs.	DDI-false
@DRUG$ @DRUG$ may or pressor effect .	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ with in patients   blocking ( e.g. , propranolol a ) channel antagonists e.g. , @DRUG$ and inhibitor because of the possible potentiation bradycardia arrest ,	DDI-false
Drug-drug interactions have not been observed between Argatroban and @DRUG$ or @DRUG$.	DDI-false
Amiodarone may CYP450 , @DRUG$ , and @DRUG$.	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
Methotrexate Renal transport methotrexate be concomitant administration of @DRUG$ , leading levels @DRUG$.	DDI-false
Elevated serum have been use @DRUG$ with @DRUG$.	DDI-mechanism
, additional studies and @DRUG$ have not demonstrated any effect on @DRUG$ plasma levels , administration a population receiving digoxin resulted in difference in the extent bioavailability of digoxin relative	DDI-false
@DRUG$ and @DRUG$ clearance were not affected co-administration of mg cerivastatin sodium .	DDI-false
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Fenfluramine slightly effect @DRUG$ e.g. @DRUG$ methyldopa , reserpine	DDI-false
Co-medications that induce ( , @DRUG$ , @DRUG$ , rifampin , phenobarbital or St.	DDI-false
High-dose @DRUG$ in concentrations above ng/mL administered with oral % increase in @DRUG$ exposure with a clearance of etoposide compared to etoposide alone .	DDI-false
Although studies been performed , coadministration with drugs that mainly by ( eg calcium channel , dapsone , @DRUG$ , amiodarone , warfarin , @DRUG$ carbamazepine , alfentanyl , alprazolam , and ) may elevated concentrations saquinavir ;	DDI-false
Suppression by @DRUG$ of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in wistar rats.	DDI-effect
- @DRUG$ (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
SINCE CONCOMITANT OF TWO LEAD TO ADMINISTERING @DRUG$ TO ON PHENYTOIN , A @DRUG$ SERUM SHOULD OBTAINED	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
That @DRUG$ Racemic exposure was decreased useof @DRUG$ , a CYP3A4 .	DDI-false
: of @DRUG$ @DRUG$ to volunteers did result in changes in time clotting compared to of warfarin placebo .	DDI-false
It may be necessary to adjust the dosage of oral @DRUG$ upon beginning or stopping @DRUG$. since disulfiram may prolong prothrombin time.	DDI-advise
Coadministration of terfenadine with @DRUG$ has led to elevated plasma concentrations of @DRUG$, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
Cholestyramine-Concomitant intake of cholestyramine and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
@DRUG$, @DRUG$, and azoles are known to cause QTc prolongation.	DDI-false
Other Although performed , finasteride doses of or more were concomitantly used in clinical acetaminophen acid a-blockers analgesics , angiotensin-converting ACE ) inhibitors , anticonvulsants benzodiazepines , , @DRUG$ , , @DRUG$ inhibitors also , anti-infectives without of adverse interactions .	DDI-false
@DRUG$ as as metabolite of , slow @DRUG$ metabolism .	DDI-false
The data suggest that @DRUG$ has a narrower spectrum of actions and will have a substantially greater therapeutic index than @DRUG$.	DDI-false
studies been coadministration with drugs mainly by CYP3A4 ( , , , , amiodarone , @DRUG$ , @DRUG$ cyclosporine ergot pimozide , fentanyl , alfentanyl , alprazolam , triazolam may coadministered with	DDI-false
of adenosine are antagonized methylxanthines as @DRUG$ and @DRUG$.	DDI-false
Molecular basis for the selective toxicity of @DRUG$ for yeast and @DRUG$ for animal cells.	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
in man include warfarin theophylline , , @DRUG$ and @DRUG$.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in vardenafil Cmax.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Methotrexate : In interaction study of patients taking @DRUG$ CELEBREX did a on of @DRUG$.	DDI-false
@DRUG$: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.	DDI-false
Rhabdomyolysis has been observed in patients receiving @DRUG$ administered alone (at recommended dosages) or concomitantly with @DRUG$ including cyclosporine.	DDI-effect
Oral Contraceptives Coadministration of atorvastatin oral contraceptive increased AUC values for @DRUG$ @DRUG$ approximately % and 20 % .	DDI-false
System Depressants : The use of DURAGESIC fentanyl transdermal system ) with including but not limited other @DRUG$ sedatives , , , phenothiazines skeletal relaxants , @DRUG$ , cause respiratory depression hypotension sedation or potentially result or death .	DDI-false
Sinus bradycardia has been with oral in with lidocaine @DRUG$ substrate given for local @DRUG$.	DDI-false
@DRUG$ : @DRUG$ have of levels and a reduction in renal clearance .	DDI-false
N-methylthiotetrazole ( cefoperazone cefotetan , @DRUG$ latamoxef ) ( .	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and @DRUG$) decrease @DRUG$ metabolism and increase gefitinib plasma concentrations.	DDI-mechanism
clinical studies with Fondaparinux , concomitant @DRUG$ ) , @DRUG$ acetylsalicylic ) , NSAIDs ( piroxicam , and did affect fondaparinux sodium	DDI-false
Other therapy not 1 or more concomitantly used in studies with , acid a-blockers analgesics angiotensin-converting inhibitors benzodiazepines , @DRUG$ , nitrates , diuretics H2 , prostaglandin synthetase referred to as ) @DRUG$ evidence of .	DDI-false
: The of administration and @DRUG$ ( verapamil , @DRUG$ peritoneal adenocarcinomas azoxymethane ( and intestinal in Wistar .	DDI-false
The intensity uniformity time of anticoagulant by phenobarbital , secobarbital , @DRUG$ , @DRUG$ were 16	DDI-false
concomitant not , doses or more concomitantly used in clinical studies with acetylsalicylic , a-blockers @DRUG$ , anticonvulsants benzodiazepines , cardiac nitrates , diuretics , antagonists @DRUG$ synthetase inhibitors also to ) and without evidence clinically adverse interactions .	DDI-false
@DRUG$ in large amounts may counteract the antiepileptic effect of @DRUG$, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
Drug-drug interactions have not been observed between @DRUG$ and digoxin or @DRUG$.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Anti-Inflammatory Drugs @DRUG$ indomethacin decreased the and significantly the plasma levels of	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
possibility @DRUG$ enalaprilat by diuretic or intake initiation treatment with @DRUG$ enalaprilat	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Concomitantly given @DRUG$ did not interfere with the absorption of a tablet of @DRUG$.	DDI-false
Compounds tested include @DRUG$ @DRUG$ diazepam aminopyrine and antipyrine .	DDI-false
These drugs include the @DRUG$ and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
SINCE THE ADMINISTRATION OF THESE TWO CAN LEAD PHENYTOIN , PRIOR TO PATIENT @DRUG$ THERAPY , A BASELINE @DRUG$ SERUM LEVEL	DDI-false
Example include azole @DRUG$ , , @DRUG$ doxycycline erythromycin , , , nicardipine , propofol protease quinidine and verapamil .	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
was significant the @DRUG$ @DRUG$ with .	DDI-false
The pressor effects of @DRUG$ such as dopamine or @DRUG$ are enhanced by Bretylium Tosylate.	DDI-false
Nervous System Depressants The of @DRUG$ transdermal other depressants , but limited to opioids , hypnotics tranquilizers , benzodiazepines ) anesthetics , @DRUG$ muscle , and alcohol may respiratory depression , hypotension sedation , or result in coma death	DDI-effect
- Anabolic steroids nandrolone , @DRUG$ , oxandrolone [ e.g. [ @DRUG$ stanozolol e.g. , Winstrol or	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Inhibit @DRUG$ P450 3A : The step in @DRUG$ metabolism 3A ( .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ : to have no effect on of @DRUG$.	DDI-false
The similarity of @DRUG$ adverse event between Study 1 co-administered 2 with co-administered AVONEX alteration clearance not necessitate of the @DRUG$ maintain	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
These results suggest that dexamethasone and retinyl acetate , and possibly other @DRUG$ , of by a of the @DRUG$ and	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
@DRUG$: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after narcotics, inhalational @DRUG$, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or @DRUG$.	DDI-effect
Warfarin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ conducted subjects , steady-state plasma increased % in receiving @DRUG$ 450 BID CELEBREX 200 mg to lithium .	DDI-false
Example include azole antifungals ciprofloxacin , clarithromycin , @DRUG$ , , erythromycin imatinib isoniazid , nicardipine , propofol @DRUG$ quinidine , .	DDI-false
Guardians children who prescribed @DRUG$ should alerted general concern especially neglect anti-inflammatory therapy of @DRUG$.	DDI-false
@DRUG$ been reported to of systemic clonidine . not the use these agents with @DRUG$ in interference the effect	DDI-false
effects were observed when @DRUG$ 20 taken	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
It is desirable to monitor @DRUG$ plasma levels whenever a @DRUG$ is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	DDI-false
@DRUG$ and @DRUG$ could exaggerate the prolongation of the QT interval observed with bepridil hydrochloride.	DDI-false
Sulfapyridine with any following @DRUG$ ( e.g. @DRUG$ ) ( , ) or	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
include other diuretics , corticosteroids phenothiazines products estrogens , contraceptives phenytoin nicotinic @DRUG$ , channel blocking drugs , @DRUG$.	DDI-false
Potassium Supplements and @DRUG$: @DRUG$ can attenuate potassium loss caused by thiazide diuretics.	DDI-false
Antihypertensives Amiodarone be used with patients   e.g. , @DRUG$ , CYP3A4 inhibitor ) calcium antagonists ( e.g. , CYP3A4 substrate @DRUG$ , a inhibitor because of the possible potentiation of bradycardia AV block ;	DDI-false
Note of of @DRUG$ in @DRUG$ model lung surfactant	DDI-false
Therefore, agents affecting sympathetic activity (e.g., @DRUG$ or @DRUG$) should be used with caution.	DDI-false
Nevertheless, the effects of @DRUG$ on travelers receiving comedication, particularly diabetics or patients using @DRUG$, should be checked before departure.	DDI-advise
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
results suggest that @DRUG$ and acetate , other and , the of prostate a dose-dependent modification activity of insulin and @DRUG$.	DDI-effect
This drug may interact or ( the effects of either antihistamines or with effects potentiated when medications used concurrently ) and @DRUG$ ( may prolong and intensify the anticholinergic depressant effects @DRUG$ .	DDI-false
The coadministration of aspirin decreases the biologic half-life of @DRUG$ because of an increase in metabolic clearance that results in a greater amount of @DRUG$ in the urine.	DDI-false
, systemic AUC0 - 12 ) DHA ) was doubled the of @DRUG$/@DRUG$.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, dexamethasone, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Therefore occur following concomitant administration drugs e.g. , @DRUG$ , antiemetics sedatives @DRUG$ ) .	DDI-false
@DRUG$ or @DRUG$ excess may the effect of , an iodine deficiency increase effect of .	DDI-false
@DRUG$ Keppra  (1500 mg twice daily) did not alter the pharmacokinetics of @DRUG$ in healthy volunteers.	DDI-false
studies performed Fondaparinux the oral anticoagulants warfarin , platelet inhibitors ( @DRUG$ ) ( piroxicam ) did significantly pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
The coadministration of @DRUG$ decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of @DRUG$ in the urine.	DDI-false
Coingestion @DRUG$ with @DRUG$ phenobarbital acetaminophen , and phenobarbital at decreases the binding drug .	DDI-effect
Use @DRUG$ detoxification @DRUG$ inhibited by allopurinol .	DDI-false
While all the @DRUG$ ( @DRUG$ ) e.g. citalopram , , fluoxetine , paroxetine , inhibit they may vary in extent inhibition .	DDI-false
Patients receiving azathioprine and @DRUG$ concomitantly should have a dose reduction of @DRUG$, to approximately 1/3 to 1/4 the usual dose.	DDI-false
@DRUG$ effects are potentiated by @DRUG$.	DDI-effect
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with alprazolam for the following: sertraline and @DRUG$.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: @DRUG$, warfarin, digoxin, Maalox, and ranitidine.	DDI-false
@DRUG$: In hypercholesterolemic patients, steady-state cerivastatin AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
Multivalent Cation-Containing Products administration a quinolone , ciprofloxacin , such as antacids , @DRUG$ chewable/buffered or pediatric products containing @DRUG$ , iron may substantially decrease absorption resulting considerably lower desired	DDI-false
Potential drug interactions between @DRUG$  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ or other iron , @DRUG$ or sucralfate concomitantly with , or , because with in urine levels of norfloxacin .	DDI-false
@DRUG$ @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of R and S warfarin.	DDI-false
Again, @DRUG$ neutralized the increase in glycemia after @DRUG$ overload both in diabetic and non-diabetic rats.	DDI-false
Although specific have not been coadministration with are mainly by CYP3A4 , channel blockers , disopyramide quinine , quinidine , , ergot derivatives pimozide fentanyl , alfentanyl , @DRUG$ , and triazolam ) have elevated plasma concentrations when with @DRUG$	DDI-mechanism
To evaluate the impact chemotherapy plus HAART clinical course of patients with ( ) , the authors compared of with were the , doxorubicin , vincristine @DRUG$ ( ) chemotherapy regimen HAART with a a i.e. , cyclophosphamide , @DRUG$ teniposide , vincristine plus bleomycin ) receiving antiretroviral therapy	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
@DRUG$: Patients on diuretics, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some @DRUG$.	DDI-false
drugs thiazides other , corticosteroids , @DRUG$ estrogens , oral contraceptives , nicotinic acid , sympathomimet-ics @DRUG$ isoniazid	DDI-false
Corticosteroids , and : Concomitant treatment @DRUG$ , @DRUG$ may potentiate a of .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
is concluded that hydrate and @DRUG$ be additional in prothrombin during oral @DRUG$ therapy	DDI-false
@DRUG$: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
Acetaminophen: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
Injection , other benzodiazepines , system administered with alcohol MAO inhibitors , other @DRUG$.When is used concomitantly @DRUG$ an sedation , hallucinations has been observed	DDI-false
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG-DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
pharmacokinetic were clinical studies ( phenytoin @DRUG$ , contraceptive , warfarin , @DRUG$ and pharmacokinetic screening clinical studies in epilepsy patients	DDI-false
from in studies of benzodiazepines alprazolam possible interaction @DRUG$ , @DRUG$ , amiodarone and	DDI-false
of 400 mg increases in AUC dose of @DRUG$ should not be a 24-hour period used in with @DRUG$ 400 mg .	DDI-advise
Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
include thiazides corticosteroids , @DRUG$ , estrogens , phenytoin , @DRUG$ , sympathomimet-ics calcium blocking ,	DDI-false
, the use @DRUG$ does not adjustment in @DRUG$ therapeutic .	DDI-false
Agents : @DRUG$ and IV have been concomitantly adrenergic-blocking @DRUG$ , , agents , , prazosin and without of adverse interactions .	DDI-false
hypoglycemic action sulfonylureas may be certain drugs nonsteroidal and that are highly protein bound salicylates chloramphenicol , probenecid , @DRUG$ inhibitors @DRUG$.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., @DRUG$]) or	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
@DRUG$ : DURAGESIC not recommended in who have received @DRUG$ within because severe potentiation MAO inhibitors has been with analgesics	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ were very completely @DRUG$-induced	DDI-effect
@DRUG$: The anorectic and stimulatory effects of @DRUG$ may be inhibited by lithium carbonate.	DDI-false
Cimetidine: @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
@DRUG$ In healthy individuals , plasma concentrations of @DRUG$ approximately 40 % coadministration of , a of P450 3A4	DDI-false
Therefore, when Hydrochlorothiazide and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.	DDI-false
Probenecid: @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of @DRUG$ in serum.	DDI-mechanism
@DRUG$ : Upon concomitant of 5 mg with 600 mg @DRUG$ and AUC of reduced by 20 .	DDI-false
A drug-drug study evaluated the use ACZONE Gel % , in combination with double strength ( 160 trimethoprim/@DRUG$ ( @DRUG$/SMX ) .	DDI-false
Nifedipine: Vardenafil 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
Note @DRUG$ in Survanta , model	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, dexamethasone, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON @DRUG$ THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
@DRUG$ no effect levels @DRUG$.	DDI-false
Co-administration of warfarin and @DRUG$ did not alter the pharmacokinetics of @DRUG$.	DDI-false
Prednisone/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or @DRUG$.	DDI-false
@DRUG$, and to a lesser extent, @DRUG$, enhanced the translocating action of oleate and increased its effectiveness in transferring the phosphohydrolase from the soluble to the microsomal fraction.	DDI-false
: recent shown that concomitan of @DRUG$ @DRUG$ may cause elevated levels , in slight the of isoniazid .	DDI-mechanism
no specific topical glaucoma or systemic medications IOPIDINE 0.5 Solution possibility of an additive or potentiating @DRUG$ ( alcohol opiates , @DRUG$ should considered	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Patients receiving hydantoins, @DRUG$, or @DRUG$ should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
@DRUG$, other, especially @DRUG$, or preanesthetic and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Although specific been performed , coadministration drugs are mainly CYP3A4 ( , calcium , disopyramide , , quinidine , @DRUG$ , @DRUG$ ergot , pimozide , carbamazepine , alprazolam , triazolam ) may have plasma concentrations with ;	DDI-false
Other therapy , finasteride doses mg or concomitantly used in clinical studies with acetaminophen acid , , analgesics angiotensin-converting ( ACE , , , beta blockers , , nitrates , , antagonists , reductase inhibitors @DRUG$ , @DRUG$ without evidence of significant interactions .	DDI-false
concomitant not , mg or more were concomitantly used studies acetaminophen acetylsalicylic acid , angiotensin-converting ( ACE ) inhibitors , @DRUG$ , blockers , blockers , cardiac nitrates , @DRUG$ , , HMG-CoA prostaglandin synthetase inhibitors also evidence of clinically significant adverse	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (@DRUG$) as the sole @DRUG$ due to the risk of decreased saquinavir plasma concentrations.	DDI-false
@DRUG$ has been to properties may the action of other	DDI-effect
Lithium : In conducted in , mean steady-state lithium plasma increased approximately subjects @DRUG$ 450 @DRUG$ mg as to receiving .	DDI-mechanism
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
Other reported with : Fentanyl @DRUG$ ) in combination with @DRUG$ cause hypotension , , decreased	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Although have reduce effects insufficiency hyperbilirubinemia , confusion and dyspnea , of these agents PROLEUKIN may antitumor effectiveness of and should be . Beta-blockers and @DRUG$ may seen @DRUG$.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
@DRUG$ : The extent of ciprofloxacin was bioequivalent when Proquin or XR was 2 @DRUG$ at dose acid secretion	DDI-false
higher of @DRUG$ ( mg ) Cmax and mg dose @DRUG$ should be 24-hour used with 400 mg	DDI-false
Although no studies have been conducted, concomitant administration of @DRUG$ and phenytoin may alter the metabolism of @DRUG$;	DDI-false
As some other @DRUG$ , administration of @DRUG$ with theophylline lead to serum concentrations prolongation elimination half-life .	DDI-false
steady state @DRUG$ @DRUG$ reported increased an 31 and 20 % , , the concomitant administration of alprazolam to	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
@DRUG$ with the	DDI-mechanism
The effects of @DRUG$ and @DRUG$ upon phencyclidine (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-false
In general , these drugs that or pharmacologic similar hydrochloride including @DRUG$ such @DRUG$ and procainamide , glycosides tricyclic anti-depressants .	DDI-false
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for apomorphine on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration.	DDI-false
: Micro-dosed @DRUG$ preparations ( minipills contain @DRUG$ ) may an method of during Accutane therapy	DDI-false
Although studies coadministration with drugs are mainly metabolized by CYP3A4 ( , @DRUG$ dapsone , , quinine amiodarone , quinidine , , tacrolimus , @DRUG$ , alprazolam triazolam may have elevated concentrations coadministered saquinavir	DDI-false
Co-administration of @DRUG$ 600 mg , , approximate 50 decrease @DRUG$ plasma .	DDI-false
@DRUG$ showed the most potent inhibition (66% inhibition at 10 microM), which was far more potent than that of crude @DRUG$.	DDI-false
strong inhibitors ( , , nefazodone , @DRUG$ ritonavir @DRUG$ ) would expected to	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
recommended to avoid administration @DRUG$ @DRUG$ containing for at least following ethambutol	DDI-advise
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other Although interaction studies were , 1 or concomitantly used in clinical with , acetylsalicylic , angiotensin-converting enzyme ( ACE ) , , calcium-channel cardiac , diuretics , @DRUG$ prostaglandin ( to as NSAIDs @DRUG$ without clinically interactions .	DDI-false
@DRUG$ serum levels should be monitored and appropriate dose adjustments considered for patients given both @DRUG$ and PEGASYS.	DDI-false
@DRUG$ with renal tubular @DRUG$ level of ciprofloxacin serum	DDI-false
@DRUG$ : Dihydroergotamine , ergonovine , ergotamine , @DRUG$ to potential for serious and such as ischemia and other .	DDI-false
Response to @DRUG$ may be enhanced by @DRUG$.	DDI-effect
Although studies not been , coadministration that mainly by CYP3A4 ( , dapsone , disopyramide , @DRUG$ , , warfarin , @DRUG$ , derivatives pimozide fentanyl , alfentanyl , alprazolam and may concentrations with saquinavir ;	DDI-false
Another @DRUG$ , , inhibits the of astemizole resulting in plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals	DDI-false
Tetracyclines: Concomitant treatment with Accutane and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
@DRUG$ @DRUG$ , well as metabolite of furazolidone , slow amphetamine metabolism .	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
This interact @DRUG$ or other CNS depressants ( may CNS depressant either these or antihistamines ) , medications anticholinergic activity effects potentiated when medications are concurrently @DRUG$ ) , monoamine oxidase concurrent antihistamines and intensify anticholinergic and depressant effects of )	DDI-false
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
These levetiracetam does not of other AEDs that these @DRUG$ not of @DRUG$.	DDI-false
drug Keppra and @DRUG$ ( , @DRUG$ , valproate were also assessed by serum concentrations levetiracetam during placebo-controlled clinical studies .	DDI-false
Omeprazole : The extent of absorption of @DRUG$ was bioequivalent @DRUG$ was given alone or when Proquin XR given hours after omeprazole at the dose maximally suppresses gastric acid	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Studies in rats shown that @DRUG$ types @DRUG$ dependent hypertension , including ACTH .	DDI-false
administered with @DRUG$ , dobutamine , @DRUG$ surfactant and high-frequency .	DDI-false
@DRUG$ metabolized CYP2C9 CYP3A4 patients require should receive low-molecular weight @DRUG$.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ on @DRUG$ , with depletion , may occasionally experience excessive blood pressure after initiation fosinopril sodium	DDI-false
Standard monitoring of @DRUG$-related toxicity should be continued if @DRUG$ and methotrexate are administered concomitantly.	DDI-false
In addition , Fondaparinux neither the of warfarin @DRUG$ , @DRUG$ , and pharmacokinetics of digoxin at steady state	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
simultaneous dosing @DRUG$ 10 mg @DRUG$ 10 6 8 subjects experienced a systolic blood pressure of less 85 mm Hg .	DDI-effect
Warfarin @DRUG$ reported to @DRUG$ .	DDI-effect
local @DRUG$ @DRUG$ patients , antidepressants or may produce severe prolonged or .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, @DRUG$, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Possible drug interactions of @DRUG$ or with other	DDI-int
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$ or @DRUG$ may produce severe, prolonged hypertension.	DDI-false
Monitoring for @DRUG$ toxicity and serial measurement of amiodarone serum concentration during concomitant @DRUG$ therapy should be considered.	DDI-false
have not , coadministration drugs are mainly eg , channel , @DRUG$ , disopyramide quinine , , @DRUG$ tacrolimus , cyclosporine , carbamazepine alfentanyl alprazolam , and triazolam may have elevated when saquinavir	DDI-false
@DRUG$ MAOI antidepressants, as well as a metabolite of furazolidone, slow @DRUG$ metabolism.	DDI-false
These drugs include @DRUG$ and other diuretics , products , contraceptives phenytoin acid , calcium channel drugs and	DDI-false
Based on the chemical resemblance of @DRUG$ and ketoconazole, coadministration of astemizole with @DRUG$ is contraindicated.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Anabolic steroids ( nandrolone [ , , @DRUG$ [ , , e.g. , @DRUG$ ] or	DDI-false
Compounds that have been tested man @DRUG$ , , @DRUG$ and warfarin and interactions found .	DDI-false
increase plasmaconcentration of metabolized e.g. triazolo-@DRUG$ , @DRUG$ HMG-CoA , etc .	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, @DRUG$, reserpine.	DDI-false
Drug : pharmacokinetic interactions between the @DRUG$ warfarin , @DRUG$ Maalox ranitidine .	DDI-false
Inhibitors II Congestive Heart Post-Myocardial Infarction)- In EPHESUS 91 % INSPRA received @DRUG$ ( @DRUG$/ARB ) .	DDI-false
Although specific interaction were not finasteride doses of or concomitantly in clinical with @DRUG$ , acid ( ) inhibitors , beta blockers @DRUG$ nitrates , antagonists HMG-CoA , prostaglandin synthetase inhibitors also referred to , and without evidence clinically significant	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-int
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
@DRUG$ A severe has reported a type II maintained tolazamide ( 1 ) 11 days the of @DRUG$ ( mg/day ) .	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, @DRUG$, ketoconazole), though this has not been studied	DDI-false
Clinical interaction studies with @DRUG$ and warfarin indicated that the coadministration of @DRUG$ with these drugs does not result in clinically- significant drug interactions.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-false
Another oral @DRUG$, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
Amiodarone bepridil , @DRUG$ @DRUG$ , CONTRAINDICATED to for serious and/or reactions .	DDI-false
@DRUG$ ( ) Use of @DRUG$ sulfapyridine may the chance of side affecting the and/or	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (@DRUG$) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
interactions were assessed in studies @DRUG$ oral contraceptive , @DRUG$ and through screening the clinical in	DDI-false
In vitro data suggest that @DRUG$, when compared to @DRUG$, has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drug Interactions : may interact some drugs like oxidase inhibitors @DRUG$ ): MAOI could theoretically affect - Arecoline - @DRUG$ Ethanol cause - Tricyclic : Flupenthixol Tricyclic antidepressants	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
Chlorpromazine: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat @DRUG$ poisoning.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
When @DRUG$ is taken concurrently with oral @DRUG$, attenuation of immunization cannot be excluded.	DDI-effect
inhibitors include @DRUG$ , ciprofloxacin @DRUG$ , doxycycline , , , isoniazid , nefazodone nicardipine , propofol , protease inhibitors verapamil .	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
This drug with or other depressants may depressant of either medications or anticholinergics anticholinergic effects be potentiated when these medications are concurrently with @DRUG$ ) and @DRUG$ ( concurrent use with intensify the anticholinergic depressant of antihistamines )	DDI-false
acid in amounts counteract antiepileptic @DRUG$ , @DRUG$ and and the seizures in susceptible pediatric patients .	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other therapy specific interaction studies were , doses of 1 mg more were clinical with @DRUG$ acid @DRUG$ ( ACE ) , beta calcium-channel blockers cardiac nitrates , H2 reductase inhibitors , also referred NSAIDs quinolone without evidence of significant adverse	DDI-false
These data that levetiracetam does influence the plasma other @DRUG$ these do influence the pharmacokinetics of	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
The safety and efficacy of @DRUG$ in combination with any @DRUG$ have not been established.	DDI-false
Adenocard has effectively in of other , as quinidine , beta-adrenergic agents @DRUG$ , and @DRUG$ , without change the reaction	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
bioavailability capsule formulation of @DRUG$ was affected when minutes following an @DRUG$.	DDI-false
Antipyrine: Because @DRUG$ does not affect the pharmacokinetics of @DRUG$, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$-@DRUG$ may sterilize the bowel and decrease the vitamin K contribution to the body by the intestinal microflora.	DDI-false
Based on the chemical resemblance of itraconazole and ketoconazole, coadministration of @DRUG$ with @DRUG$ is contraindicated.	DDI-advise
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
plasma concentrations of imipramine @DRUG$ have to increased average % , respectively by of @DRUG$ doses up to 4	DDI-mechanism
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and @DRUG$.	DDI-false
Drugs @DRUG$ plasma concentrations Drugs increase @DRUG$ concentrations when administering inhibitors the family e.g. , erythromycin clarithromycin	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
dexamethasone ) ) @DRUG$ ( 10(-8 ) - 10(-7 the of	DDI-effect
Central Nervous Depressants DURAGESIC   system with other @DRUG$ , but to @DRUG$ , sedatives ( , general anesthetics phenothiazines , relaxants may depression , sedation , or potentially result coma	DDI-false
solutions containing patients receiving @DRUG$ @DRUG$ phenothiazines may produce prolonged hypotension or hypertension	DDI-false
OTHER CONCOMITANT THERAPY specific studies were , sodium was angiotensin- , calcium-channel diuretics and @DRUG$ ( @DRUG$ evidence significant adverse interactions .	DDI-false
To evaluate the chemotherapy on the patients with HIV-related , systemic , HIV-NHL ) , the authors compared a group of 24 patients who with the cyclophosphamide , , and CHOP regimen HAART with a of 80 patients who CHOP chemotherapy a CHOP-like i.e. cyclophosphamide doxorubicin , and @DRUG$ plus @DRUG$ ) antiretroviral	DDI-false
In , bleeding been predominantly in prothrombin receiving @DRUG$ concurrently	DDI-effect
Aminosalicylic the @DRUG$ @DRUG$ , Lanoxicaps ) that gets into your	DDI-false
Drugs Demonstrated be CYP Clinical Significance on Involving @DRUG$ is during coadministration ): @DRUG$ with alprazolam increased maximum plasma concentration alprazolam by 46 % by 21 % half-life 17 % , and	DDI-false
effects @DRUG$ @DRUG$ phencyclidine (PCP)-induced locomotion behavioral in	DDI-false
Acetaminophen @DRUG$ phenobarbital , quinidine , theophylline @DRUG$ to at concentrations	DDI-false
been shown to , insufficiency , , and dyspnea concomitant administration agents may reduce antitumor effectiveness of PROLEUKIN thus avoided . 12 @DRUG$ other may the seen PROLEUKIN .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
from proposed dose is 1 100 when	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Drug Interactions : No pharmacokinetic were observed between vardenafil the drugs glyburide @DRUG$ , @DRUG$ and .	DDI-false
Levosimendan not clinically interactions with captopril , @DRUG$ felodipine warfarin mononitrate @DRUG$ .	DDI-false
may alcohol blood thinners , and ) , diabetic drugs , @DRUG$ , NSAIDs like @DRUG$ or , and pressure .	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
There have QTc prolongation with without , taking @DRUG$ when fluoroquinolones , @DRUG$ , or azoles administered	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
inhibitors activity ( eg @DRUG$ decrease @DRUG$ increase plasma concentrations .	DDI-mechanism
acetaminophen with theophylline , @DRUG$ @DRUG$ , and with to the	DDI-effect
Cholestyramine and @DRUG$ @DRUG$ Absorption of in presence of resins .	DDI-false
Acute symptoms should be treated with a short-acting, inhaled  @DRUG$ such as @DRUG$ (the physician should provide the patient with such medication and instruct the patient in how it should be used).	DDI-false
supervision careful adjustment the are required when nortriptyline hydrochloride is used with @DRUG$ @DRUG$.	DDI-false
Colestipol-Concomitant intake of @DRUG$ @DRUG$ vitamin K.	DDI-mechanism
Other : such as quinidine , @DRUG$ , procainamide , @DRUG$ , antihistamines antidepressants may be with QT-interval increased of	DDI-false
Other and enalapril been beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ @DRUG$ evidence of clinically significant interactions	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
inhibitors include antifungals ciprofloxacin , , imatinib , nefazodone , nicardipine @DRUG$ protease @DRUG$ and verapamil .	DDI-false
To evaluate impact of chemotherapy plus on of patients with HIV-related , ( HIV-NHL authors retrospectively group 24 patients with who were the , @DRUG$ and prednisone ) chemotherapy plus a of 80 were treated with CHOP chemotherapy or regimen , , , @DRUG$ , prednisone vincristine plus ) .	DDI-false
@DRUG$ @DRUG$ )	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
evaluate impact chemotherapy HAART the course patients HIV-related , non-Hodgkin lymphoma ( the authors compared group of HIV-NHL who with the , vincristine , prednisone ( ) chemotherapy a group 80 with chemotherapy CHOP-like i.e. , doxorubicin , @DRUG$ , prednisone with @DRUG$ ) .	DDI-false
@DRUG$: In normal volunteers, concomitant administration of @DRUG$ and acetaminophen resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of @DRUG$.	DDI-false
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., @DRUG$, @DRUG$, and zileuton).	DDI-false
Interactions Flupenthixol drugs MAOI ): @DRUG$ - : Flupenthixol and @DRUG$ additive : Flupenthixol the effect of Tricyclic	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$ or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$;	DDI-false
- ( e.g. @DRUG$ ) @DRUG$ with sulfapyridine affecting liver the effects of	DDI-false
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the @DRUG$ effect by @DRUG$.	DDI-false
Concurrent administration possessing nephrotoxic , , @DRUG$ , cytotoxic ) ( , @DRUG$ ) hepatotoxic ( , methotrexate ) effects PROLEUKIN may in systems	DDI-false
appears to be only relevant of with Mefloquine although coadministration of drugs known to cardiac ( or beta-adrenergic agents , calcium or , @DRUG$ @DRUG$ might also prolongation QTc	DDI-false
Example inhibitors include azole , , clarithromycin , diclofenac @DRUG$ @DRUG$ , nefazodone , protease inhibitors and verapamil	DDI-false
It is necessary to be acquainted the paraclinical pattern of @DRUG$ and discriminate @DRUG$ due to insufficient intake only requires oral supplementation magnesium related to status which requires specific of its causal dysregulation	DDI-false
@DRUG$: Co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
between carbamazepine , @DRUG$ , @DRUG$ phenytoin , primidone valproate ) were also concentrations these clinical	DDI-false
data to evaluate the , @DRUG$ @DRUG$ , an on the of developing methemoglobinemia	DDI-false
@DRUG$ : is not recommended for use within 14 unpredictable MAO has been @DRUG$	DDI-false
@DRUG$ : In arthritis taking methotrexate @DRUG$ not have effect the pharmacokinetics of methotrexate	DDI-false
Ergot Derivatives @DRUG$ @DRUG$ , ergotamine methylergonovine to potential and life-threatening acute characterized by vasospasm and other tissues	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
: Flupenthixol interact with some drugs , like Monoamine inhibitors ( MAOI @DRUG$ affect - @DRUG$ - - Flupenthixol and Ethanol cause CNS - antidepressants : increases the effect of	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Anticoagulant during the @DRUG$ @DRUG$ ;	DDI-false
@DRUG$: The effects of @DRUG$ and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-false
monitoring of @DRUG$ plasma concentrations should be considered when therapy with @DRUG$ is initiated or changed in patients	DDI-false
of @DRUG$ and the of either @DRUG$ acamprosate	DDI-false
the @DRUG$ other , phe-nothiazines , @DRUG$ , , contraceptives phenytoin , nicotinic acid , blocking isoniazid	DDI-false
Although studies , coadministration drugs that CYP3A4 eg , channel disopyramide , quinine , warfarin , cyclosporine , @DRUG$ , pimozide , @DRUG$ fentanyl , alfentanyl , have plasma concentrations when coadministered	DDI-false
Co-administration @DRUG$ , and other @DRUG$ may bleeding	DDI-effect
No data are available for the coadministration of INVIRASE/@DRUG$ or @DRUG$/ritonavir and garlic capsules.	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
@DRUG$ or other curare-like compounds ) should only be performed as the effect of @DRUG$ potentiated .	DDI-false
Combinations of @DRUG$ and @DRUG$ : on drug discrimination in	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
studies with Fondaparinux oral ( ) , platelet inhibitors ( @DRUG$ ) , @DRUG$ , did not affect sodium	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-advise
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
, ciprofloxacin diclofenac @DRUG$ , imatinib , @DRUG$ inhibitors , and .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or @DRUG$.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Cholestyramine and Absorption @DRUG$ impaired presence of	DDI-mechanism
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
studies have been performed coadministration that are mainly metabolized eg channel blockers , disopyramide quinine , amiodarone @DRUG$ warfarin , tacrolimus , ergot @DRUG$ , , and plasma coadministered saquinavir ;	DDI-false
@DRUG$ may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Injection Lorazepam , other @DRUG$ , the central nervous when administered @DRUG$ and . is injectable lorazepam increased of sedation , hallucinations , and irrational behavior been observed .	DDI-effect
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
to be clinically relevant of this @DRUG$ , , of other alter cardiac ( beta-adrenergic blocking agents channel antihistamines or H1-blocking agents @DRUG$ might QTc interval	DDI-effect
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, CYP2D6, and CYP3A4.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Other concomitant Although specific performed , of 1 mg were in clinical studies acetaminophen , acetylsalicylic a-blockers @DRUG$ enzyme ( ACE inhibitors , anticonvulsants , benzodiazepines blockers , calcium-channel cardiac H2 antagonists , HMG-CoA , prostaglandin synthetase also as NSAIDs ) and @DRUG$ without clinically interactions .	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Digoxin: When multiple doses of @DRUG$ and digoxin were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
- @DRUG$ e.g. @DRUG$ ) or	DDI-false
Therefore , interactions @DRUG$ e.g. , narcotics , , antiemetics sedatives @DRUG$	DDI-false
As the primary effect of @DRUG$ is to decrease conduction through the A-V node, higher degrees of heart block may be produced in the presence of @DRUG$.	DDI-effect
In @DRUG$ in anesthetized ketamine , , pentobarbital , the of ouabain needed to cause significantly , as was LD50 ouabain , with ketamine or @DRUG$ with	DDI-false
increase of metabolized e.g. , @DRUG$ certain @DRUG$ , etc )	DDI-false
These include the @DRUG$ , phenothiazines thyroid products , estrogens , contraceptives @DRUG$ , , channel blocking ,	DDI-false
Demonstrated be CYP Basis Studies Involving caution is recommended during coadministration @DRUG$ alprazolam increased maximum concentration of @DRUG$ 46 , clearance by , half-life and decreased measured psychomotor performance .	DDI-false
, , phenobarbital/acetaminophen , phenobarbital/valproic acid , , theophylline/acetaminophen and valproic	DDI-false
Concomitant @DRUG$, doxorubicin, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Tagamet apparently effect on microsomal enzyme , hepatic warfarin-type , @DRUG$ , chlordiazepoxide , @DRUG$ certain tricyclic lidocaine theophylline thereby elimination blood these	DDI-false
Antidepressants, @DRUG$ Amphetamines may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-false
is from the other currently HMGCoA ( @DRUG$ , @DRUG$ , and , to properties relative of	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Further , no on @DRUG$ levels or prothrombin were a study concomitant of warfarin @DRUG$.	DDI-false
Digoxin: When multiple doses of atorvastatin and @DRUG$ were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
drugs the thiazides and other , phenothiazines , @DRUG$ , oral contraceptives phenytoin , acid , calcium blocking drugs , and @DRUG$.	DDI-false
Although specific have been , with drugs that mainly CYP3A4 , calcium channel blockers , , quinine , , cyclosporine ergot @DRUG$ , carbamazepine , fentanyl @DRUG$ , and triazolam elevated when saquinavir	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
oral administration of @DRUG$ ( inhibitor of CYP3A4 activity the the ) an systemic exposure	DDI-mechanism
azole , inhibits of astemizole resulting in concentrations @DRUG$ metabolite @DRUG$ may prolong QT intervals	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although specific not been performed , coadministration with drugs are mainly metabolized CYP3A4 ( , channel blockers , @DRUG$ disopyramide , , , quinidine , warfarin , , pimozide carbamazepine , @DRUG$ alfentanyl , ) elevated plasma concentrations when coadministered saquinavir ;	DDI-false
studies sclerosis taking TYSABRI   and ( @DRUG$   mcg once ) or @DRUG$ were inconclusive with need dose glatiramer .	DDI-false
Patients receiving @DRUG$, sulfonamides, or @DRUG$ should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
Anticoagulants of warfarin-type ( and @DRUG$ ) @DRUG$ response is always seen patients receiving and in serious or bleeding .	DDI-false
OTHER CONCOMITANT : Although specific interaction studies were performed , in clinical studies cerivastatin angiotensin- converting enzyme ( ACE ) , , calcium-channel blockers , @DRUG$ @DRUG$ ( ) adverse interactions .	DDI-false
and have been compared triple the PI 48 @DRUG$ superiority	DDI-false
: such , , @DRUG$ , , @DRUG$ tricyclic may associated with prolongation an risk ventricular arrhythmia .	DDI-false
No Important Interactions Date @DRUG$ have clinically pharmacokinetic with , beta-blockers , , @DRUG$ , warfarin mononitrate , carvedilol ethanol or itraconazole	DDI-false
@DRUG$: @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.	DDI-false
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., amitriptyline, @DRUG$, and @DRUG$).	DDI-false
Glyburide : The @DRUG$ sulfonylurea @DRUG$ has , resulted hypoglycemia .	DDI-effect
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
@DRUG$ may interfere with the absorption of @DRUG$.	DDI-mechanism
Potentiation occurs with @DRUG-DRUG$.	DDI-false
@DRUG$ : , the administration of a anti-inflammatory the diuretic , , and antihypertensive of loop , potassium-sparing @DRUG$.	DDI-false
These drugs @DRUG$ corticosteroids thyroid , oral , nicotinic acid , sympathomimet-ics blocking	DDI-false
Aerosol of @DRUG$ generated from @DRUG$ and collected by impactor for or liquid impinger dissolution experiments	DDI-false
: Other such quinidine , @DRUG$ , @DRUG$ , used concurrently .	DDI-false
effects from cholinergic blockade may occur @DRUG$ concomitantly other @DRUG$ phenothiazines monoamine ( , tricyclic antidepressants or antihistamines	DDI-effect
Additive adverse from may occur LEVSIN is administered with @DRUG$ @DRUG$ , , oxidase ) , some	DDI-false
Inhibitors : @DRUG$ ( CYP3A4 ) with @DRUG$ associated of myopathy/rhabdomyolysis	DDI-false
@DRUG$ The effect @DRUG$ anti-coagulant effect studied a group of receiving daily doses of - 5 warfarin .	DDI-false
Multivitamins , other @DRUG$ zinc , @DRUG$ or be , or within hours , the of , because interfere with absorption in lower .	DDI-false
Concurrent including ciprofloxacin , cation-containing aluminum @DRUG$ sucralfate VIDEX chewable/buffered tablets or powder , products calcium @DRUG$ or substantially the in and levels desired	DDI-false
Potential interactions clinical studies @DRUG$ , valproate oral contraceptive , @DRUG$ , through screening in placebo-controlled patients .	DDI-false
Although performed coadministration drugs eg , calcium , disopyramide , , amiodarone warfarin , , @DRUG$ , @DRUG$ , alprazolam triazolam may elevated when coadministered saquinavir ;	DDI-false
Iodine or @DRUG$ excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of Carbimazole.	DDI-false
Aminosalicylic acid may decrease the amount of digoxin (@DRUG$, @DRUG$) that gets absorbed into your body.	DDI-false
Other therapy interaction studies not , doses of 1 or more clinical studies , acetylsalicylic acid , @DRUG$ anticonvulsants , beta blockers cardiac H2 , inhibitors , synthetase inhibitors ( to as @DRUG$ and quinolone evidence adverse interactions .	DDI-false
Other specific were performed , doses or more used studies acid a-blockers ( ACE anticonvulsants , diuretics , H2 , @DRUG$ @DRUG$ also referred ) quinolone evidence of clinically adverse interactions .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
availability potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy regarding protease (@DRUG$)-related metabolic have led significant shifts treatment in HIV	DDI-false
Interactions To Levosimendan not clinically pharmacokinetic @DRUG$ , felodipine , digoxin , , @DRUG$ , carvedilol	DDI-false
Other concomitant therapy studies not performed finasteride doses of 1 or were concomitantly clinical , acetylsalicylic @DRUG$ , angiotensin-converting enzyme ( ACE ) benzodiazepines , @DRUG$ blockers nitrates , diuretics H2 , reductase prostaglandin inhibitors ( referred as , quinolone anti-infectives of significant	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, @DRUG$, @DRUG$, and ranitidine.	DDI-false
Interaction @DRUG$ @DRUG$ motility in chick .	DDI-effect
Antihypertensive medications , especially @DRUG$ preanesthetic @DRUG$ used	DDI-false
Higher concentrations of @DRUG$ ( ) 10(-6 ) @DRUG$ X - 10(-7 ) .	DDI-false
of the risk of reactions patients have benzodiazepines on regular basis it is particularly physicians or about @DRUG$ , alcohol and sedative of history procedure which use of @DRUG$ is .	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Anabolic @DRUG$ e.g. ] , , , oxymetholone ] , @DRUG$ [ , ] ) or	DDI-false
Clinical studies @DRUG$ alone or in combination with @DRUG$ did not numbers of subjects aged or determine whether from younger	DDI-false
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-advise
@DRUG$ and @DRUG$ , digoxin to increased plasma concentrations the three	DDI-mechanism
Another oral @DRUG$, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Multivalent Cation-Containing Products administration a @DRUG$ ciprofloxacin , multivalent cation-containing such magnesium @DRUG$ antacids sucralfate tablets or , calcium , or zinc may the absorption of ciprofloxacin , resulting serum and urine levels lower desired .	DDI-mechanism
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
Nevertheless, clinical studies, as well as postmarketing observations have shown that Lodine can reduce the natriuretic effect of @DRUG$ and @DRUG$ in some patients.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, propofol, @DRUG$, and @DRUG$ have been demonstrated.	DDI-false
acetaminophen/theophylline , @DRUG$/valproic acid theophylline/acetaminophen , acid/phenobarbital .	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, propofol, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
@DRUG$ multiple doses @DRUG$ and digoxin were steady-state plasma digoxin by 20 %	DDI-false
@DRUG$ (neostgmine, physostigmine), lignocaine, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Compounds tested in man include warfarin, theophylline, @DRUG$, diazepam, aminopyrine and @DRUG$.	DDI-false
Other interactions : effect the pharmacodynamics of @DRUG$ insulin and @DRUG$ other pharmacodynamic )	DDI-false
   Patients Diuretic Therapy : on @DRUG$ and in whom @DRUG$ therapy was recently as on dietary restriction or dialysis , may occasionally experience reduction of blood pressure usually first after the initial .	DDI-false
@DRUG$: Alcohol (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and @DRUG$ plasma levels were not altered when dosed simultaneously.	DDI-false
Although not performed , coadministration with drugs that are metabolized by CYP3A4 calcium blockers , @DRUG$ , , , quinidine , , @DRUG$ carbamazepine fentanyl alfentanyl and triazolam ) may have elevated concentrations when saquinavir ;	DDI-false
interactions were pharmacokinetic studies phenytoin , @DRUG$ oral @DRUG$ warfarin probenecid ) and through pharmacokinetic screening the placebo-controlled in patients .	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, CYP2D6, and @DRUG$.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (nicotinic acid), erythromycin, @DRUG$.	DDI-false
Other Cardiovascular Agents @DRUG$ and @DRUG$ been concomitantly adrenergic-blocking agents , agents , hydralazine prazosin and digoxin evidence of clinically adverse .	DDI-false
Lithium serum @DRUG$ levels and symptoms of @DRUG$ reported in receiving concomitant lithium and ACE inhibitor therapy .	DDI-false
have confirmed these sevoflurane @DRUG$ propofol , , and	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
thiazides and @DRUG$ , products , estrogens , contraceptives , phenytoin acid sympathomimetics , blocking drugs and @DRUG$.	DDI-false
Central : of   system ) with other nervous but not limited other opioids , sedatives , , @DRUG$ e.g. ) , @DRUG$ skeletal muscle relaxants alcohol may depression sedation , or potentially result in or death	DDI-false
effect on , has to reduce of , @DRUG$ chlordiazepoxide , , @DRUG$ , metronidazole , delaying and blood levels of these	DDI-false
interaction evaluated the effect of use ACZONE Gel 5 % combination with strength ( mg/800 ) trimethoprim/@DRUG$ ( TMP/@DRUG$ ) .	DDI-false
Non-selective MAO inhibitors including @DRUG$ , phenelzine sulfate and : use of @DRUG$ non-selective may cause .	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Methotrexate interaction rheumatoid taking @DRUG$ did a significant effect the	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
High-dose cyclosporin resulting in ng/mL with oral @DRUG$ has an 80 in @DRUG$ with in total of etoposide compared etoposide .	DDI-false
@DRUG$ and @DRUG$ use rarely associated ventricular fibrillation when combined with Adenocard .	DDI-false
@DRUG$ Antidepressants @DRUG$ be with caution in treated monoamine tricyclic formoterol the cardiovascular .	DDI-false
@DRUG$, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
@DRUG$ Amiodarone should be with blocking agents e.g. , CYP3A4 inhibitor ) channel antagonists ( e.g. , @DRUG$ , and CYP3A4 of possible potentiation of bradycardia arrest and AV	DDI-false
Nevertheless, clinical studies, as well as postmarketing observations have shown that @DRUG$ can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-effect
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
It is recommended not to exceed a single 5 mg dose of @DRUG$ in a 24-hour period when used in combination with @DRUG$.	DDI-advise
of @DRUG$ @DRUG$ did not the cerivastatin sodium	DDI-false
@DRUG$ , such quinidine @DRUG$ phenytoin , used concurrently with .	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of @DRUG$ with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of capecitabine).	DDI-false
@DRUG$ , ) , @DRUG$ can toxicity cause cardio .	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of @DRUG$.	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed progesterone preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-false
The blood pressure effect of SULAR tended to be greater in patients on @DRUG$ than in patients on no other @DRUG$ therapy.	DDI-false
inhibitors including @DRUG$ @DRUG$ HC1 : Concomitant use of non-selective MAO inhibitors may hypertension .	DDI-false
Elevated plasma levels of @DRUG$ have been reported with concomitant @DRUG$ use.	DDI-mechanism
OTHER Although were performed , in clinical studies @DRUG$ concomitantly @DRUG$ , betablockers , diuretics anti-inflammatory drugs ( without significant .	DDI-false
An interaction study with warfarin showed no clinically significant effect of @DRUG$ on @DRUG$ pharmacokinetics or anticoagulant activity.	DDI-false
blood pressure SULAR tended to in on @DRUG$ on @DRUG$ therapy .	DDI-false
interaction @DRUG$ the degree of protein , and by ) @DRUG$ not significantly	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
In addition, we have shown that @DRUG$ is a useful pharmacological tool with which to examine the @DRUG$-mediated responses of megakaryocytes.	DDI-false
@DRUG$ indinavir : Upon concomitant of 5 with BID @DRUG$ , the and AUC of ritonavir by approximately 20	DDI-false
Although have not been , coadministration with drugs are metabolized by ( eg , channel , disopyramide @DRUG$ , amiodarone , , derivatives @DRUG$ , alfentanyl alprazolam , and elevated concentrations when ;	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
In addition , higher-than expected steady-state serum concentrations of @DRUG$ been therapy patients already taking	DDI-mechanism
however, no deleterious interactions were seen when ROMAZICON was administered after @DRUG$, inhalational @DRUG$, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Fulminant has seen three weeks after combined @DRUG$ and @DRUG$ but may seen several .	DDI-effect
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
effects blockade may occur is concomitantly @DRUG$ , amantadine , @DRUG$ phenothiazines oxidase MAO ) inhibitors tricyclic antidepressants antihistamines .	DDI-false
Histamine H2-receptor antagonists: @DRUG$ appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
Coadministration Itraconazole @DRUG$ or @DRUG$ has led to plasma concentrations of the three	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.	DDI-false
Anticholinesterases (neostgmine, physostigmine), @DRUG$, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Both @DRUG$ and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, @DRUG$, niacin (nicotinic acid), erythromycin, azole antifungals.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Tagamet through an effect certain enzyme , has been to hepatic , phenytoin nifedipine @DRUG$ , diazepam certain antidepressants , @DRUG$ , , thereby delaying elimination increasing levels drugs	DDI-false
Example azole antifungals , , , , @DRUG$ isoniazid , nefazodone , protease @DRUG$ , .	DDI-false
@DRUG$ and its active metabolite, norfluoxe-tine, have long half-lives (4 to 16 days for @DRUG$), that may affect strategies during conversion from one drug to the other.	DDI-false
@DRUG$ @DRUG$ and HC1 Concomitant of non-selective MAO inhibitors may cause .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
no drug topical drugs medications were clinical of IOPIDINE Solution , possibility of an additive potentiating effect CNS depressants @DRUG$ opiates @DRUG$ , anesthetics )	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
studies have a significant reduction of trovafloxacin @DRUG$ with intravenous @DRUG$	DDI-mechanism
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( @DRUG$ cefotetan latamoxef or @DRUG$ cause vitamin hypoprothrombinemia	DDI-false
Compounds tested in man include @DRUG$ , , @DRUG$ and .	DDI-false
Effects of @DRUG$ on Drug Metabolizing Enzymes and Drug Transport Systems @DRUG$ inhibits CYP3A4 and CYP2C8 in vitro at clinically relevant concentrations.	DDI-false
Antiarrhythmics: @DRUG$, @DRUG$, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of @DRUG$ with capecitabine did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of @DRUG$).	DDI-false
Antihypertensives Amiodarone should with in   agents ( e.g. propranolol a inhibitor ) or channel ( verapamil CYP3A4 substrate and diltiazem @DRUG$ inhibitor potentiation bradycardia arrest , and block	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
@DRUG$: The effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
Other concomitant therapy specific studies not performed finasteride doses mg or were concomitantly in studies , , analgesics , enzyme ( inhibitors , , benzodiazepines @DRUG$ blockers cardiac @DRUG$ , H2 antagonists , to NSAIDs ) , quinolone anti-infectives evidence of adverse interactions	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
In @DRUG$ in dogs anesthetized @DRUG$ pentobarbital the dosage of cause higher of , ketamine or than	DDI-false
Drugs that alter imatinib plasma Drugs that recommended Gleevec with the CYP3A4 , , @DRUG$ , @DRUG$ clarithromycin	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
however, it adversely affected response duration suggesting that @DRUG$ should not be administered with HEXALEN and/or @DRUG$.1	DDI-advise
HIV Protease Inhibitors : Indinavir ( 800 t.i.d co-administered with @DRUG$ mg in 16-fold increase in @DRUG$ AUC , a increase in Cmax 2-fold half-life	DDI-false
Agents Enalapril @DRUG$ IV been with adrenergic-blocking agents @DRUG$ , , agents hydralazine prazosin and without clinically significant interactions .	DDI-false
@DRUG$ transport of may inhibited concomitant of @DRUG$ to increased plasma levels of .	DDI-false
: In a , of an @DRUG$ aluminum , magnesium simethicone with reduced serum levels of fosinoprilat as compared with @DRUG$ administered that antacids of fosinopril	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-effect
therefore concomitant administration of @DRUG$ @DRUG$	DDI-advise
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, methanol, higher @DRUG$ and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF.	DDI-false
Example @DRUG$ , , clarithromycin , @DRUG$ imatinib , isoniazid nefazodone , , propofol , quinidine , verapamil .	DDI-false
@DRUG$: The effect of celecoxib on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
concomitant clinical , in subjects with Acamprosate concomitantly @DRUG$ , @DRUG$ analgesics similar to that of placebo these .	DDI-false
data from clinical trials exist 3 approved @DRUG$ , or @DRUG$	DDI-false
Therefore could following administration psychotropic ( e.g. , , @DRUG$ antiemetics , @DRUG$ , tranquilizers )	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
of and @DRUG$ or other interfering with e.g. , @DRUG$ ) should with the potentiated .	DDI-false
@DRUG$ ( e.g. @DRUG$	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
@DRUG$ : The concomitant use of @DRUG$ with and short-acting nitrates been patients with stable angina .	DDI-false
The successive of @DRUG$ ( or ( . ) and @DRUG$ ( mg/kg e.w . ) in 10 min the activation of spontaneous motility of 17-day-old embryos comparison effect alone .	DDI-effect
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
: to @DRUG$ increase levels be to concurrent administration with isoniazid signs of @DRUG$ should , and dosage adjustment of the anticonvulsant be	DDI-false
@DRUG$ and @DRUG$ resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-false
@DRUG$ @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of digoxin given as a 0.25 mg dose every day.	DDI-false
Acetaminophen, @DRUG$, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$, tricyclic Amphetamines may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-false
Since higher doses of @DRUG$ (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of @DRUG$ should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily.	DDI-false
acetaminophen/@DRUG$ lidocaine/quinidine , @DRUG$/acetaminophen phenobarbital/valproic acid , acid/phenobarbital .	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, sedatives, @DRUG$) should be considered.	DDI-false
@DRUG$ should not be used in patients receiving @DRUG$..	DDI-advise
Antiarrhythmics: @DRUG$, bepridil, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
therapy interaction studies not , finasteride doses of 1 mg with acid , a-blockers , analgesics angiotensin-converting ACE ) , benzodiazepines @DRUG$ , calcium-channel blockers , nitrates , diuretics H2 , inhibitors @DRUG$ ( also referred to , and without clinically significant interactions	DDI-false
Antacids In pharmacology of an aluminum hydroxide , , and @DRUG$ with fosinopril serum levels urinary of compared with alone , that @DRUG$ impair absorption of fosinopril	DDI-false
Other interactions: @DRUG$ had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and @DRUG$ (prothrombin time or other pharmacodynamic parameters).	DDI-false
The immediate release, but not the coat-core formulation of @DRUG$ increased plasma @DRUG$ concentrations by about 20%.	DDI-mechanism
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
effects cholinergic blockade may occur @DRUG$ is with antimuscarinics , amantadine , , @DRUG$ , tricyclic antidepressants some antihistamines	DDI-effect
Compounds tested in @DRUG$ , , , and	DDI-false
Acetaminophen, lidocaine, @DRUG$, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of @DRUG$ to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-mechanism
Although specific have performed , coadministration with that mainly ( , , disopyramide , quinine , , @DRUG$ , warfarin tacrolimus , @DRUG$ , , pimozide , , , alfentanyl , may elevated plasma concentrations saquinavir	DDI-false
Since the concomitant administration of warfarin with @DRUG$ increases the prothrombin time by 100% after 3 to 4 days, the dose of the @DRUG$ should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
is @DRUG$ @DRUG$ without caution in oral therapy .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ ( @DRUG$ [ e.g. , ] , oxandrolone [ e.g. , , , e.g. Winstrol ] ) or	DDI-false
concomitant interaction studies not performed doses of or more were concomitantly used in clinical studies with acetaminophen , acid , a-blockers , @DRUG$ angiotensin-converting enzyme ( ACE inhibitors , anticonvulsants benzodiazepines , beta calcium-channel blockers nitrates , , , inhibitors @DRUG$ also as NSAIDs quinolone anti-infectives evidence of significant adverse interactions .	DDI-false
Like @DRUG$ ( 40 mg/kg , 18-MC ( 40 mg/kg of @DRUG$ and the self-administration and in ;	DDI-false
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and @DRUG$.	DDI-false
@DRUG$ may decrease the amount of digoxin (@DRUG$, Lanoxicaps) that gets absorbed into your body.	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
generally should not given with @DRUG$ because they reduce lithiums and high of @DRUG$ .	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with acetaminophen, and @DRUG$ with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
@DRUG$ may displace acidic drugs such as @DRUG$ or tolbutamide from their binding sites.	DDI-mechanism
Between @DRUG$   Other Antiepileptic Drugs ( @DRUG$ ) Phenytoin 3000 mg daily had no effect pharmacokinetic phenytoin refractory .	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
concomitant therapy interaction not performed finasteride doses 1 mg or were concomitantly in clinical studies with acetylsalicylic , a-blockers , @DRUG$ @DRUG$ anticonvulsants beta calcium-channel blockers , , , antagonists , HMG-CoA prostaglandin synthetase also to NSAIDs ) , and without evidence of clinically significant	DDI-false
Warfarin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG-DRUG$.	DDI-false
inhibitors itraconazole clarithromycin , @DRUG$ , , , @DRUG$ be behave .	DDI-false
Furosemide: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-effect
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, @DRUG$, and cimetidine.	DDI-advise
Chlorpromazine: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat amphetamine poisoning.	DDI-effect
@DRUG$ had significant on the Cmax AUC of zidovudine , decreased zidovudine by 44 % increased the intracellular phosphorylated @DRUG$ %	DDI-mechanism
This that enzyme-inducer @DRUG$ did have a on @DRUG$ in increase when patients DSM-IV-diagnosed , schizoaffective bipolar .	DDI-mechanism
These include the @DRUG$ other diuretics , , phenothiazines thyroid products , contraceptives phenytoin , , sympathomimetics @DRUG$ and isoniazid	DDI-false
@DRUG$ may decrease arterial responsiveness to @DRUG$.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
inhibitors azole , , , @DRUG$ , erythromycin imatinib , , nefazodone , , @DRUG$ , and verapamil .	DDI-false
@DRUG$ Concomitant treatment with Accutane and @DRUG$ because use has a number of cases of pseudotumor intracranial hypertension some of which use of tetracyclines	DDI-false
administration e.g. aminoglycosides indomethacin myelotoxic e.g. , ) , ( e.g. , doxorubicin or e.g. , @DRUG$ ) effects @DRUG$ toxicity organ systems .	DDI-effect
@DRUG$ may augment the activity of other @DRUG$.	DDI-effect
Notably, systemic exposure (AUC0-12) of @DRUG$ (DHA) was more than doubled in the presence of @DRUG$/SMX.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ @DRUG$ with renal tubular ciprofloxacin produces an increase the ciprofloxacin in	DDI-false
, lidocaine , @DRUG$ , quinidine @DRUG$ , were added to human .	DDI-false
concomitant therapy Although interaction not performed finasteride mg or more concomitantly studies with acetaminophen acetylsalicylic , a-blockers ACE anticonvulsants , benzodiazepines , beta , blockers cardiac , , HMG-CoA prostaglandin inhibitors to @DRUG$ , and @DRUG$ evidence of significant interactions	DDI-false
The effects of @DRUG$ and L-CCG-1 upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
@DRUG$ 200 10-fold increase in vardenafil AUC a 4-fold increase Cmax when with @DRUG$ 5 mg in healthy volunteers .	DDI-false
At steady state, @DRUG$ 50 mg once daily had no effect on the anti-platelet activity of low-dose (81 mg once daily) @DRUG$, as assessed by ex vivo platelet aggregation and serum TXB2 generation in clotting blood.	DDI-false
Warfarin: @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment.	DDI-false
Administration of anti-inflammatory drugs concomitantly @DRUG$ with an @DRUG$-induced , to decreased of renal prostacyclin .	DDI-false
comparison @DRUG$ with ketamine Innovar Vet pentobarbital the dosage of @DRUG$ to cause ventricular tachycardia was significantly higher as was the ouabain or Innovar with pentobarbital	DDI-false
It is important patients understand how to use @DRUG$ ( @DRUG$ capsules the inhalation and in relation to COPD they taking	DDI-false
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with @DRUG$ and prednisone.	DDI-false
: levels @DRUG$ steady-state co-administration of 0.2 mg	DDI-false
@DRUG$ interact with alcohol , blood thinners , @DRUG$ , and sinus medicines drugs lithium , or and medications .	DDI-int
: volunteers a in @DRUG$ observed when @DRUG$ were .	DDI-false
, and time of @DRUG$ interference , , , chloral and @DRUG$ were systematically investigated in patients therapy .	DDI-false
studies have not performed , coadministration with drugs are mainly metabolized CYP3A4 eg , dapsone , quinidine warfarin , @DRUG$ cyclosporine derivatives , pimozide , @DRUG$ , alfentanyl alprazolam ) have elevated plasma concentrations when saquinavir ;	DDI-false
interactions concomitant use drugs that the cytochrome P450 phenytoin , @DRUG$ , cimetidine @DRUG$ though studied	DDI-false
@DRUG$ : is to slow of carbamazepine serum @DRUG$ determined with , signs symptoms of should be monitored closely adjustment the anticonvulsant be made .	DDI-false
: @DRUG$ days not affect pharmacokinetics of (R)- or @DRUG$ , nor any in profile ( time following mg dose of warfarin	DDI-false
may with use of drugs increase or inhibit the P450 system e.g. , @DRUG$ @DRUG$ ketoconazole ) has	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
Digoxin Methotrexate @DRUG$ , other through , may cause in elimination of drugs serum levels @DRUG$ , digoxin , toxicity .	DDI-mechanism
INOmax has administered @DRUG$ dopamine , , @DRUG$ surfactant and high-frequency	DDI-false
There 3 types of indications ( of forms @DRUG$ ) i.e. alterations @DRUG$ status and mixed -- pharmacological and aetiopathogenic--(for of chronic alcoholism )	DDI-false
@DRUG$: astemizole*, @DRUG$* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
Additive adverse effects cholinergic may LEVSIN administered with , , @DRUG$ @DRUG$ , tricyclic or antihistamines	DDI-false
: @DRUG$ has patients @DRUG$ concomitantly with drugs cause of sodium including ACE	DDI-false
@DRUG$ mg for days does not alter the @DRUG$ 0.5 dose .	DDI-false
These include the and diuretics @DRUG$ , phe-nothiazines estrogens , contraceptives , @DRUG$ nicotinic calcium channel drugs , isoniazid	DDI-false
Suppression @DRUG$ of peritoneal metastasis induced by @DRUG$ wistar .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
@DRUG$ : In some patients with renal being treated nonsteroidal anti-inflammatory co-administration of @DRUG$ result a further .	DDI-false
@DRUG$: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
BACKGROUND : The of combined verapamil ( verapamil ) a calcium of adenocarcinomas induced by @DRUG$ @DRUG$ ) and index intestinal were investigated in male rats	DDI-false
solutions containing or @DRUG$ patients receiving monoamine inhibitors , or @DRUG$ severe prolonged	DDI-effect
: enalapril IV concomitantly with beta , methyldopa , @DRUG$ , calcium-blocking @DRUG$ evidence of significant adverse	DDI-false
No are for the of INVIRASE/@DRUG$ FORTOVASE/@DRUG$ and	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
like Monoamine @DRUG$ could @DRUG$ pharmacodynamics - - : and Ethanol depression antidepressants : Flupenthixol increases the effect	DDI-effect
: Flupenthixol interact with some drugs oxidase inhibitors ( theoretically @DRUG$ pharmacodynamics @DRUG$ - Eproxindine Ethanol : cause Tricyclic : Flupenthixol effect antidepressants	DDI-false
@DRUG$ containing @DRUG$ or norepinephrine to patients receiving tricyclic produce or	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free @DRUG$.	DDI-false
recent study shown concomitan of isoniazid @DRUG$ theophylline in some instances slight in elimination @DRUG$.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, @DRUG$, erythromycin, clarithromycin).	DDI-false
In Fondaparinux , the of oral @DRUG$ ( ) , platelet ) @DRUG$ ) , and digoxin did significantly the pharmacokinetics/pharmacodynamics of	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.	DDI-effect
Short-term have demonstrated concomitant of @DRUG$ Lodine ( @DRUG$ capsules and tablets ) reduced binding there was of free	DDI-mechanism
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
@DRUG$/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Hypersensitivity in receiving combination sequential high dose PROLEUKIN @DRUG$ specifically @DRUG$ tamoxifen interferon-alfa	DDI-false
To the of plus the with HIV-related , non-Hodgkin lymphoma ) compared a of 24 patients with were treated the @DRUG$ prednisone CHOP ) chemotherapy a of who with CHOP chemotherapy ( , cyclophosphamide , @DRUG$ , , prednisone vincristine plus bleomycin ) receiving antiretroviral therapy .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
: The effects combined bombesin hydrochloride ( @DRUG$ ) a channel the incidence peritoneal adenocarcinomas induced @DRUG$ ( AOM ) and the of were in male Wistar rats	DDI-false
strong inhibitors of CYP3A4 @DRUG$ @DRUG$ , nefazodone troleandomycin ritonavir , nelfinavir ) be expected to similarly	DDI-false
@DRUG$ : In normal , concomitant of @DRUG$ and acetaminophen an in acetaminophen	DDI-false
Agents : @DRUG$ since of this in an antiretroviral regimen plasma @DRUG$.	DDI-false
The of potent @DRUG$ antiretroviral and concerns regarding protease inhibitor metabolic disturbances have led to significant shifts treatment practices in HIV infection .	DDI-false
@DRUG$: The concomitant use of @DRUG$ with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris.	DDI-false
Tagamet apparently through , been reported reduce the hepatic anticoagulants , @DRUG$ nifedipine chlordiazepoxide , @DRUG$ , certain , theophylline and thereby elimination increasing blood of these drugs .	DDI-false
This drug interact or other @DRUG$ CNS depressant these medications antihistamines anticholinergics or other medications anticholinergic activity ( anticholinergic be when these medications are used antihistamines , and monoamine MAO ) use with @DRUG$ intensify CNS depressant antihistamines .	DDI-false
Antidepressants , @DRUG$ @DRUG$ may enhance the activity tricyclic agents	DDI-false
The initiation of @DRUG$ or @DRUG$ use may be precipitated by similar personality characteristics in the user, such as impulsivity and sensation seeking.	DDI-false
Nevertheless, clinical studies, as well as postmarketing observations have shown that @DRUG$ can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-effect
@DRUG$ : an interaction study arthritis patients taking did not have effect the pharmacokinetics @DRUG$.	DDI-false
No Interactions Date Levosimendan not clinically pharmacokinetic , @DRUG$ , @DRUG$ , ethanol or	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
@DRUG$: Vardenafil 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
, lidocaine/quinidine phenobarbital/acetaminophen phenobarbital/valproic quinidine/@DRUG$ , , acid/phenobarbital .	DDI-false
@DRUG$ e.g. @DRUG$ )	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Coingestion acetaminophen @DRUG$ @DRUG$ with acetaminophen and valproic with phenobarbital at high toxic decreases the of target .	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
, it affected response duration suggesting @DRUG$ should not be with @DRUG$ and/or	DDI-advise
all ( SSRIs ) citalopram , @DRUG$ , @DRUG$ , paroxetine , inhibit 2D6 they vary in the inhibition .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Products : Concurrent administration a ciprofloxacin with multivalent cation-containing products @DRUG$ , VIDEX chewable/buffered tablets or pediatric , or , iron , or substantially decrease @DRUG$ considerably lower desired .	DDI-false
Garlic Garlic capsules should be used while taking ) as the sole @DRUG$ due decreased @DRUG$ plasma .	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value amphotericin B rationalized at the and level observations : ( @DRUG$ differential effects on cells ;	DDI-false
Use with @DRUG$ : principal pathway detoxification by @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Potential drug interactions @DRUG$   and AEDs ( , gabapentin lamotrigine , phenobarbital phenytoin primidone were assessed serum concentrations levetiracetam and these @DRUG$ placebo-controlled clinical .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drugs that alter imatinib concentrations may plasma : is when administering @DRUG$ of the family e.g. @DRUG$ , clarithromycin .	DDI-advise
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
studies with @DRUG$ concomitant of anticoagulants @DRUG$ ) , acetylsalicylic acid ) NSAIDs ) , digoxin did not significantly the pharmacokinetics/pharmacodynamics of sodium .	DDI-false
the effects of glutamate agonists , @DRUG$ and on the above changes @DRUG$ found .	DDI-false
@DRUG$ decrease the amount of Lanoxin @DRUG$ gets into .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
Olanzapine: Coadministration of @DRUG$ 3 mg and @DRUG$ 10 mg produced a decrease in DSST scores.	DDI-effect
These both dexamethasone and retinyl acetate , other glucocorticoids and @DRUG$ may regulate of by modification activity of @DRUG$ and EGF .	DDI-effect
Oral @DRUG$: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-false
@DRUG$ and @DRUG$ have to triple the over 48 as therapy , similar responses being observed with nevirapine and superiority	DDI-false
@DRUG$ diminished the binding of @DRUG$ to human serum by a net change of 5.7% (percentage increase in free drug fraction [FDF], 11.0%) at 662 micromol/L and by a net change of 7.1% (percentage increase in FDF, 13.7%) at 1324 micromol/L.	DDI-mechanism
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of @DRUG$.	DDI-mechanism
- @DRUG$ ( Use of @DRUG$ increase chance of side effects these medicines	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, @DRUG$, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic @DRUG$.	DDI-effect
and @DRUG$ @DRUG$ antagonize the in vitro antiviral activity against HIV	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
tested in man @DRUG$ , @DRUG$ , theophylline and warfarin and meaningful .	DDI-false
@DRUG$ : Plasma of atorvastatin decreased approximately 25 when @DRUG$ and .	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other AEDs and that these @DRUG$ do not influence the pharmacokinetics of levetiracetam.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : serum of increased ) reported in patients receiving	DDI-false
have steady-state levels @DRUG$ @DRUG$ therapy amiodarone .	DDI-false
These drugs the thiazides other corticosteroids @DRUG$ products , , phenytoin , acid , channel , and @DRUG$.	DDI-false
@DRUG$ has been reported to increase the @DRUG$ requirements in human subjects ingesting these agents simultaneously.	DDI-mechanism
AUC of R ) and isomers @DRUG$ were unaffected mg @DRUG$.	DDI-false
@DRUG$ are potentiated the @DRUG$ be cautiously the treatment of	DDI-advise
have shown to side effects , renal , , confusion , dyspnea administration with @DRUG$ the antitumor effectiveness of @DRUG$ and should 12 Beta-blockers and other the with PROLEUKIN .	DDI-false
Warfarin: @DRUG$ have been reported to enhance the effects of the oral @DRUG$ warfarin or its derivatives.	DDI-false
Both @DRUG$ and 18-MC block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
: Amiodarone be used caution patients receiving   agents propranolol , a inhibitor ) @DRUG$ ( , @DRUG$ a CYP3A4 substrate diltiazem inhibitor because of the possible of bradycardia , sinus arrest block	DDI-false
Concomitant administration of other @DRUG$ may potentiate the undesirable effects of @DRUG$.	DDI-effect
The @DRUG$ or @DRUG$ may precipitated similar personality characteristics in , as and seeking	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
Other Although specific were performed , finasteride of 1 were in clinical with acetaminophen , @DRUG$ , a-blockers angiotensin-converting inhibitors @DRUG$ , blockers blockers , , diuretics , antagonists HMG-CoA reductase inhibitors synthetase ( referred to NSAIDs , and anti-infectives evidence significant .	DDI-false
Although dexamethasone nor retinyl affected proliferation of prostatic in @DRUG$ , modify mitogenic of @DRUG$ and .	DDI-false
Aspirin: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly.	DDI-false
@DRUG$-Broad-spectrum antibiotics may sterilize the bowel and decrease the @DRUG$ contribution to the body by the intestinal microflora.	DDI-false
The effects of @DRUG$ and of @DRUG$ anesthesia on digitalis tolerance in dogs.	DDI-false
example vitamin antagonists administered concomitantly with @DRUG$ prothrombin time monitored of @DRUG$ should	DDI-false
Drugs elevation in histamine H2-receptor antagonists such as @DRUG$ ) concentrations @DRUG$ and therefore potentially may reduce efficacy .	DDI-mechanism
Monoamine Inhibitors and Tricyclic : extreme caution patients with @DRUG$ or tricyclic because the of @DRUG$ the system be these agents .	DDI-false
Multivalent Cation-Containing Products Concurrent a @DRUG$ including ciprofloxacin with multivalent cation-containing products aluminum sucralfate , VIDEX chewable/buffered tablets pediatric powder products , @DRUG$ , substantially the absorption of ciprofloxacin resulting and urine levels considerably desired	DDI-mechanism
@DRUG$/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
However, @DRUG$ stimulated, but did not significantly inhibit, proliferation in the presence of @DRUG$.	DDI-effect
Co-medications induce @DRUG$ phenytoin , @DRUG$ phenobarbital	DDI-false
@DRUG$ : administration and cerivastatin healthy volunteers did result any changes in time or when to of @DRUG$ and .	DDI-false
Since @DRUG$ is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced amiodarone levels.	DDI-false
These drugs include the thiazides @DRUG$ , phe-nothiazines , thyroid , estrogens contraceptives , , , sympathomimet-ics , @DRUG$ , and	DDI-false
Colestipol: Plasma concentrations of atorvastatin decreased approximately 25% when @DRUG$ and @DRUG$ were coadministered.	DDI-mechanism
of @DRUG$ and may elevated serum levels of @DRUG$.	DDI-false
Multivalent Products Concurrent of quinolone , ciprofloxacin cation-containing such magnesium or aluminum antacids @DRUG$ , VIDEX chewable/buffered tablets or pediatric or containing calcium @DRUG$ may substantially absorption of ciprofloxacin , and urine levels than desired .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
, , phenobarbital/valproic acid quinidine/lidocaine , and acid/phenobarbital	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
addition to the noted   2 weeks @DRUG$ administration metabolism @DRUG$ , , and	DDI-false
@DRUG$: @DRUG$ has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic antidepressants.	DDI-false
with @DRUG$ , as phenobarbitone and @DRUG$ , which hepatic microsomal .	DDI-false
we have @DRUG$ a useful pharmacological which to examine @DRUG$-mediated megakaryocytes	DDI-false
superiority @DRUG$ has been comparative data a patients with high .	DDI-false
multiple taking @DRUG$ and @DRUG$ ( AVONEX IM once weekly or to for the or glatiramer	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
Probenecid : @DRUG$ produces an the of @DRUG$	DDI-mechanism
The pressor effects of catecholamines such as @DRUG$ or norepinephrine are enhanced by @DRUG$.	DDI-effect
Important Interactions Date does not clinically pharmacokinetic interactions with @DRUG$ , , felodipine , , warfarin , isosorbide @DRUG$ ethanol .	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-false
Although specific studies been performed with that are metabolized by CYP3A4 ( eg channel blockers @DRUG$ , , , warfarin , , , pimozide @DRUG$ fentanyl , alprazolam and ) when with	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
: Concomitant with Accutane and @DRUG$ should avoided associated cases pseudotumor of which use @DRUG$	DDI-false
The effects of ketamine and of @DRUG$ anesthesia on @DRUG$ tolerance in dogs.	DDI-false
@DRUG$, including @DRUG$, may enhance the effects of oral anticoagulants, including warfarin or its derivatives or similar agents.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
phenobarbital @DRUG$ @DRUG$ to concentrations of the .	DDI-effect
containing of ( cefmenoxime , cefoperazone , @DRUG$ cefamandole , or @DRUG$ can cause vitamin	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Note: dissolution of aerosol particles of @DRUG$ in @DRUG$, a model lung surfactant.	DDI-false
Multivitamins or containing @DRUG$ zinc , or sucralfate not be administered with , or within 2 hours of , the administration of @DRUG$ may interfere absorption lower serum norfloxacin .	DDI-advise
In general these or more pharmacologic similar , including @DRUG$ as quinidine and @DRUG$ , glycosides	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated aspirin plus @DRUG$ 25 mg daily, as compared to those taking @DRUG$ 2400 mg daily alone.	DDI-false
interactions between Keppra and other AEDs ( carbamazepine , gabapentin lamotrigine , phenobarbital , phenytoin , @DRUG$ and valproate were assessed @DRUG$ and these placebo-controlled clinical studies	DDI-false
Naproxen : The concomitant @DRUG$ and in volunteers had no effect on the plasma of naproxen but the urinary @DRUG$ its .	DDI-false
Other Cardiovascular Agents: @DRUG$ and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of AOM (7.4 mg/kg body weight) and subcutaneous injections of @DRUG$ (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of @DRUG$ (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
Co-administration Concomitant @DRUG$ with @DRUG$ , other anticoagulants may the .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking amiodarone when @DRUG$, @DRUG$, or azoles were administered concomitantly.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
from prospective comparing the 3 approved ( efavirenz , @DRUG$ @DRUG$	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-advise
Lithium: Increased serum @DRUG$ levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
a pharmacology study of antacid ( @DRUG$ , magnesium hydroxide , with fosinopril reduced serum and excretion of @DRUG$ with fosinopril suggesting that may of	DDI-false
Concomitant use of @DRUG$ with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the @DRUG$ or the other drug.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
@DRUG$: @DRUG$ may delay intestinal absorption of phenytoin;	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Pediatric Use The safety and effectiveness of @DRUG$, alone or in combination with @DRUG$ in patients below the age of 18 years have not been established.	DDI-false
Injection @DRUG$ injectable produces depression of the nervous when ethyl alcohol , , inhibitors , and @DRUG$ used concomitantly with injectable , an increased sedation , , and irrational has observed	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
@DRUG$ has apparent @DRUG$.	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
sympathetic activity ( @DRUG$ or @DRUG$ should caution .	DDI-false
Although glucocorticoids have to side effects renal insufficiency , , concomitant administration these agents reduce effectiveness @DRUG$ and thus avoided 12 antihypertensives may potentiate the hypotension seen PROLEUKIN	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Administration of rifampin concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone.	DDI-false
@DRUG$ , 18-MC 40 ) the self-administration and self-administration @DRUG$ nicotine rats	DDI-false
Lithium: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-advise
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or @DRUG$.	DDI-false
: @DRUG$ , co-administered with nifedipine 30 or once , the relative bioavailability ) or concentration ( Cmax ) of @DRUG$ a that is metabolized CYP3A4	DDI-false
Tagamet , through on certain enzyme has reported of anticoagulants @DRUG$ , , nifedipine , @DRUG$ antidepressants theophylline and metronidazole elimination and increasing drugs	DDI-false
@DRUG$: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Central Nervous System : concomitant use DURAGESIC   system with other nervous including to , sedatives @DRUG$ ( benzodiazepines , phenothiazines @DRUG$ , may respiratory , hypotension profound or potentially result or death	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Iodine @DRUG$ may decrease the of and @DRUG$ increase the effect of .	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
: @DRUG$ , other injectable benzodiazepines depression central system when administered with @DRUG$ barbiturates , MAO , and antidepressants scopolamine is used concomitantly an increased , has been observed	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ been blunt hypotensive effect of @DRUG$.	DDI-effect
@DRUG$ the muscle of all muscle relaxants , most notably @DRUG$ and MAC ( concentration ) reduced by of N 2O	DDI-effect
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, @DRUG$, Maalox, and ranitidine.	DDI-false
Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and @DRUG$ were administered concomitantly.	DDI-mechanism
Although there is published concomitant administration @DRUG$ and @DRUG$ these drugs are often without any resulting effects or .	DDI-false
@DRUG$ : @DRUG$ ( ) co-administered with mg resulted in a 16-fold increase in 7-fold Cmax and a in half-life .	DDI-false
acetaminophen/@DRUG$ , acid quinidine/lidocaine , theophylline/acetaminophen and valproic	DDI-false
availability of non-nucleoside regimens antiretroviral and regarding @DRUG$ (PI)-related have significant shifts in practices HIV infection	DDI-false
Coadministration of @DRUG$ with Itraconazole has led to elevated plasma concentrations of @DRUG$, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Antihypertensives : @DRUG$ should be used in receiving   -receptor blocking e.g. , CYP3A4 or @DRUG$ , CYP3A4 substrate , and diltiazem , a because of , sinus and AV ;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
There was no significant difference in the pharmacodynamic effect of warfarin administered alone and @DRUG$ administered with @DRUG$ as measured by prothrombin time.	DDI-false
@DRUG$-@DRUG$ effect of warfarin	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
glucocorticoids have been reduce effects renal insufficiency , hyperbilirubinemia , dyspnea agents @DRUG$ the of thus be avoided . Beta-blockers may potentiate PROLEUKIN	DDI-false
Cyclosporine , Digoxin , Methotrexate Lodine , like @DRUG$ effects renal may changes the elimination these elevated of cyclosporine , , @DRUG$ , and toxicity	DDI-mechanism
ingestion @DRUG$ @DRUG$ 78 weeks has been to cause tumors , and suggested that may with nitrites in the rat to which is tumorigenic	DDI-effect
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, digoxin, @DRUG$, and ranitidine.	DDI-false
Drug Interactions interact , @DRUG$ MAOI ): theoretically affect @DRUG$ Ethanol : Flupenthixol Ethanol additive - Tricyclic antidepressants : Flupenthixol increases of Tricyclic	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, @DRUG$, and isoniazid.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., @DRUG$, analgesics, antiemetics, sedatives, tranquilizers).	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Inhibitors @DRUG$   not for use in patients have received MAOI within because and unpredictable potentiation by @DRUG$ reported opioid analgesics	DDI-false
Important To @DRUG$ not clinically , felodipine , digoxin , , ethanol or @DRUG$.	DDI-false
Drugs That Inhibit CYP3A4 (@DRUG$) CYP3A4 is a major metabolic pathway for elimination of @DRUG$.	DDI-false
In the study of 0.2 mg @DRUG$ and g @DRUG$ decreases of % for AUC and 40 % for compared to sodium alone	DDI-mechanism
@DRUG$ dosed subjects with mg/day of n to 600 mg/day [ n ] ) for Days 8 21 of 21-day course of mg five times/day of @DRUG$.	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$: Amphetamines may antagonize the hypotensive effects of @DRUG$.	DDI-false
@DRUG$ ( mg . on @DRUG$ AUC and concentration ) vardenafil co-administered mg Vardenafil .	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., @DRUG$, methyldopa, reserpine.	DDI-false
acetaminophen/theophylline , phenobarbital/acetaminophen quinidine/lidocaine , , and	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-effect
@DRUG$: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Although studies not coadministration with drugs that CYP3A4 , calcium , dapsone , @DRUG$ quinine amiodarone , quinidine , tacrolimus , cyclosporine , ergot , pimozide , , alfentanyl alprazolam elevated when coadministered with @DRUG$ ;	DDI-mechanism
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
John s wort) may increase the formation of @DRUG$, a metabolite of @DRUG$ associated with hemolysis.	DDI-false
@DRUG$ , spironolactone , , supplements @DRUG$-containing may lead to potassium	DDI-false
between @DRUG$ and @DRUG$ in has demonstrated .	DDI-effect
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, @DRUG$, and CYP3A4.	DDI-false
Drug Flupenthixol interact drugs , Monoamine oxidase ( MAOI MAOI theoretically pharmacodynamics - Ethanol : @DRUG$ Ethanol cause additive CNS - @DRUG$ : Flupenthixol the of antidepressants	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-effect
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
interactions may occur use of Antizol and inhibit cytochrome ( e.g. @DRUG$ , carbamazepine , @DRUG$ ketoconazole ) though this has been	DDI-false
is to avoid concurrent administration of with @DRUG$ antacids for 4 @DRUG$ administration	DDI-false
No significant interactions were found between @DRUG$ and @DRUG$ or digoxin.	DDI-false
Serious anticholinergic symptoms (i.e., severe dry mouth, urinary retention and blurred vision) have been associated with elevations in the serum levels of @DRUG$ when @DRUG$ therapy is initiated.	DDI-effect
include antifungals , clarithromycin , , , imatinib isoniazid , @DRUG$ , nicardipine @DRUG$ protease	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Like ibogaine ( 40 18-MC ( 40 intravenous self-administration of morphine @DRUG$ self-administration of @DRUG$ nicotine in rats ;	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Antimycobacterial Agents rifampin since the product with @DRUG$ antiretroviral reduces the plasma of	DDI-false
Other concomitant Although specific , finasteride doses 1 or were concomitantly in clinical with acetaminophen @DRUG$ angiotensin-converting ( ) , benzodiazepines @DRUG$ , blockers nitrates , diuretics antagonists , reductase inhibitors , ( referred to as ) anti-infectives without of significant interactions .	DDI-false
pharmacokinetic interactions @DRUG$ @DRUG$ , alfentanil and midazolam have been .	DDI-false
@DRUG$ : be used with receiving   blocking agents e.g. @DRUG$ a or calcium channel antagonists ( , CYP3A4 , and a because the potentiation bradycardia sinus , AV	DDI-false
A between @DRUG$ @DRUG$ a fluoroquinolone , resulting in potentiation the action .	DDI-int
Drug-Drug Interactions Between @DRUG$  And Other @DRUG$ (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
After dosing @DRUG$ ( @DRUG$   ) reduced clearance by approximately % .	DDI-false
possibility of with minimized by either the @DRUG$ one week to with captopril @DRUG$ tablets USP ) initiating ( 6.25 ) .	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, @DRUG$, digoxin, Maalox, and ranitidine.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Multivalent Concurrent administration of a including ciprofloxacin , with such @DRUG$ antacids , chewable/buffered tablets or powder , or containing @DRUG$ may substantially decrease the levels lower desired .	DDI-false
@DRUG$ suggest that antihypertensive effect @DRUG$.	DDI-false
@DRUG$: @DRUG$ (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and vardenafil plasma levels were not altered when dosed simultaneously.	DDI-false
Central Nervous System The concomitant DURAGESIC   ( fentanyl transdermal system with nervous system including not to @DRUG$ , , hypnotics @DRUG$ , ) , general phenothiazines skeletal , may cause profound sedation , or in coma death .	DDI-false
Fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another @DRUG$ and @DRUG$ but may be seen after several months.	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
steroids nandrolone ] , oxandrolone [ ] , oxymetholone [ @DRUG$ @DRUG$ [ e.g. , )	DDI-false
Nervous System Depressants The use of DURAGESIC system ) other system , limited to other @DRUG$ @DRUG$ , e.g. ) , general , phenothiazines , skeletal muscle , and alcohol , may cause depression , hypotension and profound sedation or potentially result in coma death .	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Important To @DRUG$ not important interactions beta-blockers , felodipine , digoxin mononitrate , , @DRUG$ .	DDI-false
of other inhibitors such as @DRUG$ and erythromycin transdermal @DRUG$ may also result in an increase in fentanyl plasma which could increase drug effects and cause serious	DDI-mechanism
with compounds that inducers of eg , phenobarbital , , @DRUG$ , @DRUG$ ) in decreased of .	DDI-false
aim of this was to the @DRUG$ and both enkephalins or its analogue , @DRUG$ the effect these mice after intracisternal injection .	DDI-false
The of during with of this is increased administration cyclosporine , acid , @DRUG$ ( @DRUG$ ) erythromycin , azole .	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, methyldopa, @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Concurrent administration of HEXALEN and @DRUG$ may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-effect
To evaluate HAART on course of , , lymphoma ( the authors compared retrospectively a with with , doxorubicin vincristine regimen 80 patients CHOP chemotherapy or CHOP-like regimen i.e. cyclophosphamide @DRUG$ with vincristine plus bleomycin ) receiving @DRUG$ .	DDI-false
through an on certain microsomal systems has anticoagulants phenytoin , @DRUG$ , nifedipine , , tricyclic and @DRUG$ , and increasing blood levels of	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-mechanism
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a @DRUG$) and ethanol under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
@DRUG$ and @DRUG$ may reduce or reverse the pressor effect of epinephrine.	DDI-false
Central Nervous Depressants : The of @DRUG$ ( transdermal system ) with central depressants including but other opioids hypnotics , tranquilizers ( general anesthetics , @DRUG$ skeletal muscle relaxants , and alcohol , and result coma or .	DDI-effect
@DRUG$: Altered serum levels of @DRUG$ (increased and decreased) have been reported in patients receiving concomitant ciprofloxacin.	DDI-false
Results in sclerosis TYSABRI   concomitant @DRUG$ @DRUG$   30 mcg once ) or were inconclusive with the for dose the glatiramer .	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
These drugs @DRUG$ and other @DRUG$ corticosteroids , products , estrogens , , , nicotinic acid , channel drugs .	DDI-false
ACE inhibitors: Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
In clinical studies with @DRUG$ , use of , platelet inhibitors @DRUG$ , ) digoxin not affect of sodium	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
- Vitamin ( @DRUG$ , @DRUG$ ) Use with increase the chance of	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), @DRUG$, @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
An encephalopathic syndrome (characterized by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN, and FBS) followed by irreversible brain damage has occurred in a few patients treated with @DRUG$ plus @DRUG$.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/@DRUG$.	DDI-false
In clinical pharmacology , an antacid @DRUG$ hydroxide , simethicone ) reduced and urinary fosinoprilat as compared with @DRUG$ alone suggesting that impair of .	DDI-false
Although interaction studies were performed finasteride 1 clinical with , acetylsalicylic , analgesics , @DRUG$ , @DRUG$ , diuretics , H2 inhibitors , prostaglandin synthetase ( also referred NSAIDs and quinolone anti-infectives without evidence of clinically	DDI-false
Monitoring for amiodarone toxicity and serial measurement of @DRUG$ serum concentration during concomitant @DRUG$ therapy should be considered.	DDI-advise
Lithium Increased @DRUG$ symptoms of toxicity have in receiving @DRUG$ and inhibitor .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, @DRUG$, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
hypotensive with @DRUG$ can be minimized either discontinuing the diuretic or increasing intake approximately week to of treatment with ( @DRUG$ tablets USP or therapy with 6.25 or 12.5 mg	DDI-false
Agents a study , concomitant of @DRUG$ with meaningfully pharmacokinetics agent or of @DRUG$ )	DDI-false
Mineral Oil-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
Antidiabetics , you take ) @DRUG$ with @DRUG$ the of side and/or side effects oral	DDI-effect
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
These drugs include the @DRUG$ and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
The availability potent non-nucleoside (NNRTI)-based regimens for @DRUG$ therapy inhibitor (@DRUG$)-related disturbances have led to treatment practices	DDI-false
between @DRUG$ carbamazepine , , primidone and @DRUG$ ) assessed serum concentrations of and these AEDs clinical	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
for toxicity of @DRUG$ for yeast @DRUG$ .	DDI-false
comparison of tolerance in with , or pentobarbital , dosage of @DRUG$ needed ventricular tachycardia was higher , as LD50 ouabain , @DRUG$ than pentobarbital	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Additive from cholinergic blockade when LEVSIN is administered with , phenothiazines , @DRUG$ tricyclic	DDI-false
concomitant @DRUG$ not recommended since antagonize of @DRUG$ in urinary tract .	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
DIGOXIN: Plasma @DRUG$ levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
@DRUG$ : no apparent pharmacokinetic with @DRUG$ or hydrochlorothiazide .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Our objective was to characterize pharmacokinetics everolimus and @DRUG$ ( INN @DRUG$ ) in novo allograft recipients year	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ should be taken as directed and @DRUG$ should be taken with a main meal of the day, preferably the evening meal..	DDI-false
@DRUG$ or iodine excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
: may interact with some drugs , like @DRUG$ ( MAOI could flupenthixol pharmacodynamics - Arecoline - - : @DRUG$ and CNS depression - Tricyclic effect of Tricyclic antidepressants	DDI-false
have been shown reduce PROLEUKIN-induced including fever , , confusion and concomitant of agents with reduce the effectiveness @DRUG$ and thus be avoided . 12 @DRUG$ and antihypertensives may potentiate the hypotension	DDI-false
Concurrent administration of @DRUG$ and androgens may result in elevated serum levels of @DRUG$.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of @DRUG$ with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-mechanism
Naproxen : administration of @DRUG$ and @DRUG$ had effect on the plasma levels of naproxen significantly decreased excretion of naproxen and metabolite	DDI-mechanism
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving @DRUG$ therapy, administration of oral @DRUG$ regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of @DRUG$ and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
The concomitant use of nitrofurantoin is not recommended since @DRUG$ may antagonize the antibacterial effect of @DRUG$ in the urinary tract.	DDI-effect
Potential @DRUG$   carbamazepine , gabapentin lamotrigine @DRUG$ , primidone valproate ) also by evaluating the serum concentrations levetiracetam these during placebo-controlled clinical studies	DDI-false
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
Example inhibitors azole antifungals ciprofloxacin , diclofenac , erythromycin , , @DRUG$ , @DRUG$ , propofol ,	DDI-false
Adverse reactions related to @DRUG$s, such as CNS, cardiac, and systemic (eg, flu-like) effects may be more severe in the elderly and caution should be exercised in the use of @DRUG$ in this population.	DDI-false
specific studies have been , with drugs are mainly metabolized eg , channel blockers dapsone , , amiodarone , quinidine warfarin @DRUG$ ergot @DRUG$ carbamazepine , , alfentanyl , alprazolam may have elevated with saquinavir ;	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
No Important Interactions Levosimendan not have important pharmacokinetic captopril beta-blockers , , @DRUG$ , isosorbide @DRUG$ , or itraconazole	DDI-false
administration of @DRUG$ and related eg quinine quinidine and @DRUG$ ) may electrocardiographic abnormalities of .	DDI-effect
While the @DRUG$ ( ) , escitalopram @DRUG$ paroxetine , 2D6 , they may vary in the extent	DDI-false
The interaction metabolism of @DRUG$ @DRUG$ a potent inhibitor ,	DDI-mechanism
Oral @DRUG$   ( twice ) did the pharmacokinetics of oral contraceptive containing @DRUG$ 0.15 mg the luteinizing hormone progesterone levels , indicating that efficacy unlikely .	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
, neither the @DRUG$ , , and pharmacokinetics @DRUG$ at	DDI-false
Tolbutamide: In diabetic patients receiving diflunisal and @DRUG$, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
@DRUG$ , Methylxanthines Diuretics : treatment with derivatives @DRUG$ , diuretics may a effect   beta2-agonists .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Coadministration of Itraconazole and cyclosporine, @DRUG$ or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-false
@DRUG$ @DRUG$ ( 10 and 20 mg ) not potentiate in time aspirin ( two tablets	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, CYP2D6, and CYP3A4.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Anticoagulant was administration of @DRUG$ , @DRUG$ and ;	DDI-false
Fenfluramine slightly of @DRUG$ , ,	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
@DRUG$: In a study of young healthy male subjects no evidence of a direct pharmacokinetic @DRUG$-digoxin interaction could be found.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
It may be necessary to adjust the dosage of oral anticoagulants upon beginning or stopping @DRUG$. since @DRUG$ may prolong prothrombin time.	DDI-false
Drugs Demonstrated to be CYP Inhibitors of Clinical on the Basis of Involving caution is during with @DRUG$ ): of @DRUG$ increased plasma of by 46 21 % half-life by 17 and measured psychomotor performance .	DDI-false
Coingestion acetaminophen with theophylline , @DRUG$ with acetaminophen , valproic with @DRUG$ high to toxic concentrations the target	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of @DRUG$ (7.4 mg/kg body weight) and subcutaneous injections of bombesin (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of @DRUG$ (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
While all the @DRUG$ (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Stavudine and Ribavirin the @DRUG$ @DRUG$ .	DDI-false
@DRUG$ may with like Monoamine oxidase @DRUG$ ): theoretically flupenthixol pharmacodynamics - Arecoline - Eproxindine Ethanol and cause CNS depression antidepressants Flupenthixol the	DDI-int
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Drug pharmacokinetic interactions were observed vardenafil the following drugs : @DRUG$ , warfarin , @DRUG$ , and	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$: When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although specific been , with that are mainly ( eg blockers , dapsone , , quinine , , @DRUG$ , cyclosporine derivatives , , carbamazepine , , , alprazolam , and @DRUG$ coadministered saquinavir ;	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ , tricyclic enhance activity of tricyclic antidepressants or @DRUG$ ;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
Concomitant cyclophosphamide, doxorubicin, vincristine, and @DRUG$ chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (@DRUG$/SMX).	DDI-false
Data studies benzodiazepines other than @DRUG$ suggest a interaction the following : cyclosporine , , @DRUG$ , and .	DDI-int
Methotrexate Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of methotrexate.	DDI-mechanism
studies in patients taking   and concomitant interferon beta-1a ( 30 mcg IM once ) or glatiramer acetate were inconclusive with regard to the need for adjustment of @DRUG$ or	DDI-false
Flupenthixol may with some , oxidase ( ): could affect Arecoline - Ethanol @DRUG$ Ethanol additive : Flupenthixol increases of @DRUG$	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
lidocaine/quinidine , phenobarbital/valproic acid , quinidine/lidocaine theophylline/acetaminophen , .	DDI-false
When Itraconazole was coadministered with @DRUG$, rifampin, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and @DRUG$ with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
: From the beginning the experiment , rats were given 10 weekly subcutaneous injections @DRUG$ ( 7.4 body ) subcutaneous injections @DRUG$ ( weight every other day week , intraperitoneal verapamil ( 10 or 20 ) every other day end fo the experiment in week	DDI-false
drugs ( e.g. , aminoglycosides , indomethacin ) myelotoxic ( e.g. , cytotoxic chemotherapy ) cardiotoxic e.g. doxorubicin ) hepatotoxic ( , @DRUG$ ) with @DRUG$ may increase toxicity in these	DDI-effect
Drug Interactions : No interactions between and following glyburide , @DRUG$ , Maalox and @DRUG$.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Potential drug interactions between Keppra  and other AEDs (@DRUG$, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
In view of the long and variable half-life @DRUG$ potential interactions not only but drugs after discontinuation @DRUG$.	DDI-false
In general , are that or more pharmacologic activities similar to bepridil anti-arrhythmic agents @DRUG$	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Alcohol : @DRUG$ g/kg body weight approximately 40 mL absolute a kg person ) @DRUG$ plasma levels were not altered when simultaneously	DDI-false
Five days of @DRUG$ treatment did not significantly affect steady-state pharmacokinetic variables of @DRUG$ compared with placebo;	DDI-false
Central Nervous System : DURAGESIC ( ) with other depressants not limited @DRUG$ @DRUG$ , hypnotics , tranquilizers ( , ) phenothiazines , skeletal muscle relaxants , alcohol cause respiratory and , or potentially in coma or .	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, reserpine.	DDI-effect
the impact of chemotherapy plus on the of with systemic HIV-NHL ) , the authors a group of 24 patients HIV-NHL the cyclophosphamide , @DRUG$ , , ) chemotherapy regimen plus a group patients who were treated or i.e. , doxorubicin , with plus bleomycin @DRUG$ therapy .	DDI-false
These drugs the @DRUG$ other diuretics corticosteroids phe-nothiazines , products oral , phenytoin , @DRUG$ sympathomimet-ics calcium channel drugs and .	DDI-false
of terfenadine with @DRUG$ has elevated @DRUG$ rare instances of threatening and one .	DDI-false
not been performed , drugs are metabolized by CYP3A4 ( eg , , dapsone , @DRUG$ , quinidine , tacrolimus , , @DRUG$ , carbamazepine , fentanyl , , , and may have plasma concentrations saquinavir ;	DDI-false
may @DRUG$ blood drugs ( cold , medicines , norepinephrine @DRUG$ Ibuprofen blood .	DDI-false
exercised @DRUG$ conjunction @DRUG$.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ has been shown to be antagonistic to beta-lactam antibiotics, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Example azole , , , diclofenac , @DRUG$ , @DRUG$ , , nicardipine propofol protease , and .	DDI-false
interact with @DRUG$ depressants ( may potentiate the depressant these or @DRUG$ with activity ( anticholinergic effects may be potentiated when these ) , and monoamine MAO ( concurrent use with may anticholinergic effects of antihistamines .	DDI-false
Rhabdomyolysis has receiving @DRUG$ administered alone recommended dosages immunosuppressive drugs including	DDI-effect
ANTACID (Magnesium-Aluminum Hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
include thiazides diuretics corticosteroids @DRUG$ thyroid , estrogens , , @DRUG$ , .	DDI-false
suppress , including @DRUG$ @DRUG$ , and	DDI-false
1 hour after starting the @DRUG$ or @DRUG$ 500 mg p.o.	DDI-false
effects @DRUG$ are antagonized @DRUG$ as caffeine .	DDI-effect
In these patients whose hypertension was controlled with @DRUG$, @DRUG$ 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mm Hg compared to placebo.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and @DRUG$.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent @DRUG$ such as furosemide.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Lithium : a conducted in healthy , lithium increased % receiving @DRUG$ 450 mg 200 mg subjects @DRUG$ alone	DDI-false
To determine injection permit larger doses of @DRUG$ be administered a fixed 9.9-g/m2 dose of over hours with @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Phenytoin: @DRUG$ may delay intestinal absorption of @DRUG$;	DDI-mechanism
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
@DRUG$: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
Drug : may with some drugs like oxidase inhibitors MAOI @DRUG$ theoretically affect flupenthixol - Eproxindine @DRUG$ Ethanol cause CNS - antidepressants : Flupenthixol increases the Tricyclic antidepressants	DDI-false
of drugs possessing ( aminoglycosides @DRUG$ , ( , cytotoxic ) , cardiotoxic doxorubicin or ( , , @DRUG$ ) with may increase .	DDI-false
include the @DRUG$ and , phe-nothiazines products , @DRUG$ oral , , channel isoniazid .	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Pretreatment healthy volunteers with @DRUG$ by single dose @DRUG$ , increased Gleevec oral-dose clearance by , ( mean and - .	DDI-mechanism
@DRUG$ : causes ( by about % the fraction @DRUG$.	DDI-false
of @DRUG$ @DRUG$ has associated with an increase in cyclosporine-induced toxicity possibly due to decreased synthesis .	DDI-mechanism
If a @DRUG$ is used it @DRUG$ toxicity .	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-effect
This small with doses of @DRUG$ , may clinically significant when @DRUG$ are used a continuous schedule .	DDI-false
Tagamet , through effect on microsomal enzyme systems , been reported the of phenytoin , propranolol @DRUG$ , chlordiazepoxide , antidepressants , @DRUG$ theophylline and thereby delaying and blood levels of these drugs .	DDI-false
Compounds that have been tested in man include @DRUG$, digoxin, propranolol, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
@DRUG$ other products or antacids or @DRUG$ should not be concomitantly with , or hours , administration of , they may interfere with absorption resulting in lower and norfloxacin .	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, @DRUG$, @DRUG$ and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
@DRUG$ is a substrate for both CYP2D6 and @DRUG$.	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Cation-Containing Products Concurrent of quinolone , products as magnesium or aluminum antacids @DRUG$ VIDEX chewable/buffered tablets or products containing @DRUG$ , zinc may substantially the absorption resulting in and considerably than	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
WARFARIN : @DRUG$ and cerivastatin to did result any changes in time clotting factor VII when compared to co-administration @DRUG$ and .	DDI-false
METHOD : study was a multicenter double-blind of 101 patients who randomly assigned to @DRUG$ at doses of 0.5 , 1 or 2 mg and @DRUG$.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
the only of kind Mefloquine , although theoretically , other drugs known cardiac conduction ( eg , @DRUG$ or , @DRUG$ or , antidepressants and phenothiazines ) also contribute a interval	DDI-false
inhibitors e.g. , itraconazole @DRUG$ , nefazodone , @DRUG$ , ritonavir , nelfinavir ) would .	DDI-false
- Anabolic @DRUG$ [ e.g. , Anabolin , Anavar ] , [ e.g. , @DRUG$ , stanozolol , Winstrol ) or	DDI-false
Administration of rifampin concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
When @DRUG$ oral @DRUG$ attenuation immunization not be excluded .	DDI-effect
@DRUG$: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on @DRUG$ (1 gm/day) 11 days after the addition of doxepin (75 mg/day).	DDI-false
@DRUG$ other , @DRUG$ , preanesthetic and anesthetic agents used surgery or , in surgery	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
drugs include other corticosteroids , @DRUG$ , , oral @DRUG$ , calcium blocking drugs and	DDI-false
Sinus reported @DRUG$ in with substrate ) given	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Stavudine and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-effect
Drug Interactions Flupenthixol some , like oxidase inhibitors MAOI ): MAOI affect flupenthixol - Eproxindine - @DRUG$ : Flupenthixol additive CNS - increases effect @DRUG$	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
adverse blockade LEVSIN administered concomitantly antimuscarinics @DRUG$ haloperidol , phenothiazines @DRUG$ , antidepressants antihistamines .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Bacteriostatic Antibiotics @DRUG$ , erythromycins , sulfonamides , tetracyclines interfere the effect of	DDI-effect
@DRUG$ Eszopiclone 3 administered daily for 5 days did affect the of@DRUG$n , were there any ( prothrombin a mg of warfarin	DDI-false
however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational @DRUG$, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Tolazamide A case of hypoglycemia has reported in II diabetic maintained on @DRUG$ ( ) days addition @DRUG$ 75	DDI-effect
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Flupenthixol may some drugs , Monoamine MAOI MAOI could Eproxindine Flupenthixol and Ethanol depression @DRUG$ : Flupenthixol effect of @DRUG$	DDI-false
These the and other @DRUG$ , , thyroid products , estrogens oral contraceptives , @DRUG$ sympathomimetics , calcium channel and isoniazid .	DDI-false
Single of cholestyramine or @DRUG$ @DRUG$ reduce gastrointestinal tract to 85 respectively	DDI-false
Agents Enalapril and enalapril IV been used concomitantly adrenergic-blocking agents , , @DRUG$ @DRUG$ , and evidence of	DDI-false
This appears be clinically interaction of @DRUG$ , although theoretically , of to conduction anti-arrhythmic @DRUG$ , channel blockers , or agents antidepressants and also contribute to a prolongation QTc .	DDI-effect
@DRUG$: The concomitant use of Bepridil and @DRUG$ has been well tolerated in patients with stable angina.	DDI-false
: other injectable benzodiazepines , depression of the nervous administered alcohol @DRUG$ , @DRUG$ MAO inhibitors , and . scopolamine used with injectable , incidence of sedation , and irrational behavior has been observed	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
other related @DRUG$ , quinidine and @DRUG$ produce abnormalities risk .	DDI-false
@DRUG$ and procainamide doses should be reduced by one-third when either is administered with @DRUG$.	DDI-false
The following eight target drug/added drug combinations were studied: @DRUG$/@DRUG$.	DDI-false
specific interaction studies , 1 mg more used in with acetaminophen acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting ACE ) inhibitors @DRUG$ blockers , blockers cardiac nitrates diuretics @DRUG$ , HMG-CoA reductase prostaglandin also NSAIDs and anti-infectives of .	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of amphotericin B can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
@DRUG$ : @DRUG$ has to clinically significant fluctuations in various .	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
Therefore @DRUG$ and non-steroidal anti-inflammatory used the be observed closely to determine the desired effect the @DRUG$ is .	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-effect
acetaminophen/theophylline , phenobarbital/acetaminophen , , , and @DRUG$/phenobarbital	DDI-false
Additive effects blockade when is administered concomitantly with @DRUG$ , amantadine , haloperidol phenothiazines , monoamine oxidase ( inhibitors , @DRUG$ antihistamines .	DDI-false
@DRUG$ , @DRUG$ , , , theophylline and valproic were added pooled serum therapeutic	DDI-false
Carbamazepine Isoniazid known metabolism increase its serum levels levels be to concurrent with @DRUG$ and symptoms of @DRUG$ should be monitored appropriate adjustment of the anticonvulsant should .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Potential drug interactions between   other ( , gabapentin phenobarbital , , @DRUG$ valproate ) were also assessed evaluating the concentrations levetiracetam and these @DRUG$	DDI-false
including sulfate , @DRUG$ @DRUG$ HC1 : use MAO inhibitors may	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Methotrexate e.g. , ) of methotrexate @DRUG$ may increase of side affecting the liver and/or @DRUG$	DDI-false
@DRUG$ a substrate for @DRUG$ there the potential that the use of St. s patients receiving in amiodarone .	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, opiates, and @DRUG$.	DDI-effect
no specific drug interactions with topical glaucoma drugs or systemic were identified in studies of IOPIDINE % Solution possibility of an additive potentiating with @DRUG$ alcohol , @DRUG$ sedatives ) should	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Glyburide: The concomitant administration of ciprofloxacin with the @DRUG$ @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or @DRUG$).	DDI-advise
: may , oxidase ( MAOI MAOI theoretically pharmacodynamics Arecoline - and Ethanol depression @DRUG$ : @DRUG$ the antidepressants	DDI-false
@DRUG$ generally should be given @DRUG$.	DDI-advise
Important Interactions To Date clinically captopril beta-blockers @DRUG$ isosorbide , ethanol	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, diazepam, aminopyrine and @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Co-administration: Concomitant use of @DRUG$ with antiplatelet agents, thrombolytics, and other @DRUG$ may increase the risk of bleeding.	DDI-effect
Other concomitant therapy specific interaction studies were , @DRUG$ mg more clinical with acetaminophen acid , a-blockers , angiotensin-converting enzyme ( ACE ) @DRUG$ , , , calcium-channel blockers , , , , inhibitors , prostaglandin synthetase ( also to as NSAIDs anti-infectives without of adverse	DDI-false
amiodarone a , there the of s Wort in patients @DRUG$ could in @DRUG$	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (@DRUG$)-A drug interaction study of @DRUG$ with an NSAID has not been conducted.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
be used caution receiving -receptor agents ( e.g. @DRUG$ ( e.g. , @DRUG$ , ) the potentiation bradycardia sinus AV ;	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane, @DRUG$, alfentanil, and @DRUG$.	DDI-false
@DRUG$ ( Use with @DRUG$ side affecting the and/or side effects antidiabetics	DDI-false
Patients receiving both @DRUG$ and furosemide should be observed closely to determine if the desired diuretic and/or antihypertensive effect of @DRUG$ is achieved.	DDI-false
hypoglycemic of sulfonylureas be potentiated drugs including anti-inflammatory agents that are highly protein bound , @DRUG$ , probenecid @DRUG$ , oxidase and	DDI-false
Use with : The principal pathway for detoxification @DRUG$ is by @DRUG$.	DDI-mechanism
caution when @DRUG$ CYP3A4 substrates that have ( e.g. , @DRUG$ )	DDI-advise
@DRUG$ the activity of other	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
@DRUG$: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat @DRUG$ poisoning.	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both zidovudine and @DRUG$.	DDI-false
@DRUG$-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Tetracyclines Concomitant with @DRUG$ and @DRUG$ should be has associated a number of pseudotumor ( hypertension ) involved concomitant	DDI-advise
studies have been , are metabolized CYP3A4 eg channel blockers dapsone quinine amiodarone , quinidine warfarin , @DRUG$ , ergot derivatives , pimozide , carbamazepine fentanyl , alfentanyl , @DRUG$ ) elevated plasma ;	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
acetaminophen/theophylline lidocaine/@DRUG$ , @DRUG$/acetaminophen .	DDI-false
Example inhibitors , ciprofloxacin , , diclofenac , doxycycline , @DRUG$ , imatinib , , , propofol protease inhibitors ,	DDI-false
These results suggest that dexamethasone and retinyl acetate and @DRUG$ retinoids may regulate prostate epithelium by a dose-dependent of insulin and @DRUG$.	DDI-effect
therefore, nitroglycerin or other @DRUG$ (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting @DRUG$.	DDI-advise
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ for than seven plasma procainamide and n-acetyl @DRUG$ % % , .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Refer to the package insert for @DRUG$ preparations before use of such preparations with @DRUG$.	DDI-advise
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
, apparently effect on microsomal enzyme , been reduce the metabolism of anticoagulants phenytoin nifedipine , @DRUG$ , diazepam tricyclic lidocaine and @DRUG$ elimination increasing levels of drugs	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
Patients taking low-dose @DRUG$ plus @DRUG$ .	DDI-false
@DRUG$ or iodine excess may the effect of @DRUG$ , iodine deficiency can increase Carbimazole	DDI-effect
@DRUG$ Hydroxide @DRUG$ were affected co-administration of antacid .	DDI-false
@DRUG$ may increase the of @DRUG$ especially in the presence of .	DDI-effect
Although studies not been performed coadministration with metabolized by eg calcium channel dapsone , quinine @DRUG$ quinidine warfarin , @DRUG$ cyclosporine ergot derivatives , carbamazepine alfentanyl , triazolam have elevated concentrations coadministered ;	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many @DRUG$ (tricyclic antidepressants, @DRUG$, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for @DRUG$ versus levofloxacin/@DRUG$ regimens.	DDI-false
a clinical , of aluminum and with @DRUG$ reduced serum levels excretion of as compared suggesting that impair @DRUG$.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
wort may the formation of @DRUG$ , a metabolite of @DRUG$ with hemolysis .	DDI-false
There are case reports of patients who developed increased BUN, serum creatinine and serum potassium levels, and weight gain when @DRUG$ was used in conjunction with @DRUG$.	DDI-effect
Five @DRUG$ treatment did affect pharmacokinetic of @DRUG$ compared placebo	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Therefore , @DRUG$ should be discontinued least two weeks of @DRUG$.	DDI-advise
hypoglycemia has reported patients concomitantly receiving @DRUG$ and oral	DDI-effect
@DRUG$ may drugs as or @DRUG$ from binding sites .	DDI-mechanism
@DRUG$ : rifampin the coadministration this with saquinavir antiretroviral of @DRUG$.	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or pimozide).	DDI-advise
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
: administration @DRUG$ ciprofloxacin products as or aluminum , @DRUG$ , or powder , or products containing calcium or zinc substantially absorption urine considerably lower desired .	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
whether injection of larger doses of @DRUG$ to be , fixed 9.9-g/m2 @DRUG$ given intravenously concurrently escalating doses cisplatin .	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
@DRUG$: Co-administration of VIOXX with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-false
Naproxen: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$ and moclobemide increased blood @DRUG$ at different times after the glucose overload.	DDI-false
of with increased with @DRUG$ fibric derivatives , ( , @DRUG$.	DDI-false
CONCOMITANT THESE CAN LEAD TO @DRUG$ INTOXICATION , TO ADMINISTERING DISULFIRAM PATIENT THERAPY , BASELINE @DRUG$ BE .	DDI-false
Plasma valproate should be monitored @DRUG$ valproate co administered , appropriate adjustments @DRUG$ should made	DDI-false
Co-administration of @DRUG$ and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
@DRUG$ e.g. , @DRUG$ ) or	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
@DRUG$ with of the @DRUG$ ( ) ( , use )	DDI-int
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Cyclosporine: Administration of @DRUG$ concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-mechanism
Example azole antifungals , clarithromycin diclofenac , , @DRUG$ , isoniazid @DRUG$ propofol protease and verapamil	DDI-false
@DRUG$ atorvastatin affect the of @DRUG$ , interactions with drugs metabolized via the isozymes expected	DDI-false
Clinical studies of @DRUG$ alone or in combination with @DRUG$ did not include sufficient numbers of subjects aged 65 or over to determine whether they respond differently from younger subjects.	DDI-false
Other concomitant not performed doses of 1 more concomitantly used in clinical acetylsalicylic a-blockers , angiotensin-converting ) inhibitors , @DRUG$ beta blockers , cardiac diuretics antagonists , reductase prostaglandin inhibitors ( also to as @DRUG$ ) , anti-infectives without evidence of significant adverse	DDI-false
lidocaine/@DRUG$ , phenobarbital/@DRUG$ , and acid/phenobarbital	DDI-false
@DRUG$ resulting in above ng/mL administered with oral led to an 80 etoposide exposure with 38 in body clearance etoposide compared to @DRUG$ alone	DDI-false
case that taking @DRUG$ , doses @DRUG$ may be .	DDI-false
Other specific interaction of 1 mg or were used studies acetaminophen , acetylsalicylic , analgesics angiotensin-converting enzyme ( ) inhibitors , anticonvulsants benzodiazepines beta blockers blockers , @DRUG$ H2 , @DRUG$ , prostaglandin referred to , evidence clinically adverse interactions .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Therefore, @DRUG$ should be discontinued at least two weeks prior to the cautious initiation of therapy with @DRUG$.	DDI-advise
Lithium: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
Cephalosporins-Cephalosporins containing chains cefmenoxime , @DRUG$ @DRUG$ , cefamandole latamoxef methylthiadiazole ) can cause K and .	DDI-false
Since the therapeutic range of theophylline is narrow @DRUG$ serum levels should be monitored closely, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-false
Potential drug @DRUG$ other carbamazepine , @DRUG$ , phenobarbital , primidone and were also by evaluating the serum of these AEDs	DDI-false
These drugs include the and diuretics , , @DRUG$ , @DRUG$ , phenytoin nicotinic acid calcium , and	DDI-false
Acetaminophen lidocaine @DRUG$ , quinidine , theophylline and @DRUG$ were added to serum therapeutic .	DDI-false
Cephalosporins-Cephalosporins N-methylthiotetrazole cefmenoxime , @DRUG$ , cefotetan , @DRUG$ ) or methylthiadiazole ( cefazolin ) cause vitamin K and hypoprothrombinemia .	DDI-false
Drug/Laboratory @DRUG$ may a low of serum levels the Digi-   Kit	DDI-false
Causing Release : effect of @DRUG$ enalapril is augmented by antihypertensive renin release @DRUG$ ) .	DDI-effect
Drug Interactions : interactions were observed the following : @DRUG$ warfarin , Maalox , and	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
Tricyclic Antidepressants : @DRUG$ administered in being monoamine @DRUG$ because of formoterol the system may be potentiated by	DDI-advise
This drug may interact with alcohol other CNS depressants ( potentiate the depressant effects either these or antihistamines ) anticholinergics or ( anticholinergic may be potentiated when these are used @DRUG$ oxidase ( MAO inhibitors @DRUG$ may prolong and anticholinergic effects antihistamines )	DDI-false
appears be only relevant interaction this Mefloquine , , of other to cardiac conduction @DRUG$ channel , antihistamines H1-blocking agents @DRUG$ and might also to a of the QTc interval .	DDI-false
Although interaction studies not performed , doses of 1 mg more with , acetylsalicylic acid , enzyme inhibitors , @DRUG$ beta , calcium-channel , nitrates , diuretics antagonists @DRUG$ prostaglandin synthetase inhibitors also referred to as , quinolone evidence of clinically significant interactions .	DDI-false
Data from in of other @DRUG$ a drug the following ergotamine @DRUG$ , amiodarone nicardipine	DDI-int
: healthy individuals , plasma concentrations @DRUG$ increased approximately with coadministration of atorvastatin and @DRUG$ a known	DDI-false
, @DRUG$/acetaminophen , and	DDI-false
Antipyrine: Because @DRUG$ does not affect the pharmacokinetics of antipyrine, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
It may necessary dosage of oral @DRUG$ upon beginning stopping @DRUG$. may prolong .	DDI-advise
Dose adjustment no on plasma concentrations of @DRUG$ lamotrigine	DDI-false
@DRUG$: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
@DRUG$: Plasma concentrations of atorvastatin decreased approximately 25% when @DRUG$ and atorvastatin were coadministered.	DDI-false
@DRUG$ generally should not be given with diuretics because they reduce @DRUG$s renal clearance and add a high risk of lithium toxicity.	DDI-false
Dosage adjustment @DRUG$ be when CYP2D6 inhibitors , ,	DDI-advise
Compounds that have been tested in man include antipyrine, @DRUG$, @DRUG$, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
@DRUG$ (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with @DRUG$ (0.5 g/kg body weight).	DDI-false
Clinical well as post marketing shown @DRUG$ the @DRUG$ in some	DDI-effect
, well observations have shown @DRUG$ can the natriuretic of @DRUG$ thiazides some .	DDI-effect
@DRUG$: @DRUG$ are known to cause osteoporosis.	DDI-false
In , diflunisal levels observed when multiple doses of @DRUG$ and @DRUG$ administered concomitantly	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
Substances are inhibitors of CYP3A4 activity ( @DRUG$ increase @DRUG$	DDI-mechanism
Carbamazepine @DRUG$ is the metabolism of its levels Carbamazepine levels be determined concurrent administration with @DRUG$ signs and carbamazepine toxicity should closely appropriate of anticonvulsant made .	DDI-false
: Concomitant Accutane and tetracyclines @DRUG$ has been with a number of pseudotumor benign hypertension ) , of which @DRUG$	DDI-effect
@DRUG$ : @DRUG$ are to osteoporosis	DDI-false
Tagamet apparently effect on enzyme systems , has of , propranolol nifedipine , diazepam , , @DRUG$ theophylline and @DRUG$ , delaying blood these drugs	DDI-false
Because @DRUG$ is metabolized by CYP2C9 and CYP3A4, patients who require anticoagulation should receive low-molecular weight or standard @DRUG$.	DDI-false
therapy studies were performed finasteride mg or were used studies with acetaminophen , , a-blockers , enzyme ( ACE inhibitors , anticonvulsants @DRUG$ , beta , calcium-channel cardiac nitrates , , H2 , , inhibitors ( as , and @DRUG$ without evidence clinically significant interactions	DDI-false
Coingestion of @DRUG$ , phenobarbital @DRUG$ valproic with phenobarbital at high decreases the binding target	DDI-false
In the presence of these methylxanthines doses @DRUG$ may be required or @DRUG$ be	DDI-false
Because of of patients who have taking @DRUG$ it is particularly important query or their @DRUG$ , and sedative use the history in which the use of ROMAZICON planned .	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or @DRUG$.	DDI-false
Antacids clinical pharmacology study of @DRUG$ aluminum and simethicone ) with reduced serum levels urinary excretion of @DRUG$ as compared administered suggesting that impair of	DDI-false
These other diuretics corticosteroids , , thyroid products , estrogens , @DRUG$ , @DRUG$ , , sympathomimetics isoniazid .	DDI-false
neither dexamethasone retinyl acetate affected proliferation epithelium in transferrin alone they modify the effect @DRUG$	DDI-false
Dose adjustment not . had no effect on concentrations @DRUG$ , @DRUG$ , or	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
Use in Ambulatory Patients effects @DRUG$ wear off @DRUG$ completely cleared from	DDI-false
: Rofecoxib did have clinically effect the pharmacokinetics @DRUG$ prednisone	DDI-false
- Methotrexate (e.g., @DRUG$) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Drug Interactions @DRUG$ @DRUG$   ( mg twice ) did not influence an oral mg ethinyl levonorgestrel or of progesterone levels , that impairment of contraceptive unlikely	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Clinical interaction studies with cimetidine and @DRUG$ indicated that the coadministration of @DRUG$ with these drugs does not result in clinically- significant drug interactions.	DDI-false
concomitant Although performed @DRUG$ of more concomitantly in studies acetaminophen acetylsalicylic , analgesics enzyme ACE ) , benzodiazepines , , blockers cardiac , , @DRUG$ HMG-CoA reductase , prostaglandin synthetase inhibitors ( as without evidence of adverse .	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
In patients with in @DRUG$ PEGASYS did affect @DRUG$ distribution or clearance	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$, such as verapamil, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
for @DRUG$ serial measurement of @DRUG$ serum during protease inhibitor should be	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Tagamet apparently an , has reported reduce metabolism @DRUG$ , propranolol nifedipine , chlordiazepoxide tricyclic , and @DRUG$ , thereby elimination these drugs	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
@DRUG$ increase	DDI-effect
Therefore interactions could occur administration psychotropic drugs ( @DRUG$ @DRUG$ , , sedatives , .	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Quetiapine ( ' @DRUG$ is introduced @DRUG$ demonstrated efficacy in the of negative schizophrenia	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Other Although studies were of mg or more used in clinical , acetylsalicylic , angiotensin-converting enzyme ) @DRUG$ , benzodiazepines beta , blockers , nitrates , diuretics antagonists , HMG-CoA prostaglandin synthetase ( also referred as , and @DRUG$ evidence of adverse interactions	DDI-false
@DRUG$ @DRUG$ zinc , antacids or with , within 2 of , norfloxacin , because they in serum norfloxacin .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-advise
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
drugs include the thiazides and other @DRUG$ , thyroid products , estrogens oral contraceptives , , nicotinic , sympathomimetics calcium blocking	DDI-false
These results suggest that acute dosing with @DRUG$ would not affect behaviors most closely associated with @DRUG$ intoxication.	DDI-false
Interactions : Flupenthixol may interact like Monoamine inhibitors @DRUG$ MAOI could affect pharmacodynamics - Arecoline - Ethanol Flupenthixol and Ethanol CNS - @DRUG$ Flupenthixol effect Tricyclic	DDI-false
The concomitant intake of @DRUG$ and @DRUG$ does not affect the pharmacokinetics of either alcohol or acamprosate.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
vitro that @DRUG$ when compared to , effect on the system responsible metabolism of @DRUG$.	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ and metabolite @DRUG$ .	DDI-false
Concurrent @DRUG$ @DRUG$ cause orthostatic hypotension . Cimetidine , an inhibitor of microsomal metabolism , increased and toxicity model	DDI-effect
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
MAO inhibitors @DRUG$, as well as a metabolite of furazolidone, slow @DRUG$ metabolism.	DDI-mechanism
in studies alprazolam a possible @DRUG$ for the : @DRUG$ and	DDI-int
@DRUG$ and a lesser extent @DRUG$ , action oleate and increased transferring from soluble to fraction .	DDI-false
In a similar study with in volunteers , 1 subjects with @DRUG$ mg and @DRUG$ mg separated standing systolic blood pressure 85 Hg .	DDI-effect
@DRUG$ and tricyclic anti-depressants could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
This be in taking @DRUG$	DDI-advise
available for coadministration @DRUG$/@DRUG$ or garlic .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ : Other @DRUG$ drugs , such , procainamide , and phenytoin , have been	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, @DRUG$, ethanol or itraconazole.	DDI-false
These the and other diuretics , @DRUG$ , phe-nothiazines products , @DRUG$ contraceptives , , acid sympathomimet-ics , drugs , .	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, diazepam, @DRUG$ and @DRUG$.	DDI-false
are recommended coadministration with @DRUG$ @DRUG$ are below	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Intravenous @DRUG$ ( @DRUG$ administered of other , such as beta-adrenergic blocking agents converting enzyme inhibitors , without in the adverse profile	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective @DRUG$ may cause hypertension.	DDI-effect
may enhance the effects @DRUG$ , @DRUG$ and other depressants .	DDI-false
Cyclosporine: Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, cimetidine, ketoconazole), though this has not been studied	DDI-mechanism
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Since @DRUG$ prothrombin time % 3 to days , the dose @DRUG$ should and should	DDI-false
@DRUG$ intoxication , appropriate the @DRUG$ made	DDI-false
@DRUG$: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
calcium such as @DRUG$ @DRUG$ , inhibit , decrease platelet adhesion intravascularly	DDI-false
: Lorazepam , injectable @DRUG$ , produces of system when with ethyl , @DRUG$ inhibitors , and When is used concomitantly with , an increased , hallucinations been observed	DDI-effect
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
Hypotension   Patients on @DRUG$ Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
ACE : Reports @DRUG$ of	DDI-effect
As the primary of @DRUG$ is to node higher may be produced	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
@DRUG$: @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum.	DDI-false
specific been coadministration are mainly metabolized CYP3A4 ( , @DRUG$ dapsone , disopyramide , amiodarone , @DRUG$ , cyclosporine , derivatives , alfentanyl alprazolam , triazolam plasma concentrations when saquinavir	DDI-false
Important Levosimendan does clinically important interactions @DRUG$ , beta-blockers , felodipine , , warfarin , @DRUG$ , carvedilol ethanol or .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$: Concurrent administration of @DRUG$ may lower meclofenamate sodium plasma levels, possibly by competing for protein-binding sites.	DDI-false
@DRUG$ : The concomitant of DURAGESIC   ( fentanyl system ) other , but not limited sedatives , hypnotics , tranquilizers ( e.g. , general , @DRUG$ , skeletal muscle relaxants , and alcohol may respiratory hypotension sedation potentially .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Concurrent administration and @DRUG$ may severe an inhibitor of , increased altretamines half-life and in a	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
, lidocaine/quinidine phenobarbital/acetaminophen , phenobarbital/@DRUG$ @DRUG$/lidocaine , and valproic acid/phenobarbital .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ retinyl and insulin-induced of epithelium	DDI-effect
Central Nervous System The concomitant   ( fentanyl ) other central system depressants not limited other @DRUG$ , hypnotics , e.g. , benzodiazepines , , @DRUG$ , alcohol respiratory , profound sedation or potentially result coma death	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ @DRUG$ have been demonstrated .	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
of @DRUG$ phenobarbital , and @DRUG$ with phenobarbital high toxic decreases the the target drug	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
In the present study, the @DRUG$ @DRUG$ was tested in combination with an active dose of PCP in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
@DRUG$ ( [ e.g. oxandrolone [ , ] , @DRUG$ , , Winstrol ] or	DDI-false
@DRUG$ , @DRUG$ e.g. ] [ e.g. , , stanozolol [ , Winstrol ) or	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
medications , especially @DRUG$ , or anesthetic agents in or relaxants nondepolarizing surgery	DDI-false
@DRUG$: Amphetamines enhance the adrenergic effect of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
and @DRUG$ should be with extreme in patients being @DRUG$ tricyclic the action formoterol the cardiovascular may be agents .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-advise
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
co-administration levels @DRUG$ @DRUG$ essentially unchanged	DDI-false
@DRUG$ apparently on microsomal enzyme been reported to reduce hepatic @DRUG$ , , nifedipine , diazepam , certain antidepressants , , theophylline and , thereby levels .	DDI-mechanism
acetaminophen/@DRUG$, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Serum @DRUG$ levels should be @DRUG$ is concomitantly with .	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, methotrexate, and increased toxicity.	DDI-mechanism
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
of healthy volunteers with @DRUG$ followed by a dose of Gleevec , @DRUG$ , which p 0.05 ) cmax 8)	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
, @DRUG$/acetaminophen , phenobarbital/valproic acid quinidine/lidocaine , acid/@DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
of with @DRUG$ ) also inhibited	DDI-effect
@DRUG$ may interact @DRUG$ , blood , decongestant ( allergy cold sinus ) , diabetic , lithium , , NSAIDs like Ibuprofen high medications	DDI-int
systemic ( AUC0 - 12 @DRUG$ ( more than @DRUG$/SMX .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with @DRUG$.	DDI-false
of may be drugs @DRUG$ and other that are highly , salicylates , @DRUG$ , monoamine and beta	DDI-false
@DRUG$ (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and @DRUG$ given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
@DRUG$-containing therapies should not be used with @DRUG$ as they may diminish its pharmacologic action.	DDI-advise
with inhibitors CYP3A4 activity , intraconazole indinavir @DRUG$ @DRUG$ indicated reduction the budesonide dose should be considered .	DDI-false
Compounds that have been tested in man include @DRUG$, digoxin, @DRUG$, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$ or hydrochlorothiazide.	DDI-false
Compounds that have been tested in man digoxin , propranolol , @DRUG$ , and @DRUG$ no clinically meaningful	DDI-false
Potential drug @DRUG$ other carbamazepine , , phenobarbital , phenytoin , primidone and valproate ) assessed by evaluating the concentrations @DRUG$ and these AEDs clinical studies .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Nervous System Depressants The use of ( @DRUG$ transdermal ) with other depressants , including but not opioids , @DRUG$ ( e.g. general anesthetics phenothiazines skeletal muscle and may respiratory , , or	DDI-effect
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
of HAART on clinical course , , non-Hodgkin lymphoma HIV-NHL , authors retrospectively a group 24 patients HIV-NHL who treated the cyclophosphamide , doxorubicin vincristine chemotherapy with 80 who with CHOP or CHOP-like i.e. cyclophosphamide , @DRUG$ , teniposide , and with plus @DRUG$ without receiving therapy .	DDI-false
Furosemide: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-effect
However , study either h.s concomitantly mg . @DRUG$ @DRUG$ , Inc. ) demonstrated alteration steady-state theophylline levels the 800 , subjects 54 years and older	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Although there are no study evaluate the nitric oxide donor , @DRUG$ may @DRUG$ on the developing	DDI-effect
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and acetaminophen resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
from occur when administered concomitantly with other antimuscarinics amantadine @DRUG$ , phenothiazines oxidase ( MAO ) @DRUG$ or .	DDI-false
Probenecid: Probenecid interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of @DRUG$ in serum.	DDI-false
specific studies have not performed , drugs are mainly metabolized CYP3A4 ( @DRUG$ dapsone , , quinine , amiodarone , @DRUG$ , pimozide carbamazepine , fentanyl alfentanyl , alprazolam triazolam may plasma coadministered with	DDI-false
@DRUG$ and II Congestive Infarction)- In , 3020 91 % receiving @DRUG$ mg also received ACE receptor	DDI-false
Warfarin: The effects of @DRUG$ and @DRUG$ on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-effect
Drugs With A Narrow Therapeutic Index Digoxin A single dose of @DRUG$ 3 mg did not affect the pharmacokinetics of @DRUG$ measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Serious anticholinergic symptoms (severe dry mouth, urinary retention, blurred vision) have been associated with elevations in the serum levels of @DRUG$ when @DRUG$ is added to the drug regimen.	DDI-effect
@DRUG$ : The and stimulatory effects of may @DRUG$.	DDI-false
Caution should be exercised when administering @DRUG$ with drugs that are known to inhibit phosphatase activities (e.g., @DRUG$).	DDI-advise
Corticosteroids , @DRUG$ and @DRUG$ treatment with xanthine steroids , diuretics potentiate of   .	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with @DRUG$, @DRUG$ treatment did not affect ribavirin distribution or clearance.	DDI-false
tested man theophylline @DRUG$ , diazepam and @DRUG$.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
hypoglycemic of sulfonylureas may be by including agents and highly , salicylates sulfonamides , @DRUG$ probenecid , @DRUG$ , monoamine oxidase , and beta agents	DDI-false
@DRUG$ 5 mg/kg ) , moclobemide ( mg/kg ) , ( @DRUG$ ( 20 ) ( vehicle	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Monitoring for @DRUG$ toxicity and serial measurement of @DRUG$ serum concentration during concomitant protease inhibitor therapy should be considered.	DDI-false
from in vitro benzodiazepines other than alprazolam suggest possible drug interaction for following : , cyclosporine , @DRUG$ , and	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, @DRUG$, and phenytoin during concomitant therapy with amiodarone.	DDI-false
Interactions clinically captopril , , @DRUG$ digoxin , , isosorbide ,	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing @DRUG$ therapy in patients receiving @DRUG$ or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-advise
BACKGROUND : of bombesin and @DRUG$ ( verapamil ) , a calcium channel blocker on incidence peritoneal metastasis adenocarcinomas induced @DRUG$ AOM and the index intestinal cancers investigated in Wistar rats .	DDI-false
As with other @DRUG$, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, opiates, and alcohol.	DDI-false
from in benzodiazepines other than alprazolam suggest a possible drug the @DRUG$ , @DRUG$ nicardipine and .	DDI-false
Cation-Containing : Concurrent of a quinolone including ciprofloxacin with multivalent cation-containing products such magnesium or @DRUG$ sucralfate , VIDEX chewable/buffered tablets or products containing @DRUG$ , substantially , resulting in serum and levels lower desired	DDI-false
Lithium serum lithium levels and of receiving concomitant @DRUG$ @DRUG$ .	DDI-effect
In @DRUG$ healthy volunteers , 1 subjects dosed @DRUG$ and 0.4 mg separated by hours experienced blood mm	DDI-false
Aspirin: Concomitant administration of low-dose aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
In vitro data suggest that itraconazole, when compared to @DRUG$, has a less pronounced effect on the biotransformation system responsible for the metabolism of @DRUG$.	DDI-false
As @DRUG$ , be noted that may be such @DRUG$ , , alcohol	DDI-effect
all the reuptake inhibitors ) e.g. , , @DRUG$ , @DRUG$ , inhibit 2D6 they vary extent of .	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including @DRUG$ such as quinidine and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
If treatment of CYP3A4 activity such as ketoconazole , @DRUG$ , ritonavir , indinavir saquinavir @DRUG$ . indicated , of the dose	DDI-false
@DRUG$ : Increased serum lithium symptoms been reported patients concomitant @DRUG$ therapy	DDI-false
It is important that patients understand how to use @DRUG$  (@DRUG$) capsules with the supplied AerolizerTM inhalation device and how it should be used in relation to other asthma or COPD medications they are taking.	DDI-false
@DRUG$ should administered with caution patients receiving ( @DRUG$ Wyeth-Ayerst Laboratories ) .	DDI-advise
These drugs the @DRUG$ and other , phenothiazines thyroid products , estrogens , @DRUG$ , , and isoniazid .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Example inhibitors include antifungals , , @DRUG$ , , , nefazodone , nicardipine , , @DRUG$ , verapamil .	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Elevated serum levels of cyclosporine have been reported with concomitant use of @DRUG$ with @DRUG$.	DDI-mechanism
data of @DRUG$/ritonavir .	DDI-false
have in previously plasma @DRUG$ , nortriptyline , @DRUG$ agents	DDI-mechanism
Erythromycin: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of atorvastatin and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
Example include , doxycycline , erythromycin , imatinib , isoniazid , , , @DRUG$ , @DRUG$ , verapamil	DDI-false
derivatives indandione and @DRUG$ such as nonsteroidal anti-inflammatory ( NSAIDs ) , @DRUG$ may risk bleeding administered with	DDI-false
@DRUG$ ('@DRUG$') is a newly introduced atypical antipsychotic with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
In clinical pharmacology , of an antacid aluminum hydroxide , and @DRUG$ reduced levels urinary of @DRUG$ administered , suggesting that antacids may absorption fosinopril .	DDI-false
Contraceptives Coadministration of oral @DRUG$ increased AUC and @DRUG$ by 30 and % .	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$ @DRUG$ Ribavirin can the in vitro antiviral of stavudine and zidovudine .	DDI-false
Another oral , the metabolism @DRUG$ , resulting in plasma concentrations of @DRUG$ its which may QT intervals .	DDI-false
@DRUG$ , phenobarbital @DRUG$ theophylline and were added human serum	DDI-false
Drugs to 3A Clinical the Clinical Involving Alprazolam during with alprazolam @DRUG$ with @DRUG$ maximum alprazolam 46 % decreased clearance 21 , 17 % , and performance	DDI-mechanism
Antihypertensives @DRUG$ with in patients -@DRUG$ agents ( , a CYP3A4 inhibitor ) or calcium channel verapamil , a substrate diltiazem , because bradycardia , sinus arrest , block	DDI-false
- @DRUG$ ( @DRUG$ ) may of side affecting the and/or the side methotrexate	DDI-false
drug @DRUG$   and other ( @DRUG$ gabapentin phenobarbital phenytoin ) also by concentrations of placebo-controlled	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
To whether of thiosulfate would permit cisplatin to be administered , a fixed 9.9-g/m2 of @DRUG$ intravenously three with escalating doses of	DDI-false
@DRUG$, lidocaine, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
: @DRUG$ , injectable produces of the central nervous when administered with , phenothiazines , barbiturates @DRUG$ and other . scopolamine concomitantly with injectable lorazepam , an , , behavior has been .	DDI-effect
coadministration @DRUG$ biologic half-life of fenoprofen because in metabolic that results in a greater of @DRUG$ in the .	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, @DRUG$, and @DRUG$.	DDI-false
successive application @DRUG$ 5 mg/kg egg weight ( e.w ) and glutamate ( e.w . a 10 min interval of of 17-day-old in effect @DRUG$ .	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
specific studies have coadministration with drugs that are CYP3A4 ( , calcium dapsone disopyramide , quinidine warfarin , tacrolimus , @DRUG$ , pimozide , @DRUG$ , fentanyl , alfentanyl , alprazolam and may have elevated plasma concentrations when with saquinavir	DDI-false
Nervous System use of DURAGESIC   ( ) central system but limited to other , @DRUG$ , hypnotics , tranquilizers e.g. @DRUG$ ) general , phenothiazines skeletal muscle , and alcohol respiratory , and profound or in coma or death	DDI-false
@DRUG$: As with some other @DRUG$, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
However, concomitant administration of aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
Although this effect was noted even when @DRUG$ was given 4 hours prior to @DRUG$, this regimen did not result in diminished efficacy.	DDI-effect
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
: erythromycins @DRUG$ @DRUG$.	DDI-effect
The steady of @DRUG$ and been to be an 31 % and 20 % , by the administration of @DRUG$ tablets .	DDI-mechanism
Multivalent Cation-Containing Products Concurrent @DRUG$ , , multivalent products @DRUG$ or sucralfate VIDEX or pediatric powder or products , iron , or the absorption , resulting in urine considerably lower desired .	DDI-mechanism
Other concomitant therapy specific performed finasteride doses of 1 were used in clinical studies with , a-blockers , analgesics enzyme , anticonvulsants , blockers , @DRUG$ nitrates diuretics , H2 , HMG-CoA reductase inhibitors @DRUG$ also as ) , and quinolone anti-infectives of significant	DDI-false
Multivalent Cation-Containing Products : Concurrent a , ciprofloxacin , with as @DRUG$ or aluminum @DRUG$ VIDEX chewable/buffered tablets , or calcium iron may decrease absorption ciprofloxacin , in serum and urine considerably lower desired	DDI-false
However, the absolute number of @DRUG$-related deaths is far greater than the number of deaths in amphetamine or @DRUG$ users.	DDI-false
Other strong of CYP3A4 itraconazole @DRUG$ @DRUG$ , , nelfinavir ) would be expected to behave similarly	DDI-false
Digoxin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of @DRUG$ given as a 0.25 mg dose every day.	DDI-false
was the steady-state of @DRUG$ @DRUG$ ( INN ciclosporin ) when in de novo kidney allograft recipients during first after transplantation	DDI-false
In the first study, concomitant administration of 0.2 mg @DRUG$ and 12 g cholestyramine resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing @DRUG$ alone.	DDI-false
zidovudine subjects 1200 mg/day @DRUG$ = 7 ) ( later mg/day = 5 ) 8 to of 21-day course of 100 , five of @DRUG$.	DDI-false
Antimycobacterial : rifampin CONTRAINDICATED coadministration this product @DRUG$ an @DRUG$ reduces plasma concentrations saquinavir	DDI-false
specific studies coadministration drugs are mainly eg , calcium channel blockers , dapsone , quinine , amiodarone @DRUG$ warfarin , @DRUG$ , ergot , pimozide , fentanyl , and triazolam have elevated plasma when coadministered with ;	DDI-false
of hypotensive can minimized by either discontinuing diuretic salt intake to initiation with @DRUG$ or @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
For example, when vitamin K antagonists are administered concomitantly with @DRUG$, prothrombin time should be carefully monitored and if necessary, the dosage of @DRUG$ should be reduced.	DDI-false
Acetaminophen, @DRUG$, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
appears to relevant this with @DRUG$ although theoretically , other drugs cardiac ( eg , @DRUG$ blocking calcium or H1-blocking agents , antidepressants phenothiazines contribute a the interval	DDI-effect
ACE and @DRUG$ Congestive Post-Myocardial ( 91 % ) patients INSPRA 25 50 mg ACE inhibitors @DRUG$ (	DDI-false
Like ( mg/kg @DRUG$ ( mg/kg ) the intravenous and the @DRUG$ and rats	DDI-false
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., tranexamic acid, @DRUG$) and @DRUG$.	DDI-false
ACE II Antagonists Congestive Failure Post-Myocardial , 3020 ( 91 % INSPRA to 50 received @DRUG$ or @DRUG$ ( ACEI/ARB )	DDI-false
Although specific drug interactions with or were identified in studies of @DRUG$ % Ophthalmic Solution , the or effect with @DRUG$ ( alcohol , , opiates , sedatives ) should be considered	DDI-advise
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, dexamethasone, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
possible @DRUG$ , @DRUG$ been reported , a potentiation the action .	DDI-false
@DRUG$ : The of with @DRUG$ has on rare resulted severe hypoglycemia	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
supervision and careful dosage required @DRUG$ is other drugs or	DDI-advise
Drugs be 3A of Possible Clinical Basis Clinical Studies coadministration with @DRUG$ fluoxetine alprazolam plasma of @DRUG$ 46 , decreased by % increased half-life % decreased measured	DDI-false
: diabetic @DRUG$ , significant effects @DRUG$ levels fasting glucose .	DDI-false
Other therapy Although not , finasteride of 1 mg or with acetaminophen , analgesics enzyme ( ACE ) , @DRUG$ calcium-channel cardiac , , antagonists , , synthetase ( also referred to @DRUG$ ) clinically adverse interactions	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, cimetidine, @DRUG$), though this has not been studied	DDI-mechanism
@DRUG$-Vitamin K can antagonize the effect of @DRUG$	DDI-false
Other concomitant therapy Although specific interaction studies more concomitantly used in , , analgesics @DRUG$ , anticonvulsants benzodiazepines beta , calcium-channel nitrates @DRUG$ , synthetase inhibitors ( also referred to as NSAIDs ) anti-infectives evidence of significant .	DDI-false
Although specific have been performed with mainly metabolized by CYP3A4 eg channel blockers dapsone disopyramide amiodarone quinidine , tacrolimus , cyclosporine ergot derivatives , , @DRUG$ , fentanyl , and ) may have elevated plasma when coadministered @DRUG$	DDI-mechanism
Lithium @DRUG$ have an of plasma @DRUG$ levels a reduction in	DDI-mechanism
, , @DRUG$ @DRUG$ acid pooled serum therapeutic .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Supplements @DRUG$ can potassium loss caused by	DDI-effect
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Oral Contraceptives Coadministration of @DRUG$ and an AUC for and @DRUG$ 30 % and % .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Results studies in multiple sclerosis patients taking TYSABRI and concomitant @DRUG$ ( AVONEX   IM ) or glatiramer acetate inconclusive to the for the @DRUG$ or	DDI-false
Serum @DRUG$ levels should be monitored frequently if @DRUG$ is administered concomitantly with lithium.	DDI-false
drugs such quinidine , @DRUG$ , @DRUG$ , have been with .	DDI-false
Other Cardiovascular : Enalapril IV concomitantly @DRUG$ , @DRUG$ , calcium-blocking , hydralazine prazosin digoxin of clinically significant interactions	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Sedatives/@DRUG$ : triazolam , @DRUG$ for such as or sedation .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$-A drug interaction study of eplerenone with @DRUG$ has not been conducted.	DDI-false
- Vitamin K (e.g., @DRUG$, Synkayvite) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
A possible interaction between @DRUG$ and ciprofloxacin, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, digoxin, Maalox, and @DRUG$.	DDI-false
@DRUG$-Concomitant intake of mineral oil and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Compounds tested in man include @DRUG$, @DRUG$, phenytoin, diazepam, aminopyrine and antipyrine.	DDI-false
Although no interactions with glaucoma drugs or were clinical of IOPIDINE Ophthalmic Solution , the additive depressants ( @DRUG$ @DRUG$ , opiates , sedatives , anesthetics should considered .	DDI-false
Potassium-sparing diuretics ( , spironolactone , @DRUG$ , amiloride ) , @DRUG$ supplements , or potassium-containing substitutes lead to significant in serum potassium	DDI-false
@DRUG$ had no significant effect on @DRUG$ pharmacokinetics .	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
Capsules Garlic not be used while @DRUG$ ( ) as the the risk decreased @DRUG$ plasma .	DDI-false
treatment with inhibitors CYP3A4 such as , intraconazole ritonavir , , @DRUG$ , etc . ) is @DRUG$ dose .	DDI-advise
The concomitant use of @DRUG$ is not recommended since nitrofurantoin may antagonize the antibacterial effect of @DRUG$ in the urinary tract.	DDI-false
Lithium: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal @DRUG$ clearance.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Numerous drug interactions are possible with some @DRUG$, such as phenobarbitone and @DRUG$, which affect hepatic microsomal enzyme systems.	DDI-false
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Interactions with some drugs , inhibitors ( @DRUG$ could - - Flupenthixol - Tricyclic : @DRUG$ the of Tricyclic antidepressants	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
is recommended concurrent @DRUG$ containing @DRUG$ for at 4 following	DDI-false
effects @DRUG$ anesthesia on @DRUG$	DDI-false
the of	DDI-false
Concurrent use with @DRUG$ or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of @DRUG$.	DDI-mechanism
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
@DRUG$ the effects of @DRUG$ , , CNS depressants .	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-false
EM treated with or @DRUG$ AUC @DRUG$ 6- 8-fold and Css max is about 3- 4-fold greater alone .	DDI-mechanism
Barbiturates and @DRUG$ should not be administered to patients receiving @DRUG$.	DDI-advise
Data vitro studies @DRUG$ @DRUG$ suggest possible drug interaction : ergotamine cyclosporine , nicardipine ,	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Data from vitro of benzodiazepines suggest drug interaction for the : @DRUG$ , cyclosporine and	DDI-false
Cardiovasculars: @DRUG$: In patients receiving digoxin therapy, administration of oral @DRUG$ regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
comparison of in dogs with ketamine , dosage of ouabain needed to cause was of @DRUG$ , @DRUG$ than with	DDI-false
with @DRUG$ , it noted that HALDOL may be capable of CNS anesthetics @DRUG$ , and .	DDI-effect
@DRUG$: In controlled studies in healthy volunteers, bepridil hydrochloride either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum @DRUG$ concentrations.	DDI-false
Oral Contraceptives @DRUG$ ( mg twice ) did influence of @DRUG$ containing mg ethinyl estradiol mg , or of the and levels , impairment efficacy unlikely	DDI-false
Multivitamins, or other products containing @DRUG$ or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
drugs include thiazides and other diuretics , @DRUG$ , , estrogens , contraceptives phenytoin , acid sympathomimetics @DRUG$ and isoniazid .	DDI-false
determine whether of @DRUG$ larger cisplatin to be , a 9.9-g/m2 of @DRUG$ given over three hours concurrently with of cisplatin .	DDI-false
@DRUG$ : @DRUG$ since the this product saquinavir an antiretroviral regimen concentrations of saquinavir	DDI-false
The monoamine oxidase inhibitory effects of @DRUG$ may persist for a substantial period after discontinuation of the drug, and this should be borne in mind when another drug is prescribed following @DRUG$.	DDI-false
Lithium Increased serum @DRUG$ levels and symptoms lithium toxicity have been receiving concomitant and @DRUG$ therapy	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Antidepressants, tricyclic @DRUG$ may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-effect
Central : use of DURAGESIC fentanyl transdermal system ) system depressants , to opioids , @DRUG$ , @DRUG$ ( e.g. , , muscle relaxants and alcohol hypotension profound , death	DDI-false
WARFARIN: Co- administration of @DRUG$ and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
the of @DRUG$ @DRUG$ ,	DDI-false
@DRUG$/Acetaminophen : Pharmacokinetic drug-drug interactions not demonstrated Argatroban and aspirin 162.5 mg given 2 of   g/kg/min over 4 hours ) or 1000 orally given 6 and 0 hours prior to and hours , of @DRUG$ 1.5   g/kg/min . over	DDI-false
Cardiovascular and IV have used @DRUG$ , methyldopa nitrates , @DRUG$ , without evidence significant interactions .	DDI-false
clinical data angina concomitant @DRUG$ @DRUG$ therapy no serum digoxin .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
A possible interaction between glyburide and @DRUG$, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
of treatment drugs class increased with cyclosporine , fibric acid , @DRUG$ ( , , @DRUG$.	DDI-false
@DRUG$ The administration normal @DRUG$ the and increased plasma levels of .	DDI-false
This with @DRUG$ CNS may potentiate medications or ) or medications anticholinergic anticholinergic be when these medications are , ( inhibitors with may and intensify the depressant @DRUG$ ) .	DDI-false
BACKGROUND The combined administration of @DRUG$ and verapamil hydrochloride verapamil , @DRUG$ , of of intestinal ) and index intestinal cancers were investigated in male Wistar .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The effect of @DRUG$  on @DRUG$ was not studied.	DDI-false
- Methotrexate (e.g., @DRUG$) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
is a in exposure @DRUG$ @DRUG$ is coadministered with ( )	DDI-false
ERYTHROMYCIN: In hypercholesterolemic patients, steady-state @DRUG$ AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-mechanism
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Reports suggest @DRUG$ the effect	DDI-effect
The uniformity and time course of anticoagulant interference by @DRUG$ , , glutethimide @DRUG$ methaqualone were systematically investigated in 16 patients receiving coumarin .	DDI-false
@DRUG$ 40 mg @DRUG$ tablets nisoldipine concentrations to levels	DDI-mechanism
@DRUG$ doses be reduced by administered with	DDI-false
Drug Interactions : with some , Monoamine inhibitors MAOI MAOI theoretically affect flupenthixol pharmacodynamics - @DRUG$ Flupenthixol CNS depression Tricyclic @DRUG$ the effect antidepressants	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, spironolactone, and cimetidine.	DDI-advise
to @DRUG$ A review of that 12.6 ( 28 ) of 501 treated @DRUG$ containing regimens who administered experienced acute atypical adverse reactions	DDI-false
include @DRUG$ and other diuretics corticosteroids phe-nothiazines , thyroid estrogens , @DRUG$ , acid , blocking , isoniazid	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
@DRUG$ should not be used concomitantly with @DRUG$ because of the possibility of ototoxicity.	DDI-advise
@DRUG$ Angiotensin II Receptor Antagonists ( Congestive Failure Infarction)- , 91 % patients 25 to also received ACE ACEI/@DRUG$ )	DDI-false
@DRUG$: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of @DRUG$, significant hypotension developed in a substantial number of subjects.	DDI-false
Antacids : In pharmacology , coadministration of an antacid ( hydroxide , magnesium and @DRUG$ reduced serum and urinary excretion of fosinoprilat as compared with alone , suggesting that @DRUG$ may impair of	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than @DRUG$ and does not interact with salicylate or @DRUG$.	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than tolbutamide and does not interact with @DRUG$ or dicumarol.	DDI-false
specific studies not , with drugs that mainly metabolized by ( calcium channel dapsone @DRUG$ quinine , amiodarone , , @DRUG$ ergot derivatives , pimozide , carbamazepine , alfentanyl alprazolam , ) elevated	DDI-false
Amiodarone be caution in receiving   blocking e.g. propranolol , CYP3A4 inhibitor ) @DRUG$ e.g. , , substrate , and diltiazem the potentiation sinus ;	DDI-false
( 40 ( 40 ) morphine cocaine and @DRUG$ and @DRUG$ in	DDI-false
Cardiovasculars Cardiac glycosides : @DRUG$ therapy , oral @DRUG$ regularly results in increase in digoxin concentration may reach levels toxicity .	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-int
No Interactions To Date Levosimendan does clinically important pharmacokinetic with , beta-blockers , digoxin , @DRUG$ , @DRUG$ , ethanol itraconazole .	DDI-false
, @DRUG$ and @DRUG$ should not be .	DDI-advise
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Coadministration of @DRUG$ did not influence the pharmacokinetics of @DRUG$.	DDI-false
II studies of with addition of @DRUG$ 100 mg to @DRUG$ increased serum slightly ( about 0.09 0.13 mEq/L	DDI-effect
: @DRUG$ lithium cause elimination of including	DDI-false
concomitant not , in studies with , acid a-blockers analgesics , @DRUG$ , benzodiazepines , beta , calcium-channel @DRUG$ prostaglandin inhibitors also referred to as NSAIDs , and quinolone anti-infectives evidence of interactions	DDI-false
an effect of @DRUG$ disposition @DRUG$ in .	DDI-false
@DRUG$ apparently an effect certain , reported reduce of , @DRUG$ propranolol , nifedipine , chlordiazepoxide , certain , , theophylline metronidazole , thereby delaying elimination and increasing blood drugs	DDI-mechanism
@DRUG$ @DRUG$ may decrease the emetic response the .	DDI-false
Other Drugs:Drugs such as @DRUG$, @DRUG$, procainamide, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Therefore, when @DRUG$ and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.)	DDI-advise
Dexamethasone and @DRUG$ similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Moreover, additional interaction studies with @DRUG$ and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
HMG-CoA Reductase Inhibitors: Simvastatin (@DRUG$ substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
@DRUG$: @DRUG$ may delay intestinal absorption of ethosuximide.	DDI-false
the mechanisms development dependence may similar @DRUG$ and	DDI-false
( e.g. @DRUG$ triamterene or @DRUG$ ) supplements or lead increases serum	DDI-false
Sedatives/Hypnotics @DRUG$ , @DRUG$ serious and/or such as prolonged or respiratory .	DDI-false
Aerosol particles of @DRUG$ were generated from an @DRUG$ solution, dried, and collected by a cascade impactor for characterization or by a liquid impinger for dissolution experiments.	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Fenfluramine increase slightly of antihypertensive drugs , @DRUG$ , @DRUG$ reserpine .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
, effect on certain microsomal reported reduce the warfarin-type anticoagulants , , @DRUG$ , @DRUG$ , diazepam certain tricyclic , lidocaine and metronidazole , thereby and levels these .	DDI-false
: @DRUG$ to slow the metabolism of carbamazepine its levels levels prior to with , and of toxicity monitored closely , and dosage the @DRUG$ should be .	DDI-false
Sedatives/@DRUG$: @DRUG$, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
In patients whose hypertension was controlled @DRUG$ , @DRUG$ produced additional supine systolic/diastolic blood reductions of mm Hg to placebo .	DDI-effect
These include thiazides diuretics , products @DRUG$ , phenytoin , nicotinic , @DRUG$ blocking drugs .	DDI-false
Tetracyclines: Concomitant treatment with Accutane and @DRUG$ should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
and @DRUG$ substrate ) is almost seen patients receiving @DRUG$ and result serious	DDI-false
Additive adverse effects resulting blockade occur @DRUG$ administered concomitantly with other antimuscarinics amantadine , haloperidol @DRUG$ , ) inhibitors , tricyclic antihistamines .	DDI-effect
These drugs include thiazides and other diuretics , , thyroid products estrogens @DRUG$ , phenytoin acid sympathomimet-ics , @DRUG$ , isoniazid .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
in studies @DRUG$ suggest drug for : @DRUG$ paroxetine	DDI-false
Treatment with @DRUG$ once weekly for 4 weeks in healthy subjects was associated with an inhibition of P450 1A2 and a 25% increase in @DRUG$ AUC.	DDI-mechanism
@DRUG$ Eszopiclone 3 mg for 5 affect or @DRUG$ nor changes the ( a mg dose of	DDI-false
@DRUG$ and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
and @DRUG$ may reduce or	DDI-effect
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
, lidocaine/quinidine phenobarbital/@DRUG$ , acid , , theophylline/acetaminophen and @DRUG$/phenobarbital .	DDI-false
@DRUG$ including norfloxacin may the effects anticoagulants including @DRUG$ its or similar agents .	DDI-effect
@DRUG$ and @DRUG$ coadministration of Femara with drugs not result clinically- significant	DDI-false
When @DRUG$ is added to or from dosage adjustment of @DRUG$ required .	DDI-advise
Hypotension Diuretic Therapy @DRUG$ and in whom diuretic was experience an excessive of pressure of with	DDI-effect
@DRUG$ no clinically significant on time administered patients @DRUG$ .	DDI-false
reports of steady-state levels of @DRUG$ procainamide and during with @DRUG$.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
the presence of @DRUG$ doses of adenosine required @DRUG$ not be	DDI-advise
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Previous have demonstrated a significant in the bioavailability @DRUG$ @DRUG$ when intravenous .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
- @DRUG$ (e.g., Mexate) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or @DRUG$.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
Concomitant oral administration of @DRUG$ (a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa) caused an eight-fold increase of the systemic exposure to oral @DRUG$.	DDI-mechanism
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
aim paper was to neurotensin both @DRUG$ or its @DRUG$ , or tuftsin , on antinonciceptive these peptides mice after intracisternal injection	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Cardiovascular Enalapril enalapril IV concomitantly @DRUG$ methyldopa , nitrates , calcium-blocking , , @DRUG$ and digoxin without of clinically significant adverse .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
the @DRUG$ , @DRUG$ had no prothrombin time other pharmacodynamic parameters .	DDI-false
Although not been performed , coadministration with that are mainly by ( calcium channel , , quinine , amiodarone quinidine warfarin cyclosporine ergot derivatives , @DRUG$ and @DRUG$ ) may concentrations coadministered with saquinavir	DDI-false
Drugs may plasma concentrations may increase plasma concentrations is recommended administering Gleevec with of the family ( e.g. @DRUG$ , @DRUG$ , clarithromycin .	DDI-false
Aspirin: When @DRUG$ is administered with aspirin, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
In single and multiple dose studies in healthy subjects receiving both @DRUG$ and @DRUG$, prothrombin time (measured as INR) was increased by approximately 8% to 11%.	DDI-effect
Progesterone @DRUG$ ( an estrogen an method contraception @DRUG$	DDI-effect
These drugs include @DRUG$ and , @DRUG$ thyroid oral phenytoin , , channel isoniazid	DDI-false
addition @DRUG$ neither the of acetylsalicylic acid , , and nor pharmacokinetics of @DRUG$ steady state	DDI-false
The for the @DRUG$ agent should be reviewed the of @DRUG$ established , be .	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other @DRUG$ and that these AEDs do not influence the pharmacokinetics of levetiracetam.	DDI-false
: the profile in Acamprosate concomitantly anxiolytics , @DRUG$ @DRUG$ ( benzodiazepines ) was similar that of taking	DDI-false
undergoing concurrent therapy @DRUG$ a the steady-state @DRUG$ may occur when cime-tidine is discontinued	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
This drug may interact alcohol other @DRUG$ may potentiate or or medications anticholinergic ( effects may these with antihistamines ) @DRUG$ ( with antihistamines prolong intensify and depressant effects of antihistamines	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking @DRUG$ when @DRUG$, macrolide antibiotics, or azoles were administered concomitantly.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$/@DRUG$ lidocaine/quinidine phenobarbital/acetaminophen , , quinidine/lidocaine , valproic .	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and alcohol.	DDI-effect
@DRUG$ , Methylxanthines and @DRUG$ : Concomitant xanthine steroids or diuretics potentiate a hypokalemic effect beta2-agonists .	DDI-false
sodium is given to a receiving @DRUG$ , the @DRUG$ should prevent prolongation prothrombin .	DDI-false
@DRUG$ (@DRUG$) produces psychotomimetic effects in humans that resemble schizophrenia symptoms.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including @DRUG$ and @DRUG$, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
: Isoniazid is to slow the metabolism @DRUG$ and increase its serum @DRUG$ be prior to administration with , and be , dosage adjustment should	DDI-false
Nalfon any effect that @DRUG$ alone because aspirin increases rate of Nalfon the concomitant use of @DRUG$ salicylates .	DDI-false
Caution be an @DRUG$ concomitantly with drugs decrease the or endogenous hormones , such @DRUG$	DDI-advise
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with alprazolam for the following: @DRUG$ and paroxetine.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving @DRUG$ therapy.	DDI-false
Antiarrhythmics : @DRUG$ drugs , @DRUG$ disopyramide , and phenytoin have with amiodarone .	DDI-false
@DRUG$ is metabolized to @DRUG$ by the cytochrome P450 (CYP450) enzyme group, specifically cytochromes P450 3A4 (CYP3A4) and CYP2C8.	DDI-false
, these drugs that similar @DRUG$ , including @DRUG$ quinidine , cardiac anti-depressants .	DDI-false
@DRUG$ @DRUG$	DDI-false
@DRUG$: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing @DRUG$ therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
@DRUG$: Amiodarone, bepridil, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
include the thiazides @DRUG$ , @DRUG$ oral phenytoin acid calcium blocking , and isoniazid	DDI-false
administered with tolazoline @DRUG$ @DRUG$ , , surfactant , ventilation .	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ in combination with lidocaine (CYP3A4 substrate) given for local @DRUG$.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
To impact plus HAART clinical course with , systemic , lymphoma HIV-NHL the authors compared retrospectively a group of patients with HIV-NHL were treated @DRUG$ , , vincristine , ) regimen plus a of patients who treated with chemotherapy or a i.e. , cyclophosphamide , doxorubicin @DRUG$ , and prednisone with vincristine receiving antiretroviral	DDI-false
Tolazamide: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on @DRUG$ (1 gm/day) 11 days after the addition of @DRUG$ (75 mg/day).	DDI-effect
The bioavailability of the capsule formulation of @DRUG$ was not affected when administered 5 minutes following an @DRUG$.	DDI-false
@DRUG$: Amphetamines inhibit the hypotensive effect of @DRUG$.	DDI-false
OTHER CONCOMITANT THERAPY specific interaction studies performed , in , cerivastatin was used concomitantly with @DRUG$ blockers , , @DRUG$ ) of clinically significant	DDI-false
Concomitant administration of @DRUG$ and other related compounds (eg, quinine, quinidine and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
@DRUG$ with for less than days increases plasma of procainamide and @DRUG$ 55 and 33 % respectively .	DDI-false
Compounds tested in man include @DRUG$, theophylline, @DRUG$, diazepam, aminopyrine and antipyrine.	DDI-false
@DRUG$ , or @DRUG$ of hypotension may .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
studies reduction in the oral of @DRUG$ and when administered concomitantly @DRUG$ as morphine	DDI-mechanism
- , ] , @DRUG$ [ e.g. , Anavar ] , @DRUG$ e.g. , , Winstrol ] )	DDI-false
In convulsions have been reported when @DRUG$ @DRUG$ and special care should taken when treatment regimen of these .	DDI-effect
To evaluate chemotherapy plus HAART on course of , systemic , , compared retrospectively a group with HIV-NHL who the doxorubicin , prednisone ( regimen plus HAART with a group of treated with CHOP chemotherapy or regimen ( , doxorubicin teniposide , prednisone @DRUG$ ) without @DRUG$ therapy .	DDI-false
Data from in vitro studies of @DRUG$ other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-false
and retinyl similarly and or of prostatic	DDI-false
Lithium: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
Central System Depressants use of DURAGESIC ( fentanyl transdermal system central , including but to sedatives , hypnotics ( , @DRUG$ , , @DRUG$ , skeletal muscle , , may respiratory depression hypotension and or potentially in coma	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or @DRUG$ (ACEI/ARB).	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
@DRUG$ The administration @DRUG$ and in normal no plasma levels naproxen , significantly decreased urinary glucuronide metabolite	DDI-false
Warfarin: The effect of @DRUG$ on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-effect
Cardiovasculars @DRUG$ : receiving administration of @DRUG$ an increase serum digoxin may reach toxicity .	DDI-false
@DRUG$ : Clinical studies , as well as observations shown that NSAIDs can the natriuretic effect furosemide and @DRUG$ in some	DDI-false
The pressor effects of catecholamines such as @DRUG$ or @DRUG$ are enhanced by Bretylium Tosylate.	DDI-false
Interactions Keppra   Drugs AEDs ) @DRUG$   3000 mg no of @DRUG$ in patients with epilepsy	DDI-false
@DRUG$ has pharmacokinetic interaction when administered with @DRUG$.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Multivitamins other products containing or @DRUG$ sucralfate not concomitantly within hours , the administration of @DRUG$ , they may absorption in serum urine of norfloxacin	DDI-advise
drugs include the and other diuretics , , @DRUG$ , estrogens oral , @DRUG$ , nicotinic acid , , calcium blocking and	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
Causing : antihypertensive of @DRUG$ enalapril IV is augmented by @DRUG$ cause ( , diuretics	DDI-effect
Coingestion of acetaminophen with @DRUG$, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
include the thiazides @DRUG$ , corticosteroids phenothiazines @DRUG$ estrogens , oral contraceptives , , acid sympathomimetics , drugs and isoniazid .	DDI-false
@DRUG$ have shown reduce effects insufficiency , hyperbilirubinemia , confusion concomitant of agents with PROLEUKIN may reduce the effectiveness PROLEUKIN thus should be . 12 and @DRUG$ may with	DDI-false
: @DRUG$ the effect of	DDI-false
Although have mainly ( eg blockers , disopyramide , @DRUG$ , quinidine , warfarin @DRUG$ derivatives , , , , alprazolam , and triazolam ) elevated plasma with saquinavir	DDI-false
include antifungals , @DRUG$ , , diclofenac , nicardipine , propofol inhibitors @DRUG$ ,	DDI-false
@DRUG$ enterohepatic its serum and @DRUG$/2 .	DDI-false
was a randomized double-blind study of 101 were randomly 1:1:1 receive everolimus tablets at doses , mg , or mg twice daily @DRUG$ and	DDI-false
These results that @DRUG$ and @DRUG$ and glucocorticoids retinoids the of prostate epithelium modification the insulin and	DDI-false
Antidepressants @DRUG$ Amphetamines @DRUG$ or sympathomimetic agents	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Additive adverse from cholinergic blockade occur when , amantadine , @DRUG$ , monoamine oxidase ( ) , antidepressants some	DDI-false
, other products iron @DRUG$ antacids sucralfate should not be administered with , or 2 hours , of @DRUG$ absorption resulting lower levels norfloxacin	DDI-advise
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, @DRUG$, topiramate, or lamotrigine.	DDI-false
Pharmacokinetic or pharmacodynamic drug-drug interactions not demonstrated administered @DRUG$ mg orally given 26 and to Argatroban g/kg/min over 4 or acetaminophen mg 12 0 to and 6 and hours ,   . over 18 ) .	DDI-false
phenobarbital/@DRUG$ acid , quinidine/lidocaine theophylline/acetaminophen acid/@DRUG$.	DDI-false
In patients receiving @DRUG$, the addition of @DRUG$ to therapy could prolong the prothrombin time.	DDI-effect
This to be the clinically relevant kind with , coadministration of drugs known to alter cardiac conduction eg , or blocking , @DRUG$ , or H1-blocking @DRUG$ to prolongation of the .	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
@DRUG$ 20 mg co-administered slow-release @DRUG$ 30 mg or mg once the ( AUC or Cmax ) of nifedipine drug that CYP3A4 .	DDI-false
of @DRUG$ during @DRUG$ .	DDI-mechanism
@DRUG$ elevation and reduction in @DRUG$ clearance .	DDI-false
@DRUG$ In study conducted in , steady-state plasma levels approximately % subjects lithium 450 @DRUG$ BID as compared subjects receiving lithium	DDI-false
Based on chemical resemblance @DRUG$ ketoconazole , coadministration of @DRUG$ with .	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ not have important pharmacokinetic interactions captopril isosorbide mononitrate , @DRUG$ , or .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Drugs That Induce CYP3A4 (Rifampicin) Racemic @DRUG$ exposure was decreased 80% by concomitant useof @DRUG$, a potent inducer of CYP3A4.	DDI-mechanism
is concurrent of @DRUG$ with hydroxide antacids at @DRUG$ administration .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
HIV Protease Inhibitors Indinavir ( 800 . ) co-administered with Vardenafil mg in 16-fold in @DRUG$ a @DRUG$ increase vardenafil half-life	DDI-false
@DRUG$ : is not in patients who have 14 days and potentiation @DRUG$ analgesics	DDI-false
Interactions : interact with like inhibitors @DRUG$ could theoretically pharmacodynamics - Arecoline Ethanol : Flupenthixol cause additive @DRUG$ : Flupenthixol of Tricyclic	DDI-false
, when @DRUG$ @DRUG$ are used concomitantly , the patient observed determine if the of is obtained .	DDI-advise
that Inhibit or Induce 3A4 @DRUG$ by CYP3A4 and of or of CYP3A4 @DRUG$ .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, @DRUG$, oral contraceptive, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and @DRUG$.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
@DRUG$ Adrenergic blockers are inhibited by @DRUG$.	DDI-false
@DRUG$: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-false
These that both @DRUG$ retinyl acetate and possibly glucocorticoids @DRUG$ , of prostate a of the and	DDI-false
@DRUG$/theophylline , , phenobarbital/valproic acid , quinidine/lidocaine , and	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$, secobarbital and @DRUG$;	DDI-false
In , plasma atorvastatin @DRUG$ @DRUG$ , a known of cytochrome	DDI-mechanism
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
These drugs include the other @DRUG$ , products , estrogens oral @DRUG$ acid , channel and .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium sparing, and @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Because Nalfon not been to produce any beyond aspirin alone because aspirin the rate of excretion of @DRUG$ , @DRUG$ is recommended	DDI-false
tolerance dogs with @DRUG$ , Innovar Vet or , the dosage of ouabain to tachycardia , as LD50 of @DRUG$ with ketamine or Innovar .	DDI-false
Bacteriostatic Antibiotics : @DRUG$ or @DRUG$ with bactericidal effect .	DDI-false
@DRUG$ (@DRUG$)-A drug study of with not conducted .	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
The rate and of absorption @DRUG$ was given alone when Proquin given @DRUG$ at the dose maximally suppresses gastric acid .	DDI-false
@DRUG$: The concomitant use of @DRUG$ and beta-blocking agents has been well tolerated in patients with stable angina.	DDI-false
, @DRUG$ may reduce the of @DRUG$.	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Ritonavir and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-mechanism
Concomitant administration of @DRUG$ and other related compounds (eg, @DRUG$, quinidine and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
There been previously stable plasma of @DRUG$ including @DRUG$ fluoxetine been administered in combination agents .	DDI-false
@DRUG$ is @DRUG$ be clinical has studied in since 1986 .	DDI-false
As antipsychotic should be that be capable @DRUG$ such as anesthetics @DRUG$ alcohol	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
a comparison of @DRUG$ dogs anesthetized with , pentobarbital dosage of ouabain needed ventricular tachycardia was higher , was the LD50 with ketamine than	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Adequate monitoring of theophylline plasma concentrations should be considered when therapy with @DRUG$ is initiated or changed in patients receiving @DRUG$.	DDI-advise
concomitant therapy studies , of 1 or more were concomitantly used in , acetylsalicylic acid , , @DRUG$ , ACE ) , benzodiazepines beta , @DRUG$ , nitrates diuretics , HMG-CoA reductase inhibitors prostaglandin synthetase also to as ) , anti-infectives significant adverse interactions	DDI-false
specific studies have not , with mainly CYP3A4 ( , calcium , warfarin , , cyclosporine , ergot , carbamazepine fentanyl , @DRUG$ , , triazolam ) coadministered @DRUG$ ;	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
HAART the clinical systemic , non-Hodgkin lymphoma HIV-NHL , the compared patients with who with vincristine and @DRUG$ ( regimen plus HAART with group of who CHOP chemotherapy a CHOP-like ( , @DRUG$ , , and plus antiretroviral therapy	DDI-false
Depressants : of @DRUG$ ( fentanyl system other depressants including to other sedatives , @DRUG$ tranquilizers ( , benzodiazepines ) general , , and alcohol cause respiratory depression , , and , or result in coma or death .	DDI-effect
Methotrexate ( @DRUG$ ) methotrexate @DRUG$ increase the side affecting the liver side	DDI-false
Since amiodarone is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced @DRUG$ levels.	DDI-false
diuretics e.g. , @DRUG$ @DRUG$ ) potassium supplements , potassium-containing salt substitutes to increases in serum .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ may decrease the amount of digoxin (Lanoxin, @DRUG$) that gets absorbed into your body.	DDI-false
In @DRUG$ with ketamine Vet , or , the of ouabain needed to was significantly higher the LD50 of ouabain , @DRUG$ .	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Although no specific glaucoma drugs identified in @DRUG$ 0.5 Ophthalmic Solution possibility additive potentiating ( alcohol , opiates @DRUG$ , ) be considered	DDI-advise
naltrexone with @DRUG$ a increase in AUC a increase Cmax	DDI-false
These the @DRUG$ corticosteroids , estrogens , oral contraceptives , @DRUG$ , sympathomimet-ics calcium channel blocking drugs isoniazid .	DDI-false
These drugs include the @DRUG$ and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
no drug interactions with topical medications identified in clinical of 0.5 % Solution of additive with depressants alcohol @DRUG$ , , , @DRUG$ be .	DDI-false
in vitro benzodiazepines alprazolam a drug the @DRUG$ , amiodarone @DRUG$	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with @DRUG$ or @DRUG$.	DDI-false
Potential drug interactions Keppra   and @DRUG$ ( @DRUG$ , gabapentin lamotrigine , , primidone ) were assessed by evaluating of levetiracetam and AEDs placebo-controlled studies	DDI-false
have been coadministration that are CYP3A4 ( calcium quinine @DRUG$ , warfarin , , , derivatives , @DRUG$ , carbamazepine fentanyl , alfentanyl triazolam ) may have elevated coadministered with saquinavir	DDI-false
Other interaction studies were performed , doses of 1 or more were concomitantly used clinical a-blockers , @DRUG$ , angiotensin-converting , , benzodiazepines , beta , calcium-channel , nitrates , @DRUG$ , HMG-CoA reductase , inhibitors ( to NSAIDs ) and evidence of clinically interactions	DDI-false
concomitant interaction studies were not performed of or more were used in studies with acetaminophen , @DRUG$ a-blockers angiotensin-converting enzyme ACE ) anticonvulsants beta blockers , cardiac nitrates , diuretics , inhibitors prostaglandin inhibitors also @DRUG$ ) , and quinolone evidence clinically significant adverse	DDI-false
drug interactions AEDs carbamazepine @DRUG$ , @DRUG$ , phenobarbital , , primidone were also assessed by evaluating concentrations of and these during studies .	DDI-false
sulfonylureas may by certain drugs anti-inflammatory agents other drugs bound salicylates sulfonamides , @DRUG$ @DRUG$ , coumarins inhibitors and adrenergic agents	DDI-false
Interactions Keppra   Other @DRUG$ ( AEDs ) Phenytoin   mg daily ) on pharmacokinetic disposition of @DRUG$ in refractory .	DDI-false
An interaction study with @DRUG$ showed no clinically significant effect of anastrozole on @DRUG$ pharmacokinetics or anticoagulant activity.	DDI-false
, phenobarbital/acetaminophen phenobarbital/valproic acid , theophylline/acetaminophen	DDI-false
Example inhibitors azole ciprofloxacin clarithromycin , , doxycycline , @DRUG$ , isoniazid nefazodone , , , protease , , and	DDI-false
For @DRUG$ are concomitantly with nilutamide prothrombin monitored necessary , the of @DRUG$ be .	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (@DRUG$, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-false
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
@DRUG$ The effects of and @DRUG$ on GI bleeding are synergistic that users of both together risk serious GI than that of drug alone	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-mechanism
The risk of myopathy during with this is with concurrent administration @DRUG$ acid , ( nicotinic ) , @DRUG$ , .	DDI-false
necessary to be well acquainted the clinical paraclinical of @DRUG$ to magnesium deficiency magnesium intake which only oral supplementation and @DRUG$ related to the mechanisms magnesium status which more less specific regulation of causal dysregulation	DDI-false
@DRUG$ generally should not be given with @DRUG$ because they reduce lithiums renal clearance and add a high risk of lithium toxicity.	DDI-advise
containing side chains N-methylthiotetrazole cefoperazone , cefotetan ) or methylthiadiazole ( @DRUG$ ) cause vitamin deficiency .	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (FORTOVASE) as the sole @DRUG$ due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
High-dose in concentrations administered with oral has led 80 % etoposide 38 % decrease in body clearance @DRUG$ compared to @DRUG$	DDI-false
acetaminophen/@DRUG$, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
EM or @DRUG$ , AUC atomoxetine is approximately 6- 8-fold Css , max is 4-fold @DRUG$	DDI-false
@DRUG$ : warfarin-type response almost always in @DRUG$ can or fatal bleeding .	DDI-false
@DRUG$ been shown reduce side including renal insufficiency , hyperbilirubinemia confusion dyspnea agents with PROLEUKIN may effectiveness of PROLEUKIN and thus . 12 Beta-blockers may potentiate hypotension @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Prednisone/@DRUG$: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
Ritonavir and Upon of 5 of @DRUG$ 600 mg ritonavir AUC @DRUG$ were 20	DDI-false
Patients receiving @DRUG$, @DRUG$, or sulfonylureas should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
reactions have reported in containing dose agents specifically @DRUG$ cis-platinum @DRUG$ .	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although @DRUG$ administered at either dose had little or no effect on the enhancement of intestinal carcinogenesis by @DRUG$ or on the location, histologic type, depth of involvement, labeling index, apoptotic index or tumor vascularity of intestinal cancers, it significantly decreased the incidence of cancer metastasis.	DDI-false
Patients receiving @DRUG$ dose reduction @DRUG$ to approximately 1/3 1/4 the .	DDI-false
This increase is due to the inhibition of @DRUG$ metabolism via P450 2C9 by @DRUG$ (see CLINICAL PHARMACOLOGY - Pharmacokinetics: Metabolism).	DDI-mechanism
Non-steroidal Drugs : In patients the administration of @DRUG$ reduce diuretic , natriuretic , of , potassium-sparing	DDI-effect
HIV Protease : 800 t.i.d . co-administered @DRUG$ 10 mg in a 16-fold vardenafil a 7-fold @DRUG$ Cmax and a 2-fold increase in .	DDI-false
Cation-Containing Concurrent of , including ciprofloxacin , cation-containing products VIDEX or , or calcium @DRUG$ , or @DRUG$ decrease absorption of , in and levels considerably lower than	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
studies been performed drugs that are mainly metabolized CYP3A4 eg , channel blockers @DRUG$ quinine @DRUG$ tacrolimus , carbamazepine , , , and have plasma concentrations with saquinavir ;	DDI-false
@DRUG$ may increase slightly effect of antihypertensive , @DRUG$	DDI-effect
Iodine or @DRUG$ excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
Other strong of CYP3A4 @DRUG$ , , @DRUG$ expected behave similarly .	DDI-false
Antacids In a clinical pharmacology study of @DRUG$ magnesium ) reduced serum levels and urinary excretion fosinopril alone , suggesting impair absorption @DRUG$.	DDI-false
: Rofecoxib any clinically the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
Iodine or excess may the , @DRUG$ deficiency the @DRUG$.	DDI-effect
- Methotrexate (e.g., @DRUG$) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, @DRUG$, higher alcohols and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Cardiovascular Agents Enalapril and IV have concomitantly with @DRUG$ , methyldopa nitrates @DRUG$ , and digoxin without of clinically significant adverse interactions	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, sedatives, @DRUG$).	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Vitamin A: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
@DRUG$ @DRUG$ , amiloride ) supplements , potassium-containing salt substitutes may increases serum .	DDI-false
Dose Levetiracetam on plasma concentrations of , valproate @DRUG$ or @DRUG$.	DDI-false
In volunteers , concomitant administration of @DRUG$ @DRUG$ resulted approximate 50 in plasma .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
These results suggest that the hepatoxicity of @DRUG$ in alcoholic beverages is enhanced by interaction with its congeners and @DRUG$;	DDI-effect
steady state @DRUG$ 50 had effect on anti-platelet activity of low-dose 81 once @DRUG$ assessed ex platelet generation in .	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Drugs imatinib concentrations that may imatinib : Caution recommended Gleevec inhibitors CYP3A4 , @DRUG$ , itraconazole , erythromycin @DRUG$	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than @DRUG$ and does not interact with salicylate or dicumarol.	DDI-false
study effect the ACZONE Gel , 5 % , combination ( 160 mg/800 ) (	DDI-false
@DRUG$ Methylxanthines Diuretics with steroids , or may potentiate a possible hypokalemic effect   @DRUG$	DDI-false
In a comparison of tolerance in , @DRUG$ or pentobarbital , needed ventricular was significantly higher , as the ouabain @DRUG$ Innovar than pentobarbital .	DDI-false
The coadministration of @DRUG$ decreases the biologic half-life of @DRUG$ because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine.	DDI-mechanism
therapy Although interaction performed doses of more concomitantly clinical studies @DRUG$ , acid enzyme , anticonvulsants , benzodiazepines beta blockers , calcium-channel , cardiac diuretics H2 antagonists , @DRUG$ ( ) , and of clinically significant adverse .	DDI-false
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
While @DRUG$ and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, @DRUG$, and cimetidine.	DDI-false
specific studies have not been coadministration with mainly metabolized by CYP3A4 , calcium channel , disopyramide quinine amiodarone quinidine , ergot @DRUG$ , @DRUG$ , alfentanyl , alprazolam , triazolam ) may plasma with	DDI-false
Adverse Reactions @DRUG$ literature revealed 12.6 range 11 - 28 % ) of patients treated various interleukin-2 containing subsequently administered @DRUG$ experienced acute , atypical .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
inhibitors include , , , @DRUG$ , imatinib , isoniazid , , protease @DRUG$ and verapamil .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ : quinolones concurrent of @DRUG$ with theophylline may to elevated serum concentrations of elimination	DDI-false
Other reported interactions with amiodarone: @DRUG$ (@DRUG$ substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Antibiotics Chloramphenicol , @DRUG$ , @DRUG$ interfere the bactericidal effect of	DDI-false
@DRUG$: When @DRUG$ 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.	DDI-false
general are drugs have more activities similar @DRUG$ including anti-arrhythmic agents such as and procainamide	DDI-false
This effect is small with occasional doses of @DRUG$, but may be clinically significant when @DRUG$ are used on a continuous schedule.	DDI-false
include @DRUG$ , corticosteroids , thyroid @DRUG$ , nicotinic acid , sympathomimetics , calcium channel blocking , isoniazid	DDI-false
efavirenz compared therapy @DRUG$ over 48 initial with similar responses being observed nevirapine and superiority observed	DDI-false
Antidepressants @DRUG$ be extreme in being treated oxidase tricyclic the of @DRUG$ on be	DDI-false
drugs include thiazides and other diuretics , phenothiazines products , estrogens , oral @DRUG$ , , nicotinic acid @DRUG$	DDI-false
adverse resulting cholinergic blockade when LEVSIN is administered concomitantly other , amantadine , haloperidol , phenothiazines , @DRUG$ @DRUG$ or some .	DDI-false
@DRUG$: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Among the @DRUG$, many, like @DRUG$, cannot be used clinically because they are toxic;	DDI-false
or pharmacodynamic interactions have not demonstrated between Argatroban concomitantly administered aspirin 162.5 and initiation @DRUG$   . hours ) or ( mg orally given 12 , and prior to , 6 subsequent initiation @DRUG$ 1.5   . over )	DDI-false
however , deleterious were seen ROMAZICON was administered @DRUG$ inhalational anesthetics , @DRUG$ muscle administered sedation or	DDI-false
@DRUG$: The administration of diflunisal to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-false
of patients HIV-related , non-Hodgkin ( ) the authors a group of 24 with who were treated doxorubicin vincristine , prednisone CHOP ) chemotherapy HAART with of patients were with chemotherapy or CHOP-like , @DRUG$ doxorubicin @DRUG$ , prednisone vincristine plus bleomycin without receiving therapy .	DDI-false
inhibitors , erythromycin , @DRUG$ nefazodone , nicardipine , , quinidine and @DRUG$.	DDI-false
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Acetaminophen, lidocaine, phenobarbital, quinidine, @DRUG$, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
In , ingestion of disulfiram and nitrite in the diet for weeks to cause and been @DRUG$ react with @DRUG$ the stomach form which tumorigenic .	DDI-effect
Although specific studies have been performed , coadministration are mainly metabolized CYP3A4 calcium channel , dapsone disopyramide , @DRUG$ , quinidine , tacrolimus , , ergot derivatives @DRUG$ fentanyl , alfentanyl triazolam have plasma with ;	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
containing side N-methylthiotetrazole ( @DRUG$ , latamoxef ( cefazolin ) vitamin K hypoprothrombinemia .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
When was coadministered @DRUG$ rifampin , reduced plasma concentrations @DRUG$ were .	DDI-false
@DRUG$ should not be used as a substitute for oral or inhaled @DRUG$.	DDI-false
Nervous System : The concomitant use DURAGESIC   fentanyl transdermal system ) with other @DRUG$ including limited opioids , sedatives , benzodiazepines ) , general anesthetics , , @DRUG$ , alcohol , may respiratory , profound , or or .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
Antiarrhythmics : @DRUG$ , @DRUG$ flecainide , , quinidine CONTRAINDICATED to for	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ : a clinical pharmacology , an antacid , simethicone ) with fosinopril serum levels urinary excretion of fosinoprilat as with fosinopril administered , suggesting that antacids absorption of @DRUG$.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or @DRUG$).	DDI-false
@DRUG$ did not alter the plasma levels of @DRUG$ when taken in combination.	DDI-false
acidifying agents These @DRUG$ @DRUG$ etc . ) of species of amphetamine , increasing urinary	DDI-false
In a comparison of digitalis tolerance @DRUG$ , Vet , or pentobarbital , of ouabain needed to cause ventricular tachycardia was significantly was the with @DRUG$	DDI-false
, when @DRUG$ is @DRUG$ should closely and several concomitant	DDI-advise
The was study the @DRUG$ and both @DRUG$ or synthetic analogue or , on the antinonciceptive mice injection	DDI-false
Co-administration @DRUG$ and or agents interfering transmission ( e.g. @DRUG$ only be performed caution toxin	DDI-advise
Prednisone/prednisolone : Rofecoxib clinically important effect pharmacokinetics of @DRUG$ or @DRUG$.	DDI-false
Drug , like Monoamine oxidase ( MAOI affect @DRUG$ pharmacodynamics - - Ethanol : Flupenthixol Ethanol cause - : Flupenthixol increases the @DRUG$	DDI-false
Other not performed 1 more in with acetylsalicylic acid , angiotensin-converting enzyme ( ) , beta blockers calcium-channel @DRUG$ , @DRUG$ H2 , inhibitors also referred to as NSAIDs and quinolone evidence of adverse .	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
, , phenobarbital/acetaminophen acid quinidine/lidocaine , @DRUG$/acetaminophen @DRUG$/phenobarbital .	DDI-false
reactions been reported in patients combination sequential high PROLEUKIN and @DRUG$ specifically @DRUG$ ,	DDI-false
colestipol @DRUG$ : Absorption of hydrochlorothiazide in of	DDI-false
Although have been shown to reduce side including renal hyperbilirubinemia confusion , , concomitant administration with PROLEUKIN may reduce the effectiveness of PROLEUKIN and be @DRUG$ and antihypertensives may potentiate hypotension @DRUG$.	DDI-effect
No pharmacokinetic interactions between dexmedetomidine and isoflurane, @DRUG$, @DRUG$, and midazolam have been demonstrated.	DDI-false
@DRUG$ administered at dose had no on enhancement by @DRUG$ or on the location , type depth of , labeling tumor vascularity of intestinal decreased the incidence	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Antihypertensives: @DRUG$ may antagonize the hypotensive effects of @DRUG$.	DDI-effect
Nervous Depressants The of fentanyl transdermal ) other central system including but other opioids sedatives hypnotics , @DRUG$ ( e.g. , , anesthetics , phenothiazines , @DRUG$ , may cause respiratory hypotension and sedation or potentially in death	DDI-false
, Digoxin Lodine , like NSAIDs , effects renal , may cause changes elimination of drugs serum levels of @DRUG$ , digoxin , @DRUG$ , increased .	DDI-false
Multivalent Cation-Containing Products : of , ciprofloxacin multivalent products aluminum antacids , @DRUG$ or powder , or products calcium , , or may substantially decrease absorption of @DRUG$ resulting serum and urine lower desired .	DDI-false
There been reports of steady-state @DRUG$ , @DRUG$ and phenytoin during concomitant therapy with amiodarone .	DDI-false
Since the range of @DRUG$ is serum levels should monitored closely and appropriate @DRUG$ made	DDI-false
Warfarin-@DRUG$ can antagonize the effect of @DRUG$	DDI-effect
The hypoglycemic of sulfonylureas may potentiated by drugs including @DRUG$ and other are protein bound , @DRUG$ , sulfonamides , , , , and beta adrenergic	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-effect
The of TYSABRI event profile Study co-administered @DRUG$ ) 2 ( with @DRUG$ that this in clearance does not necessitate the   dose General )	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
between Keppra and AEDs ( @DRUG$ lamotrigine , phenobarbital , phenytoin , valproate ) were assessed serum concentrations @DRUG$ these AEDs clinical	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or @DRUG$, and high blood pressure medications.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
The during of this class with administration of cyclosporine @DRUG$ , @DRUG$ ( ) , erythromycin , azole	DDI-false
there a potential an interaction drugs that metabolized ( e.g. amitriptyline , @DRUG$ , and @DRUG$	DDI-false
All subjects received @DRUG$ and 100 mg @DRUG$ as single for seven	DDI-false
@DRUG$ single doses @DRUG$ 3 paroxetine mg 7 no .	DDI-false
@DRUG$ may drugs as @DRUG$ tolbutamide their binding .	DDI-mechanism
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and @DRUG$.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
drug Keppra   other AEDs ( @DRUG$ , @DRUG$ , , phenobarbital , phenytoin primidone and valproate ) were also by evaluating the serum concentrations levetiracetam and these during clinical studies	DDI-false
antifungal , @DRUG$ , the of astemizole , resulting elevated @DRUG$ and its QT intervals .	DDI-false
- @DRUG$ (e.g., AquaMEPHYTON, @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of phenytoin, dextromethorphan, and @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
on antinociceptive effect between and @DRUG$ or @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
@DRUG$ ( ) introduced @DRUG$ demonstrated in the treatment positive negative of schizophrenia .	DDI-false
Nursing Mothers It is not known whether @DRUG$ or @DRUG$ or its components are excreted in human milk.	DDI-false
Tagamet apparently on certain microsomal enzyme systems the hepatic metabolism of phenytoin , nifedipine , , , antidepressants , @DRUG$ @DRUG$ delaying elimination and increasing these .	DDI-false
inhibitors azole @DRUG$ erythromycin , , isoniazid nicardipine propofol , @DRUG$	DDI-false
Drug @DRUG$ may interact some like Monoamine ( ): @DRUG$ affect flupenthixol pharmacodynamics - Arecoline - Ethanol : Flupenthixol cause depression Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic	DDI-false
This appears to be only clinically relevant of this theoretically , of drugs known to , anti-arrhythmic channel , antihistamines @DRUG$ , tricyclic antidepressants and @DRUG$ contribute to of interval	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Interactions And Drugs Phenytoin @DRUG$   ( 3000 daily ) pharmacokinetic @DRUG$ refractory	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and @DRUG$.	DDI-false
@DRUG$ : to slow the @DRUG$ its serum Carbamazepine levels determined to with signs symptoms should closely and anticonvulsant should be made .	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
@DRUG$ used caution in   blocking agents ( e.g. , CYP3A4 ) channel ( , a CYP3A4 , diltiazem a @DRUG$ ) the possible potentiation , arrest and AV block	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Warfarin: @DRUG$ have been reported to enhance the effects of the oral anticoagulant @DRUG$ or its derivatives.	DDI-effect
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Although nor @DRUG$ affected of prostatic RPMI1640 @DRUG$ they modify EGF insulin	DDI-false
@DRUG$ @DRUG$-enhanced metastasis adenocarcinomas by azoxymethane in rats	DDI-effect
Two 16 dosed with @DRUG$ @DRUG$ 0.4 a blood pressure 85 Hg	DDI-effect
Ritonavir and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
clinical pharmacology study coadministration antacid ( , magnesium , @DRUG$ ) serum levels urinary of fosinoprilat as compared with @DRUG$ administered antacids may impair of .	DDI-false
The successive application of glycine (5 or 10 mg/kg egg weight (e.w.) and @DRUG$ (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of @DRUG$ alone.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
azole antifungals , @DRUG$ clarithromycin , , @DRUG$ , imatinib nefazodone , , , quinidine , .	DDI-false
interaction should patients @DRUG$ concomitantly with	DDI-advise
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Drug may with , like @DRUG$ ): @DRUG$ could theoretically affect flupenthixol Arecoline Eproxindine : Flupenthixol cause depression Tricyclic :	DDI-false
Other Drug Interactions Oral @DRUG$ @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
have shown to reduce @DRUG$-induced including renal insufficiency , confusion agents with PROLEUKIN reduce effectiveness of thus be @DRUG$ may hypotension seen with PROLEUKIN	DDI-false
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In rats, simultaneous ingestion of @DRUG$ and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-effect
@DRUG$ : diflunisal is administered concomitantly with @DRUG$.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
The extent to which @DRUG$-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the @DRUG$ involved.	DDI-false
Possible drug interactions of @DRUG$ with succinylcholine or with other @DRUG$.	DDI-int
@DRUG$/theophylline , lidocaine/quinidine phenobarbital/@DRUG$ , quinidine/lidocaine , and .	DDI-false
No pharmacokinetic interactions between @DRUG$ and @DRUG$, propofol, alfentanil, and midazolam have been demonstrated.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
In study , the @DRUG$ clozapine tested combination dose of @DRUG$ in discrimination mixed ( procedures	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
The @DRUG$ upon @DRUG$ locomotion in	DDI-false
Cephalosporins-Cephalosporins side chains of , @DRUG$ cefotetan , @DRUG$ , latamoxef or ( ) can cause K hypoprothrombinemia .	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-false
@DRUG$: @DRUG$ (CYP3A4 substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
@DRUG$ not pharmacokinetics of .	DDI-false
As with other @DRUG$ , should that @DRUG$ of potentiating such ,	DDI-false
Other concomitant : trials the safety profile in subjects treated with Acamprosate anxiolytics @DRUG$ ( benzodiazepines @DRUG$ was to that concomitant .	DDI-false
Central Nervous System Depressants The @DRUG$ transdermal system depressants including but limited , sedatives , , tranquilizers , @DRUG$ ) , anesthetics skeletal and cause , and , or result in coma or death	DDI-effect
interactions possible @DRUG$ such as @DRUG$ phenytoin hepatic microsomal systems	DDI-false
interactions may @DRUG$ drugs that increase cytochrome system e.g. , , , @DRUG$ , though not	DDI-mechanism
Imipramine (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
@DRUG$-based regimens may have several advantages over @DRUG$-based therapy for initial or prolonged therapy, including more convenient administration regimens, lower tablet volume, fewer drug interactions, and central nervous system penetration.	DDI-false
may @DRUG$ @DRUG$ gets your body .	DDI-false
specific studies have not been that are mainly by ( , , dapsone , @DRUG$ quinine , , warfarin tacrolimus cyclosporine @DRUG$ , carbamazepine , fentanyl , alprazolam , and triazolam have elevated plasma coadministered	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Therefore, when @DRUG$ and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.	DDI-advise
, @DRUG$/acetaminophen , acid quinidine/lidocaine theophylline/acetaminophen , and acid/phenobarbital .	DDI-false
@DRUG$: Amiodarone, bepridil, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], @DRUG$ [e.g., Winstrol]) or	DDI-false
of @DRUG$ and @DRUG$.	DDI-false
Phenytoin: @DRUG$ has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
with inhibitors of ( , @DRUG$ ritonavir , indinavir , @DRUG$ , erythromycin , ) , of budesonide dose be .	DDI-false
Interaction with @DRUG$ other than @DRUG$ has not been specifically studied;	DDI-false
@DRUG$ t.i.d . ) with Vardenafil mg in increase in @DRUG$ AUC , a 7-fold in vardenafil Cmax and increase	DDI-false
or other products iron @DRUG$ , or @DRUG$ be , or within hours of the administration of , they may interfere with resulting in levels of norfloxacin .	DDI-false
Quinolones, including @DRUG$, may enhance the effects of oral anticoagulants, including @DRUG$ or its derivatives or similar agents.	DDI-effect
Example inhibitors include azole , ciprofloxacin clarithromycin , @DRUG$ , erythromycin , , , @DRUG$ propofol , protease quinidine , and verapamil .	DDI-false
It is structurally distinct from the other currently available @DRUG$ (lovastatin, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-effect
: Concurrent of a @DRUG$ including , cation-containing products as magnesium or aluminum antacids VIDEX chewable/buffered or calcium , iron or zinc decrease absorption of @DRUG$ , resulting in serum and urine considerably desired .	DDI-false
@DRUG$ and have similar opioid and nicotinic , has much lower @DRUG$ , sodium , the 5-HT transporter	DDI-false
Use in Ambulatory Patients The effects of @DRUG$ may wear off before a @DRUG$ is completely cleared from the body.	DDI-false
Skeletal muscle relaxants , , @DRUG$ ): to the	DDI-false
Multivalent Cation-Containing Concurrent administration of , including cation-containing products such as or aluminum antacids , , chewable/buffered or powder products containing @DRUG$ iron , @DRUG$ may the resulting in and levels considerably desired .	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
@DRUG$ Concomitant administration of antacids plasma	DDI-false
drugs include thiazides and other , @DRUG$ @DRUG$ estrogens , , nicotinic acid , channel isoniazid .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
5 mg/kg ) moclobemide ) , @DRUG$ 0.25 mg/kg fluoxetine ( 20 mg/kg ) @DRUG$ 30 ) or .	DDI-false
Although specific have been performed , drugs that mainly metabolized CYP3A4 eg calcium channel blockers @DRUG$ , amiodarone quinidine , warfarin tacrolimus , , ergot derivatives , pimozide , @DRUG$ , alfentanyl , ) elevated when saquinavir	DDI-false
: with drugs like Monoamine oxidase ( ): affect pharmacodynamics @DRUG$ Eproxindine - Ethanol : Flupenthixol Ethanol cause CNS - @DRUG$ the effect Tricyclic antidepressants	DDI-false
Both @DRUG$ and @DRUG$ enhance the locomotor and/or stereotypic effects of stimulants.	DDI-false
Nervous System Depressants : The concomitant use @DRUG$ transdermal with other @DRUG$ but not limited opioids sedatives , tranquilizers benzodiazepines phenothiazines , skeletal relaxants , respiratory depression and potentially coma .	DDI-effect
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
is @DRUG$ CYP3A4 substrates that a narrow therapeutic window ( cyclosporine @DRUG$ ) .	DDI-advise
studies have not , with that mainly by CYP3A4 ( , channel blockers disopyramide , @DRUG$ , , , , fentanyl @DRUG$ may have elevated plasma when coadministered with saquinavir	DDI-false
@DRUG$ , indandione derivatives and platelet as nonsteroidal anti-inflammatory ( ) may increase bleeding administered concomitantly with	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, procainamide, and @DRUG$ during concomitant therapy with amiodarone.	DDI-false
However reports suggest that @DRUG$ may antihypertensive of	DDI-effect
for adult-onset diabetics, dosage adjustment of @DRUG$ may be necessary during and after @DRUG$ therapy;	DDI-advise
These include , , @DRUG$ , estrogens , oral @DRUG$ , phenytoin , acid , sympathomimetics , calcium , .	DDI-false
Although have been performed , are mainly metabolized CYP3A4 eg , calcium , , quinine , @DRUG$ , quinidine warfarin tacrolimus , ergot derivatives , pimozide carbamazepine fentanyl , , alprazolam ) have plasma concentrations when coadministered @DRUG$ ;	DDI-mechanism
These drugs @DRUG$ and corticosteroids phenothiazines , thyroid oral @DRUG$ , , nicotinic , sympathomimetics , channel blocking drugs , isoniazid .	DDI-false
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and fluvastatin.	DDI-false
acetaminophen/theophylline , phenobarbital/valproic @DRUG$/lidocaine theophylline/@DRUG$ , and valproic .	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after narcotics, inhalational anesthetics, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
@DRUG$ effect in of @DRUG$.	DDI-false
@DRUG$: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-false
in patients receiving combination sequential high dose PROLEUKIN antineoplastic , specifically @DRUG$ @DRUG$ interferon-alfa .	DDI-false
@DRUG$ , @DRUG$ and Diuretics : xanthine or a possible   beta2-agonists	DDI-false
There been side in patients on concomitant @DRUG$ and	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
of Argatroban with @DRUG$ , , and other @DRUG$ may increase the risk .	DDI-false
Additive adverse effects resulting from cholinergic LEVSIN is with @DRUG$ @DRUG$ , phenothiazines monoamine ( MAO tricyclic antihistamines .	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, @DRUG$, rifampin, phenobarbital or St.	DDI-false
These include thiazides , corticosteroids , phe-nothiazines , @DRUG$ contraceptives , @DRUG$ nicotinic , blocking drugs and .	DDI-false
other agents , it should capable of @DRUG$ such , opiates @DRUG$.	DDI-false
The addition of 540 mg/kg/day of @DRUG$ (approximately 340 times the maximum recommended daily inhalation dose in adults on a mg/m2 basis) to 2.7 mg/kg/day of @DRUG$ (approximately 7 times the maximum recommended daily inhalation dose in adults on a mg/m2 basis) appears to have increased the incidence of both resorptions and malformations.	DDI-effect
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
studies of alprazolam drug with for following @DRUG$	DDI-false
- @DRUG$ @DRUG$	DDI-false
Nifedipine: @DRUG$ 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
comparison of digitalis in anesthetized with ketamine Innovar @DRUG$ , the of ouabain to cause ventricular tachycardia higher , as was , with @DRUG$ or with	DDI-false
these subjects , @DRUG$ effect @DRUG$ determined time	DDI-false
@DRUG$: @DRUG$ causes increase (by about 80%) in the free fraction of etodolac.	DDI-false
receiving , propranolol a CYP3A4 ) antagonists , @DRUG$ a CYP3A4 diltiazem a @DRUG$ inhibitor because the possible bradycardia arrest and ;	DDI-false
The safety and effectiveness of @DRUG$ alone or @DRUG$ the age of been established	DDI-false
include azole , diclofenac erythromycin isoniazid , @DRUG$ @DRUG$ , quinidine and	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Tagamet , apparently through effect enzyme , to the hepatic metabolism , , , @DRUG$ , certain tricyclic antidepressants , @DRUG$ , theophylline , of .	DDI-false
Multivitamins, or other products containing iron or @DRUG$, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The extent to which @DRUG$-@DRUG$ interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	DDI-int
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, @DRUG$ (nicotinic acid), erythromycin, azole antifungals.	DDI-false
include azole , @DRUG$ , , , @DRUG$ , protease inhibitors , , verapamil .	DDI-false
specific studies have , coadministration drugs are metabolized eg , channel blockers , disopyramide , , @DRUG$ , quinidine warfarin , , , ergot derivatives , , @DRUG$ , alprazolam ) concentrations coadministered with	DDI-false
: a clinical study of an ( aluminum hydroxide , @DRUG$ , and simethicone ) with @DRUG$ reduced serum levels of with administered alone suggesting may impair absorption of fosinopril	DDI-mechanism
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
: In healthy individuals , plasma concentrations of @DRUG$ approximately with of @DRUG$ and , a of P450	DDI-false
addition Fondaparinux neither influenced of warfarin acetylsalicylic acid , @DRUG$ , and pharmacokinetics @DRUG$ at state .	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-false
@DRUG$ ( ) has been administered the presence of other , as @DRUG$ , beta-adrenergic agents calcium channel agents and angiotensin converting , without in the adverse profile	DDI-false
Other concomitant therapy specific studies not performed , finasteride of 1 mg or more were used clinical studies acid , , analgesics enzyme ) , @DRUG$ @DRUG$ , nitrates diuretics , H2 antagonists , ( referred as NSAIDs , quinolone without evidence clinically significant adverse interactions .	DDI-false
INOmax has been administered with tolazoline, dopamine, dobutamine, @DRUG$, @DRUG$, and high-frequency ventilation.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$ IV has been used concomitantly with @DRUG$ without evidence of clinically significant adverse reactions.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
Important Interactions To Date not have clinically important pharmacokinetic interactions with captopril beta-blockers felodipine , @DRUG$ warfarin mononitrate , , or	DDI-false
@DRUG$s may in reduced	DDI-false
Other Drugs such as @DRUG$ disopyramide , , phenothiazines , antihistamines @DRUG$ be QT-interval prolongation and an increased of ventricular arrhythmia .	DDI-false
@DRUG$: The administration of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-false
The local anesthetic solutions containing @DRUG$ @DRUG$ to , antidepressants phenothiazines may produce , prolonged or	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Some drugs/substances are known to accelerate the metabolism of @DRUG$ by stimulating the synthesis of @DRUG$ (enzyme induction).	DDI-false
To evaluate the impact chemotherapy plus course of with HIV-related systemic ( HIV-NHL the a patients with who treated @DRUG$ , @DRUG$ ( chemotherapy regimen plus HAART with group of 80 with CHOP chemotherapy a regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide and with bleomycin without antiretroviral .	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, @DRUG$ (nicotinic acid), erythromycin, azole antifungals.	DDI-false
all the selective reuptake inhibitors citalopram , , @DRUG$ , sertraline and @DRUG$ inhibit P450 2D6 , they vary in the extent inhibition .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
on pharmacokinetics @DRUG$ @DRUG$ in combination , Drug Interactions under CLINICAL .	DDI-false
@DRUG$ may necessary coadministered with CYP2D6 inhibitors @DRUG$ and	DDI-advise
Theophylline: As with some other quinolones, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
, Digoxin , Methotrexate like , prostaglandins cause in elimination these drugs to serum levels @DRUG$ , @DRUG$ , and toxicity .	DDI-false
azole antifungals , @DRUG$ @DRUG$ diclofenac , erythromycin imatinib , isoniazid , nicardipine , propofol , protease , quinidine , and verapamil .	DDI-false
@DRUG$ : The administration of @DRUG$ volunteers indomethacin decreased the and levels of	DDI-false
Both @DRUG$ decrease of accumbens @DRUG$ increases levels of serotonin in the nucleus .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
specific performed with that metabolized eg , calcium blockers , @DRUG$ , @DRUG$ , , warfarin tacrolimus cyclosporine , pimozide , carbamazepine , fentanyl alfentanyl , alprazolam , and triazolam elevated plasma when	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
FLEXERIL effects of alcohol , @DRUG$ ,	DDI-false
Cardiovasculars : patients receiving @DRUG$ therapy administration oral amiodarone results an increase in serum @DRUG$ levels resultant .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, @DRUG$, quinidine, and verapamil.	DDI-false
@DRUG$: @DRUG$ 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single 0.5 mg oral dose.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Cyclosporine: Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Potential interactions and ( , , @DRUG$ phenobarbital , @DRUG$ valproate ) also assessed by serum and these AEDs studies .	DDI-false
A possible interaction between @DRUG$ and @DRUG$, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-int
Aspirin/@DRUG$ Pharmacokinetic or drug-drug interactions have been between Argatroban and concomitantly aspirin 162.5 orally given and prior to initiation Argatroban 1   over 4 hours @DRUG$ mg orally given 6 0 prior to 12 subsequent to initiation Argatroban hours ) .	DDI-false
@DRUG$ : Because of relationship of @DRUG$ A , patients should be against taking to avoid additive toxic effects	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-int
alter plasma concentrations Drugs that may @DRUG$ plasma concentrations Caution is recommended when with inhibitors of family , @DRUG$ , itraconazole erythromycin	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of everolimus and @DRUG$ (INN, @DRUG$) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
@DRUG$ generally given diuretics because they reduce clearance and add a high risk of @DRUG$ .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$-@DRUG$ the vitamin	DDI-false
@DRUG$ counteract the of @DRUG$ , frequency of pediatric patients .	DDI-effect
Other as , disopyramide , procainamide , @DRUG$ , and @DRUG$ be associated prolongation and increased of ventricular arrhythmia .	DDI-false
@DRUG$ : of with rifampin mg , a potent inducer hepatic metabolism , produced approximate % decrease in @DRUG$ plasma concentrations .	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Iodine or iodine excess may decrease the effect of @DRUG$, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
@DRUG$ taken @DRUG$ concentration by after .	DDI-false
Pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of @DRUG$, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
Human data that @DRUG$ the of @DRUG$ an eight-fold increase in the of .	DDI-mechanism
@DRUG$ ( mg once daily ) increase @DRUG$ a 4-fold in co-administered with Vardenafil ( .	DDI-mechanism
Lorazepam like other injectable produces the nervous system when administered with ethyl alcohol , phenothiazines @DRUG$ , and antidepressants . @DRUG$ is used injectable lorazepam an of sedation hallucinations and irrational behavior has been .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and @DRUG$ or erythromycin.	DDI-false
the @DRUG$ and diuretics , @DRUG$ contraceptives , , acid channel , and	DDI-false
If with of activity such , @DRUG$ , indinavir saquinavir @DRUG$ , . ) is indicated reduction of be considered .	DDI-false
Rhabdomyolysis been observed patients reductase inhibitors ( @DRUG$ @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, @DRUG$, and verapamil.	DDI-false
With A Narrow Index A of @DRUG$ 3 mg did not affect the pharmacokinetics @DRUG$ measured at steady dosing of 0.5 twice for one and for 6 .	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
from in vitro alprazolam a drug interaction the ergotamine , cyclosporine @DRUG$ , and	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
Nevertheless, caution is indicated in the co-administration of @DRUG$ with any of the @DRUG$ and also in switching from one class to the other.	DDI-advise
, @DRUG$ : treatment xanthine @DRUG$ , diuretics may potentiate of beta2-agonists .	DDI-false
Human pharmacokinetics data indicate that oral @DRUG$ potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of @DRUG$.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
acetaminophen/theophylline , , , phenobarbital/@DRUG$ quinidine/lidocaine , , and acid/phenobarbital	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
No data are available for coadministration INVIRASE/ritonavir @DRUG$/@DRUG$ and capsules .	DDI-false
These drugs the other , , phe-nothiazines thyroid estrogens contraceptives phenytoin , @DRUG$ , sympathomimet-ics calcium channel blocking drugs , @DRUG$.	DDI-false
@DRUG$ ( but ): These in high of @DRUG$ have been shown provoke convulsions in .	DDI-false
No Important Date Levosimendan does not important pharmacokinetic interactions @DRUG$ , beta-blockers digoxin , warfarin , isosorbide carvedilol @DRUG$ itraconazole .	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
treatment inhibitors of activity such ketoconazole , @DRUG$ , ritonavir indinavir , erythromycin , etc ) indicated of @DRUG$ dose should	DDI-advise
@DRUG$ may increase sensitivity to the @DRUG$.	DDI-effect
possibility of hypotensive can be minimized either the @DRUG$ or increasing the one to of with @DRUG$ captopril tablets , USP with small doses 6.25 or 12.5 mg )	DDI-false
@DRUG$: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-false
Antiarrhythmics : @DRUG$ drugs , as procainamide @DRUG$ , have been used with .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Tagamet , apparently through on certain systems , been reported to reduce the hepatic metabolism of anticoagulants , , propranolol @DRUG$ , chlordiazepoxide antidepressants , lidocaine and @DRUG$ , thereby blood .	DDI-false
The following precautions should be kept in mind in the treatment of anticholinesterase poisoning although they do not bear directly on the use of @DRUG$ and @DRUG$.	DDI-advise
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating @DRUG$ such as anesthetics, opiates, and alcohol.	DDI-effect
In @DRUG$ influenced pharmacodynamics of warfarin @DRUG$ piroxicam , and digoxin , nor the pharmacokinetics digoxin at	DDI-false
vitro data suggest that when compared @DRUG$ has a less effect on the system	DDI-false
These include the other corticosteroids phe-nothiazines , products estrogens , oral @DRUG$ phenytoin nicotinic acid calcium drugs and	DDI-false
@DRUG$ produced each task it the training @DRUG$ and it number of responses short ( <3 ) times well as overall response the	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
Nevertheless the of @DRUG$ on travelers receiving , @DRUG$ before departure	DDI-advise
Other reported interactions with @DRUG$: Fentanyl (@DRUG$ substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
drug @DRUG$ or other ( potentiate the CNS depressant effects these medications or medications with anticholinergic effects be these medications concurrently antihistamines , and oxidase ) inhibitors ( with @DRUG$ and the CNS effects of	DDI-false
@DRUG$ : normal volunteers administration of @DRUG$ in increased plasma levels hydrochlorothiazide .	DDI-false
addition @DRUG$ influenced the pharmacodynamics @DRUG$ , acetylsalicylic acid piroxicam and digoxin , nor the digoxin	DDI-false
Results of sclerosis taking TYSABRI and concomitant interferon beta-1a ( AVONEX   IM once weekly or @DRUG$ were inconclusive regard need beta-interferon @DRUG$.	DDI-false
The intensity course interference by @DRUG$ , @DRUG$ 16 receiving coumarin	DDI-false
@DRUG$ : hypercholesterolemic patients AUC and Cmax approximately 50 and 24 % @DRUG$ known inhibitor of cytochrome P450 3A4 .	DDI-false
Since amiodarone is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels.	DDI-false
: Amiodarone be caution in receiving   -receptor e.g. , propranolol a CYP3A4 inhibitor ) or @DRUG$ ( , , a , , a @DRUG$ because of possible of , arrest , and	DDI-false
( Concurrent @DRUG$ may enhance the @DRUG$ hypokalemia .	DDI-effect
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
action @DRUG$ may by certain drugs including and drugs highly protein sulfonamides , chloramphenicol probenecid , @DRUG$ , oxidase inhibitors adrenergic blocking agents .	DDI-effect
Concomitant @DRUG$, doxorubicin, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
DIGOXIN: Plasma @DRUG$ levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
: normal a small @DRUG$ doses of @DRUG$ and aspirin were	DDI-false
Antiarrhythmics Amiodarone @DRUG$ , @DRUG$ , , quinidine CONTRAINDICATED due to potential and/or life-threatening	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with @DRUG$.	DDI-effect
Agents and enalapril IV have with agents methyldopa , nitrates , @DRUG$ , and @DRUG$ of clinically significant .	DDI-false
Other concomitant therapy Although specific studies finasteride doses 1 mg or more were used in clinical , acid , analgesics , enzyme ( ACE , anticonvulsants benzodiazepines , @DRUG$ , calcium-channel blockers , @DRUG$ , reductase prostaglandin synthetase inhibitors ) , and without of adverse interactions .	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Therefore , interactions could occur following drugs ( , @DRUG$ sedatives , @DRUG$ .	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
, have one or similar to bepridil including such @DRUG$ and @DRUG$ , glycosides .	DDI-false
No data are available for the coadministration of INVIRASE/ritonavir or @DRUG$/@DRUG$ and garlic capsules.	DDI-false
Serum @DRUG$ levels should be monitored frequently if INSPRA is administered concomitantly with @DRUG$.	DDI-false
ibogaine @DRUG$ decrease levels dopamine in the accumbens , only @DRUG$ increases levels of serotonin nucleus accumbens	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
therapies : In clinical trials the safety profile in subjects treated concomitantly with @DRUG$ and ( including @DRUG$ ) or non-opioid was similar to of subjects placebo these medications	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Both the @DRUG$ and therapeutic value of @DRUG$ can be rationalized cellular and level : ( ) these polyene showed on cells ;	DDI-false
No formal been there is interactive effect loss between @DRUG$ and @DRUG$.	DDI-false
Antidepressants, @DRUG$ @DRUG$ may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
concomitant Although finasteride of mg or were concomitantly used in with acetaminophen @DRUG$ angiotensin-converting ACE , , beta , calcium-channel @DRUG$ diuretics , , inhibitors synthetase inhibitors also , and quinolone anti-infectives without evidence significant adverse interactions	DDI-false
hepatitis treated @DRUG$ combination with @DRUG$ treatment did affect distribution or	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
The availability of inhibitor (NNRTI)-based regimens @DRUG$ therapy @DRUG$ disturbances to significant in treatment practices in HIV infection	DDI-false
@DRUG$ The administration of @DRUG$ in normal resulted plasma of the sulindac sulfide one-third .	DDI-false
glucose should be monitored when @DRUG$ @DRUG$ are .	DDI-advise
The superiority of @DRUG$ over @DRUG$-based regimens has been observed in comparative data in a subset of patients with high viral loads.	DDI-false
Suppression by verapamil of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats.	DDI-false
evaluate the impact HAART on the of HIV-related ( the a group of patients HIV-NHL who treated , @DRUG$ vincristine , prednisone ( CHOP chemotherapy plus with 80 who were treated chemotherapy or a ( , @DRUG$ , vincristine ) without antiretroviral therapy .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
@DRUG$ and its active metabolite , have long ( days @DRUG$ that strategies from one to the other	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the benzodiazepine effect by @DRUG$.	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other @DRUG$ and that these AEDs do not influence the pharmacokinetics of @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
: Dihydroergotamine @DRUG$ methylergonovine CONTRAINDICATED due to potential and reactions such as @DRUG$ toxicity characterized by peripheral vasospasm and of the other	DDI-false
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
tested in , theophylline phenytoin @DRUG$ , @DRUG$ antipyrine .	DDI-false
local anesthetic solutions containing @DRUG$ norepinephrine receiving @DRUG$ or tricyclic , hypertension	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
@DRUG$: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Omeprazole and extent of absorption of when was when @DRUG$ given hours after @DRUG$ at the maximally acid	DDI-false
Potential drug interactions and other ( @DRUG$ , gabapentin lamotrigine , phenytoin @DRUG$ and evaluating the of these AEDs placebo-controlled clinical studies	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, @DRUG$.	DDI-false
and electrophysiologic also been observed with @DRUG$ , @DRUG$ , and verapamil .	DDI-false
@DRUG$ : studies as post marketing observations , that NSAIDs natriuretic effect of @DRUG$ some .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
If treatment activity , intraconazole ritonavir , @DRUG$ erythromycin . ) is reduction of the @DRUG$ dose be .	DDI-advise
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Aspirin: Concomitant administration of low-dose @DRUG$ with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-effect
The administration of anesthetic containing @DRUG$ or patients monoamine inhibitors @DRUG$ may produce hypertension .	DDI-effect
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Results of multiple @DRUG$   concomitant ( @DRUG$ mcg IM once weekly ) glatiramer were inconclusive regard the need for dose of the beta-interferon acetate .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Antimycobacterial Agents @DRUG$ since coadministration of this product saquinavir an @DRUG$ the plasma concentrations of	DDI-false
@DRUG$ : The concomitant of @DRUG$ fentanyl ) with other central nervous system depressants to other , sedatives ( e.g. anesthetics , phenothiazines , skeletal muscle , may respiratory hypotension , potentially in coma or	DDI-false
Concomitant , @DRUG$ , , and prednisone @DRUG$ therapy in with human non-Hodgkin .	DDI-false
No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between @DRUG$ and @DRUG$.	DDI-false
therefore , @DRUG$ or other @DRUG$ used for management of angina ) or other drugs having activity should if be discontinued before starting .	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, @DRUG$, @DRUG$ and antipyrine.	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
The extent @DRUG$-TCA may pose clinical problems depend the inhibition and the of the @DRUG$	DDI-false
in receiving blocking agents ( , @DRUG$ , a inhibitor or channel antagonists ( , CYP3A4 substrate diltiazem inhibitor ) of bradycardia , arrest , and ;	DDI-false
@DRUG$ mg b.i.d ) with mg a 49-fold @DRUG$ AUC and a vardenafil .	DDI-false
of @DRUG$ ( aluminum hydroxide hydroxide , @DRUG$ with fosinopril serum and urinary with fosinopril administered alone , suggesting that antacids may of fosinopril .	DDI-false
@DRUG$ and methaqualone interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
may interact thinners ( allergy , ) , , @DRUG$ like @DRUG$ or , high medications .	DDI-false
Clinical implications @DRUG$ with five @DRUG$.	DDI-int
Antihistamines : @DRUG$ @DRUG$ * CONTRAINDICATED potential for and/or life-threatening cardiac arrhythmias	DDI-false
Antidepressants, @DRUG$ Amphetamines may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-false
@DRUG$ mg twice daily ) not the pharmacokinetics pharmacodynamics ( @DRUG$ given mg day .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ may enhance the effects of alcohol, @DRUG$, and other CNS depressants.	DDI-effect
Although there is little published information on concomitant administration of @DRUG$ and @DRUG$, these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy.	DDI-false
@DRUG$ ergonovine ergotamine , @DRUG$ CONTRAINDICATED to potential serious such acute toxicity peripheral the and other .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Both @DRUG$ and @DRUG$ block morphine-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-false
This interact with or other CNS depressants ( may CNS effects either these or antihistamines ) , anticholinergics or other medications activity ( effects may be are used concurrently with oxidase ( ( with @DRUG$ may prolong and intensify anticholinergic and depressant of @DRUG$ )	DDI-false
Important clinically important interactions with , , , mononitrate , , @DRUG$ @DRUG$.	DDI-false
@DRUG$ In diabetic @DRUG$ , no significant were on or	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than tolbutamide and does not interact with salicylate or @DRUG$.	DDI-false
However should used when administering @DRUG$ @DRUG$ these are at increased risk .	DDI-advise
@DRUG$ : controlled volunteers , @DRUG$ had with increases , about two studies in digoxin .	DDI-false
Corticosteroids, @DRUG$ and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-mechanism
Based on these data, @DRUG$ should not be used in patients on @DRUG$ therapy.	DDI-advise
Co-administration Argatroban with , @DRUG$ , and other @DRUG$ increase of	DDI-false
side in patients on therapy @DRUG$ theophylline .	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Therefore interactions could concomitant administration @DRUG$ ( e.g. narcotics , , @DRUG$ , tranquilizers	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Anti-Inflammatory Drugs drug of @DRUG$ with an @DRUG$ not been .	DDI-false
@DRUG$/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
The @DRUG$ or @DRUG$ from has been	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
For example, when @DRUG$ are administered concomitantly with nilutamide, prothrombin time should be carefully monitored and if necessary, the dosage of @DRUG$ should be reduced.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and @DRUG$.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
@DRUG$ that @DRUG$ may .	DDI-false
Co-administration of @DRUG$ with @DRUG$ been shown and the concentration-time curve	DDI-mechanism
Consequently , a low therapeutic margin , such @DRUG$ @DRUG$ and theophylline , could have delayed elimination and serum half-life leading	DDI-false
Potential drug   and ( , , , @DRUG$ primidone and ) were also assessed by serum @DRUG$ AEDs during placebo-controlled .	DDI-false
studies performed , finasteride 1 mg or more concomitantly used clinical studies with acetaminophen , acetylsalicylic , a-blockers , analgesics , @DRUG$ , @DRUG$ , blockers blockers nitrates , , H2 reductase , synthetase referred , and evidence clinically significant adverse interactions	DDI-false
Specific studies have confirmed these effects with @DRUG$, isoflurane, propofol, @DRUG$, and midazolam.	DDI-false
@DRUG$ did not the of @DRUG$.	DDI-false
Blood sampling for the pharmacokinetics of @DRUG$ and @DRUG$ was performed on day 1, on weeks 1, 2, 3, and 4, and on months 2, 3, 6, 9, and 12.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
with @DRUG$ behaviors most associated with @DRUG$ intoxication .	DDI-false
Interactions : @DRUG$ may interact some oxidase inhibitors ( MAOI ): could affect pharmacodynamics @DRUG$ - Eproxindine - : Flupenthixol and cause additive depression - Tricyclic antidepressants : the effect antidepressants	DDI-false
potent @DRUG$ @DRUG$ therapy concerns regarding protease inhibitor metabolic disturbances have led in practices in infection	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
man include warfarin @DRUG$ , @DRUG$ and antipyrine	DDI-false
To evaluate the impact on the clinical course of with , , ( HIV-NHL compared a group of 24 with HIV-NHL who were the cyclophosphamide , vincristine , and ( chemotherapy regimen a group of patients who were treated CHOP a ( @DRUG$ , @DRUG$ teniposide , and prednisone with vincristine )	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
@DRUG$ potentiates the muscle relaxant effect of all muscle relaxants, most notably @DRUG$, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-effect
Example inhibitors include , , , diclofenac , imatinib @DRUG$ @DRUG$ , , quinidine .	DDI-false
, @DRUG$ but not , in the presence of	DDI-effect
In are that pharmacologic to bepridil including agents such as @DRUG$ @DRUG$ .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
Clinical implications of @DRUG$ interactions with five @DRUG$.	DDI-int
Aminosalicylic acid may decrease the amount of @DRUG$ (Lanoxin, @DRUG$) that gets absorbed into your body.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
@DRUG$/Hypnotics : , @DRUG$ CONTRAINDICATED to potential and/or reactions as prolonged increased sedation .	DDI-false
The hypoglycemic of may potentiated by drugs nonsteroidal anti-inflammatory agents protein bound , @DRUG$ , @DRUG$ , chloramphenicol , , monoamine inhibitors , beta adrenergic blocking .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Other Drug : No and , @DRUG$ and @DRUG$.	DDI-false
a comparison of @DRUG$ tolerance anesthetized with ketamine Vet , or @DRUG$ of ouabain ventricular significantly as the LD50 of ouabain , or Innovar with pentobarbital .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
No Important Interactions To have clinically pharmacokinetic interactions @DRUG$ , felodipine , , @DRUG$ , mononitrate , carvedilol or itraconazole .	DDI-false
When @DRUG$ was coadministered with phenytoin, @DRUG$, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-mechanism
@DRUG$ in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, @DRUG$, aminopyrine and antipyrine.	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
possible between and @DRUG$ fluoroquinolone has been , resulting in the hypoglycemic of @DRUG$.	DDI-false
Interactions Date have clinically important pharmacokinetic interactions @DRUG$ beta-blockers @DRUG$ digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol itraconazole .	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and procainamide, @DRUG$ and @DRUG$.	DDI-false
@DRUG$ Angiotensin Receptor Antagonists ( Congestive Infarction)- ( 91 ) patients receiving 50 mg II receptor antagonists @DRUG$/ARB )	DDI-false
Exacerbation the initial of a of autoimmune inflammatory observed following concurrent use of @DRUG$ @DRUG$ crescentic IgA oculo-bulbar gravis inflammatory thyroiditis , ,	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ are used concomitantly the be observed closely determine if effect of @DRUG$ is obtained	DDI-false
Antagonism between @DRUG$ and @DRUG$ in vitro has been demonstrated.	DDI-effect
Limited comparative data in patients with high viral loads treated with @DRUG$- or @DRUG$-based regimens currently exist.	DDI-false
of @DRUG$ not recommended @DRUG$ may the antibacterial effect of urinary .	DDI-false
Anticoagulants : ( CYP2C9 @DRUG$ anticoagulant response is almost seen in patients receiving amiodarone result in serious .	DDI-false
High-dose cyclosporin resulting in above ng/mL with oral @DRUG$ has % increase in a 38 % in total body clearance @DRUG$ compared to etoposide alone	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ may also decrease the absorption of @DRUG$, which can lead to a deficiency.	DDI-mechanism
Potential between and AEDs ( carbamazepine gabapentin , , , @DRUG$ , primidone and were by the of and @DRUG$ during clinical studies .	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
This drug or @DRUG$ ( potentiate CNS depressant of or antihistamines ) , anticholinergics with effects potentiated medications are used @DRUG$ ) oxidase ( ( may intensify the anticholinergic CNS depressant )	DDI-false
@DRUG$ 500 mg twice daily did not modify the rate or extent of @DRUG$ absorption or its plasma clearance or urinary excretion.	DDI-false
Single doses of either cholestyramine or colestipol @DRUG$ bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Acetaminophen , @DRUG$ , @DRUG$ theophylline , acid were pooled human therapeutic concentrations	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Antihypertensives : should be with patients   -receptor agents e.g. , @DRUG$ , a inhibitor ) @DRUG$ antagonists , CYP3A4 and a inhibitor the potentiation sinus arrest AV block	DDI-false
therapy Although specific interaction studies finasteride doses mg or used in studies acetaminophen , @DRUG$ , @DRUG$ ( ACE , anticonvulsants benzodiazepines beta blockers , , diuretics , H2 , HMG-CoA reductase , synthetase ( also to as and anti-infectives evidence of clinically interactions .	DDI-false
drug Keppra carbamazepine , gabapentin , , @DRUG$ @DRUG$ , and valproate were by evaluating serum of levetiracetam and studies .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
administration oxyphenbutazone and @DRUG$ may result levels @DRUG$.	DDI-false
Although no interactions with topical glaucoma were studies of IOPIDINE 0.5 Ophthalmic Solution the possibility of additive potentiating CNS depressants ( barbiturates opiates , @DRUG$ @DRUG$ ) be considered	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
@DRUG$ over dose range to 2.2 led to a dose-dependent @DRUG$ The alternate-day 0.25 mg drug MS patients is unknown	DDI-mechanism
Although specific not coadministration are eg channel blockers dapsone disopyramide @DRUG$ amiodarone , , , derivatives , , alprazolam , and ) have concentrations when coadministered @DRUG$ ;	DDI-mechanism
drug interactions between Keppra   other ( carbamazepine , gabapentin , phenobarbital @DRUG$ @DRUG$ ) also evaluating serum concentrations of levetiracetam AEDs placebo-controlled studies	DDI-false
Flupenthixol interact with some drugs inhibitors ( @DRUG$ MAOI theoretically affect flupenthixol - Arecoline Eproxindine @DRUG$ : additive CNS - Tricyclic : Flupenthixol effect antidepressants	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
@DRUG$ @DRUG$ * , * due to potential life-threatening arrhythmias .	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
studies a significant reduction in bioavailability trovafloxacin @DRUG$ when administered concomitantly such as @DRUG$.	DDI-mechanism
drug interactions topical glaucoma or systemic identified % Ophthalmic possibility of an or potentiating depressants alcohol @DRUG$ @DRUG$ anesthetics should considered .	DDI-false
In well-controlled patients undergoing concurrent therapy with @DRUG$, a decrease in the steady-state serum concentrations of @DRUG$ may occur when cime-tidine therapy is discontinued.	DDI-mechanism
Specific effects @DRUG$ , @DRUG$ , , and midazolam	DDI-false
Multivalent Products , multivalent products such or , , @DRUG$ chewable/buffered tablets pediatric powder containing @DRUG$ zinc decrease the absorption resulting in serum and urine levels considerably lower .	DDI-false
Since @DRUG$ @DRUG$ prothrombin to days of should by one-third and prothrombin should be monitored closely .	DDI-false
of myopathy with of this class concurrent administration acid derivatives , @DRUG$ ) , erythromycin @DRUG$.	DDI-false
@DRUG$ and nevirapine compared to with the @DRUG$ 48 weeks initial therapy , responses observed with regimens and superiority observed with	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
ACE inhibitors: Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
: @DRUG$ interact drugs Monoamine ( ): theoretically affect flupenthixol - Arecoline - @DRUG$ cause depression - antidepressants Flupenthixol the effect antidepressants	DDI-false
with @DRUG$ , valproic with @DRUG$ the	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
structurally distinct from the currently lovastatin @DRUG$ , @DRUG$ to biopharmaceutical properties to the other this	DDI-false
Cardiovascular : Enalapril been used concomitantly beta adrenergic-blocking @DRUG$ @DRUG$ , agents , prazosin digoxin of adverse interactions .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
specific studies have been , coadministration drugs that mainly by , channel blockers dapsone , disopyramide @DRUG$ , , warfarin , , , fentanyl , @DRUG$ triazolam ) may have elevated concentrations when coadministered with saquinavir	DDI-false
the of chemotherapy on clinical course patients with , non-Hodgkin ( authors compared retrospectively group of 24 HIV-NHL who , , and @DRUG$ CHOP ) chemotherapy plus a group of patients chemotherapy CHOP-like , , prednisone with vincristine @DRUG$ ) therapy	DDI-false
inhibitors @DRUG$ , as a metabolite @DRUG$ amphetamine metabolism	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Compounds that have been tested in man include antipyrine, @DRUG$, propranolol, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
of Itraconazole and @DRUG$ , @DRUG$ has to of the three drugs .	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
evaluated effect the use of @DRUG$ , , in with double ( trimethoprim/sulfamethoxazole TMP/@DRUG$	DDI-false
@DRUG$ Administration anti-inflammatory drugs concomitantly has been an decreased of renal .	DDI-false
( , @DRUG$ ) , @DRUG$ , quinine , procainamide toxicity cardio respiratory .	DDI-false
@DRUG$/Hypnotics: @DRUG$, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
In some patients the combined use of @DRUG$ and @DRUG$ has been associated with fatal gastrointestinal hemorrhage.	DDI-effect
@DRUG$ : , @DRUG$ , quinidine CONTRAINDICATED to potential for and/or life-threatening reactions	DDI-false
include the thiazides other , @DRUG$ , , products @DRUG$ , oral , phenytoin , sympathomimetics calcium channel blocking drugs isoniazid	DDI-false
studies were not finasteride doses of mg clinical with a-blockers , , angiotensin-converting enzyme ( , blockers @DRUG$ , , prostaglandin inhibitors ( to ) , @DRUG$ clinically adverse .	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
@DRUG$ an anionic-binding , considerable effect in the extent of @DRUG$	DDI-mechanism
Oral anticoagulant agents: Pharmacokinetic drug-drug interactions between @DRUG$ and @DRUG$ (7.5 mg single oral dose) have not been demonstrated.	DDI-false
assessment of @DRUG$ in de first post-transplant year pharmacokinetics , exposure-response , and influence on	DDI-false
@DRUG$-@DRUG$ in large doses may inhibit vitamin K epoxide reductase resulting in vitamin K deficiency.	DDI-false
Iodine or iodine excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of lapatinib with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of @DRUG$).	DDI-false
However in the of g @DRUG$ hour before meal and 0.3 @DRUG$ hours same evening meal the cerivastatin AUC of less than 8 % , and decrease Cmax compared to sodium .	DDI-mechanism
@DRUG$: Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, @DRUG$, and @DRUG$.	DDI-false
Lithium: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-effect
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, @DRUG$, sedatives, tranquilizers).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drugs : The administration of @DRUG$ normal volunteers @DRUG$ decreased the renal and significantly increased plasma levels indomethacin	DDI-mechanism
Lorazepam: Coadministration of single doses of @DRUG$ 3 mg and @DRUG$ 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, @DRUG$, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Date does not have pharmacokinetic interactions with captopril , @DRUG$ warfarin isosorbide , @DRUG$ , ethanol .	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Drug Interaction During Pregnancy: @DRUG$ and @DRUG$ were studied following subcutaneous injections in pregnant mice.	DDI-false
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-effect
from in vitro of @DRUG$ other a possible @DRUG$ , cyclosporine nicardipine and .	DDI-int
The potent reverse inhibitor regimens for therapy and inhibitor (@DRUG$)-related metabolic disturbances to in treatment in HIV infection .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ : When Lodine , binding reduced , the clearance free @DRUG$ is altered	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
In the present study, the atypical antipsychotic @DRUG$ was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
Lorazepam injection other injectable , produces system administered with @DRUG$ , phenothiazines , other is concomitantly with injectable lorazepam an sedation , hallucinations , and irrational has been .	DDI-false
Drug Interactions : Flupenthixol , ( MAOI could flupenthixol Arecoline @DRUG$ cause depression @DRUG$ Flupenthixol increases the of	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
may or potentiate CNS depressant of either these or @DRUG$ ) , anticholinergics other with activity ( effects may be potentiated concurrently with antihistamines ) and monoamine MAO ) ( @DRUG$ and intensify and depressant ) .	DDI-false
Non-steroidal anti-inflammatory drugs (but not @DRUG$): These drugs in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies.	DDI-false
@DRUG$ indicated is @DRUG$ between Survanta and .	DDI-false
@DRUG$: @DRUG$ enhance the adrenergic effect of norepinephrine.	DDI-false
Patients receiving @DRUG$ or @DRUG$ be observed activity of these drugs and , signs of toxicity from these	DDI-false
Naproxen: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Therefore you may need to take a @DRUG$ supplement while taking @DRUG$.	DDI-advise
Injection : , like injectable @DRUG$ depression central nervous system with ethyl alcohol barbiturates MAO inhibitors and . scopolamine is used @DRUG$ an increased incidence , hallucinations , irrational behavior has	DDI-false
A : of relationship Accutane vitamin , be taking @DRUG$ @DRUG$ to	DDI-false
@DRUG$ ( @DRUG$ with other central nervous system , including but limited to opioids , , tranquilizers ( , , muscle relaxants alcohol , may cause depression , , and profound , potentially result in coma or	DDI-false
Example inhibitors include azole antifungals, @DRUG$, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ and with @DRUG$ may potentiate a hypokalemic effect beta2-agonists	DDI-false
The continued need for the other @DRUG$ agent should be reviewed after the effects of @DRUG$ have been established, and discontinuation ordinarily should be attempted.	DDI-false
@DRUG$ The concomitant use of transdermal ) central system , including limited to , hypnotics , ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ and may depression hypotension and profound sedation , or in death	DDI-false
that are inducers CYP3A4 ( , @DRUG$ , ) result in of	DDI-mechanism
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Drug-drug between @DRUG$	DDI-false
Of Endogenous has that @DRUG$ of @DRUG$ especially cases of low renin	DDI-effect
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
The administration @DRUG$ containing epinephrine or receiving @DRUG$ or tricyclic antidepressants hypertension .	DDI-false
- Anabolic steroids ( e.g. , ] , [ e.g. , ] @DRUG$ [ e.g. , Anadrol @DRUG$ [ e.g. , Winstrol	DDI-false
The availability non-nucleoside transcriptase regimens for antiretroviral concerns regarding @DRUG$ metabolic have led to significant in treatment HIV infection	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Aspirin/@DRUG$ or have not been @DRUG$ aspirin ( 162.5 mg given 26 to of ) or ( 1000 orally 6 and to , and 6 hours subsequent , of Argatroban )	DDI-false
@DRUG$ produced distinctive effects in each task: it substituted for the training dose in @DRUG$ discrimination and it increased the number of responses with short (<3 s) interresponse times as well as increasing overall response rates in the DRL schedule.	DDI-false
Dihydroergotamine @DRUG$ potential for serious life-threatening reactions as acute @DRUG$ by vasospasm other tissues .	DDI-false
Additive adverse resulting from blockade occur when @DRUG$ is , amantadine , ( MAO ) , tricyclic antidepressants or some @DRUG$.	DDI-effect
@DRUG$ : Altered levels of @DRUG$ increased and been reported concomitant	DDI-false
Additionally, higher than expected @DRUG$ levels have been observed when they are begun in patients already taking @DRUG$.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : Vardenafil 20 mg , when with slow-release 60 once daily , relative AUC concentration ) @DRUG$ that is	DDI-false
@DRUG$ taken directed and @DRUG$ with a main meal of the preferably the evening meal ..	DDI-false
Other : such as disopyramide , procainamide phenothiazines @DRUG$ and @DRUG$ be with QT-interval prolongation and risk arrhythmia	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
tubular secretion of @DRUG$ resulting increased blood and/or @DRUG$ toxicity .	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-false
Therefore, prothrombin time should be carefully monitored in patients receiving @DRUG$ and @DRUG$-like drugs simultaneously.	DDI-advise
specific not been , drugs that are mainly by eg calcium blockers , dapsone , amiodarone , @DRUG$ , @DRUG$ , cyclosporine , derivatives , carbamazepine , , , and plasma concentrations when ;	DDI-false
Phenytoin: Altered serum levels of @DRUG$ (increased and decreased) have been reported in patients receiving concomitant @DRUG$.	DDI-mechanism
Additive adverse effects from may when LEVSIN other amantadine @DRUG$ @DRUG$ monoamine ( MAO ) inhibitors antihistamines .	DDI-false
@DRUG$ potentiates the muscle relaxant effect of all @DRUG$, most notably nondepolarizing muscle relaxants, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-effect
and Angiotensin II Antagonists ( Congestive Heart 3020 ( % patients @DRUG$ 25 to 50 mg also received ACE angiotensin receptor antagonists ( ACEI/@DRUG$ ) .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Acetaminophen: In normal volunteers, concomitant administration of @DRUG$ and @DRUG$ resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-mechanism
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
include @DRUG$ and other , corticosteroids phenothiazines , thyroid products , oral contraceptives @DRUG$ , acid , drugs , isoniazid	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
There been case reports steady-state levels , , @DRUG$ therapy with @DRUG$.	DDI-false
During transfer to oral @DRUG$, the dose levels of previously administered agents should be reduced by 30 to 50% several days after the addition of oral @DRUG$.	DDI-false
Nervous The concomitant other @DRUG$ , but not sedatives , e.g. , benzodiazepines , general anesthetics relaxants @DRUG$ cause depression , hypotension and profound , or result coma .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$   1000 daily not the pharmacokinetics R	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Since @DRUG$ is a substrate for CYP3A4 and CYP2C8, drugs/substances that inhibit these isoenzymes may decrease the metabolism and increase serum concentration of @DRUG$.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (FORTOVASE) as the sole @DRUG$ due to the risk of decreased saquinavir plasma concentrations.	DDI-false
@DRUG$: Chloramphenicol, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
, additional niacin have not on @DRUG$ plasma levels and administration to patient population chronically receiving @DRUG$ resulted in in the of bioavailability digoxin relative to data .	DDI-false
Based on the chemical resemblance of itraconazole and @DRUG$, coadministration of @DRUG$ with itraconazole is contraindicated.	DDI-false
@DRUG$ : , @DRUG$ flecainide , due to serious and/or	DDI-false
Clinical studies with @DRUG$ have identified potentially significant interactions with fluconazole and @DRUG$.	DDI-int
Interactions And @DRUG$ AEDs @DRUG$ Keppra ( mg daily ) no effect on pharmacokinetic in refractory .	DDI-false
Anabolic steroids ( nandrolone [ e.g. @DRUG$ , e.g. , ] , @DRUG$ e.g. , Winstrol ] or	DDI-false
The effects of @DRUG$ (@DRUG$) on inositol 1,4,5-trisphosphate (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
effects concomitant @DRUG$ steady-state pharmacokinetics of @DRUG$.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease @DRUG$ metabolism and increase @DRUG$ plasma concentrations.	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$ : rate ciprofloxacin @DRUG$ was alone or XR was given 2 at the suppresses gastric acid	DDI-false
No data are available for the coadministration of @DRUG$/ritonavir or @DRUG$/ritonavir and garlic capsules.	DDI-false
acetaminophen/theophylline lidocaine/quinidine @DRUG$/acetaminophen phenobarbital/valproic acid , quinidine/@DRUG$ , acid/phenobarbital .	DDI-false
side of cefmenoxime , , , @DRUG$ or cause K deficiency	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Cephalosporins-Cephalosporins chains of ( @DRUG$ , latamoxef methylthiadiazole @DRUG$ ) can K	DDI-false
@DRUG$ been administered with dobutamine @DRUG$ , and ventilation .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
: @DRUG$ the hypotensive @DRUG$.	DDI-effect
trials administration @DRUG$ and @DRUG$ not alter profile	DDI-false
@DRUG$: Coadministration of single doses of eszopiclone 3 mg and @DRUG$ 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of @DRUG$, valproate, topiramate, or lamotrigine.	DDI-false
INOmax has been administered with @DRUG$, @DRUG$, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
patients moderate hypertension of 25 daily @DRUG$ ACE benazepril , to , associated with an arterial 3 mm @DRUG$ alone .	DDI-false
Therefore e.g. , narcotics , antiemetics , @DRUG$ , @DRUG$ .	DDI-false
, these are that have one or more pharmacologic activities similar bepridil , including anti-arrhythmic such as @DRUG$ , glycosides and	DDI-false
@DRUG$: In controlled studies in healthy volunteers, @DRUG$ either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum digoxin concentrations.	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-mechanism
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/@DRUG$ (TMP/SMX).	DDI-false
Therefore, when @DRUG$ and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
@DRUG$ : mg t.i.d Vardenafil mg resulted in increase in AUC , a in vardenafil and @DRUG$ .	DDI-false
concluded oral @DRUG$ and @DRUG$ be administered without significant decrease in ,	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
In with proteins indicate @DRUG$ differently than @DRUG$ and does not interact with salicylate or	DDI-false
Although other @DRUG$ are highly effective, there have been reports of pregnancy from women who have used @DRUG$, as well as topical/injectable/implantable/insertable hormonal birth control products.	DDI-false
Coadministration of @DRUG$ with 40 mg @DRUG$ tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.	DDI-mechanism
Other therapy studies were performed finasteride doses of more concomitantly used clinical studies with acetaminophen , , @DRUG$ , enzyme ( ACE inhibitors @DRUG$ benzodiazepines , beta blockers nitrates , diuretics , H2 HMG-CoA reductase , inhibitors ( also referred to NSAIDs , and quinolone anti-infectives clinically .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ Absorption hydrochlorothiazide is impaired in presence of	DDI-false
administration possessing e.g. , ( e.g. @DRUG$ chemotherapy ) cardiotoxic ( e.g. @DRUG$ hepatotoxic ( e.g. methotrexate asparaginase ) toxicity these organ systems	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Additive adverse resulting from occur when administered concomitantly with other antimuscarinics @DRUG$ haloperidol @DRUG$ , ( ) , some antihistamines .	DDI-false
Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that @DRUG$ may reduce the antihypertensive effect of @DRUG$, especially in cases of low renin hypertension.	DDI-effect
Interaction with @DRUG$, @DRUG$ and theophylline has also been reported to produce adverse clinical effects.	DDI-false
Carbamazepine : @DRUG$ is known to metabolism of and serum levels @DRUG$ should determined prior to concurrent , carbamazepine monitored closely and appropriate adjustment of should be .	DDI-false
The pharmacokinetics of @DRUG$ and its major metabolite @DRUG$ were unaffected following co-administration with Acamprosate.	DDI-false
include the @DRUG$ diuretics corticosteroids phe-nothiazines , thyroid products , estrogens oral , , , , @DRUG$ , and isoniazid	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with propranolol, @DRUG$, and @DRUG$.	DDI-false
To of chemotherapy HAART with HIV-related systemic , non-Hodgkin lymphoma ( ) , the authors compared retrospectively a 24 with were , vincristine , and prednisone ( CHOP HAART with of patients treated with CHOP or regimen i.e. , @DRUG$ teniposide prednisone @DRUG$ plus ) without receiving	DDI-false
@DRUG$ a subjects plasma levels increased approximately 17 in receiving mg BID CELEBREX 200 BID as compared to receiving @DRUG$	DDI-false
@DRUG$ (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
ACE and @DRUG$ (Hypertension)- clinical studies patients hypertension , of @DRUG$ 50 to ACE and II antagonists mean serum ( about 0.13	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
suggest that @DRUG$ has a narrower spectrum of and have substantially greater than @DRUG$.	DDI-false
If treatment CYP3A4 activity such ketoconazole @DRUG$ , @DRUG$ , , saquinavir , erythromycin etc , budesonide dose be considered .	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$/theophylline lidocaine/quinidine , , acid , @DRUG$/lidocaine , valproic acid/phenobarbital	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Methotrexate: Caution should be used if @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
The agonists at benzodiazepine , as @DRUG$ , triazolopyridazines and others blocked by @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Injection Lorazepam injection , like @DRUG$ , produces the when ethyl alcohol @DRUG$ , barbiturates , and other . When scopolamine is concomitantly injectable increased sedation , .	DDI-effect
Interactions Levosimendan does not have clinically pharmacokinetic , @DRUG$ , @DRUG$ , , warfarin , carvedilol , ethanol or	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
include the and other , @DRUG$ , , @DRUG$ , , , sympathomimetics , blocking isoniazid	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Potentiation of warfarin-type ( @DRUG$ @DRUG$ substrate ) response almost patients amiodarone result in or fatal .	DDI-false
Another oral @DRUG$ , @DRUG$ metabolism of astemizole , concentrations and its metabolite desmethylastermizole prolong intervals .	DDI-false
- Mephenytoin ( e.g. , @DRUG$ ) of @DRUG$ with these medicines may increase the chance these medicines	DDI-false
results both dexamethasone and @DRUG$ and other @DRUG$ , regulate the by a of the activity and EGF .	DDI-false
Compounds in include @DRUG$ phenytoin , aminopyrine	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
@DRUG$: The concomitant administration of @DRUG$ and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-false
@DRUG$: In diabetic patients receiving diflunisal and @DRUG$, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
Anti-arrhythmics and @DRUG$ could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
to have done noted corticosteroid or @DRUG$ treatment for periods to days has been administered to patients N=180 )	DDI-false
There was no significant difference in the pharmacodynamic effect of @DRUG$ administered alone and @DRUG$ administered with Lodine as measured by prothrombin time.	DDI-false
that been tested @DRUG$ , @DRUG$ , propranolol , theophylline , warfarin and no meaningful	DDI-false
@DRUG$ (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
These effects were not observed when @DRUG$ 20 mg was taken 24 hours before the @DRUG$.	DDI-false
concomitant specific were performed , finasteride doses of or more concomitantly in acetaminophen , acetylsalicylic a-blockers analgesics , angiotensin-converting enzyme , , , beta blockers , calcium-channel , , @DRUG$ @DRUG$ , prostaglandin synthetase inhibitors ( referred as NSAIDs ) anti-infectives evidence significant adverse interactions .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
pharmacokinetic propofol @DRUG$ , @DRUG$ .	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (TMP/@DRUG$).	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
acetaminophen/theophylline, @DRUG$/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
ACE-inhibitors Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
The authors investigated the possibility of a similar interaction between @DRUG$ and @DRUG$.	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for @DRUG$ versus @DRUG$/oxycodone regimens.	DDI-false
other @DRUG$ highly , been reports from who have @DRUG$ topical/injectable/implantable/insertable hormonal .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
@DRUG$: The effects of warfarin and @DRUG$ on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
MAO sulfate @DRUG$ and HC1 use of non-selective @DRUG$	DDI-false
Other studies were , finasteride doses more were concomitantly used in clinical @DRUG$ , acetylsalicylic analgesics angiotensin-converting enzyme ) anticonvulsants , blockers cardiac diuretics , H2 HMG-CoA reductase synthetase also @DRUG$ ) , and quinolone anti-infectives of .	DDI-false
Multivitamins, or other products containing iron or zinc, @DRUG$ or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
These include the thiazides other diuretics , phe-nothiazines , estrogens , , @DRUG$ acid @DRUG$	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
@DRUG$ or other or antacids or sucralfate should not be hours of , @DRUG$ , may with serum and levels of norfloxacin .	DDI-advise
Ergot Derivatives @DRUG$ , ergonovine @DRUG$ , methylergonovine CONTRAINDICATED due potential for serious and life-threatening reactions such as acute ergot toxicity by peripheral vasospasm and ischemia of the extremities tissues .	DDI-false
The effect of @DRUG$ on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal.	DDI-effect
@DRUG$ large amounts may effect , @DRUG$ and , and increase frequency seizures susceptible patients	DDI-effect
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
appears relevant interaction of this kind with @DRUG$ although of other drugs to alter conduction eg , anti-arrhythmic beta-adrenergic @DRUG$ or H1-blocking agents tricyclic antidepressants phenothiazines might to a prolongation of interval .	DDI-effect
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
@DRUG$ generally should @DRUG$ because they reduce add a risk of lithium .	DDI-advise
Coadministration of phenytoin with 40 mg @DRUG$ the @DRUG$ plasma to undetectable .	DDI-false
@DRUG$ impaired presence of @DRUG$.	DDI-false
@DRUG$: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Coingestion of @DRUG$ with @DRUG$, phenobarbital with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$ ( @DRUG$ )	DDI-false
@DRUG$ SHOULD CAUTION REVEIVING @DRUG$ ITS CONGENERS	DDI-advise
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Hypotension : on Diuretic : Patients on and those diuretic therapy instituted may reduction of blood initiation @DRUG$ @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
, nitroglycerin @DRUG$ used angina having vasodilator activity should , , be discontinued before	DDI-advise
BACKGROUND : The @DRUG$ hydrochloride ( @DRUG$ ) calcium on the incidence peritoneal by ) and the intestinal cancers were .	DDI-false
apparently through effect certain systems , has hepatic of @DRUG$ , propranolol , @DRUG$ , , thereby delaying elimination levels of drugs .	DDI-false
@DRUG$ physostigmine @DRUG$ quinine procainamide can enhance toxicity .	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many @DRUG$ (@DRUG$, selective serotonin reuptake inhibitors, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
of @DRUG$ @DRUG$ hydrochlorothiazide reduce its absorption from the gastrointestinal tract up 85 and percent .	DDI-false
drugs include the @DRUG$ , , thyroid products , , oral nicotinic , calcium channel @DRUG$.	DDI-false
Coadministration of @DRUG$ decreased the maximum plasma concentration of @DRUG$ by 6%, decreased clearance by 38%, and increased half-life by 58%.	DDI-mechanism
diuretics e.g. , triamterene , @DRUG$ @DRUG$ , potassium-containing salt substitutes may to increases serum potassium .	DDI-false
Agents Having Vasodilator Activity: Data on the effect of concomitant use of other @DRUG$ in patients receiving @DRUG$ for heart failure are not available;	DDI-false
@DRUG$ may suppress certain CYP450 , including CYP1A2 , @DRUG$ CYP2D6 ,	DDI-false
An additive hypotensive effect has been reported with the combination of systemic @DRUG$ and @DRUG$ therapy.	DDI-effect
@DRUG$ or @DRUG$ excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of Carbimazole.	DDI-false
interaction not finasteride doses mg were used in clinical acetaminophen acetylsalicylic acid , angiotensin-converting , anticonvulsants , benzodiazepines , @DRUG$ nitrates , , H2 , @DRUG$ prostaglandin synthetase also referred to as NSAIDs ) anti-infectives significant	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (@DRUG$, @DRUG$ or delavirdine).	DDI-false
adjustment not no effect plasma concentrations @DRUG$ , valproate , or	DDI-false
Substances inhibitors CYP3A4 activity @DRUG$ and @DRUG$ decrease gefitinib metabolism and increase gefitinib concentrations .	DDI-false
@DRUG$ (increases bioavailability by 50%), @DRUG$, and valproates.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$: Coadministration of single doses of @DRUG$ 3 mg and paroxetine 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
At a median follow-up of 33 months, the combination of @DRUG$ and tamoxifen did not demonstrate any efficacy benefit when compared with @DRUG$ in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
Fluconazole: Concomitant administration of @DRUG$ at 200 mg QD resulted in a two-fold increase in @DRUG$ plasma concentration.	DDI-mechanism
Drug/Laboratory Test Interaction Because @DRUG$ may affect the APTT assay, @DRUG$ present in plasma samples may interfere with one-stage coagulation assays based on the APTT (such as factor VIII, IX, and XI assays).	DDI-false
@DRUG$ including derivatives , derivatives , and aggregation inhibitors such nonsteroidal anti-inflammatory drugs NSAIDs ) @DRUG$ increase the risk administered with ardeparin	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
However, reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
The anesthetic solutions containing epinephrine to patients oxidase @DRUG$ @DRUG$ produce severe prolonged or hypertension	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, @DRUG$, Maalox, and @DRUG$.	DDI-false
, no seen when was administered @DRUG$ , @DRUG$ relaxant antagonists with	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Both ibogaine and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
Protease ( 800 mg ) co-administered with Vardenafil 10 resulted in 16-fold increase in AUC , a increase @DRUG$ Cmax a increase in @DRUG$ half-life .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
Warfarin The of @DRUG$ on the anti-coagulant effect of warfarin was in a group healthy subjects daily doses 2 5 mg @DRUG$.	DDI-false
acetaminophen/theophylline , @DRUG$/@DRUG$ , phenobarbital/acetaminophen , theophylline/acetaminophen , and valproic	DDI-false
@DRUG$: Reports suggest that @DRUG$ may diminish the antihypertensive effect of Angiotensin Converting Enzyme (ACE) inhibitors.	DDI-false
@DRUG$ @DRUG$ of mammary tumor	DDI-false
OTHER interaction studies were , in clinical , was concomitantly @DRUG$ betablockers , @DRUG$ , diuretics nonsteroidal anti-inflammatory evidence significant adverse interactions .	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
This may interact alcohol or other may the these or antihistamines , @DRUG$ or with anticholinergic activity effects may potentiated medications are used concurrently with @DRUG$ ) , and oxidase MAO inhibitors ( use antihistamines prolong the CNS antihistamines .	DDI-false
OTHER CONCOMITANT THERAPY : studies , clinical sodium was concomitantly with angiotensin- ( ACE ) @DRUG$ , calcium-channel blockers , nonsteroidal drugs @DRUG$ clinically significant adverse interactions .	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of @DRUG$, dextromethorphan, and @DRUG$.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Interactions @DRUG$ have , beta-blockers @DRUG$ digoxin , warfarin isosorbide mononitrate , carvedilol , or .	DDI-false
OTHER CONCOMITANT were in clinical studies , sodium was enzyme ( inhibitors @DRUG$ , calcium-channel blockers @DRUG$ , drugs ) without of clinically significant adverse	DDI-false
@DRUG$ : @DRUG$ have been to the of the oral	DDI-false
@DRUG$: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when @DRUG$ and allopurinol were administered concomitantly for 6 days.	DDI-false
inhibitors azole , , clarithromycin , diclofenac , , , @DRUG$ @DRUG$ nicardipine , propofol , protease inhibitors , quinidine , verapamil .	DDI-false
@DRUG$ @DRUG$ produced elevation plasma and a reduction in	DDI-false
@DRUG$, including norfloxacin, may enhance the effects of oral @DRUG$, including warfarin or its derivatives or similar agents.	DDI-effect
@DRUG$: Meclofenamate sodium enhances the effect of @DRUG$.	DDI-false
If treatment inhibitors as @DRUG$ @DRUG$ , ritonavir , etc . ) is reduction the dose considered	DDI-false
studies niacin and @DRUG$ not demonstrated fluvastatin and to a receiving @DRUG$ resulted in no difference in the of bioavailability of relative to .	DDI-false
Other concomitant trials in with Acamprosate concomitantly with anxiolytics @DRUG$ and @DRUG$ or analgesics was similar to subjects these .	DDI-false
Higher concentrations of @DRUG$ 10(-8 M ( 10(-8 ) 10(-7 ) ) enhance mitogenic activity of	DDI-effect
This appears the clinically relevant of this Mefloquine , , coadministration drugs alter eg @DRUG$ channel blockers , H1-blocking tricyclic @DRUG$ also contribute the interval .	DDI-false
This study demonstrated that the potent cytochrome P450 enzyme-inducer @DRUG$ did indeed have a marked effect on the metabolism of @DRUG$, resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder.	DDI-mechanism
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ and @DRUG$ exaggerate the prolongation of QT interval observed bepridil hydrochloride	DDI-false
@DRUG$ may alcohol , , ( , sinus medicines lithium , , @DRUG$ high medications .	DDI-int
the currently available @DRUG$ ( @DRUG$ , simvastatin , pravastatin properties other this	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In patients chronic treated with in combination @DRUG$ treatment did @DRUG$ distribution .	DDI-false
The use of @DRUG$ patients receiving @DRUG$ be rarely associated fibrillation .	DDI-effect
Theophylline should be for patients given @DRUG$ and @DRUG$.	DDI-advise
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
In addition the pharmacodynamics of warfarin acetylsalicylic , @DRUG$ and @DRUG$ , the digoxin state .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ : @DRUG$ pharmacokinetic interaction administered with glyburide .	DDI-false
with alcohol , @DRUG$s decongestant ( allergy cold medicines , diabetic , , NSAIDs @DRUG$ , high pressure	DDI-false
therapies : clinical , in treated with Acamprosate concomitantly @DRUG$ , hypnotics @DRUG$ benzodiazepines , analgesics was similar to that subjects placebo concomitant .	DDI-false
@DRUG$ II Receptor Antagonists In studies with hypertension of INSPRA to to ACE and @DRUG$ increased slightly 0.09 - mEq/L )	DDI-false
Antidepressants , @DRUG$ may the @DRUG$ ;	DDI-effect
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
: @DRUG$ been to produce significant serum concentrations various	DDI-mechanism
@DRUG$ and methaqualone interact pharmacologically administered @DRUG$ but the effect significant .	DDI-int
intensity uniformity and time phenobarbital @DRUG$ , glutethimide chloral hydrate were systematically investigated in receiving @DRUG$ therapy .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The rifampin on @DRUG$ of our patient be maximal 5 rifampin and a similar length time @DRUG$ .	DDI-false
@DRUG$: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
Drug Flupenthixol may interact with like Monoamine inhibitors ): could affect flupenthixol - @DRUG$ - - @DRUG$ : Ethanol additive CNS depression - Tricyclic antidepressants the effect of Tricyclic antidepressants	DDI-false
with that inducers CYP3A4 eg , phenytoin , @DRUG$ , carbamazepine ) may @DRUG$.	DDI-mechanism
@DRUG$ : The use DURAGESIC   ( transdermal other system limited to opioids , sedatives , hypnotics , tranquilizers ( , @DRUG$ ) , anesthetics , phenothiazines , skeletal alcohol , may cause hypotension , sedation potentially result in coma .	DDI-false
Mineral of @DRUG$ and vitamin K may reduce absorption of @DRUG$.	DDI-false
@DRUG$ Potentiation of warfarin-type ( @DRUG$ ) anticoagulant response is almost seen in patients receiving amiodarone can or	DDI-false
Elevated serum levels @DRUG$ with with	DDI-false
The action of be certain including @DRUG$ and other drugs that highly protein bound , salicylates , sulfonamides , @DRUG$ , probenecid , coumarins oxidase inhibitors beta blocking .	DDI-false
Steady-state serum of @DRUG$ reported to significantly when @DRUG$ either added the regimen	DDI-mechanism
Sulindac: The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-mechanism
Co-administration : use of @DRUG$ antiplatelet agents , @DRUG$ and increase the risk of	DDI-effect
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
While all the selective serotonin inhibitors @DRUG$ ) , citalopram escitalopram , fluoxetine @DRUG$ , inhibit P450 they may extent of .	DDI-false
has been following concomitant of with or @DRUG$	DDI-false
@DRUG$ used @DRUG$ because of possibility	DDI-advise
High-dose cyclosporin concentrations above 2000 with has led 80 in @DRUG$ exposure with a 38 decrease total body clearance of to @DRUG$ alone	DDI-false
Co-administration BOTOX and interfering with ( @DRUG$ should only performed as the the @DRUG$ may	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, @DRUG$, ketoconazole), though this has not been studied	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
The effects of @DRUG$ (RR) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Interactions No between @DRUG$ and the following drugs , warfarin , and	DDI-false
The the possibility of interaction @DRUG$ and @DRUG$.	DDI-false
with @DRUG$ can directly with blood glucose levels or may interact	DDI-int
a of cerivastatin bedtime @DRUG$ before evening would result a decrease in clinical of @DRUG$.	DDI-false
@DRUG$ including @DRUG$ , may the oral including warfarin derivatives .	DDI-false
To determine whether injection @DRUG$ permit doses of @DRUG$ to be administered , dose thiosulfate concurrently escalating .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other @DRUG$ and that these @DRUG$ do not influence the pharmacokinetics of levetiracetam.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, @DRUG$, tranquilizers).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
MAO inhibitors MAOI antidepressants, as well as a metabolite of @DRUG$, slow @DRUG$ metabolism.	DDI-mechanism
These drugs include the @DRUG$ and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Lithium generally should not be given with diuretics because they reduce @DRUG$s renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
- Anabolic [ e.g. @DRUG$ @DRUG$ [ , Anavar ] , [ , Anadrol ] e.g. Winstrol ]	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Rhabdomyolysis has been observed in patients receiving HMG-CoA reductase inhibitors administered alone (at recommended dosages) or concomitantly with @DRUG$ including @DRUG$.	DDI-false
Diuretics: Patients on @DRUG$, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$.	DDI-effect
@DRUG$: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as @DRUG$, opiates, and alcohol.	DDI-effect
has been in patients receiving @DRUG$ alone ( recommended or concomitantly with @DRUG$ including cyclosporine .	DDI-effect
To avoid @DRUG$ intoxication, appropriate adjustment of the @DRUG$ should be made.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
study concurrent @DRUG$ permits twofold increase in and total to @DRUG$.	DDI-mechanism
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, @DRUG$, topiramate, or @DRUG$.	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-advise
: injection injectable , depression central nervous when administered @DRUG$ , phenothiazines , , @DRUG$ and other antidepressants scopolamine is concomitantly injectable lorazepam , increased incidence hallucinations irrational behavior observed	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and itraconazole) decrease @DRUG$ metabolism and increase gefitinib plasma concentrations.	DDI-mechanism
however , no deleterious interactions were when ROMAZICON was @DRUG$ inhalational @DRUG$ relaxants muscle relaxant antagonists administered in conjunction sedation or .	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the ACE inhibitor benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
Renin : enalapril @DRUG$ cause renin release ( e.g. , @DRUG$	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Although noted even @DRUG$ was given 4 hours prior @DRUG$ , did result .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Omeprazole The and extent absorption @DRUG$ Proquin was given alone or @DRUG$ given hours after omeprazole the suppresses .	DDI-false
specific were not performed , 1 mg or concomitantly in clinical , acetylsalicylic acid , @DRUG$ ACE inhibitors benzodiazepines diuretics H2 HMG-CoA , synthetase ( as @DRUG$ ) , and .	DDI-false
Effects @DRUG$ on Metabolizing Enzymes and Drug @DRUG$ inhibits CYP3A4 and vitro clinically relevant concentrations .	DDI-false
Multivalent Products : administration of a quinolone @DRUG$ with multivalent cation-containing products such as magnesium or aluminum @DRUG$ sucralfate , tablets or powder , or products containing calcium , , zinc may the ciprofloxacin , serum urine considerably lower than desired .	DDI-mechanism
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
from benzodiazepines suggest possible drug the following : @DRUG$ amiodarone , @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and @DRUG$/phenobarbital.	DDI-false
Example inhibitors azole , ciprofloxacin clarithromycin , , @DRUG$ , @DRUG$ nefazodone , nicardipine , inhibitors quinidine	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (TMP/@DRUG$).	DDI-false
600 with 5 mg resulted a 49-fold in @DRUG$ and 13-fold in @DRUG$ Cmax .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Methotrexate : if @DRUG$ is administered concomitantly with	DDI-advise
: Isoniazid is known the metabolism carbamazepine its serum levels @DRUG$ be prior concurrent administration isoniazid signs symptoms carbamazepine should be closely , @DRUG$ be made .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Hypotension   Patients on @DRUG$ Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-false
HIV Protease Inhibitors @DRUG$ ( mg . with 10 resulted a 16-fold in AUC , a 7-fold @DRUG$ and 2-fold in .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Potential Keppra AEDs ( @DRUG$ phenobarbital @DRUG$ and valproate ) also by evaluating the serum concentrations AEDs placebo-controlled clinical	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
The myopathy during with of is increased with administration @DRUG$ derivatives , ( @DRUG$ ,	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
apomorphine - prior ingestion of @DRUG$ may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-effect
@DRUG$ : study NIDDM @DRUG$ AUC Cmax but variable .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
concentrations Drugs that increase @DRUG$ plasma : is when administering family ( ketoconazole , @DRUG$	DDI-false
of toxicity @DRUG$ and are concomitantly	DDI-false
@DRUG$ of atomoxetine to and , about 3- to 4-fold @DRUG$ alone .	DDI-false
has been , , @DRUG$ @DRUG$ surfactant and .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Drug : No pharmacokinetic interactions were observed @DRUG$ drugs : , , , @DRUG$ and ranitidine	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
@DRUG$ Rofecoxib 75 once daily 11 concentration or renal elimination @DRUG$ after single 0.5 .	DDI-false
Tagamet , on certain has reduce the hepatic metabolism warfarin-type , @DRUG$ propranolol nifedipine diazepam , antidepressants , @DRUG$ , theophylline , thereby elimination and increasing levels drugs .	DDI-false
At a median follow-up of 33 months, the combination of @DRUG$ and @DRUG$ did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
@DRUG$ effect of all @DRUG$ , most notably nondepolarizing muscle , and MAC ( minimum alveolar reduced administration N .	DDI-effect
are inhibitors of eg , ketoconazole and itraconazole decrease @DRUG$ @DRUG$ plasma concentrations	DDI-false
Chlorpromazine: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat @DRUG$ poisoning.	DDI-false
It to concurrent ethambutol with @DRUG$ @DRUG$ for at hours administration	DDI-false
@DRUG$ inhibits @DRUG$.	DDI-false
@DRUG$ In pharmacology , of antacid aluminum hydroxide , @DRUG$ and with reduced serum levels as compared with administered suggesting impair .	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Standard of methotrexate-related should if @DRUG$ and @DRUG$ are administered concomitantly	DDI-advise
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
antifungals , ciprofloxacin @DRUG$ doxycycline , @DRUG$ , isoniazid propofol , quinidine .	DDI-false
concentrations @DRUG$ decreased approximately colestipol and @DRUG$ coadministered .	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Patients taking @DRUG$ concomitantly with @DRUG$ more commonly reported both weight gain and weight loss, compared with patients taking either medication alone.	DDI-effect
in the second of cholestyramine 1 before the meal 0.3 @DRUG$ approximately 4 same evening resulted a decrease @DRUG$ AUC than 8 % , a in Cmax about 30 when to	DDI-false
include @DRUG$ @DRUG$ , doxycycline , isoniazid , nefazodone nicardipine , inhibitors	DDI-false
include the and diuretics corticosteroids , , thyroid estrogens oral @DRUG$ , nicotinic , calcium channel , @DRUG$.	DDI-false
Aspirin: When Lodine is administered with @DRUG$, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Use with Angiotensln Converting Enzyme Inhibitors: The use of @DRUG$ to control hypertension in patients on @DRUG$ has been reported to induce severe leukopenia.	DDI-effect
@DRUG$ : atorvastatin does the antipyrine , other @DRUG$ metabolized via the cytochrome not expected	DDI-false
In and @DRUG$ for been reported to suggested that disulfiram may with @DRUG$ the to a nitrosamine , .	DDI-false
Patients concomitantly with @DRUG$ as rheumatic disease experience @DRUG$ because of competitive excretory .	DDI-false
@DRUG$ , take mouth of @DRUG$ with sulfapyridine effects affecting the side	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
@DRUG$: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
CONCLUSIONS/INTERPRETATION : @DRUG$ and @DRUG$ can exert properties renal circulation	DDI-false
vitro with serum proteins @DRUG$ binds differently than does @DRUG$ or .	DDI-false
therapy Although specific doses mg more were in with acetaminophen acid , a-blockers , @DRUG$ , angiotensin-converting enzyme ) inhibitors @DRUG$ , beta blockers , , cardiac diuretics H2 antagonists prostaglandin synthetase ( to as ) quinolone anti-infectives without of clinically significant adverse .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Intravenous @DRUG$ ) has administered the presence other cardioactive drugs as @DRUG$ calcium channel agents , and converting inhibitors any change in the .	DDI-false
Example inhibitors @DRUG$ ciprofloxacin clarithromycin diclofenac erythromycin , , nicardipine ,	DDI-false
@DRUG$ of @DRUG$ 600 mg BID Cmax and AUC of 20 % .	DDI-false
Digoxin: In controlled studies in healthy volunteers, @DRUG$ either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum @DRUG$ concentrations.	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Potential in @DRUG$ dosing at different levels @DRUG$ assessed in the ANOVA	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Although studies been performed , coadministration drugs mainly metabolized eg dapsone , disopyramide @DRUG$ , amiodarone , cyclosporine , derivatives , pimozide fentanyl , @DRUG$ , , and triazolam ) elevated when coadministered	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Theophylline with some , concurrent administration of ciprofloxacin @DRUG$ may elevated serum concentrations of @DRUG$ and prolongation of half-life .	DDI-false
@DRUG$: @DRUG$ has no apparent pharmacokinetic interaction when administered with glyburide.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
@DRUG$ to @DRUG$ ) enzyme cytochromes ( CYP3A4	DDI-false
The effects of adenosine are antagonized by @DRUG$ such as @DRUG$ and theophylline.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine phenobarbital/@DRUG$ , phenobarbital/valproic , quinidine/lidocaine valproic	DDI-false
An interaction study with @DRUG$ showed no clinically significant effect of @DRUG$ on warfarin pharmacokinetics or anticoagulant activity.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Depressants : concomitant use of DURAGESIC   transdermal including to , hypnotics , @DRUG$ , benzodiazepines , general , @DRUG$ may and profound , potentially result in coma or	DDI-false
There have been greater than 2-fold increases in previously stable plasma levels of other antidepressants, including @DRUG$, when @DRUG$ has been administered in combination with these agents.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
It is therefore necessary be with and paraclinical pattern of magnesium deficit between @DRUG$ due an insufficient magnesium intake which depletion related to a of control of @DRUG$ status which requires less regulation of .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., @DRUG$]) or	DDI-false
following be mind in the treatment poisoning they not on use of @DRUG$ @DRUG$.	DDI-advise
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
Expected changes in laboratory assessments of PT and INR were observed after @DRUG$ administration, but these changes were not affected by concomitant @DRUG$ administration.	DDI-false
In clinical studies performed with use ( ) @DRUG$ ) NSAIDs piroxicam and digoxin not the @DRUG$.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
: @DRUG$ administered daily days did affect or (S)-warfarin , nor were there changes in profile prothrombin ) following single mg dose of @DRUG$	DDI-false
@DRUG$ ( 20 mg ) not @DRUG$ observation period in when administered ( body .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ @DRUG$ known slow the metabolism of carbamazepine its serum levels determined , and of carbamazepine should be monitored , appropriate adjustment of anticonvulsant	DDI-false
e.g. @DRUG$ , @DRUG$ , or amiloride ) supplements , potassium-containing salt substitutes lead to in potassium	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
@DRUG$ Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of methotrexate.	DDI-false
has following concomitant administration @DRUG$ or potent @DRUG$ such furosemide	DDI-effect
- Anabolic steroids (nandrolone [e.g., @DRUG$], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Oral Contraceptives Keppra ( 500 daily not of oral 0.03 @DRUG$ mg @DRUG$ , or and progesterone that contraceptive efficacy is	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
In a clinical study indomethacin @DRUG$ administered patients receiving @DRUG$.	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
interactions between Keppra   and ( @DRUG$ , gabapentin , phenobarbital , primidone @DRUG$ ) the concentrations levetiracetam clinical studies	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
administration possessing e.g. , @DRUG$ , cytotoxic chemotherapy ) , cardiotoxic e.g. , ) or ( , @DRUG$ , asparaginase ) PROLEUKIN toxicity these systems	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Use With @DRUG$ @DRUG$ is genotoxic and mutagenic.	DDI-false
Broad-Spectrum Antibiotics-@DRUG$ may sterilize the bowel and decrease the @DRUG$ contribution to the body by the intestinal microflora.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Example include ciprofloxacin @DRUG$ , , , , , nefazodone nicardipine propofol protease inhibitors @DRUG$	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (TMP/SMX).	DDI-false
These thiazides and other diuretics , corticosteroids , , thyroid products , oral contraceptives sympathomimetics , @DRUG$ ,	DDI-false
Sedatives/@DRUG$ @DRUG$ to potential for life-threatening such as prolonged increased depression	DDI-false
18-MC ibogaine opioid possibly receptors , @DRUG$ has much lower affinities than @DRUG$ receptors channels 5-HT transporter	DDI-false
Stavudine and Zidovudine @DRUG$ antagonize the in antiviral of and @DRUG$	DDI-effect
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
Tinnitus and decreased hearing have been reported in patients concomitantly receiving @DRUG$ and @DRUG$.	DDI-effect
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, valproate, @DRUG$, or lamotrigine.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
Methenamine therapy Urinary excretion of @DRUG$ is increased, and efficacy is reduced by acidifying agents used in @DRUG$ therapy.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Coadministration of @DRUG$ the pharmacokinetics @DRUG$.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
In this interaction chemical reaction ( @DRUG$ ) @DRUG$ acidic conditions similar in vivo resulting in a 3-ethoxylated product .	DDI-false
Adequate monitoring of @DRUG$ plasma concentrations should be considered when therapy with @DRUG$ is initiated or changed in patients receiving theophylline.	DDI-false
Interactions Flupenthixol may some like @DRUG$ ( @DRUG$ ): MAOI could theoretically affect - and additive : increases the effect Tricyclic	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Although specific studies performed , coadministration with are by ( , calcium blockers @DRUG$ disopyramide , quinine , amiodarone , derivatives , , , fentanyl , , and elevated concentrations when with @DRUG$ ;	DDI-mechanism
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Other concomitant therapy interaction studies not performed finasteride of 1 mg or used , @DRUG$ , a-blockers , , @DRUG$ , , benzodiazepines , , calcium-channel blockers , , diuretics , antagonists HMG-CoA reductase , prostaglandin synthetase to as and of clinically adverse interactions .	DDI-false
Other Drug pharmacokinetic interactions @DRUG$ and the following : warfarin , @DRUG$ , Maalox and ranitidine .	DDI-false
Central Depressants The concomitant use of DURAGESIC   ( fentanyl system central including but not limited other , @DRUG$ , tranquilizers , , @DRUG$ , phenothiazines skeletal muscle relaxants and alcohol , may depression hypotension , and sedation , in coma or .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
Multivalent Cation-Containing Concurrent a quinolone ciprofloxacin , with cation-containing products as or antacids , @DRUG$ , VIDEX chewable/buffered or powder or products containing , @DRUG$ , resulting in serum and levels lower .	DDI-false
In clinical the use of @DRUG$ , inhibitors @DRUG$ ) ( ) , and did affect pharmacokinetics/pharmacodynamics of fondaparinux .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-advise
@DRUG$ Pharmacokinetic drug-drug interactions @DRUG$ oral dose ) been .	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Plasma levels of @DRUG$ may become subtherapeutic during @DRUG$ therapy.	DDI-mechanism
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Although no studies have been conducted, concomitant administration of Itraconazole and @DRUG$ may alter the metabolism of @DRUG$;	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, @DRUG$, methotrexate, and increased toxicity.	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
, @DRUG$ , may the effects oral @DRUG$ warfarin derivatives or	DDI-effect
@DRUG$ , Mexate ) Use methotrexate side of @DRUG$	DDI-false
Example azole antifungals , ciprofloxacin , clarithromycin @DRUG$ , doxycycline , erythromycin , isoniazid @DRUG$ , nicardipine , protease quinidine and verapamil	DDI-false
@DRUG$ has any with @DRUG$ alone and because aspirin the rate excretion , use Nalfon and is not recommended .	DDI-false
necessary the of @DRUG$ upon or . since @DRUG$ prolong time	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
While all @DRUG$ SSRIs ) , citalopram @DRUG$ , and they may vary the of .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (@DRUG$), @DRUG$, azole antifungals.	DDI-false
interactions with drugs systemic were identified in of IOPIDINE Solution , additive CNS ( alcohol , @DRUG$ @DRUG$ ) should considered	DDI-false
Results multiple sclerosis TYSABRI and @DRUG$ ( 30 mcg once weekly or @DRUG$ were regard adjustment of or glatiramer	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
It is believed that the toxicity may have resulted from a previously unrecognized interaction between @DRUG$ and @DRUG$ and a molecular basis for this interaction has been proposed.	DDI-effect
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
@DRUG$ can antagonize the vitro @DRUG$ zidovudine against HIV	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.	DDI-mechanism
Because @DRUG$ been shown effect beyond that obtained with and because the rate of excretion Nalfon the of @DRUG$ is not	DDI-false
Both @DRUG$ have compared to triple with the PI over 48 weeks as initial with similar observed @DRUG$ regimens superiority .	DDI-false
receiving @DRUG$ furosemide be closely the and/or effect @DRUG$ is achieved	DDI-false
Injection : Lorazepam , like injectable produces depression of the central administered with @DRUG$ , phenothiazines , , other antidepressants . When @DRUG$ used lorazepam of sedation hallucinations and irrational behavior been observed .	DDI-false
Digoxin: When multiple doses of @DRUG$ and @DRUG$ were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-mechanism
@DRUG$ is primarily metabolized the CYP2D6 to	DDI-false
@DRUG$: Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
However, concomitant administration of @DRUG$ with CELEBREX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
include antifungals , clarithromycin , , @DRUG$ , imatinib , isoniazid , @DRUG$ propofol verapamil	DDI-false
Warfarin : activity should , particularly days after or @DRUG$ @DRUG$ or similar agents these are an risk .	DDI-advise
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
The interaction is a consequence of blocking hepatic metabolism of @DRUG$ by @DRUG$, a highly potent CYP3A4 inhibitor, which also inhibits CYP2C9.	DDI-mechanism
It is recommended to avoid concurrent administration of @DRUG$ with aluminum hydroxide containing antacids for at least 4 hours following @DRUG$ administration.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-int
Although no drug interactions glaucoma drugs or medications identified IOPIDINE Ophthalmic the of potentiating CNS depressants alcohol , , @DRUG$ , @DRUG$ , anesthetics ) be .	DDI-false
This was study 101 were randomly to @DRUG$ at doses of 0.5 mg mg 2 twice daily with @DRUG$ and .	DDI-false
Garlic Capsules capsules be while taking saquinavir @DRUG$ as the @DRUG$ due the risk of decreased saquinavir plasma .	DDI-false
Both @DRUG$ and 18-MC decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
its of effects , @DRUG$ a substitute @DRUG$ for .	DDI-false
INOmax has been administered with tolazoline, dopamine, @DRUG$, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
and @DRUG$ Upon administration of mg 600 BID AUC of @DRUG$ 20 .	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the ACE inhibitor @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-effect
@DRUG$ is a substrate for both @DRUG$ and CYP3A4.	DDI-false
Like 40 , @DRUG$ ( ) the oral ethanol @DRUG$ rats	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
These results suggest both dexamethasone and and possibly other @DRUG$ and @DRUG$ , regulate the of epithelium by dose-dependent modification and .	DDI-false
Administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and @DRUG$.	DDI-false
Coadministration of @DRUG$ and cyclosporine, tacrolimus or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of @DRUG$ given as a 0.25 mg dose every day.	DDI-false
Although specific not been , with drugs are mainly CYP3A4 @DRUG$ , @DRUG$ amiodarone , quinidine , warfarin , cyclosporine , ergot , pimozide , , , alprazolam and ) elevated concentrations when coadministered with saquinavir ;	DDI-false
because @DRUG$ competitively displaces @DRUG$ binding sites .	DDI-mechanism
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, @DRUG$, rifampin, phenobarbital or St.	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
: Amiodarone be used with caution in patients receiving -receptor , a ) or @DRUG$ antagonists e.g. , , @DRUG$ , a CYP3A4 ) of the possible potentiation , sinus arrest and AV block	DDI-false
Nervous System Depressants use of ( fentanyl central nervous system depressants but limited other @DRUG$ @DRUG$ , phenothiazines , muscle may hypotension , profound sedation or coma or death .	DDI-false
: @DRUG$ injection , like other injectable @DRUG$ depression nervous administered with ethyl alcohol , phenothiazines barbiturates , MAO and . scopolamine is concomitantly with injectable lorazepam an incidence of , behavior been	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Other Agents enalapril IV used concomitantly @DRUG$ , @DRUG$ , agents hydralazine prazosin digoxin without adverse interactions	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Stavudine and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-false
In with @DRUG$ with PEGASYS treatment did not @DRUG$ distribution	DDI-false
: @DRUG$ may interact with some like ( ): pharmacodynamics - Eproxindine : Flupenthixol and Ethanol additive depression : effect @DRUG$	DDI-false
Carbamazepine known the metabolism of carbamazepine increase serum levels @DRUG$ be prior with isoniazid signs @DRUG$ should be closely and adjustment of the anticonvulsant .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, @DRUG$, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
Therefore could following concomitant administration psychotropic ( e.g. @DRUG$ analgesics , @DRUG$ sedatives , tranquilizers )	DDI-false
There is no pharmacokinetic interaction between @DRUG$ and @DRUG$.	DDI-false
@DRUG$ levels should be administered @DRUG$.	DDI-false
Therophylline A recent study has that concomitan administration of cause elevated plasma levels of @DRUG$ in some instances a slight decrease of	DDI-false
concomitant Although specific interaction , or more clinical studies acetaminophen , , a-blockers , , angiotensin-converting , , benzodiazepines , beta blockers blockers cardiac , diuretics , antagonists , @DRUG$ , prostaglandin ( also referred to @DRUG$ ) , and quinolone anti-infectives evidence clinically adverse interactions	DDI-false
Concurrent administration of oxyphenbutazone and @DRUG$ may result in elevated serum levels of @DRUG$.	DDI-false
@DRUG$ Alcohol ( 0.5 weight : mL absolute 70 @DRUG$ plasma not when simultaneously	DDI-false
: produced an elevation of plasma @DRUG$ and a renal @DRUG$ clearance .	DDI-false
@DRUG$ may block the antihypertensive action of @DRUG$ and similarly acting compounds.	DDI-effect
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
A 5-mg @DRUG$ dose should not be exceeded when used in combination with 200 mg once daily @DRUG$.	DDI-advise
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
@DRUG$ @DRUG$ 1500 mg twice daily did in healthy volunteers	DDI-false
[ to treatment with @DRUG$ therapeutic ] The problems during the longterm treatment patients with @DRUG$ by six .	DDI-false
No Important Interactions Date Levosimendan not interactions captopril , @DRUG$ , digoxin , , @DRUG$ ethanol or itraconazole .	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
risk myopathy drugs this increased with administration of cyclosporine , @DRUG$ niacin ( @DRUG$ ) , azole	DDI-false
Compounds have been tested @DRUG$ @DRUG$ , warfarin clinically were	DDI-false
Compounds that have @DRUG$ theophylline , @DRUG$ clinically interactions found .	DDI-false
To evaluate impact of chemotherapy the course of patients HIV-related non-Hodgkin ( , the authors retrospectively a group of with doxorubicin , vincristine , and ( plus a 80 a CHOP-like regimen , cyclophosphamide , teniposide prednisone with @DRUG$ plus @DRUG$ ) receiving therapy .	DDI-false
@DRUG$ should given with diuretics they renal clearance high of lithium .	DDI-false
toxicity has been patients receiving @DRUG$ elimination , including @DRUG$.	DDI-effect
Vitamin A: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ toxicity has been receiving concomitantly which cause elimination sodium ,	DDI-false
Cyclosporine Methotrexate @DRUG$ other , through effects on renal the elimination drugs leading to elevated of , @DRUG$ , methotrexate , and increased	DDI-mechanism
Coadministration @DRUG$ @DRUG$ elevated plasma terfenadine in instances of cardiac death .	DDI-mechanism
Furthermore it has been proposed that @DRUG$ resulted In induction of P-450IIE1 in the patients liver which, in turn, resulted in a greater proportion of the ingested @DRUG$ being converted to the toxic metabolites.	DDI-mechanism
@DRUG$ and colestipol resins: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
is not recommended . no on plasma concentrations of @DRUG$ @DRUG$ or .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
of @DRUG$ @DRUG$ , , antiemetics , , tranquilizers )	DDI-false
Therefore, it would be expected that a dosing schedule of @DRUG$ given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
Concurrent administration of possessing nephrotoxic e.g. , ) myelotoxic ( e.g. cytotoxic chemotherapy ) cardiotoxic ( e.g. , @DRUG$ ) ( e.g. , @DRUG$ asparaginase effects may toxicity organ	DDI-false
@DRUG$ (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with @DRUG$ (5 mg) in healthy volunteers.	DDI-false
Other Chemotherapy Agents , concomitant with @DRUG$ did meaningfully alter the agent ( the metabolites @DRUG$ ) .	DDI-false
apparently on certain microsomal systems , reported to hepatic metabolism of , @DRUG$ , propranolol , nifedipine chlordiazepoxide , diazepam tricyclic antidepressants , , @DRUG$ metronidazole , thereby and increasing levels of drugs	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
) had @DRUG$ ( AUC ) maximum ) @DRUG$ healthy volunteers	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$: Coadministration of @DRUG$ 3 mg and olanzapine 10 mg produced a decrease in DSST scores.	DDI-false
@DRUG$ have interactions with @DRUG$ lithium	DDI-int
Carbamazepine : is the metabolism @DRUG$ and its serum Carbamazepine levels prior concurrent isoniazid signs symptoms of carbamazepine toxicity be monitored closely and of @DRUG$ made	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (@DRUG$/ARB).	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
@DRUG$ , with bactericidal of	DDI-effect
Reactions to Iodinated Contrast Media : A review of revealed % ( range - % of 501 with various @DRUG$ containing regimens were @DRUG$ experienced acute adverse reactions	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, @DRUG$ or itraconazole.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
multiple taking TYSABRI   @DRUG$ ( IM ) or glatiramer acetate regard the beta-interferon @DRUG$.	DDI-false
@DRUG$ : @DRUG$ of lithium toxicity reported receiving lithium ACE inhibitor therapy .	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
clinical studies with the concomitant use of ( @DRUG$ ) , inhibitors ( acetylsalicylic acid @DRUG$ ( ) , not affect .	DDI-false
sampling for the @DRUG$ @DRUG$ was performed on day 1 on weeks , , months , , .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
of @DRUG$ @DRUG$ be monitored and adjustments be made	DDI-false
: @DRUG$ have an of plasma a in renal @DRUG$ .	DDI-false
comparison digitalis anesthetized ketamine Innovar Vet pentobarbital dosage of @DRUG$ significantly as the of with ketamine Innovar than @DRUG$.	DDI-false
HIV Protease : @DRUG$ ( 800 mg t.i.d co-administered Vardenafil 10 in 16-fold increase , 7-fold increase in 2-fold increase in @DRUG$ half-life	DDI-false
Both @DRUG$ @DRUG$ dopamine in nucleus	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, sedatives, @DRUG$) should be considered.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
A possible @DRUG$ and , a fluoroquinolone , been reported , resulting in a potentiation of the hypoglycemic action of	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
There is a significant in @DRUG$ when is @DRUG$ CYP3A4	DDI-false
Specific studies have confirmed these effects with @DRUG$, @DRUG$, propofol, alfentanil, and midazolam.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ In normal a small decrease in diflunisal was observed when of @DRUG$ concomitantly .	DDI-false
: @DRUG$ interact with some , oxidase ( MAOI theoretically affect flupenthixol - - Ethanol cause additive depression @DRUG$ : the effect of	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the @DRUG$ @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-false
Aminosalicylic acid may decrease the amount of @DRUG$ (@DRUG$, Lanoxicaps) that gets absorbed into your body.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
No data available of or	DDI-false
- Methotrexate (e.g., Mexate) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
The of ( @DRUG$ ) inositol (@DRUG$)-induced responses studied rat marrow patch-clamp recording in combination microfluorometry .	DDI-false
Therefore, patients under @DRUG$ therapy should be carefully monitored when concomitant @DRUG$ therapy is indicated.	DDI-advise
@DRUG$ : When @DRUG$ administered , is reduced , the clearance is not altered	DDI-false
Anticholinesterases , ) , lignocaine @DRUG$ @DRUG$ can enhance toxicity cardio respiratory .	DDI-false
include the thiazides and other , corticosteroids phenothiazines , @DRUG$ estrogens oral , phenytoin nicotinic acid , , calcium blocking ,	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Imipramine (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
Interactions To Date @DRUG$ does not have clinically interactions captopril beta-blockers , digoxin , @DRUG$ , , or .	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$ ibogaine for and receptors , @DRUG$ lower for and , sodium and the 5-HT .	DDI-false
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-false
Methotrexate Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of @DRUG$.	DDI-false
In EM individuals treated with @DRUG$ or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-false
@DRUG$ : Amiodarone , bepridil @DRUG$ quinidine CONTRAINDICATED to and/or life-threatening .	DDI-false
: and @DRUG$ IV been concomitantly with beta adrenergic-blocking , methyldopa , calcium-blocking hydralazine and @DRUG$ of significant adverse	DDI-false
of drugs possessing nephrotoxic , indomethacin , myelotoxic e.g. @DRUG$ ( e.g. , ) hepatotoxic e.g. @DRUG$ , ) may increase organ	DDI-false
Antihypertensives : Amiodarone should used with in -receptor blocking agents propranolol , a @DRUG$ antagonists , a CYP3A4 substrate , and a @DRUG$ of the possible potentiation bradycardia , sinus arrest , AV block ;	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Central Nervous System : The of fentanyl transdermal system with other central depressants but not other opioids , , hypnotics benzodiazepines ) , general @DRUG$ @DRUG$ skeletal , alcohol , respiratory depression profound sedation , or result coma death	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
To evaluate of chemotherapy plus on course of with HIV-related , systemic , non-Hodgkin lymphoma compared patients HIV-NHL who the cyclophosphamide , doxorubicin , vincristine and prednisone ) plus a patients who were CHOP chemotherapy ( i.e. @DRUG$ teniposide and @DRUG$ vincristine ) receiving .	DDI-false
@DRUG$ In a study young healthy male no of direct pharmacokinetic be found	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
binding with human indicate that @DRUG$ differently and does interact with	DDI-false
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Anti-arrhythmics and @DRUG$ could exaggerate the prolongation the @DRUG$.	DDI-effect
Data from studies @DRUG$ suggest a possible drug @DRUG$ for the following and	DDI-false
Bacteriostatic Antibiotics @DRUG$ , @DRUG$ or with bactericidal of .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a @DRUG$ cation-containing magnesium aluminum antacids @DRUG$ powder , products containing iron , or zinc substantially decrease ciprofloxacin resulting and urine considerably lower .	DDI-mechanism
Close supervision and careful adjustment of the dosage are required when @DRUG$ is used with other anticholinergic drugs or @DRUG$.	DDI-advise
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Concurrent administration possessing nephrotoxic e.g. , , indomethacin myelotoxic e.g. , cytotoxic , cardiotoxic ( e.g. @DRUG$ or hepatotoxic ( e.g. , asparaginase effects @DRUG$ may toxicity in organ	DDI-effect
- @DRUG$ (e.g., AquaMEPHYTON, Synkayvite) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
@DRUG$ may interact , decongestant , cold medicines , , norepinephrine , NSAIDs or Ibuprofen , blood medications	DDI-int
Warfarin : have to the of oral @DRUG$ @DRUG$ or its derivatives .	DDI-false
Physiological oral @DRUG$ load constitutes the best tool for diagnosis of @DRUG$ deficiency and the first step of its treatment.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Specific these with sevoflurane @DRUG$ , @DRUG$ .	DDI-false
The hypoglycemic @DRUG$ be potentiated by certain including nonsteroidal anti-inflammatory and other drugs that protein @DRUG$ , coumarins , monoamine oxidase inhibitors beta agents .	DDI-effect
of @DRUG$ theophylline , @DRUG$ at high to toxic concentrations drug	DDI-false
@DRUG$: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat amphetamine poisoning.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
alter @DRUG$ Drugs may imatinib concentrations Caution when Gleevec inhibitors of CYP3A4 family ( ketoconazole erythromycin , @DRUG$ ) .	DDI-false
Other strong inhibitors of ( e.g. @DRUG$ , clarithromycin troleandomycin @DRUG$ ) to behave	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
: @DRUG$ causes increase about % in fraction of	DDI-mechanism
Other concomitant Although specific , mg or more clinical studies with acetaminophen , analgesics , angiotensin-converting enzyme ( ACE , anticonvulsants benzodiazepines , blockers @DRUG$ cardiac , , H2 , HMG-CoA inhibitors , synthetase inhibitors ( to as @DRUG$ quinolone anti-infectives without of significant interactions	DDI-false
Amiodarone , @DRUG$ , , propafenone @DRUG$ CONTRAINDICATED to for reactions	DDI-false
other diuretics , @DRUG$ , products , estrogens , phenytoin , @DRUG$ , sympathomimetics , calcium blocking drugs	DDI-false
Cholestyramine and colestipol resins: Absorption of @DRUG$ is impaired in the presence of @DRUG$.	DDI-mechanism
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$ : concomitant use DURAGESIC   ( @DRUG$ ) nervous system not to other , tranquilizers ( general anesthetics muscle and may profound , or result coma death	DDI-false
@DRUG$ The use of DURAGESIC   ( fentanyl transdermal system central nervous system depressants but limited @DRUG$ , sedatives hypnotics , tranquilizers e.g. , , , , and , profound sedation , potentially coma or death	DDI-false
Aspirin/Acetaminophen : or drug-drug interactions been Argatroban concomitantly administered @DRUG$ ( 162.5 mg given 26 and to of hours ) @DRUG$ ( 1000 mg given 12 and 0 prior to and 6 12 hours of Argatroban 1.5 g/kg/min . over )	DDI-false
This may occur because @DRUG$ competitively displaces @DRUG$ from protein binding sites.	DDI-mechanism
These drugs include @DRUG$ corticosteroids products , oral contraceptives , nicotinic acid , sympathomimetics @DRUG$	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Multivalent Products : Concurrent administration a quinolone , ciprofloxacin multivalent cation-containing such or antacids sucralfate , tablets powder , containing @DRUG$ , @DRUG$ , or may substantially decrease the of , serum and levels considerably than desired .	DDI-false
Co-administration of @DRUG$ with @DRUG$ has been shown to increase the mean half-life and the area under the concentration-time curve.	DDI-mechanism
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Depressants : use of @DRUG$ transdermal system ) with other nervous depressants but not to other sedatives @DRUG$ e.g. , benzodiazepines , general anesthetics , relaxants , and alcohol may cause depression , and or in or death	DDI-effect
Ritonavir and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
@DRUG$: (oral agents and insulin) - dosage adjustment of the @DRUG$ may be required.	DDI-false
Short-term pharmacokinetic demonstrated administration warfarin and Lodine   etodolac and ) in reduced protein @DRUG$ there change in the of	DDI-false
The hypotensive @DRUG$ be by discontinuing the @DRUG$ or increasing the salt one to of treatment with captopril tablets USP ) initiating with doses ( ) .	DDI-effect
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Specific confirmed @DRUG$ isoflurane , propofol , , @DRUG$.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
@DRUG$ : @DRUG$ dopamine norepinephrine receptors , inhibiting central effects of and be treat amphetamine	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
@DRUG$ : Concomitant administration mg a in @DRUG$ plasma .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
, @DRUG$ other @DRUG$ , through effects on may cause changes in the of these leading elevated of cyclosporine , , increased .	DDI-false
to relevant interaction with although theoretically drugs known alter cardiac anti-arrhythmic beta-adrenergic , @DRUG$ @DRUG$ or , antidepressants ) might also a prolongation of the QTc interval .	DDI-false
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., @DRUG$, tacrine, and @DRUG$).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ rifampin CONTRAINDICATED since with @DRUG$ in antiretroviral concentrations saquinavir .	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ and @DRUG$.	DDI-effect
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG-DRUG$.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, @DRUG$, clarithromycin).	DDI-false
Multivitamins, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
@DRUG$ been with PI @DRUG$ over 48 weeks therapy with nevirapine regimens and observed with efavirenz	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
is not recommended.@DRUG$ no on carbamazepine , , topiramate or @DRUG$.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
: a healthy subjects lithium plasma 450 mg @DRUG$ 200 as to subjects @DRUG$	DDI-false
have not been performed coadministration that are metabolized eg , calcium channel , , @DRUG$ quinine , @DRUG$ , cyclosporine , ergot pimozide carbamazepine , , and may have elevated saquinavir ;	DDI-false
@DRUG$ : The concomitant use of DURAGESIC   transdermal with other @DRUG$ , not limited opioids , , hypnotics ( e.g. general , , relaxants , alcohol cause , and profound sedation , result or death .	DDI-false
Norepinephrine @DRUG$ the effect of	DDI-effect
studies have shown that precipitation occurs when drops @DRUG$ with	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
interactions of @DRUG$ @DRUG$ .	DDI-int
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ ( b.i.d . co-administered with Vardenafil mg 49-fold a 13-fold increase in @DRUG$ Cmax .	DDI-false
Data in vitro studies benzodiazepines other than alprazolam a interaction for the following : ergotamine , , @DRUG$ , @DRUG$ , and	DDI-false
Methenamine therapy @DRUG$ , reduced by acidifying agents @DRUG$ .	DDI-mechanism
@DRUG$ and cyclosporine , @DRUG$ or to of .	DDI-mechanism
@DRUG$ of to indomethacin decreased the renal clearance significantly the plasma levels @DRUG$.	DDI-false
The risk of a potential interaction between @DRUG$ and @DRUG$ concentrates has not been adequately evaluated in preclinical or clinical studies.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Concomitant use of Argatroban @DRUG$ @DRUG$ anticoagulants the of bleeding .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
: injection , other benzodiazepines , of the central when @DRUG$ barbiturates , inhibitors , and other . When used concomitantly with @DRUG$ , increased sedation hallucinations irrational behavior observed	DDI-false
@DRUG$ decreases the biologic @DRUG$ of increase in clearance that results in greater amount hydroxylated in urine	DDI-mechanism
and other diuretics corticosteroids , products estrogens , , , @DRUG$ , , @DRUG$ and isoniazid .	DDI-false
Other Cardiovascular Agents : Enalapril IV have used concomitantly with adrenergic-blocking , @DRUG$ @DRUG$ prazosin without evidence of clinically adverse interactions	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide, cardiac glycosides and @DRUG$.	DDI-false
@DRUG$ : Increased levels of lithium toxicity been in @DRUG$ .	DDI-false
@DRUG$ : In conducted in healthy steady-state @DRUG$ levels increased approximately in subjects receiving 450 BID with mg BID to subjects lithium alone .	DDI-false
drug interact or depressants potentiate the CNS depressant either these medications @DRUG$ ) , anticholinergics or other anticholinergic activity effects may potentiated these medications used concurrently with antihistamines ) , and @DRUG$ ( concurrent use with and effects .	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these polyene antibiotics showed differential effects on cells;	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
After multiple dosing, @DRUG$ (@DRUG$  30 mcg IM once weekly) reduced TYSABRI  clearance by approximately 30%.	DDI-false
vitro in , of CYP2A6 of @DRUG$ by @DRUG$ , was 17 - .	DDI-mechanism
@DRUG$ Simvastatin @DRUG$ ) combination amiodarone with reports of myopathy/rhabdomyolysis	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
However, if Argatroban is to be initiated after cessation of @DRUG$ therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of @DRUG$ therapy.	DDI-false
Cholestyramine and @DRUG$ @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
Vardenafil (20 mg) did not potentiate the hypotensive effects of @DRUG$ during the 4-hour observation period in healthy volunteers when administered with @DRUG$ (0.5 g/kg body weight).	DDI-false
AEDs a 22 % increase total clearance @DRUG$ was co-administered	DDI-mechanism
@DRUG$-A drug interaction study of @DRUG$ with lithium has not been conducted.	DDI-false
@DRUG$ and @DRUG$ resins : of hydrochlorothiazide is impaired the presence anionic exchange .	DDI-false
Lithium : Increased serum and @DRUG$ have receiving concomitant @DRUG$ and inhibitor	DDI-false
@DRUG$: @DRUG$, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$: Concomitant administration of fluconazole at 200 mg QD resulted in a two-fold increase in @DRUG$ plasma concentration.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and @DRUG$, @DRUG$ and tricyclic anti-depressants.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , , theophylline/@DRUG$ valproic acid/phenobarbital .	DDI-false
@DRUG$ : administration of @DRUG$ VIOXX may an of GI ulceration other complications , to use of VIOXX alone .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Rifampin: Co-administration of VIOXX with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
with @DRUG$ , @DRUG$ and has also been reported produce	DDI-false
Warfarin : administered for 5 days not affect the pharmacokinetics of@DRUG$n changes in ( following a 25 oral dose @DRUG$	DDI-false
@DRUG$ should not used patients @DRUG$ ..	DDI-advise
Dexamethasone and retinyl acetate similarly inhibit and stimulate @DRUG$- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
@DRUG$ e.g. , @DRUG$ , , amiloride , supplements , or substitutes may significant in serum .	DDI-false
(@DRUG$ may increase the responsiveness to @DRUG$.)	DDI-effect
Ergot Derivatives: @DRUG$, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Aspirin When @DRUG$ is administered aspirin , binding reduced , although the of @DRUG$ not	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
Warfarin: Quinolones have been reported to enhance the effects of the oral @DRUG$ @DRUG$ or its derivatives.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (TMP/@DRUG$).	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
interaction studies clinical , sodium enzyme ACE ) inhibitors , betablockers @DRUG$ and nonsteroidal drugs @DRUG$ ) without evidence of clinically significant interactions	DDI-false
@DRUG$ other antiarrhythmic therapy life-threatening arrhythmias who are single agent or	DDI-false
@DRUG$ @DRUG$ with rifampin mg inducer hepatic metabolism	DDI-false
Drug Interactions may , Monoamine ( MAOI ): @DRUG$ could theoretically affect Arecoline Eproxindine Ethanol : Flupenthixol Ethanol cause additive CNS depression - the effect of @DRUG$	DDI-false
Coadministration are of eg @DRUG$ , @DRUG$ result plasma levels of	DDI-false
to be relevant interaction of kind Mefloquine , although theoretically other drugs to alter cardiac conduction eg , @DRUG$ beta-adrenergic agents blockers antihistamines @DRUG$ , antidepressants phenothiazines might contribute of the QTc interval	DDI-false
Therefore , be that of @DRUG$ bedtime cholestyramine before evening meal not result a in the of	DDI-false
intensity uniformity and course anticoagulant @DRUG$ , @DRUG$ systematically investigated in patients receiving	DDI-false
Both efavirenz and @DRUG$ compared the PI indinavir over 48 weeks as initial similar being superiority observed	DDI-false
On administration of oral @DRUG$, the need for @DRUG$ therapy should be reviewed and the dose reduced by approximately 50% or discontinued.	DDI-advise
@DRUG$: @DRUG$ appear to have no significant effect on the bioavailability of ciprofloxacin.	DDI-false
System : concomitant of ( fentanyl transdermal with depressants , including but other opioids @DRUG$ tranquilizers e.g. ) , anesthetics , , skeletal muscle , @DRUG$ , , sedation or death .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although there have been no formal interaction studies other @DRUG$ , based on these in vivo and in it is unlikely that co-administration of 1 mg dose of @DRUG$ other result significant of cytochrome metabolism drugs	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, procainamide, and phenytoin during concomitant therapy with @DRUG$.	DDI-false
a comparison tolerance dogs anesthetized @DRUG$ , the dosage to tachycardia was significantly higher as the LD50 ouabain , with with @DRUG$.	DDI-false
@DRUG$ erythromycins sulfonamides @DRUG$ interfere with bactericidal effect of .	DDI-false
thiazides and corticosteroids phenothiazines , @DRUG$ , estrogens nicotinic acid , @DRUG$ calcium channel drugs , .	DDI-false
acetaminophen/@DRUG$, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In performed with Fondaparinux use of @DRUG$ , @DRUG$ ( acetylsalicylic , ( piroxicam and significantly the pharmacokinetics/pharmacodynamics fondaparinux	DDI-false
recent has shown @DRUG$ theophylline cause plasma levels @DRUG$ instances a slight decrease the .	DDI-false
@DRUG$: Concomitant administration of @DRUG$ may reduce plasma levels of diflunisal.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Drug : Flupenthixol may oxidase could theoretically affect - Arecoline - Eproxindine - @DRUG$ : @DRUG$ and cause depression - Flupenthixol increases the effect Tricyclic antidepressants	DDI-false
Therefore, when meclofenamate sodium is given to a patient receiving @DRUG$, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
Antidepressants, tricyclic @DRUG$ may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-effect
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
@DRUG$ decreased the hyperuricemic of @DRUG$.	DDI-effect
Human pharmacokinetics data indicate that oral @DRUG$ potently inhibits the metabolism of @DRUG$ resulting in an eight-fold increase in the mean AUC of cisapride.	DDI-mechanism
Injection : @DRUG$ injection injectable benzodiazepines , the when administered with ethyl @DRUG$ barbiturates inhibitors and other . is concomitantly lorazepam incidence sedation , has been .	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
interact with blood , allergy , cold , medicines drugs lithium @DRUG$ , NSAIDs like Aleve or @DRUG$ , pressure medications	DDI-false
Potassium Supplements and @DRUG$: Fosinopril sodium can attenuate potassium loss caused by @DRUG$.	DDI-false
@DRUG$ not the plasma of @DRUG$ when combination	DDI-false
The advised to the plasma concentrations of @DRUG$ any of is concurrently to dose @DRUG$ necessary .	DDI-false
The of the requirement our patient to be to 7 after initiation @DRUG$ similar time @DRUG$ withdrawal	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and @DRUG$ when administered concomitantly with an intravenous opiate such as morphine.	DDI-false
@DRUG$ butyrophenones may reduce reverse pressor	DDI-effect
: @DRUG$ and receptors thus inhibiting the central effects @DRUG$ and be used to treat .	DDI-effect
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-mechanism
Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of @DRUG$ should not be exceeded in a 24-hour period when used in combination with @DRUG$ 400 mg daily.	DDI-advise
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Antihypertensives @DRUG$ used caution in receiving -receptor blocking agents e.g. , a @DRUG$ calcium antagonists , a CYP3A4 substrate , and a inhibitor ) because the possible potentiation , , AV	DDI-false
you may to take a @DRUG$ supplement while	DDI-advise
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Interaction on the antinociceptive effect between @DRUG$ and @DRUG$ or tuftsin.	DDI-effect
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$: When Lodine is administered with @DRUG$, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-false
Furosemide Clinical studies as well as observations , have reduce natriuretic of @DRUG$ @DRUG$ in patients	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Therefore @DRUG$ is given patient the @DRUG$ should be excessive prolongation of prothrombin time .	DDI-false
Other concomitant therapy Although specific studies were not , @DRUG$ 1 more concomitantly in studies acetaminophen , a-blockers angiotensin-converting ( ACE , @DRUG$ , nitrates , , HMG-CoA inhibitors also referred NSAIDs anti-infectives evidence of clinically significant interactions .	DDI-false
Multivitamins, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
concomitantly than days increases of @DRUG$ and n-acetyl @DRUG$ % .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
SINCE ADMINISTRATION OF THESE DRUGS CAN @DRUG$ INTOXICATION TO @DRUG$ PATIENT ON THERAPY , A BASELINE PHENYTOIN SHOULD BE OBTAINED	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The risk myopathy of this increased administration of @DRUG$ fibric acid derivatives @DRUG$ ( nicotinic ) , , antifungals	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
specific interaction not , mg were concomitantly used in clinical with , acetylsalicylic a-blockers , analgesics angiotensin-converting ( ACE ) inhibitors , benzodiazepines , beta blockers , blockers , @DRUG$ , , HMG-CoA also to @DRUG$ ) , and quinolone of adverse .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Patients receiving high doses of @DRUG$ concomitantly with @DRUG$, as in rheumatic disease, may experience salicylate toxicity at lower doses because of competitive renal excretory sites.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
that increased between and affinity binding for @DRUG$ on dopamine2- serotonin2-receptors underlies the of @DRUG$ after their prolonged administration	DDI-false
@DRUG$, nondepolarizing (e.g., @DRUG$): possible increased responsiveness to the muscle relaxant.	DDI-false
To evaluate the impact chemotherapy plus HAART the with , systemic , non-Hodgkin lymphoma ( ) , retrospectively with @DRUG$ @DRUG$ and prednisone ( CHOP ) chemotherapy regimen plus with group of 80 or CHOP-like regimen i.e. , cyclophosphamide , doxorubicin teniposide , and prednisone vincristine plus bleomycin without receiving therapy	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Additive may occur @DRUG$ is administered concomitantly with other antimuscarinics amantadine , ( MAO ) , @DRUG$ some antihistamines	DDI-effect
time of @DRUG$ glutethimide @DRUG$ and in 16 patients receiving coumarin .	DDI-false
Coadministration of @DRUG$ affect the pharmacokinetics of @DRUG$.	DDI-false
Although have not performed , coadministration mainly metabolized by , blockers , @DRUG$ , , amiodarone warfarin , @DRUG$ derivatives , carbamazepine , , , alprazolam , and plasma when	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Adverse reactions to @DRUG$s as , systemic ( flu-like ) severe the caution be in the use of @DRUG$ .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing transferrin (1 microgram/ml), @DRUG$ (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
caution necessary when using @DRUG$ in cases of mixed drug the toxic effects ( as cardiac ) of other the @DRUG$ effect flumazenil .	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$ : , erythromycins , sulfonamides , tetracyclines interfere the bactericidal @DRUG$.	DDI-false
These results both and retinyl acetate , and possibly glucocorticoids and , may the proliferation of prostate by dose-dependent modification @DRUG$ and	DDI-false
@DRUG$ been be @DRUG$ , time kill curves bacilli	DDI-effect
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Although have been to effects fever insufficiency hyperbilirubinemia confusion and dyspnea concomitant administration these PROLEUKIN reduce the effectiveness of @DRUG$ should be avoided . 12 Beta-blockers and other @DRUG$ may hypotension with .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although specific have not been performed drugs mainly by CYP3A4 ( eg @DRUG$ , @DRUG$ , , , , cyclosporine ergot carbamazepine , , alprazolam triazolam plasma concentrations when coadministered saquinavir	DDI-false
Other reported interactions with amiodarone: Fentanyl (@DRUG$ substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, @DRUG$, Maalox, and ranitidine.	DDI-false
@DRUG$ : Clinical , as as , have @DRUG$ furosemide thiazides	DDI-false
acetaminophen/theophylline , , , phenobarbital/valproic acid , , , and valproic	DDI-false
At higher than recommended doses, @DRUG$ 75 mg administered once daily for 10 days increased plasma concentrations by 23% as measured by AUC0-24hr in patients receiving @DRUG$ 7.5 to 15 mg/week for rheumatoid arthritis.	DDI-mechanism
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
Interaction with phenytoin, @DRUG$ and @DRUG$ has also been reported to produce adverse clinical effects.	DDI-false
In ingestion @DRUG$ diet for has been cause , has suggested that @DRUG$ react with nitrites in the rat stomach form which is tumorigenic	DDI-false
Injection Lorazepam injection depression central system with @DRUG$ , phenothiazines , @DRUG$ , inhibitors , and other . scopolamine is used concomitantly with lorazepam , an increased sedation , hallucinations and irrational behavior	DDI-false
Keppra and other ( , @DRUG$ , phenobarbital , phenytoin , and valproate ) assessed by the concentrations @DRUG$ and these placebo-controlled	DDI-false
Lithium: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than @DRUG$ and does not interact with @DRUG$ or dicumarol.	DDI-false
@DRUG$: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving @DRUG$ or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
It is to well with and paraclinical @DRUG$ and magnesium @DRUG$ requires oral and magnesium related to of control mechanisms of magnesium status requires more or less specific regulation of	DDI-false
Injection @DRUG$ injection , other , depression of central nervous system when , barbiturates , MAO inhibitors and other antidepressants . scopolamine used @DRUG$ , an of behavior has been observed	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapy Although specific not performed , or concomitantly used in clinical acetaminophen , acetylsalicylic , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , calcium-channel , H2 antagonists , , @DRUG$ ( referred to @DRUG$ ) , and without evidence of clinically	DDI-false
some patients the use @DRUG$ and @DRUG$ been associated with .	DDI-effect
Antihypertensives @DRUG$ should used patients receiving blocking propranolol , ) channel , , CYP3A4 substrate and @DRUG$ , inhibitor of the possible potentiation bradycardia arrest , and	DDI-false
@DRUG$ should be used with caution in patients taking @DRUG$, and renal function should be carefully monitored.	DDI-advise
Other inhibitors ( , @DRUG$ , clarithromycin nefazodone , ritonavir @DRUG$ ) would expected	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
of benzodiazepines other possible drug interaction for the : ergotamine , @DRUG$ , , @DRUG$ .	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Tagamet an effect certain microsomal has been reduce hepatic metabolism of warfarin-type , , @DRUG$ certain @DRUG$ , lidocaine theophylline , thereby and levels these drugs .	DDI-false
@DRUG$ of @DRUG$ net change % ( increase in 21.2 % ) at 1732 micromol/L.	DDI-mechanism
@DRUG$ , tricyclic Amphetamines may activity @DRUG$ or agents	DDI-false
Other reported interactions with amiodarone: @DRUG$ (CYP3A4 substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
@DRUG$ study of rheumatoid taking @DRUG$ , CELEBREX not have a significant effect on the methotrexate	DDI-false
However, if @DRUG$ is to be initiated after cessation of @DRUG$ therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of Argatroban therapy.	DDI-false
no impact the @DRUG$ although it decreased the tmax by 44 % and intracellular phosphorylated @DRUG$ by 110 %	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (@DRUG$/SMX).	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, digoxin, @DRUG$, and ranitidine.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
This to be the clinically interaction this @DRUG$ , coadministration of drugs known alter cardiac eg , channel @DRUG$ H1-blocking agents , also contribute to a the interval .	DDI-effect
@DRUG$ Angiotensin Antagonists ( Failure Post-Myocardial Infarction)- In EPHESUS , ) patients 25 50 received inhibitors @DRUG$ ACEI/ARB ) .	DDI-false
The zidovudine study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
: of combined @DRUG$ and verapamil hydrochloride ( verapamil , a calcium blocker incidence intestinal @DRUG$ ( and index intestinal cancers investigated Wistar	DDI-false
that @DRUG$ phenytoin carbamazepine , rifampin @DRUG$ or	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for levofloxacin versus @DRUG$/@DRUG$ regimens.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Oral doses of @DRUG$ (10-20 mg/kg), via alcohol dehydrogenase inhibition, significantly reduced the rate of elimination of @DRUG$ (by approximately 40%) given to healthy volunteers in moderate doses.	DDI-mechanism
Specific confirmed these @DRUG$ , , @DRUG$ , midazolam	DDI-false
containing side of ( cefmenoxime cefoperazone , @DRUG$ , @DRUG$ latamoxef or methylthiadiazole ( ) can vitamin and hypoprothrombinemia .	DDI-false
inhibitors Reports that @DRUG$ the antihypertensive of	DDI-effect
No pharmacokinetic interactions between dexmedetomidine and isoflurane, @DRUG$, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
however, no deleterious interactions were seen when ROMAZICON was administered after @DRUG$, inhalational anesthetics, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
@DRUG$, but not @DRUG$, decreases heart rate at high doses.	DDI-false
injection of @DRUG$ (@DRUG$) were observed by measuring locomotor activity and stereotyped behavior.	DDI-false
@DRUG$/Hypnotics : @DRUG$ , midazolam due potential and/or such or sedation respiratory depression .	DDI-false
Nervous System The use DURAGESIC ( fentanyl ) other @DRUG$ , including but to opioids , sedatives @DRUG$ , tranquilizers e.g. ) , skeletal muscle hypotension profound sedation , potentially coma .	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
Anabolic ( nandrolone e.g. oxandrolone [ e.g. @DRUG$ ] , @DRUG$ , stanozolol ] ) or	DDI-false
from currently @DRUG$ ( , simvastatin , and @DRUG$ , leading to biopharmaceutical to the agents this .	DDI-false
Cardiovascular : and been concomitantly adrenergic-blocking agents , , @DRUG$ calcium-blocking @DRUG$ without evidence of clinically adverse	DDI-false
possessing nephrotoxic @DRUG$ ) , e.g. , cytotoxic chemotherapy , cardiotoxic ( e.g. , doxorubicin ) ( e.g. methotrexate , asparaginase @DRUG$ may increase these systems	DDI-effect
As @DRUG$ it should be that capable potentiating CNS depressants opiates , and @DRUG$.	DDI-effect
phenobarbital/acetaminophen , phenobarbital/valproic acid @DRUG$/lidocaine theophylline/acetaminophen and	DDI-false
Drugs With A Narrow Therapeutic Index @DRUG$ A single dose of @DRUG$ 3 mg did not affect the pharmacokinetics of digoxin measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
Although specific , coadministration with that mainly metabolized by ( eg @DRUG$ dapsone , , , @DRUG$ , , cyclosporine derivatives pimozide , carbamazepine , , alfentanyl , and may have elevated plasma concentrations when with	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
@DRUG$ blockers by	DDI-false
@DRUG$ Atorvastatin had no clinically significant time when administered to patients chronic @DRUG$ treatment	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
acetaminophen/theophylline phenobarbital/acetaminophen @DRUG$/valproic , @DRUG$/lidocaine and acid/phenobarbital .	DDI-false
It is assumed that increased interaction between 3H-spiroperidol and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration.	DDI-false
of @DRUG$ , need @DRUG$ should and dose reduced % discontinued	DDI-advise
Concurrent administration of @DRUG$ and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-false
Hydrochlorothiazide : In diflunisal and @DRUG$ resulted in significantly levels	DDI-false
chemical itraconazole and @DRUG$ , @DRUG$ .	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
a of digitalis tolerance dogs anesthetized with ketamine @DRUG$ @DRUG$ , the dosage needed to ventricular tachycardia significantly higher , as was LD50 of ouabain with ketamine or Innovar than	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although specific studies have been performed coadministration that are by CYP3A4 ( , dapsone , quinine amiodarone quinidine , , , , @DRUG$ @DRUG$ alprazolam may elevated plasma coadministered saquinavir ;	DDI-false
Although no studies and @DRUG$ may alter of @DRUG$	DDI-false
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
@DRUG$ normal decrease diflunisal was observed when doses and @DRUG$ concomitantly .	DDI-false
@DRUG$ : Atorvastatin plasma concentrations LDL-C reduction coadministration	DDI-false
EM individuals @DRUG$ , the AUC of @DRUG$ approximately and Css , about to .	DDI-mechanism
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
receiving @DRUG$ , of @DRUG$ to therapy could prolong the	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
the selective serotonin reuptake @DRUG$ ) e.g. , @DRUG$ escitalopram , sertraline paroxetine , they vary in .	DDI-false
Valproate @DRUG$  (1500 mg twice daily) did not alter the pharmacokinetics of @DRUG$ in healthy volunteers.	DDI-false
Rhabdomyolysis has been observed in patients receiving @DRUG$ administered alone (at recommended dosages) or concomitantly with immunosuppressive drugs including @DRUG$.	DDI-effect
@DRUG$ generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
@DRUG$ (but not @DRUG$): These drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.	DDI-false
phenobarbital/@DRUG$ acid , valproic .	DDI-false
There have greater than 2-fold increases previously plasma of other antidepressants @DRUG$ , @DRUG$ has been combination agents .	DDI-mechanism
tested in include @DRUG$ , , @DRUG$ aminopyrine and antipyrine .	DDI-false
Like ( 40 mg/kg , 40 ) self-administration of @DRUG$ the oral self-administration @DRUG$ and nicotine in rats	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-int
@DRUG$-Orlistat may decrease the absorption of @DRUG$.	DDI-false
@DRUG$ ( @DRUG$ or	DDI-false
@DRUG$ : concomitant of Bepridil long- and short-acting @DRUG$ safely in angina	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
Example inhibitors azole ciprofloxacin clarithromycin diclofenac doxycycline , imatinib , , , , @DRUG$ , protease @DRUG$.	DDI-false
@DRUG$: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
In rats, simultaneous ingestion of disulfiram and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Micro-dosed @DRUG$ Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during Accutane therapy.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-effect
Use with @DRUG$: The use of @DRUG$ to control hypertension in patients on azathioprine has been reported to induce severe leukopenia.	DDI-false
It that @DRUG$ and methaqualone safely in test during @DRUG$	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
concomitant therapy Although were , finasteride doses of more concomitantly used in clinical studies with , , , @DRUG$ , benzodiazepines beta cardiac @DRUG$ , prostaglandin inhibitors ( also , anti-infectives without evidence adverse interactions	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Multivalent : administration quinolone with cation-containing products @DRUG$ or antacids @DRUG$ VIDEX chewable/buffered tablets or powder products containing , may substantially decrease absorption of ciprofloxacin , resulting in serum and urine levels than .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of @DRUG$ and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
all the , @DRUG$ escitalopram , , @DRUG$ and paroxetine may in the extent of inhibition	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-effect
The effect @DRUG$ on the warfarin of patient to after the initiation rifampin extended length of time @DRUG$	DDI-false
to the noted above , chronic   weeks Cordarone administration metabolism , @DRUG$ @DRUG$.	DDI-false
The concomitant use of @DRUG$ is not recommended since @DRUG$ may antagonize the antibacterial effect of Norfloxacin in the urinary tract.	DDI-false
rifampin concomitantly with @DRUG$ decreases concentrations and	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
Other Interactions Oral Contraceptives @DRUG$   ( 500 influence the pharmacokinetics of an oral containing estradiol mg @DRUG$ or of hormone and impairment	DDI-false
@DRUG$: @DRUG$ (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by aspirin (two 81 mg tablets).	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, digoxin, @DRUG$, and ranitidine.	DDI-false
ACE and II Receptor Antagonists Infarction)- In EPHESUS 3020 ( % ) @DRUG$ mg also @DRUG$ or angiotensin II receptor antagonists ( ACEI/ARB ) .	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , , quinidine/lidocaine , , and	DDI-false
Other therapy interaction studies not @DRUG$ of 1 or more concomitantly used in with acetaminophen , acetylsalicylic acid a-blockers , analgesics ( inhibitors , anticonvulsants blockers calcium-channel , cardiac , diuretics , H2 antagonists , HMG-CoA , prostaglandin synthetase inhibitors to @DRUG$ without evidence clinically .	DDI-false
@DRUG$-Concomitant colestipol vitamin reduce absorption @DRUG$.	DDI-false
While the @DRUG$ ( SSRIs , @DRUG$ escitalopram , and paroxetine , P450 2D6 , they vary in inhibition .	DDI-false
Potential   AEDs ( , , @DRUG$ , , valproate ) were also the serum @DRUG$ during clinical	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
As with antipsychotic agents it be @DRUG$ of potentiating such anesthetics , opiates and @DRUG$.	DDI-effect
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
therefore to be well acquainted with the pattern magnesium deficit and discriminate between @DRUG$ deficiency due to intake which requires oral physiological @DRUG$ related a dysregulation of the mechanisms magnesium status requires more of causal	DDI-false
Digoxin When doses atorvastatin and @DRUG$ were coadministered steady-state plasma @DRUG$ increased by 20	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Affecting Cytochrome 3A4 Isoenzyme @DRUG$ is mainly the human P450 3A4 system CYP3A4 ) , therefore potential may when @DRUG$ is given concurrently with that CYP3A4	DDI-false
For example, @DRUG$ (e.g., @DRUG$) may activate the renin-angiotensin-aldosterone system.	DDI-false
@DRUG$: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-false
@DRUG$ , administration of non-steroidal can reduce the , antihypertensive effects of @DRUG$.	DDI-false
Notably , systemic exposure ( 12 ) ( @DRUG$ ) than the @DRUG$/SMX .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Vitamin : Because relationship of @DRUG$ advised supplements containing @DRUG$	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
@DRUG$: Amphetamines may delay intestinal absorption of @DRUG$;	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
: volunteers of @DRUG$ in significantly @DRUG$.	DDI-false
Antihypertensives : Amiodarone should be used patients receiving   -receptor blocking agents ( , @DRUG$ or calcium antagonists e.g. , verapamil a substrate , a @DRUG$ ) of potentiation of and block	DDI-false
Vitamin A: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Antihypertensives with -@DRUG$ blocking ( , , inhibitor ) channel antagonists ( @DRUG$ , , potentiation , , and AV block ;	DDI-false
@DRUG$ , apparently through on certain enzyme has been reduce hepatic of anticoagulants propranolol chlordiazepoxide , @DRUG$ , theophylline metronidazole , thereby delaying and blood of drugs	DDI-mechanism
@DRUG$: In normal volunteers, concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
@DRUG$ the seizure in patients @DRUG$	DDI-effect
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
studies been , coadministration with drugs that are mainly metabolized by ( eg , channel , dapsone disopyramide quinine , quinidine , warfarin , , derivatives , , , fentanyl , @DRUG$ , @DRUG$ ) may elevated plasma saquinavir	DDI-false
Antiarrhythmics : @DRUG$ flecainide , @DRUG$ , quinidine due to potential for and/or life-threatening reactions .	DDI-false
- Anabolic steroids ( nandrolone e.g. , @DRUG$ ] oxandrolone [ e.g. , @DRUG$ e.g. , ] , [ ) or	DDI-false
@DRUG$ effects are by	DDI-effect
, agonists @DRUG$ and @DRUG$ on the above behavioral changes induced by PCP were found	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Glyburide : The of @DRUG$ with @DRUG$ glyburide has on rare in .	DDI-effect
Anabolic steroids @DRUG$ oxandrolone Anavar ] @DRUG$ Anadrol ] stanozolol [ e.g. , Winstrol ] or	DDI-false
Compounds tested in man include warfarin, theophylline, @DRUG$, diazepam, @DRUG$ and antipyrine.	DDI-false
therapeutic theophylline narrow @DRUG$ serum levels monitored closely and dosage @DRUG$ made .	DDI-false
The effects of DCG-IV and @DRUG$ upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Drugs that @DRUG$ plasma concentrations Drugs may imatinib plasma concentrations : is recommended administering inhibitors the CYP3A4 family , ketoconazole , @DRUG$ ) .	DDI-false
and ( ) of @DRUG$ more inhibited cholesterol membrane sterol human , effects of @DRUG$ more efficiently by , the major sterol in yeast	DDI-false
@DRUG$ Keppra ( daily not alter pharmacokinetics @DRUG$ healthy volunteers	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Drug-Drug Between   And @DRUG$ @DRUG$ ) Phenytoin   ( ) effect on pharmacokinetic refractory .	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
of sulfonylureas may certain nonsteroidal anti-inflammatory and that are highly , @DRUG$ , probenecid , @DRUG$ and beta blocking	DDI-false
In the @DRUG$ study, @DRUG$ had no effect on the prothrombin time or other pharmacodynamic parameters.	DDI-false
with compounds that ( eg , @DRUG$ phenytoin , , ) may in levels	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Anticoagulants including coumarin derivatives indandione derivatives , and such @DRUG$ ( NSAIDs ) @DRUG$ may the risk of bleeding concomitantly ardeparin	DDI-false
It has been reported that @DRUG$ enhances the anticoagulant effect of @DRUG$-like drugs.	DDI-effect
Because of the potential for adverse reactions from the drugs in nursing infants, a decision must be made whether to discontinue nursing or discontinue @DRUG$ and @DRUG$ treatment.	DDI-false
In the case that you are taking @DRUG$ while taking @DRUG$, higher doses of digoxin may be needed.	DDI-advise
Cyclosporine Methotrexate @DRUG$ , like other , renal , cause in elimination these drugs elevated serum of cyclosporine digoxin , @DRUG$ and	DDI-mechanism
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
@DRUG$ : @DRUG$ may antagonize the hypotensive of	DDI-false
has reported following of cephalosporins with @DRUG$ or @DRUG$ as furosemide	DDI-false
@DRUG$: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when captopril and @DRUG$ were administered concomitantly for 6 days.	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with captopril (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Antacids clinical coadministration an antacid ( , hydroxide @DRUG$ ) fosinopril serum levels and urinary of fosinoprilat compared fosinopril administered , that antacids of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$ tubocurarine ): increased responsiveness to @DRUG$.	DDI-false
Drug Flupenthixol with drugs , oxidase MAOI MAOI theoretically @DRUG$ pharmacodynamics - Arecoline Eproxindine Ethanol : @DRUG$ depression Tricyclic Flupenthixol increases of Tricyclic antidepressants	DDI-false
This appears to be the only relevant interaction this kind with Mefloquine , , of drugs to alter conduction , or @DRUG$ , calcium channel antihistamines @DRUG$ , antidepressants and phenothiazines a prolongation of the QTc interval .	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
drugs thiazides and , corticosteroids @DRUG$ @DRUG$ , phenytoin , nicotinic calcium blocking isoniazid .	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and @DRUG$.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, @DRUG$).	DDI-false
  ( twice ) did influence the	DDI-false
@DRUG$: In healthy subjects receiving @DRUG$, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-false
Drug/Laboratory Test Interaction @DRUG$ may cause a false low measurement of serum digoxin levels with the Digi- Tab  RIA Kit for @DRUG$.	DDI-false
@DRUG$ administration @DRUG$ the plasma levels active metabolite by .	DDI-false
Hypotension    Patients on @DRUG$ : on @DRUG$ and especially those whom therapy recently as severe dietary restriction dialysis may occasionally a precipitous of blood pressure within hour after initial of captopril .	DDI-false
Non-selective MAO including phenelzine @DRUG$ : L-tyrosine and non-selective @DRUG$ may cause	DDI-false
@DRUG$ and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-false
@DRUG$: Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and @DRUG$ were coadministered.	DDI-false
Exacerbation or the initial presentation of a number of autoimmune and inflammatory disorders has been observed following concurrent use of @DRUG$ and @DRUG$, including crescentic IgA glomerulonephritis, oculo-bulbar myasthenia gravis, inflammatory arthritis, thyroiditis, bullous pemphigoid, and Stevens-Johnson syndrome.	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some @DRUG$.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
interactions were found between and @DRUG$ @DRUG$.	DDI-false
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (@DRUG$) was more than doubled in the presence of TMP/@DRUG$.	DDI-false
To the impact plus HAART the course of patients with HIV-related , lymphoma ) , the a of 24 with the , @DRUG$ and ( CHOP ) chemotherapy regimen plus HAART a 80 treated CHOP or CHOP-like ( i.e. , @DRUG$ , teniposide , with plus bleomycin antiretroviral therapy .	DDI-false
Warfarin @DRUG$   ( 1000 twice ) did influence the	DDI-false
Vasodilator Activity : on effect of concomitant @DRUG$ patients @DRUG$ for available ;	DDI-false
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as ranitidine or @DRUG$) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
@DRUG$ , or iron or @DRUG$ antacids sucralfate should not administered concomitantly or 2 of , administration of norfloxacin , interfere absorption resulting lower serum	DDI-false
In Fondaparinux neither @DRUG$ @DRUG$ , digoxin , nor pharmacokinetics digoxin at	DDI-false
@DRUG$ In subjects ketoconazole , a CYP3A4 , 200 mg twice daily for ( AUC @DRUG$ was increased approximately 3.6-fold increased 1.7-fold of control .	DDI-false
clinical studies @DRUG$ , the concomitant of oral anticoagulants ( warfarin ) , @DRUG$ NSAIDs ( piroxicam digoxin significantly affect of fondaparinux sodium	DDI-false
BACKGROUND : effects of combined administration of bombesin and ( @DRUG$ ) , @DRUG$ on the incidence of metastasis of induced azoxymethane AOM ) and index cancers were rats .	DDI-false
Although specific performed , coadministration with that are blockers , , , tacrolimus @DRUG$ , ergot derivatives , pimozide , carbamazepine , @DRUG$ , , alprazolam , and ) elevated when	DDI-false
Other @DRUG$ drugs , @DRUG$ , , and have concurrently	DDI-false
@DRUG$: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
specific have not been performed , drugs metabolized ( eg , @DRUG$ , dapsone disopyramide quinine amiodarone , quinidine , tacrolimus , cyclosporine derivatives , , carbamazepine fentanyl , alfentanyl , , triazolam elevated concentrations when coadministered @DRUG$	DDI-mechanism
@DRUG$, such as verapamil, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
may interact alcohol , blood thinners @DRUG$ , and sinus ) , , lithium , @DRUG$ Aleve Ibuprofen , high medications	DDI-false
Coadministration of @DRUG$ and @DRUG$ has led to increased plasma concentrations the latter	DDI-mechanism
Phenylbutazone: @DRUG$ causes increase (by about 80%) in the free fraction of @DRUG$.	DDI-mechanism
When Itraconazole was coadministered with phenytoin, @DRUG$, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$-Concomitant intake of colestipol and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Accordingly, when @DRUG$ is administered with oral @DRUG$, the prothrombin time should be closely monitored during and for several days after concomitant drug administration.	DDI-advise
Antipyrine Because @DRUG$ not affect pharmacokinetics with other @DRUG$ the isozymes are not .	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
drug-drug interaction study evaluated the of the use @DRUG$ Gel % , combination double strength ( 160 mg/800 mg ) )	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Multivitamins , or other products containing iron or @DRUG$ , @DRUG$ or sucralfate should not be administered concomitantly with , or within 2 hours of , the in serum levels of	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Example ciprofloxacin , , diclofenac , @DRUG$ , imatinib , isoniazid , nefazodone , nicardipine @DRUG$ , quinidine and verapamil	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and erythromycin with transdermal @DRUG$ may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
inhibitors ( e.g. itraconazole @DRUG$ , @DRUG$ ) be behave similarly	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Coadministration of single doses of @DRUG$ 3 mg and lorazepam 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
Lack of an effect of @DRUG$ on the disposition of @DRUG$ and dideoxyinosine in HIV-infected patients.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Potential assessed clinical studies phenytoin , valproate oral @DRUG$ @DRUG$ probenecid ) screening the placebo-controlled studies in .	DDI-false
@DRUG$ and : should administered patients being monoamine or action of @DRUG$ on may be by .	DDI-false
@DRUG$ therapy Urinary excretion of amphetamines is increased, and efficacy is reduced by acidifying agents used in @DRUG$ therapy.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, phenothiazines, @DRUG$, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
possible , a @DRUG$ , has been in potentiation of the	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (FORTOVASE) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( @DRUG$ , , , @DRUG$ , latamoxef ) or methylthiadiazole ( cefazolin can vitamin K and .	DDI-false
Interactions @DRUG$ @DRUG$ are occasionally induce positive .	DDI-false
interaction studies have with both @DRUG$ and	DDI-false
For these reasons that , subjects who an unsatisfactory drug possible benefits of with @DRUG$ and a @DRUG$ outweigh the risks of severe myopathy , , and .	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
These drugs include thiazides and other diuretics @DRUG$ , phe-nothiazines , products , oral nicotinic acid sympathomimet-ics calcium channel blocking drugs @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
, , acid , , valproic	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
and @DRUG$ dopamine release nucleus	DDI-effect
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following: @DRUG$ and paroxetine.	DDI-int
Other concomitant Although performed @DRUG$ doses of 1 or used in clinical acetaminophen , @DRUG$ analgesics enzyme ( ACE inhibitors anticonvulsants benzodiazepines , beta blockers calcium-channel blockers , H2 antagonists HMG-CoA reductase inhibitors , prostaglandin ( also NSAIDs ) quinolone anti-infectives evidence clinically adverse	DDI-false
No pharmacokinetic were following drugs : @DRUG$ , @DRUG$ , digoxin , Maalox , ranitidine .	DDI-false
Nervous Depressants The concomitant of DURAGESIC   ( ) other central nervous depressants not hypnotics tranquilizers e.g. , ) , @DRUG$ @DRUG$ cause respiratory depression , profound sedation or in or death	DDI-false
Other as quinidine , disopyramide @DRUG$ , @DRUG$ antihistamines , antidepressants may be with QT-interval prolongation an increased of ventricular arrhythmia .	DDI-false
Naproxen: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
Iodine or @DRUG$ may the of the effect @DRUG$.	DDI-false
Consequently, drugs with a low therapeutic margin, such as @DRUG$, phenytoin, and @DRUG$, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
, adversely response duration that @DRUG$ not be with HEXALEN and/or	DDI-advise
@DRUG$ : NSAIDs have @DRUG$ renal .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
Although studies have been performed with are metabolized by blockers disopyramide , , quinidine @DRUG$ tacrolimus , cyclosporine ergot derivatives carbamazepine , , , ) may plasma when @DRUG$ ;	DDI-mechanism
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with @DRUG$ and @DRUG$.	DDI-false
Reciprocal @DRUG$ drugs that cytochrome P450 system ( e.g. , cimetidine @DRUG$ ) this has been	DDI-mechanism
Potassium @DRUG$ : @DRUG$ loss thiazide diuretics .	DDI-false
@DRUG$ : The concomitant use of DURAGESIC ( fentanyl transdermal system with system , including not opioids , hypnotics , @DRUG$ e.g. , , , and , may cause respiratory depression , hypotension , profound or potentially result in death .	DDI-false
@DRUG$ increases of @DRUG$ may serum .	DDI-false
Non-steroidal : In patients , a @DRUG$ can diuretic natriuretic , and antihypertensive effects @DRUG$.	DDI-effect
Therefore, it would be expected that a dosing schedule of @DRUG$ given at bedtime and @DRUG$ given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium.	DDI-false
@DRUG$ rate of of @DRUG$ was bioequivalent when was given or Proquin XR given hours the maximally suppresses acid secretion .	DDI-false
Antihypertensives should be used with in patients -receptor blocking e.g. , , a CYP3A4 inhibitor ) channel ( , a CYP3A4 , and @DRUG$ , a @DRUG$ inhibitor ) possible potentiation of , arrest	DDI-false
ANTACID ( @DRUG$ ): Cerivastatin affected by	DDI-false
Aspirin: Concomitant administration of low-dose @DRUG$ with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$ toxicity may aggravated by initial of by @DRUG$ Injection .	DDI-effect
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, @DRUG$, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
In normal concomitant of @DRUG$ acetaminophen an % plasma @DRUG$.	DDI-false
Central System : concomitant use of ( transdermal other central nervous including not limited to other sedatives tranquilizers ( benzodiazepines , general @DRUG$ , @DRUG$ and may respiratory hypotension and profound sedation potentially result in death	DDI-false
@DRUG$: Dihydroergotamine, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
In clinical trials, the concomitant administration of @DRUG$ and @DRUG$ did not alter the adverse reaction profile.	DDI-false
@DRUG$ and Antidepressants FORADIL extreme patients being treated with @DRUG$ or because action formoterol on the cardiovascular may be by these agents	DDI-false
Co-administration of @DRUG$ and cerivastatin did not alter the pharmacokinetics of @DRUG$.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, dexamethasone, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
specific have , with drugs by eg , blockers dapsone , amiodarone , @DRUG$ , cyclosporine derivatives , pimozide carbamazepine , fentanyl @DRUG$ , alprazolam may concentrations coadministered	DDI-false
@DRUG$ : studies , had no effect one study ) or was with modest increases ( two studies ) in @DRUG$ .	DDI-false
@DRUG$: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-false
Multivitamins other containing iron or zinc , antacids @DRUG$ be or 2 administration of norfloxacin because absorption resulting and urine levels of @DRUG$.	DDI-false
Plasma valproate concentration monitored @DRUG$ are co appropriate adjustments @DRUG$ be made	DDI-false
drugs and diuretics , @DRUG$ , products , , , nicotinic acid sympathomimet-ics @DRUG$ , .	DDI-false
@DRUG$: Quinolones have been reported to enhance the effects of the oral @DRUG$ warfarin or its derivatives.	DDI-false
Notably , systemic exposure AUC0 - 12 of @DRUG$ was more than doubled the presence of	DDI-false
@DRUG$ (neostgmine, @DRUG$), lignocaine, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Analysis of the concentration of @DRUG$ following ultracentrifugation indicated that there is rapid equilibration of @DRUG$ between the Survanta and aqueous phase.	DDI-false
Example inhibitors include @DRUG$, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-mechanism
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
To impact of plus on patients with HIV-related systemic lymphoma ( ) the compared retrospectively of 24 patients were treated @DRUG$ , doxorubicin vincristine prednisone ) chemotherapy regimen with were with or regimen ( , , @DRUG$ , teniposide , prednisone with vincristine bleomycin ) receiving	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-mechanism
Central System The concomitant use of ( fentanyl system with nervous system depressants , including but to opioids sedatives @DRUG$ tranquilizers , benzodiazepines , anesthetics @DRUG$ skeletal relaxants , may hypotension , profound , coma death .	DDI-false
Causing : antihypertensive of enalapril @DRUG$ IV @DRUG$ cause e.g. diuretics	DDI-effect
contrast @DRUG$ 1 ) and @DRUG$ mM had added	DDI-false
OTHER CONCOMITANT THERAPY : not performed , in clinical studies , used concomitantly ( ACE ) inhibitors betablockers @DRUG$ , and @DRUG$ NSAIDs ) significant adverse interactions	DDI-false
Multivitamins products containing or @DRUG$ antacids sucralfate not be administered within 2 , the administration norfloxacin because they may interfere with absorption and of	DDI-false
evaluate the impact chemotherapy plus HAART clinical course with HIV-related , systemic non-Hodgkin lymphoma HIV-NHL ) , the compared retrospectively of patients with HIV-NHL who were treated with @DRUG$ , , prednisone ( CHOP chemotherapy regimen plus with a group of patients who treated CHOP or CHOP-like regimen , cyclophosphamide , prednisone vincristine plus @DRUG$ ) without .	DDI-false
Compounds that have been tested in man include antipyrine, @DRUG$, propranolol, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline lidocaine/quinidine , acid @DRUG$/lidocaine , valproic acid/@DRUG$.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
@DRUG$ does not affect serum @DRUG$ levels.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-mechanism
@DRUG$-@DRUG$ can antagonize the effect of warfarin	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Tetracyclines @DRUG$ @DRUG$ has associated number of pseudotumor ( intracranial ) , of which involved concomitant tetracyclines	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ May renal of in levels and/or @DRUG$ .	DDI-false
Drugs may @DRUG$ concentrations that may increase plasma is with of the CYP3A4 family ( ketoconazole , @DRUG$ , clarithromycin .	DDI-false
Oxidase Tricyclic Antidepressants : FORADIL should be administered with extreme caution in being treated with @DRUG$ or @DRUG$ because the action of formoterol on cardiovascular may be potentiated by these	DDI-false
Slow-channel blockers , such @DRUG$ , diltiazem @DRUG$ , inhibit platelet in , decrease platelet intravascularly	DDI-false
should exercised @DRUG$ with drugs activities ( e.g. @DRUG$ ) .	DDI-advise
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
@DRUG$ : @DRUG$ ( body : approximately mL absolute in a kg vardenafil levels were when dosed .	DDI-false
Ritonavir 600 with @DRUG$ 5 mg in a increase in vardenafil a increase @DRUG$ Cmax	DDI-false
Therefore, @DRUG$ serum levels should be monitored and appropriate @DRUG$ dosage adjustments made when these drugs are used concomitantly.	DDI-false
, on certain microsomal enzyme , has been reported to reduce the hepatic warfarin-type anticoagulants @DRUG$ , @DRUG$ nifedipine , , , lidocaine theophylline thereby delaying elimination increasing levels of these .	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
has following concomitant of @DRUG$	DDI-effect
@DRUG$ Lodine is @DRUG$ protein binding reduced the clearance free etodolac is	DDI-false
Effect @DRUG$ in There about 22 increase apparent total body @DRUG$ when	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the @DRUG$ benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-false
Ketoconazole (200 mg once daily) produced a 10-fold increase in @DRUG$ AUC and a 4-fold increase in Cmax when co-administered with @DRUG$ (5 mg) in healthy volunteers.	DDI-false
Coadministration of @DRUG$ with @DRUG$ has led to elevated plasma concentrations of terfenadine, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-mechanism
Both @DRUG$ @DRUG$ extracellular dopamine accumbens , extracellular serotonin in the nucleus .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
concomitant specific not , doses of or were used studies with , acetylsalicylic a-blockers angiotensin-converting ACE inhibitors , benzodiazepines calcium-channel , , @DRUG$ , synthetase inhibitors ( also referred NSAIDs @DRUG$ clinically adverse interactions	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Nervous fentanyl transdermal system ) with other central nervous system not limited to other opioids @DRUG$ , e.g. ) anesthetics @DRUG$ , relaxants alcohol cause respiratory depression , in coma or death	DDI-false
nor affected the in RPMI1640 @DRUG$ they the mitogenic effect and @DRUG$.	DDI-false
Specific studies have confirmed these effects with sevoflurane, @DRUG$, propofol, @DRUG$, and midazolam.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and @DRUG$.	DDI-effect
Co-medications induce e.g. , @DRUG$ , @DRUG$ St.	DDI-false
- @DRUG$ e.g. , @DRUG$ ) or	DDI-false
However , if @DRUG$ is be after of heparin , sufficient time heparins on to prior initiation of @DRUG$ therapy	DDI-false
@DRUG$: Histamine H2-receptor antagonists appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and @DRUG$, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
of @DRUG$ produced a AUC and a 33 the Cmax @DRUG$.	DDI-false
Although studies have not been with are mainly metabolized CYP3A4 blockers , disopyramide quinine , amiodarone @DRUG$ warfarin tacrolimus , , pimozide , carbamazepine , , , @DRUG$ and elevated plasma concentrations with ;	DDI-false
@DRUG$/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
: Other antiarrhythmic , such @DRUG$ , procainamide disopyramide , and , have used	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with @DRUG$.	DDI-false
: rate and ciprofloxacin was bioequivalent when @DRUG$ was given when @DRUG$ given 2 after at dose that maximally gastric	DDI-false
interactions : @DRUG$ on the pharmacodynamics ( and insulin @DRUG$ prothrombin parameters	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of phenytoin, @DRUG$, and methotrexate.	DDI-false
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of @DRUG$, increased Gleevec oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-mechanism
Slow-channel calcium blockers, such as @DRUG$, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
The with captopril can be either the diuretic increasing the intake prior initiation of treatment @DRUG$ ( @DRUG$ , USP ) or small doses .	DDI-false
- @DRUG$ (e.g., @DRUG$) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
therefore, the use of @DRUG$ does not necessitate an adjustment in @DRUG$ dose to maintain therapeutic digoxin levels.	DDI-false
, @DRUG$ , @DRUG$ theophylline , and valproic human at .	DDI-false
However , the second study , 12 @DRUG$ 1 hour the 0.3 approximately hours after same meal a decrease cerivastatin AUC than , decrease in Cmax 30 to dosing @DRUG$ alone .	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Carbamazepine is known the carbamazepine its levels be prior administration signs and symptoms of @DRUG$ closely , and @DRUG$ should be .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ had no effect on plasma levels of @DRUG$.	DDI-false
@DRUG$ , apparently an effect certain been reported to reduce of warfarin-type anticoagulants phenytoin , @DRUG$ chlordiazepoxide , tricyclic , lidocaine theophylline and metronidazole , elimination blood levels of	DDI-mechanism
Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
@DRUG$ Dihydroergotamine @DRUG$ , potential serious life-threatening reactions such as ergot toxicity by peripheral ischemia other tissues	DDI-false
unlike @DRUG$ @DRUG$ does not affect responding a nondrug ( water ) .	DDI-false
@DRUG$ @DRUG$ , Synkayvite Use of increase chance of side	DDI-false
studies with Fondaparinux , the concomitant oral , @DRUG$ ( acetylsalicylic ) NSAIDs @DRUG$ ) did not significantly affect the of sodium .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Based the results these , is concluded @DRUG$ may coadministered with both @DRUG$ and .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Interactions Flupenthixol may interact with like Monoamine ( MAOI ): flupenthixol pharmacodynamics Arecoline Eproxindine - @DRUG$ @DRUG$ cause additive CNS depression Tricyclic effect Tricyclic	DDI-effect
Because the risk adverse reactions in have been on regular , is particularly important physicians query patients their guardians benzodiazepine alcohol @DRUG$ as part of the prior to use @DRUG$ planned	DDI-false
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
- @DRUG$ e.g. , @DRUG$ or	DDI-false
Patients on @DRUG$ treatment should be closely monitored when @DRUG$ is introduced or withdrawn.	DDI-advise
The availability of potent @DRUG$ (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
dialyzed @DRUG$ and at with @DRUG$ at three different in serum	DDI-false
High-dose @DRUG$ with @DRUG$	DDI-effect
Interactions Flupenthixol may drugs Monoamine oxidase ( MAOI MAOI could @DRUG$ pharmacodynamics Arecoline - Ethanol Ethanol cause - antidepressants : @DRUG$ the effect Tricyclic	DDI-false
can the of @DRUG$	DDI-effect
inhibitors CYP3A4 activity ( such ketoconazole , intraconazole ritonavir , @DRUG$ saquinavir @DRUG$ , etc . is indicated the budesonide dose be considered	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on diuretics and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-false
Cation-Containing Products Concurrent of a including , with multivalent as magnesium aluminum antacids , sucralfate VIDEX chewable/buffered tablets pediatric , calcium , iron , or @DRUG$ may decrease absorption of @DRUG$ , in serum urine levels lower .	DDI-false
In a in dogs anesthetized @DRUG$ , or , the dosage @DRUG$ needed to cause ventricular higher as LD50 of ouabain , with than .	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ of and @DRUG$ were coadministered , digoxin concentrations increased approximately	DDI-false
@DRUG$ significantly decreased of of , was enhanced by @DRUG$.	DDI-effect
Based on the resemblance @DRUG$ astemizole with @DRUG$ is	DDI-false
there was no significant change in prothrombin test results during the trials of @DRUG$ and @DRUG$.	DDI-false
concomitant therapy interaction were finasteride doses of 1 mg were concomitantly in clinical with acetaminophen acetylsalicylic a-blockers , enzyme ( ACE ) inhibitors , anticonvulsants , @DRUG$ beta blockers , @DRUG$ , , H2 antagonists HMG-CoA , prostaglandin inhibitors ( referred to as NSAIDs ) and anti-infectives without	DDI-false
Data from vitro @DRUG$ than suggest possible drug interaction the following : ergotamine , @DRUG$ and	DDI-int
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, cimetidine, @DRUG$), though this has not been studied	DDI-false
studies been performed , coadministration drugs mainly ( eg blockers , quinine , warfarin , tacrolimus cyclosporine @DRUG$ , , , fentanyl , alprazolam , and triazolam ) may plasma coadministered @DRUG$ ;	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Bacteriostatic @DRUG$ , @DRUG$ sulfonamides , or tetracyclines interfere with the bactericidal effect of	DDI-false
Stavudine @DRUG$ can antiviral of @DRUG$ and zidovudine HIV .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or @DRUG$ than with pentobarbital.	DDI-false
a clinical , coadministration of an ( aluminum hydroxide , hydroxide , and with @DRUG$ excretion of fosinoprilat as with @DRUG$ may impair fosinopril .	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
some , steroidal reduce the diuretic , natriuretic antihypertensive effects of @DRUG-DRUG$.	DDI-false
@DRUG$: Plasma concentrations of @DRUG$ decreased approximately 25% when colestipol and atorvastatin were coadministered.	DDI-false
@DRUG$ and @DRUG$ with administered not significant .	DDI-false
@DRUG$ : Concomitant of @DRUG$ at QD in celecoxib concentration .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and @DRUG$) decrease gefitinib metabolism and increase gefitinib plasma concentrations.	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
data @DRUG$ , compared @DRUG$ , a less effect on the biotransformation system for the metabolism astemizole	DDI-false
Moreover, the mechanisms underlying the development of dependence may be similar for @DRUG$ and @DRUG$.	DDI-false
The AUC of @DRUG$ was increased 2.2-fold by coadministration of @DRUG$, a potent inhibitor of CYP3A4, 400 mg daily for 5 days.	DDI-mechanism
Co-administration of @DRUG$ with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.	DDI-mechanism
@DRUG$ : @DRUG$ an contraceptive AUC for estradiol approximately %	DDI-false
Short-term pharmacokinetic and @DRUG$ ( etodolac in reduced protein binding @DRUG$ in the of free warfarin	DDI-false
Previous demonstrated a significant in trovafloxacin when concomitantly an @DRUG$ such @DRUG$.	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
including derivatives , indandione derivatives @DRUG$ as @DRUG$ ) , and increase risk of bleeding when administered with ardeparin	DDI-false
action of sulfonylureas be potentiated drugs anti-inflammatory drugs are highly bound , salicylates sulfonamides , @DRUG$ , monoamine oxidase , @DRUG$.	DDI-false
selective serotonin reuptake inhibitors ) , e.g. , @DRUG$ , , sertraline and @DRUG$ , P450 , they may the .	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (@DRUG$)-A drug interaction study of eplerenone with an @DRUG$ has not been conducted.	DDI-false
In a pharmacology study @DRUG$ @DRUG$ was administered to patients receiving	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
METHODS From the beginning the , rats given injections of ( mg/kg body weight ) and subcutaneous @DRUG$ ( 40 ) day from , of @DRUG$ 10 body weight end fo the week .	DDI-false
be the interaction this with Mefloquine , although of other known conduction ( anti-arrhythmic blocking calcium channel , @DRUG$ , @DRUG$ phenothiazines ) might contribute to of the QTc .	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, @DRUG$, anesthetics) should be considered.	DDI-false
However , concomitant @DRUG$ @DRUG$ 5 mg initial dose followed by - 6 mg/day for 6 10 the prothrombin time PT ) and Normalized ( INR ) .	DDI-effect
Other as , @DRUG$ , phenothiazines , @DRUG$ , tricyclic antidepressants may be QT-interval and ventricular arrhythmia	DDI-false
However , deaths than number @DRUG$ or @DRUG$	DDI-false
Interaction with @DRUG$, lidocaine and @DRUG$ has also been reported to produce adverse clinical effects.	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-false
Other Cardiovascular : and with adrenergic-blocking agents , @DRUG$ nitrates , calcium-blocking @DRUG$ , prazosin and digoxin of interactions	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
reactions have been receiving containing high dose @DRUG$ @DRUG$ , specifically dacarbazine cis-platinum tamoxifen and .	DDI-effect
Although specific studies been coadministration that are CYP3A4 eg , dapsone , , , , @DRUG$ , tacrolimus , cyclosporine ergot pimozide carbamazepine @DRUG$ , alprazolam triazolam may elevated concentrations coadministered saquinavir	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during Accutane therapy.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$: Plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ cerivastatin the	DDI-false
Example include @DRUG$ , ciprofloxacin , clarithromycin , diclofenac , erythromycin , imatinib isoniazid , @DRUG$ , , protease inhibitors , quinidine verapamil	DDI-false
In performed with Fondaparinux concomitant of oral warfarin ) , platelet inhibitors ( acetylsalicylic ( @DRUG$ , @DRUG$ did not the of sodium	DDI-false
Angiotensin Receptor Antagonists Heart Failure Infarction)- In EPHESUS , 3020 % ) patients 50 received @DRUG$ angiotensin receptor ( ACEI/@DRUG$ .	DDI-false
intensity course of @DRUG$ interference , secobarbital @DRUG$ , chloral hydrate and patients coumarin therapy	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and @DRUG$.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Anticoagulants including coumarin derivatives indandione derivatives , @DRUG$ ( and aspirin may administered concomitantly @DRUG$.	DDI-effect
with alcohol thinners , decongestant drugs ( allergy , cold , sinus medicines ) diabetic , @DRUG$ , norepinephrine like Aleve @DRUG$ .	DDI-false
Other therapy Although were , doses more were used in studies acetaminophen , acetylsalicylic a-blockers , @DRUG$ anticonvulsants benzodiazepines , blockers , calcium-channel blockers , nitrates , , H2 antagonists , inhibitors prostaglandin synthetase inhibitors also referred , and @DRUG$ without evidence adverse .	DDI-false
drug @DRUG$   other , , @DRUG$ phenytoin and ) were assessed by the concentrations of levetiracetam these during studies .	DDI-false
, , phenobarbital/acetaminophen quinidine/lidocaine , , and	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-int
: Eszopiclone mg daily 5 the nor there any in profile ( ) a oral dose	DDI-false
Although been conducted concomitant of @DRUG$ and @DRUG$ alter the of ;	DDI-mechanism
Both @DRUG$ 18-MC block @DRUG$-induced nicotine-induced the ;	DDI-effect
of antagonized @DRUG$ such @DRUG$ theophylline	DDI-false
However if Argatroban is be initiated after cessation @DRUG$ , effect on aPTT to prior to initiation @DRUG$ .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-effect
@DRUG$ (@DRUG$)-A drug interaction study of eplerenone with an NSAID has not been conducted.	DDI-false
This drug may interact with @DRUG$ or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
, phenobarbital/acetaminophen @DRUG$/valproic theophylline/acetaminophen and @DRUG$/phenobarbital	DDI-false
are potent inhibitors ( , @DRUG$ ) decrease metabolism increase @DRUG$ concentrations .	DDI-mechanism
Cholestyramine and @DRUG$ resins: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
Single doses of either cholestyramine or @DRUG$ resins bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-mechanism
administration local @DRUG$ epinephrine norepinephrine to patients monoamine or @DRUG$ may produce , prolonged .	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
to the noted above , chronic   2 ) @DRUG$ administration impairs and	DDI-false
The benzodiazepines are a family of @DRUG$ and @DRUG$.	DDI-false
@DRUG$ @DRUG$ 3 olanzapine a decrease scores .	DDI-false
have been in patients combination high dose , specifically , dacarbazine @DRUG$ tamoxifen	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
acetaminophen/theophylline , @DRUG$/@DRUG$ , theophylline/acetaminophen , and acid/phenobarbital .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, sedatives, @DRUG$).	DDI-false
Drugs That Inhibit CYP3A4 @DRUG$ CYP3A4 pathway for	DDI-false
acetaminophen/theophylline lidocaine/@DRUG$ , , , , theophylline/@DRUG$ , and valproic	DDI-false
It is concluded that chloral hydrate and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
inhibitors include @DRUG$ , , , @DRUG$ , erythromycin , imatinib , , propofol inhibitors quinidine and verapamil	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
unlike @DRUG$, @DRUG$ does not affect responding for a nondrug reinforcer (water).	DDI-false
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., @DRUG$, aminocaproic acid) and @DRUG$.	DDI-false
receiving regimens containing sequential high dose @DRUG$ , specifically , @DRUG$ .	DDI-effect
In a comparison of @DRUG$ tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
and have compared therapy the @DRUG$ weeks as initial therapy , similar nevirapine and observed	DDI-false
apparently an effect on certain enzyme has reported reduce the metabolism of warfarin-type @DRUG$ nifedipine , chlordiazepoxide diazepam certain tricyclic antidepressants @DRUG$ , thereby delaying elimination and increasing blood these	DDI-false
The effects of ruthenium red (@DRUG$) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Two groups ( ; to daily hydroalcoholic solutions @DRUG$ , methanol @DRUG$ and acetaldehyde proportions found in most common and fermented	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$-Concomitant intake of @DRUG$ K may reduce the of vitamin	DDI-false
@DRUG$-Concomitant intake of colestipol and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
THERAPY Although interaction not performed studies , @DRUG$ was used concomitantly with angiotensin- enzyme ( ACE ) betablockers @DRUG$ , , nonsteroidal drugs NSAIDs clinically significant interactions	DDI-false
Anabolic steroids ( @DRUG$ e.g. , @DRUG$ ] , oxandrolone [ e.g. Anavar , oxymetholone [ e.g. , stanozolol [ e.g. or	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
While selective reuptake inhibitors , citalopram @DRUG$ , sertraline @DRUG$ , inhibit 2D6 , they may the of	DDI-false
effects of DCG-IV @DRUG$ upon @DRUG$ (PCP)-induced changes mice .	DDI-false
Non-selective inhibitors @DRUG$ , sulfate , pargyline use of and non-selective @DRUG$ cause hypertension	DDI-false
no specific interactions topical drugs or systemic medications in clinical @DRUG$ % Ophthalmic Solution , the of an potentiating effect with CNS ( , barbiturates @DRUG$ , sedatives anesthetics ) should be considered .	DDI-advise
additional studies with niacin propranolol any effect and to patient population chronically receiving @DRUG$ resulted in difference of bioavailability of @DRUG$ relative control	DDI-false
Antibiotics : Chloramphenicol , @DRUG$ @DRUG$ , or interfere of penicillins	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
@DRUG$: @DRUG$ inhibit the hypotensive effect of veratrum alkaloids.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Agents Renin Release of and @DRUG$ IV is augmented antihypertensive agents , @DRUG$	DDI-effect
intensity uniformity time @DRUG$ @DRUG$ chloral were systematically receiving coumarin therapy	DDI-false
Antacids : clinical pharmacology study coadministration of ( hydroxide , hydroxide , ) levels excretion of with @DRUG$ alone may impair absorption of	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
These drugs and @DRUG$ , , @DRUG$ products , oral contraceptives nicotinic sympathomimetics drugs and isoniazid	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
With simultaneous dosing of @DRUG$ 20 mg and @DRUG$ 10 mg, 2 of 9 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.	DDI-effect
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
@DRUG$ taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
@DRUG$ moclobemide blood @DRUG$ at after the overload	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON @DRUG$ THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Oral @DRUG$ : drug-drug between Argatroban @DRUG$ ( mg single ) been demonstrated .	DDI-false
injection , other injectable benzodiazepines , produces of the system administered alcohol , @DRUG$ , MAO inhibitors , and scopolamine is injectable lorazepam an incidence of , hallucinations and irrational behavior has observed .	DDI-false
Other reported interactions with @DRUG$: Fentanyl (CYP3A4 substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
These be considered selecting an @DRUG$ for taking @DRUG$.	DDI-advise
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Similarly dialyzed were , @DRUG$ at in serum and with @DRUG$ at different concentrations serum .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Response to @DRUG$ be @DRUG$.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Methylxanthines and Diuretics treatment xanthine , @DRUG$ or a effect of   @DRUG$	DDI-effect
@DRUG$: @DRUG$, bepridil, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$, @DRUG$ Amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
Garlic Garlic not be used ( @DRUG$ the sole protease risk of decreased @DRUG$ plasma concentrations .	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and L-CCG-1, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
HMG-CoA Inhibitors : @DRUG$ @DRUG$ substrate combination with amiodarone has associated with of myopathy/rhabdomyolysis .	DDI-false
Multivalent Concurrent administration of a quinolone ciprofloxacin , multivalent or aluminum , or products containing calcium , @DRUG$ , or zinc may substantially the of @DRUG$ , levels considerably lower than desired	DDI-false
There not a 0.05 ) in AUC ) , Cmax ( + vs. 6.6 + /- ) and 1.1 + /- 0.6 1.6 + /- 1.1 for @DRUG$ levofloxacin/@DRUG$	DDI-false
To impact on the clinical , non-Hodgkin lymphoma ( HIV-NHL ) , the retrospectively a of 24 patients with HIV-NHL who were treated the @DRUG$ , @DRUG$ vincristine prednisone ( ) HAART a group treated with CHOP a , cyclophosphamide , , teniposide , vincristine plus without therapy .	DDI-false
Antihypertensive medications, other, especially diazoxide, or pre@DRUG$ and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
comparison of ketamine @DRUG$ , dosage of ouabain needed to cause ventricular tachycardia , as was the of , with or @DRUG$ than with .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Glyburide: The concomitant administration of @DRUG$ with the @DRUG$ glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-effect
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
The steady state plasma concentrations of @DRUG$ and @DRUG$ have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of alprazolam tablets in doses up to 4 mg/day.	DDI-false
Plasma @DRUG$ concentration should be monitored when isoniazid and @DRUG$ are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
@DRUG$ @DRUG$ enhance activity antidepressants sympathomimetic ;	DDI-false
Lithium : anorectic and stimulatory effects of @DRUG$ may inhibited by	DDI-effect
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
Additive adverse from blockade may occur administered concomitantly with antimuscarinics , @DRUG$ , haloperidol monoamine ( MAO @DRUG$ some .	DDI-false
hypoglycemic sulfonylureas may be certain nonsteroidal anti-inflammatory agents other drugs that protein salicylates chloramphenicol , , @DRUG$ , and	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Methotrexate: In an interaction study of rheumatoid arthritis patients taking methotrexate, @DRUG$ did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
Drug : @DRUG$ some like oxidase ( MAOI ): MAOI theoretically pharmacodynamics Arecoline and @DRUG$ cause - Tricyclic : Flupenthixol increases the effect of antidepressants	DDI-false
Hypotension Diuretic Therapy : Patients on especially those in @DRUG$ therapy was well dietary or , a blood within the after the of @DRUG$.	DDI-false
When @DRUG$ was coadministered with @DRUG$, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-mechanism
of this , the dosage @DRUG$ should be these @DRUG$ administered	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
endocrine liver function tests may affected by	DDI-false
There are 3 types of indications: specific (for the treatment of some forms of @DRUG$ deficit i.e. acute), pharmacological (i.e. without alterations of @DRUG$ status) and mixed--pharmacological and aetiopathogenic--(for example complications of chronic alcoholism).	DDI-false
Adrenergic blockers @DRUG$ are inhibited by @DRUG$.	DDI-effect
Sinus bradycardia has been reported with oral amiodarone in combination with lidocaine (@DRUG$ substrate) given for local @DRUG$.	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
In Fondaparinux neither influenced pharmacodynamics of warfarin @DRUG$ piroxicam @DRUG$ the of digoxin at state	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
Concurrent administration of @DRUG$ and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-false
Drugs With A Narrow Therapeutic Index @DRUG$ A single dose of eszopiclone 3 mg did not affect the pharmacokinetics of @DRUG$ measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
, following concomitant administration of psychotropic ( e.g. narcotics @DRUG$ , @DRUG$ , tranquilizers ) .	DDI-false
, physostigmine ) , @DRUG$ quinine , @DRUG$ enhance and cardio respiratory depression	DDI-false
@DRUG$ clearance lithium a of @DRUG$	DDI-effect
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
The of and @DRUG$ affect of @DRUG$ or acamprosate .	DDI-false
Other Drug Oral 500 daily the pharmacokinetics an oral @DRUG$ 0.03 mg @DRUG$ mg levonorgestrel of the luteinizing progesterone levels , indicating that contraceptive is	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
of @DRUG$ ( @DRUG$ inositol 1,4,5-trisphosphate ( responses were in with patch-clamp recording in fura-2 .	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Corticosteroids , @DRUG$ and Diuretics : Concomitant treatment derivatives a possible @DRUG$	DDI-false
Acetaminophen, @DRUG$, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
: dissolution of budesonide in @DRUG$ model	DDI-false
patients receiving @DRUG$ and steroid , in steroid should be in sudden @DRUG$ withdrawal	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In a comparison of @DRUG$ tolerance dogs Vet or dosage of ventricular tachycardia was significantly higher as the LD50 @DRUG$ , with ketamine Innovar with pentobarbital	DDI-false
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as @DRUG$ or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
@DRUG$ is a CYP3A4 there is potential that the use of St. amiodarone in reduced @DRUG$	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
The mean percentage increase in the @DRUG$ AUC after @DRUG$ administration was 56.9% (range: 35 to 81).	DDI-mechanism
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
, phenobarbital/acetaminophen , , quinidine/lidocaine , theophylline/acetaminophen and valproic	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Based on the chemical resemblance of @DRUG$ and @DRUG$, coadministration of astemizole with itraconazole is contraindicated.	DDI-false
Both @DRUG$ have been triple therapy with PI indinavir over weeks as initial with similar responses being with nevirapine superiority observed @DRUG$.	DDI-false
Reciprocal interactions with concomitant use Antizol and drugs that cytochrome system @DRUG$ , @DRUG$ , has studied	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Although specific not performed that are metabolized CYP3A4 calcium channel , , quinine @DRUG$ , @DRUG$ warfarin , ergot derivatives pimozide carbamazepine fentanyl , ) may have concentrations when with saquinavir	DDI-false
Particular caution when Gleevec with substrates a narrow therapeutic window ( e.g. @DRUG$ @DRUG$	DDI-false
Compounds include , phenytoin , @DRUG$ , and	DDI-false
and other diuretics @DRUG$ phenothiazines , thyroid products , oral @DRUG$ , phenytoin , nicotinic acid , blocking drugs isoniazid .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Inhibitors and @DRUG$ : @DRUG$ be administered caution being treated with monoamine oxidase inhibitors the system may potentiated these agents	DDI-false
Colestipol: Plasma concentrations of @DRUG$ decreased approximately 25% when colestipol and @DRUG$ were coadministered.	DDI-false
reactions have been reported in patients combination regimens containing high PROLEUKIN , , dacarbazine cis-platinum @DRUG$ and @DRUG$.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, rifampin, @DRUG$ or St.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and @DRUG$.	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
@DRUG$/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
Analysis of the concentration of @DRUG$ following ultracentrifugation indicated that there is rapid equilibration of budesonide between the @DRUG$ and aqueous phase.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and @DRUG$ in rats;	DDI-false
Anticholinesterases (neostgmine, physostigmine), lignocaine, @DRUG$, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Other strong inhibitors , itraconazole , @DRUG$ , @DRUG$ ) would expected behave similarly .	DDI-false
The hypoglycemic action of @DRUG$ be by certain agents and other drugs are highly protein bound salicylates , sulfonamides , , probenecid , coumarins @DRUG$ , beta adrenergic blocking agents	DDI-effect
@DRUG$: A report of severe acetaminophen toxicity was reported in a patient receiving @DRUG$.	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$ : @DRUG$ 75 mg once daily for 11 days does not plasma profile elimination digoxin after 0.5 mg .	DDI-false
been reported with oral @DRUG$ in ( @DRUG$ substrate given anesthesia .	DDI-false
Other therapy finasteride 1 mg or more were concomitantly in with @DRUG$ acetylsalicylic a-blockers , , ACE ) , , @DRUG$ calcium-channel blockers , , , H2 antagonists , reductase inhibitors prostaglandin synthetase inhibitors ( referred ) anti-infectives without significant adverse interactions	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Another oral azole antifungal , @DRUG$ inhibits the metabolism astemizole elevated plasma concentrations and active metabolite @DRUG$ which may prolong intervals	DDI-false
@DRUG$ and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG$, @DRUG$ or St.	DDI-false
@DRUG$ Potentiation ( @DRUG$ and CYP3A4 substrate anticoagulant always in patients amiodarone serious or fatal .	DDI-false
@DRUG$ toxicity may be aggravated by the initial release of norepinephrine caused by @DRUG$ Injection.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
These drugs include the other corticosteroids , @DRUG$ , , , @DRUG$ , , blocking drugs isoniazid .	DDI-false
Notably, systemic exposure (AUC0-12) of @DRUG$ (DHA) was more than doubled in the presence of TMP/@DRUG$.	DDI-false
In the first study, concomitant administration of 0.2 mg cerivastatin sodium and 12 g @DRUG$ resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing @DRUG$ alone.	DDI-false
@DRUG$: A report of severe @DRUG$ toxicity was reported in a patient receiving Isoniazid.	DDI-false
, if @DRUG$ is to be initiated after cessation @DRUG$ effect on the aPTT to decrease prior to Argatroban .	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
Anabolic steroids ( nandrolone ] , @DRUG$ , e.g. , , @DRUG$ [ e.g. , or	DDI-false
To evaluate impact plus HAART course patients with systemic ( HIV-NHL authors compared 24 patients with HIV-NHL with the , , prednisone ( regimen plus with a group 80 CHOP CHOP-like i.e. , @DRUG$ , and prednisone with plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
@DRUG$: @DRUG$ have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Drug/Laboratory @DRUG$ may false measurement of @DRUG$ levels RIA for Digoxin	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
specific studies have been drugs are metabolized by , calcium channel blockers , quinine , @DRUG$ , derivatives , , , fentanyl , alfentanyl , @DRUG$ , have elevated plasma coadministered	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
ACE Inhibitors @DRUG$ Congestive Failure Post-Myocardial 3020 ( 91 % patients to mg also inhibitors or angiotensin II receptor antagonists ) .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ : with sulfonylurea @DRUG$ has on ,	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Paroxetine Coadministration @DRUG$ 3 @DRUG$ daily 7 no interaction	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
@DRUG$ has when administered with @DRUG$.	DDI-false
Lithium should given with diuretics they reduce @DRUG$s a high risk of @DRUG$	DDI-false
Multivalent Concurrent administration quinolone ciprofloxacin with such as @DRUG$ or antacids , VIDEX chewable/buffered tablets pediatric , products containing calcium , @DRUG$ zinc decrease the , serum urine levels lower than .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
was in the effect of warfarin administered and @DRUG$ with @DRUG$ as measured prothrombin	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
Antiarrhythmics antiarrhythmic drugs , quinidine , , @DRUG$ , have concurrently with @DRUG$.	DDI-false
@DRUG$: Administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
@DRUG$ Chloramphenicol , @DRUG$ sulfonamides interfere with bactericidal effect of penicillins	DDI-false
injection like other , of central nervous when administered , @DRUG$ barbiturates MAO and other . @DRUG$ injectable lorazepam increased of sedation , irrational behavior has been observed	DDI-false
Tagamet , through an on microsomal enzyme systems , reported reduce metabolism of warfarin-type anticoagulants , propranolol , , chlordiazepoxide @DRUG$ , certain tricyclic lidocaine and @DRUG$ thereby blood of these	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ @DRUG$, as well as a metabolite of furazolidone, slow amphetamine metabolism.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
with other agents should be @DRUG$ be capable potentiating CNS depressants anesthetics @DRUG$ and alcohol	DDI-effect
Other CYP3A4 @DRUG$ , clarithromycin , @DRUG$ , troleandomycin , ritonavir , expected behave	DDI-false
with other agents , should that may potentiating such @DRUG$ opiates @DRUG$.	DDI-false
Similarly @DRUG$ decreased the rate of @DRUG$ ( 50 ) the same mechanism .	DDI-mechanism
action of be certain drugs including @DRUG$ and other drugs bound , , @DRUG$ , beta agents	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$/theophylline , , , acid quinidine/lidocaine theophylline/acetaminophen , valproic .	DDI-false
Other concomitant therapy Although interaction studies finasteride mg or more were concomitantly studies with , acetylsalicylic acid , @DRUG$ , benzodiazepines @DRUG$ , , diuretics H2 , , prostaglandin inhibitors referred as NSAIDs , quinolone anti-infectives without evidence	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
@DRUG$ As other , of lead to elevated serum concentrations @DRUG$ of its half-life	DDI-false
: antiarrhythmic drugs , such as @DRUG$ @DRUG$ , used with	DDI-false
Central Nervous Depressants concomitant fentanyl transdermal system ) other including not limited opioids @DRUG$ , hypnotics , tranquilizers ( benzodiazepines ) , anesthetics phenothiazines @DRUG$ , depression , hypotension and sedation or coma death .	DDI-false
action of be potentiated by certain anti-inflammatory and other that are highly protein , salicylates @DRUG$ , @DRUG$ monoamine oxidase inhibitors , and beta adrenergic blocking	DDI-false
@DRUG$ on the pharmacokinetics	DDI-false
therapy interaction were performed , finasteride doses mg more were studies with acetaminophen , acetylsalicylic acid , analgesics , angiotensin-converting ( ) , @DRUG$ , benzodiazepines blockers cardiac , @DRUG$ , HMG-CoA inhibitors ( also to NSAIDs ) and quinolone without significant adverse .	DDI-false
Administering @DRUG$ together @DRUG$ - 500 microM inhibited InsP(3)-induced ( both and responses ) in fashion	DDI-effect
Although specific studies not performed , coadministration with drugs mainly metabolized calcium channel blockers , , amiodarone quinidine , warfarin tacrolimus cyclosporine , derivatives , carbamazepine alfentanyl , @DRUG$ , @DRUG$ ) may have elevated concentrations when ;	DDI-false
- @DRUG$ , @DRUG$ )	DDI-false
@DRUG$ should to patients receiving @DRUG$.	DDI-advise
@DRUG$ Supplements and Potassium-Sparing Diuretics : @DRUG$ can potassium caused diuretics	DDI-false
specific drug interactions with glaucoma systemic medications were clinical studies @DRUG$ 0.5 % Ophthalmic Solution an additive or with ( @DRUG$ sedatives , ) should be considered .	DDI-advise
Probenecid Probenecid with tubular of @DRUG$ produces in @DRUG$ serum	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
The myopathy with of this class increased with administration of fibric derivatives , ( nicotinic ) , @DRUG$ , @DRUG$.	DDI-false
Digoxin multiple of @DRUG$ and digoxin were , @DRUG$ concentrations by approximately 20	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Although neither @DRUG$ nor @DRUG$ proliferation prostatic RPMI1640 containing alone they modify mitogenic EGF .	DDI-false
Steady-state serum concentrations of @DRUG$ are reported to fluctuate significantly when @DRUG$ is either added or deleted from the drug regimen.	DDI-mechanism
is be well acquainted the clinical magnesium deficit to @DRUG$ due insufficient @DRUG$ which oral and magnesium to dysregulation the control mechanisms magnesium status which requires or less regulation of its	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
addition neither pharmacodynamics of @DRUG$ , acid , @DRUG$ digoxin nor pharmacokinetics steady .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline lidocaine/quinidine , , acid , quinidine/lidocaine @DRUG$/@DRUG$ and valproic acid/phenobarbital	DDI-false
evaluate impact plus HAART on the clinical course of patients HIV-related , the compared retrospectively a 24 patients who vincristine ( CHOP plus with a of patients who treated CHOP chemotherapy or regimen ( i.e. , @DRUG$ , @DRUG$ plus without receiving	DDI-false
Two of 16 subjects dosed simultaneously with @DRUG$ 10 mg and @DRUG$ 0.4 mg experienced a standing systolic blood pressure below 85 mm Hg.	DDI-effect
Other specific were not , 1 mg more were concomitantly used in clinical studies with acetaminophen , acid , , @DRUG$ , enzyme ( ACE ) , anticonvulsants , blockers calcium-channel blockers cardiac @DRUG$ , diuretics , H2 HMG-CoA inhibitors ( also referred to quinolone anti-infectives evidence significant interactions .	DDI-false
Theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both @DRUG$ and @DRUG$.	DDI-advise
groups SH/DA ; ) submitted to daily synthetic containing ethanol , @DRUG$ and @DRUG$ in the same as those found most distilled alcoholic ;	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
interactions between @DRUG$ @DRUG$ digoxin	DDI-false
These drugs include and other diuretics corticosteroids , thyroid , @DRUG$ @DRUG$ phenytoin , acid , sympathomimet-ics , calcium channel blocking drugs and	DDI-false
Other Interactions @DRUG$ Keppra ( daily ) influence of oral 0.03 ethinyl mg @DRUG$ , or the luteinizing hormone and levels , that impairment of contraceptive is unlikely	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
therapy Although specific studies were @DRUG$ doses of 1 mg concomitantly used clinical studies with , acid , enzyme ACE ) , anticonvulsants benzodiazepines blockers @DRUG$ , cardiac nitrates antagonists , HMG-CoA prostaglandin ( to as NSAIDs and quinolone anti-infectives without clinically adverse .	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, diazepam, @DRUG$ and antipyrine.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Other concomitant therapy Although specific interaction not , of or more were used in studies @DRUG$ , acid , analgesics ( anticonvulsants , , blockers calcium-channel , nitrates diuretics , @DRUG$ reductase , prostaglandin inhibitors as NSAIDs and quinolone without of clinically significant interactions .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Products Concurrent a quinolone , @DRUG$ , products such as @DRUG$ or aluminum antacids , sucralfate chewable/buffered or , or , zinc may substantially the ciprofloxacin in serum urine levels lower than desired	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
clinical studies performed Fondaparinux , concomitant use of oral ( warfarin inhibitors ( acetylsalicylic , @DRUG$ @DRUG$ did not the sodium	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Nervous The use of DURAGESIC system with other central nervous depressants , including limited other opioids , sedatives , @DRUG$ , tranquilizers ( e.g. , ) general , phenothiazines , @DRUG$ and , cause depression hypotension , sedation coma	DDI-false
Anticoagulants coumarin derivatives derivatives , and platelet aggregation @DRUG$ @DRUG$ ) and may increase of when administered ardeparin .	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
study the effect the use of ACZONE Gel , 5 % , in combination with strength 160 mg @DRUG$/@DRUG$ ( TMP/SMX ) .	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-advise
Co-administration: Concomitant use of Argatroban with @DRUG$, @DRUG$, and other anticoagulants may increase the risk of bleeding.	DDI-false
@DRUG$ such as , @DRUG$ and nifedipine in and platelet .	DDI-false
Fluoxetine and @DRUG$ increased blood @DRUG$ at different times after the glucose overload.	DDI-false
No formal studies have assess is an bone @DRUG$ and	DDI-false
Concurrent drugs possessing ( e.g. , @DRUG$ indomethacin ( , cytotoxic chemotherapy , e.g. , doxorubicin e.g. @DRUG$ ) with PROLEUKIN increase toxicity in these .	DDI-false
These that @DRUG$ does not influence plasma concentration @DRUG$ and these AEDs not the	DDI-false
Coadministration of @DRUG$ and @DRUG$, tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
Co-administration: Concomitant use of Argatroban with antiplatelet agents, @DRUG$, and other @DRUG$ may increase the risk of bleeding.	DDI-false
drug-drug interaction evaluated the use Gel 5 in combination with double strength ( mg trimethoprim/sulfamethoxazole @DRUG$/@DRUG$	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
of @DRUG$ with , @DRUG$ acetaminophen , and acid phenobarbital at to concentrations the binding of the target drug .	DDI-false
Demonstrated CYP 3A Clinical on Involving @DRUG$ ( is coadministration with @DRUG$ Coadministration fluoxetine alprazolam maximum plasma concentration by , and performance .	DDI-false
This effect ability of @DRUG$ enzymes , , catabolism	DDI-mechanism
@DRUG$: @DRUG$ blocks dopamine receptors, thus inhibiting the central stimulant effects of amphetamines.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or @DRUG$.	DDI-false
include azole , clarithromycin , erythromycin , @DRUG$ , nefazodone , nicardipine , @DRUG$ inhibitors , ,	DDI-false
therapy specific interaction were performed , of more concomitantly in clinical with acetaminophen a-blockers @DRUG$ , enzyme ( ) anticonvulsants , , blockers , calcium-channel blockers , , diuretics , @DRUG$ , HMG-CoA reductase inhibitors prostaglandin synthetase inhibitors ( also referred to quinolone anti-infectives evidence interactions	DDI-false
comparison digitalis in dogs anesthetized ketamine , Innovar Vet @DRUG$ the of needed cause tachycardia was significantly higher as was LD50 ouabain ketamine or	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
In addition to this this report @DRUG$ ) @DRUG$ under acidic conditions those found in .	DDI-mechanism
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
inhibitors azole , ciprofloxacin , @DRUG$ diclofenac doxycycline , isoniazid @DRUG$ nicardipine , propofol , inhibitors , and .	DDI-false
@DRUG$ : In diabetic patients receiving seen @DRUG$ blood .	DDI-false
To evaluate the impact chemotherapy plus HAART on patients systemic , lymphoma ( the compared retrospectively a group of 24 with who with cyclophosphamide , , @DRUG$ chemotherapy of patients who with or a CHOP-like ( , doxorubicin and @DRUG$ ) receiving antiretroviral	DDI-false
effects @DRUG$ ) on @DRUG$ ( InsP(3))-induced bone marrow with patch-clamp recording technique with fura-2 microfluorometry .	DDI-false
Blood glucose concentrations should be carefully monitored when @DRUG$ and oral @DRUG$ are coadministered.	DDI-advise
@DRUG$ , drugs ( , cold ) , , , @DRUG$ NSAIDs like or , pressure medications .	DDI-int
Moreover , interaction studies with niacin effect @DRUG$ plasma levels , and digoxin resulted difference in extent of of @DRUG$ to data .	DDI-false
In comparison tolerance in with ketamine Vet or pentobarbital , dosage ouabain needed to significantly higher , was @DRUG$ , ketamine Innovar with @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , quinidine/@DRUG$ , theophylline/acetaminophen , valproic	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
CONCLUSIONS/INTERPRETATION: @DRUG$ and @DRUG$ can exert additive vasodilator properties on renal and ocular circulation.	DDI-false
Example inhibitors include azole antifungals , , clarithromycin , erythromycin , @DRUG$ , , , inhibitors , @DRUG$ verapamil .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ @DRUG$ , renal agent , administered at a times a day did change pharmacokinetics of levetiracetam 1000 mg twice	DDI-false
When Itraconazole was coadministered with @DRUG$, @DRUG$, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Ethosuximide: @DRUG$ may delay intestinal absorption of @DRUG$.	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Aspirin low-dose @DRUG$ with @DRUG$ may result of GI or other complications compared to VIOXX alone	DDI-effect
@DRUG$ ( 600 b.i.d @DRUG$ resulted a 49-fold increase in vardenafil a 13-fold increase	DDI-mechanism
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Although specific coadministration drugs that are mainly metabolized ( eg channel @DRUG$ , , @DRUG$ quinidine , , derivatives , fentanyl , , and ) have elevated plasma concentrations when saquinavir	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
@DRUG$: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Co-administration of @DRUG$ and @DRUG$ did not alter the pharmacokinetics of cerivastatin sodium.	DDI-false
decrease the of @DRUG$ @DRUG$ ) that into your .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, @DRUG$, dexamethasone, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
Drug : Flupenthixol may some , Monoamine inhibitors ( MAOI ): theoretically affect flupenthixol pharmacodynamics - @DRUG$ - - Flupenthixol and Ethanol cause CNS depression Flupenthixol the of @DRUG$	DDI-false
Inhibitors Angiotensin II Heart Failure Infarction)- EPHESUS , ( 91 % patients INSPRA to mg also ACE @DRUG$	DDI-false
@DRUG$ once 4 weeks in was an inhibition of P450 and a increase in @DRUG$ .	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Other therapy Although studies were not doses 1 mg or were used in clinical acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting ( ACE , beta blockers @DRUG$ nitrates , @DRUG$ , H2 antagonists HMG-CoA reductase synthetase inhibitors ( to as NSAIDs ) , and anti-infectives without of clinically adverse .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
, @DRUG$ influenced pharmacodynamics warfarin , acid , @DRUG$ , and digoxin nor pharmacokinetics digoxin at state .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ have been reported to the secretion @DRUG$ to its toxicity	DDI-mechanism
Plasma @DRUG$ concentration should when @DRUG$ and , and dosage of should made	DDI-false
It was shown that @DRUG$ antagonized evidently the antinociceptive effect of @DRUG$ and their analogue.	DDI-effect
Sinus bradycardia has been reported with oral @DRUG$ in combination with lidocaine (@DRUG$ substrate) given for local anesthesia.	DDI-false
Digoxin : In studies in healthy volunteers , @DRUG$ had effect one study ) or was with , about 30 ( @DRUG$ .	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
pharmacokinetic studies that concomitant of warfarin Lodine @DRUG$ capsules and tablets ) results reduced binding of @DRUG$ , there was no in the clearance of free warfarin	DDI-false
@DRUG$ stimulate @DRUG$-induced proliferation of prostatic .	DDI-effect
Drug Interactions Flupenthixol interact with some like oxidase MAOI could theoretically affect flupenthixol - @DRUG$ Ethanol : @DRUG$ Ethanol CNS - : Flupenthixol increases the effect of	DDI-false
@DRUG$ adenosine ) been effectively administered in the of , as , @DRUG$ , calcium channel , and angiotensin enzyme any the adverse reaction profile	DDI-false
@DRUG$ : ) with 10 a 16-fold @DRUG$ AUC , a 7-fold vardenafil and a increase in half-life .	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
@DRUG$ : produced of plasma and a @DRUG$ clearance	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, @DRUG$).	DDI-false
For these reasons, it is felt that, in most subjects who have had an unsatisfactory lipid response to either drug alone, the possible benefits of combined therapy with @DRUG$ and a @DRUG$ do not outweigh the risks of severe myopathy, rhabdomyolysis, and acute renal failure.	DDI-effect
Although performed , drugs that are mainly metabolized CYP3A4 eg @DRUG$ , disopyramide quinine , amiodarone , , , ergot derivatives , pimozide @DRUG$ , , , and triazolam may elevated plasma concentrations coadministered ;	DDI-false
specific studies not been , with drugs are mainly metabolized by CYP3A4 ( , blockers dapsone , disopyramide , warfarin @DRUG$ , @DRUG$ , , , , alfentanyl , triazolam plasma coadministered with	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
@DRUG$ (neostgmine, physostigmine), @DRUG$, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
action of may by including @DRUG$ and are highly protein salicylates sulfonamides , and	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
the selective reuptake ( citalopram @DRUG$ @DRUG$ , and inhibit P450 2D6 , they vary in the .	DDI-false
Coadministration with compounds inducers of CYP3A4 ( eg phenobarbital @DRUG$ @DRUG$ carbamazepine of saquinavir	DDI-false
@DRUG$: Concomitant administration of low-dose aspirin with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
In general are that one to bepridil anti-arrhythmic agents such as @DRUG$ procainamide , @DRUG$ and anti-depressants	DDI-false
in multiple taking @DRUG$ concomitant ( AVONEX   30 mcg IM once ) acetate were regard the need of @DRUG$ glatiramer acetate .	DDI-false
effect of @DRUG$ tended to greater @DRUG$ than in other antihypertensive therapy .	DDI-effect
INOmax has been administered with @DRUG$, dopamine, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
@DRUG$ : The concomitant administration of diflunisal and @DRUG$ normal volunteers had no effect plasma , but decreased of metabolite .	DDI-false
The extent @DRUG$-@DRUG$ interactions may problems will depend the and the pharmacokinetics of SSRI	DDI-int
The of solutions containing epinephrine or receiving @DRUG$ tricyclic antidepressants or @DRUG$ may produce prolonged .	DDI-false
This drug interact with or other ( may the CNS depressant of either these medications @DRUG$ ) or other medications anticholinergic anticholinergic effects may potentiated these antihistamines ) , monoamine ( MAO ) use with may prolong and anticholinergic CNS depressant effects of @DRUG$ )	DDI-false
Both ibogaine and @DRUG$ block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
@DRUG$ and verapamil use may be rarely associated with ventricular fibrillation when combined with @DRUG$.	DDI-effect
The hypoglycemic action of sulfonylureas be certain drugs anti-inflammatory agents and other drugs that are highly bound @DRUG$ sulfonamides chloramphenicol @DRUG$ , monoamine oxidase and adrenergic blocking agents .	DDI-false
Concomitant use with @DRUG$s may result in the reduced absorption of @DRUG$.	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Potential drug Keppra   and , gabapentin @DRUG$ , , primidone and ) were evaluating serum of levetiracetam and @DRUG$ placebo-controlled clinical studies .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Anabolic nandrolone [ , Anabolin ] , e.g. Anavar , oxymetholone [ , @DRUG$ @DRUG$ ] ) or	DDI-false
Drugs Demonstrated CYP Inhibitors Possible on the of Clinical Involving @DRUG$ caution is recommended during coadministration with ): Coadministration fluoxetine @DRUG$ increased the maximum plasma concentration of alprazolam by decreased clearance by 21 % , increased by 17 % decreased measured psychomotor performance	DDI-false
with alcohol blood thinners drugs , and sinus ) diabetic drugs @DRUG$ @DRUG$ , like Aleve or Ibuprofen , blood medications	DDI-false
Probenecid: May decrease renal tubular secretion of @DRUG$ resulting in increased blood levels and/or @DRUG$ toxicity.	DDI-false
Patients receiving both indomethacin and @DRUG$ should be observed closely to determine if the desired diuretic and/or antihypertensive effect of @DRUG$ is achieved.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Phenytoin serum levels of @DRUG$ ( increased and decreased reported	DDI-mechanism
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
patients @DRUG$ any reduction in @DRUG$ dosage should be gradual in order the possible complications of sudden steroid withdrawal	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
No pharmacokinetic interactions between @DRUG$ and isoflurane, propofol, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, @DRUG$, and alcohol.	DDI-false
Coadministration of @DRUG$ the maximum plasma @DRUG$ 6 % increased half-life by 58 %	DDI-mechanism
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
@DRUG$, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
, , , quinidine/lidocaine ,	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$ The DURAGESIC ( transdermal system with other central system , but not limited to other opioids , @DRUG$ , ( anesthetics , relaxants , and alcohol cause depression hypotension , and sedation result in coma or	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
Lithium : NSAIDs an of @DRUG$ a in @DRUG$ clearance	DDI-false
Although been performed , drugs by ( , calcium channel dapsone , , quinine , amiodarone , @DRUG$ , warfarin tacrolimus , derivatives , @DRUG$ alfentanyl alprazolam and triazolam plasma when coadministered with saquinavir	DDI-false
@DRUG$ [ e.g. , Anabolin , e.g. @DRUG$ oxymetholone e.g. Anadrol , or	DDI-false
@DRUG$ Potentiation of ( CYP2C9 and CYP3A4 @DRUG$ response almost always in patients receiving and can result in serious or .	DDI-false
with @DRUG$ angiotensin converting enzyme in @DRUG$ been reported severe	DDI-false
Bacteriostatic Antibiotics: @DRUG$, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
To chemotherapy HAART clinical of patients HIV-related , systemic lymphoma ) the authors compared retrospectively group of 24 patients with HIV-NHL were treated cyclophosphamide @DRUG$ vincristine , prednisone ( CHOP ) plus group of with or a CHOP-like ( i.e. @DRUG$ doxorubicin , prednisone vincristine bleomycin without antiretroviral	DDI-false
Example include azole , ciprofloxacin , , doxycycline , @DRUG$ , imatinib , propofol , @DRUG$ quinidine , .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
use inhibitors such as @DRUG$ and @DRUG$ with transdermal fentanyl also result an in fentanyl plasma concentrations , prolong adverse drug effects and may serious depression	DDI-false
No Important Interactions Date Levosimendan not important interactions felodipine , digoxin , @DRUG$ , isosorbide mononitrate carvedilol @DRUG$ or	DDI-false
@DRUG$ been shown reduce @DRUG$-induced including fever , renal insufficiency , agents with antitumor of and thus should be . may .	DDI-effect
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
In patients receiving Nalfon and a steroid concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Other concomitant interaction studies were performed , finasteride or concomitantly in clinical studies with acetaminophen acetylsalicylic , a-blockers , , angiotensin-converting enzyme ( ACE inhibitors , , @DRUG$ blockers cardiac diuretics H2 antagonists , @DRUG$ , synthetase inhibitors also NSAIDs and without evidence clinically .	DDI-false
Guardians of children who have been prescribed @DRUG$ should be alerted to the general concern regarding asthma therapy compliance, especially neglect of anti-inflammatory therapy and overuse of @DRUG$.	DDI-false
Micro-dosed @DRUG$ Preparations : @DRUG$ preparations minipills that do an ) may be an inadequate method therapy	DDI-false
: @DRUG$ with @DRUG$ protein binding is reduced the clearance of is	DDI-mechanism
Both the toxicity of filipin and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
Anticholinesterases (neostgmine, @DRUG$), lignocaine, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Inhibitors : is not use in who have received @DRUG$ within 14 days severe potentiation MAO @DRUG$	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
- Oral @DRUG$ (birth control pills) containing @DRUG$ or	DDI-false
dosage @DRUG$ may be and @DRUG$ therapy	DDI-advise
Co-administration: Concomitant use of @DRUG$ with antiplatelet agents, @DRUG$, and other anticoagulants may increase the risk of bleeding.	DDI-effect
No Important To Levosimendan have interactions @DRUG$ , @DRUG$ , isosorbide carvedilol , ethanol or .	DDI-false
If treatment with inhibitors of such as ketoconazole intraconazole , @DRUG$ , saquinavir etc . ) is , reduction of the @DRUG$ dose should considered	DDI-advise
Other concomitant specific performed of more were concomitantly used , @DRUG$ , analgesics angiotensin-converting ACE , anticonvulsants , beta blockers , nitrates , , @DRUG$ ( also to as NSAIDs quinolone without of clinically significant interactions .	DDI-false
@DRUG$: Amiodarone, @DRUG$, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, dexamethasone, @DRUG$) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Observations from drug interaction studies with @DRUG$ may not be predictive for @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ @DRUG$ toxicity has been reported patients concomitantly which cause elimination including ACE inhibitors	DDI-false
been therapy with the @DRUG$ @DRUG$ 48 weeks initial therapy with responses being observed with nevirapine regimens with efavirenz .	DDI-false
@DRUG$ has a tendency to antagonize the skeletal muscle relaxing effect of @DRUG$ and may potentiate the action of succinylcholine.	DDI-effect
concomitant of other such diltiazem @DRUG$ with may in increase in @DRUG$ concentrations , which prolong effects may cause serious depression .	DDI-false
Oral of @DRUG$ ( 10 , via dehydrogenase the rate elimination @DRUG$ by % given doses	DDI-mechanism
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
The hypoglycemic of be by including nonsteroidal anti-inflammatory other are highly salicylates , sulfonamides @DRUG$ monoamine inhibitors and	DDI-false
acetaminophen/theophylline , phenobarbital/acetaminophen acid and valproic acid/phenobarbital	DDI-false
specific have not drugs are metabolized by ( eg , channel blockers , disopyramide amiodarone quinidine warfarin , tacrolimus @DRUG$ ergot derivatives , , carbamazepine @DRUG$ , ) may plasma when ;	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
The addition of 540 @DRUG$ ( approximately maximum recommended daily dose adults mg/m2 to mg/kg/day of @DRUG$ ( approximately times maximum recommended daily inhalation in adults on mg/m2 basis appears have the of both resorptions and .	DDI-effect
- Methotrexate (e.g., Mexate) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Plasma concentrations of @DRUG$ are reduced when given concurrently with @DRUG$.	DDI-mechanism
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, @DRUG$, and CYP3A4.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (@DRUG$/@DRUG$).	DDI-false
MAO inhibitors @DRUG$, as well as a metabolite of @DRUG$, slow amphetamine metabolism.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
the other , thyroid products , estrogens , oral phenytoin , @DRUG$ @DRUG$ channel drugs	DDI-false
Administration of @DRUG$ concomitantly with oral has in decreases serum concentrations and	DDI-false
Furosemide has a tendency to antagonize the skeletal muscle relaxing effect of @DRUG$ and may potentiate the action of @DRUG$.	DDI-false
a comparison of digitalis dogs anesthetized with @DRUG$ Innovar Vet or @DRUG$ , needed to cause tachycardia was , was ouabain or	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Some @DRUG$/substances are known to @DRUG$ stimulating the synthesis of enzyme .	DDI-false
@DRUG$ @DRUG$ increased blood glucose different times the glucose overload	DDI-false
not been to additional obtained alone because @DRUG$ the excretion Nalfon , concomitant use of @DRUG$ is not recommended .	DDI-false
specific not been , with drugs that are metabolized by ( eg , calcium , dapsone , warfarin , tacrolimus ergot , carbamazepine @DRUG$ @DRUG$ , ) have elevated coadministered with saquinavir	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, @DRUG$, and increased toxicity.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
apomorphine - prior ingestion of @DRUG$ may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
@DRUG$ : Other drugs such as @DRUG$ and have been used with amiodarone	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Both toxicity of filipin @DRUG$ at cellular and molecular ( @DRUG$ showed differential effects on	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ the @DRUG$.	DDI-false
@DRUG$ @DRUG$  (1500 mg twice daily) did not alter the pharmacokinetics of valproate in healthy volunteers.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The extent to which SSRI-@DRUG$ interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the @DRUG$ involved.	DDI-false
Studies in rats have shown that neomycin administration attenuates certain types of @DRUG$ dependent hypertension, including @DRUG$ hypertension.	DDI-false
@DRUG$ : has been significant in serum concentrations of various @DRUG$.	DDI-false
azole , clarithromycin , diclofenac , erythromycin , imatinib , isoniazid nefazodone @DRUG$ , @DRUG$ , , quinidine , and .	DDI-false
Concurrent @DRUG$ and MAO inhibitor class cause orthostatic hypotension inhibitor , increased half-life rat model .	DDI-false
Prednisone/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-advise
of acetaminophen with theophylline , @DRUG$ , @DRUG$ with at high concentrations decreases the binding of drug .	DDI-false
, Diuretics : treatment or @DRUG$ potentiate possible hypokalemic effect @DRUG$	DDI-effect
studies have demonstrated concomitant of @DRUG$ capsules and tablets results in reduced binding warfarin but there was no in the clearance	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
This interact other potentiate CNS effects of either medications or @DRUG$ , anticholinergics other with activity may used with @DRUG$ ) monoamine oxidase ( with prolong and intensify the CNS depressant antihistamines .	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
@DRUG$ a neutralizing agent for @DRUG$ that against	DDI-effect
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
and upon @DRUG$ (@DRUG$)-induced locomotion and changes .	DDI-false
drug interactions possible some anticonvulsant @DRUG$ @DRUG$ , which hepatic enzyme	DDI-false
occur with of @DRUG$ and drugs that or inhibit the cytochrome system ( e.g. phenytoin @DRUG$ , , has been	DDI-mechanism
There is thus an enhancement effect of @DRUG$ upon the reaction of placental vessels to @DRUG$ in vitro.	DDI-effect
@DRUG$ : The concomitant administration @DRUG$ with the sulfonylurea has , occasions in hypoglycemia .	DDI-false
of the increased adverse reactions who been on regular is particularly important that query their guardians carefully , @DRUG$ and @DRUG$ as the history any procedure which the is planned	DDI-false
Coadministration @DRUG$ and @DRUG$ increased values estradiol .	DDI-mechanism
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$ ( e.g. , or amiloride , @DRUG$ supplements or substitutes to significant increases	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
alkaloids @DRUG$ the effect @DRUG$.	DDI-effect
Coadministration of @DRUG$ did not affect the pharmacokinetics of @DRUG$.	DDI-false
For , @DRUG$ are administered concomitantly with @DRUG$ , prothrombin should monitored and necessary , vitamin should be	DDI-advise
: Amiodarone should used with receiving   blocking @DRUG$ a @DRUG$ or calcium antagonists ( e.g. , and diltiazem a CYP3A4 because of the possible potentiation bradycardia , arrest , block	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
, lidocaine/quinidine , acid/phenobarbital	DDI-false
Anabolic e.g. , , @DRUG$ , ] , e.g. @DRUG$ , stanozolol e.g. Winstrol ) or	DDI-false
Fenfluramine slightly the effect antihypertensive drugs e.g. , @DRUG$ , @DRUG$.	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
rats neomycin administration certain types @DRUG$ , including @DRUG$	DDI-false
acetaminophen/theophylline , lidocaine/quinidine phenobarbital/acetaminophen , acid , , theophylline/acetaminophen and	DDI-false
Drug Interactions : some @DRUG$ ( MAOI ): MAOI theoretically flupenthixol pharmacodynamics - - and cause additive CNS depression - @DRUG$ effect of antidepressants	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Like @DRUG$ the intravenous self-administration of @DRUG$ the oral of and nicotine in ;	DDI-false
, an certain enzyme systems been reported to metabolism warfarin-type , , , , , , certain @DRUG$ , @DRUG$ , and metronidazole , delaying and increasing these drugs	DDI-false
BACKGROUND The effects combined administration ) , @DRUG$ , on the incidence of peritoneal of intestinal adenocarcinomas azoxymethane @DRUG$ ) labeling index of male Wistar	DDI-false
that coadministration oral @DRUG$ @DRUG$ can in prolongation on the ECG .	DDI-effect
Veratrum alkaloids: @DRUG$ inhibit the hypotensive effect of @DRUG$.	DDI-effect
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
that CYP3A4 ( e.g. @DRUG$ , @DRUG$ rifampin , phenobarbital or	DDI-false
interactions occur of @DRUG$ ( , @DRUG$ , ) , though	DDI-mechanism
is a potential for drugs metabolized by CYP @DRUG$ @DRUG$	DDI-false
@DRUG$ (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
@DRUG$ may increase the ototoxic potential of @DRUG$, especially in the presence of impaired renal function.	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in vardenafil Cmax.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
does not affect the pharmacokinetics @DRUG$ , other @DRUG$ metabolized via same cytochrome isozymes not expected .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Mineral Oil-Concomitant intake and @DRUG$ reduce absorption of	DDI-false
@DRUG$ ( e.g. Synkayvite Use @DRUG$ with these may the chance side affecting the blood	DDI-false
Concurrent administration of @DRUG$ may cause severe hypotension inhibitor , @DRUG$s and in a rat model	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with COPEGUS, PEGASYS treatment did not affect @DRUG$ distribution or clearance.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
have important beta-blockers , digoxin warfarin @DRUG$ , ethanol @DRUG$.	DDI-false
If treatment inhibitors of CYP3A4 ( such @DRUG$ , , ritonavir @DRUG$ saquinavir , , etc . ) reduction of be considered .	DDI-false
Hypersensitivity reactions have reported in combination containing sequential high dose antineoplastic , @DRUG$ , tamoxifen @DRUG$.	DDI-false
@DRUG$ @DRUG$ and LDL-C were not altered by of .	DDI-false
: injection , like injectable benzodiazepines produces nervous when administered alcohol @DRUG$ , other When scopolamine used concomitantly with injectable @DRUG$ an increased sedation , hallucinations has .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., @DRUG$).	DDI-false
@DRUG$: @DRUG$ enhances the effect of warfarin.	DDI-effect
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
@DRUG$ also dissolution , in manner	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Numerous drug interactions are possible with some @DRUG$, such as @DRUG$ and phenytoin, which affect hepatic microsomal enzyme systems.	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and @DRUG$, on the above behavioral changes induced by PCP were found.	DDI-false
@DRUG$-A drug interaction of @DRUG$ has .	DDI-false
@DRUG$ @DRUG$ are inhibited by amphetamines.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Antiarrhythmics : , bepridil flecainide , @DRUG$ @DRUG$ due potential serious life-threatening reactions .	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
@DRUG$ for therapy and concerns @DRUG$ (PI)-related metabolic disturbances shifts in .	DDI-false
resemblance and @DRUG$ with @DRUG$ is contraindicated .	DDI-advise
@DRUG$ Supplements and @DRUG$: Fosinopril sodium can attenuate potassium loss caused by thiazide diuretics.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
be CYP 3A Inhibitors of Significance the Basis Clinical Studies caution is recommended coadministration with @DRUG$ ): Coadministration @DRUG$ increased maximum of alprazolam by % , clearance 21 % by % , decreased measured psychomotor	DDI-false
@DRUG$ have to including fever , , , confusion , , these agents with PROLEUKIN may reduce the antitumor and avoided . @DRUG$ and antihypertensives may hypotension PROLEUKIN .	DDI-false
Drug : Flupenthixol interact with @DRUG$ ( MAOI @DRUG$ pharmacodynamics - Arecoline Eproxindine - : Ethanol depression antidepressants Flupenthixol of Tricyclic	DDI-false
Diuretics : Patients on @DRUG$ , especially those with depletion , may experience excessive reduction pressure initiation therapy @DRUG$.	DDI-effect
Although specific interaction performed , doses of mg more were concomitantly in clinical with acetaminophen , acetylsalicylic enzyme ( inhibitors benzodiazepines , calcium-channel blockers cardiac @DRUG$ H2 , HMG-CoA reductase prostaglandin inhibitors as @DRUG$ ) , and quinolone clinically significant interactions .	DDI-false
@DRUG$ may enhance the effects of alcohol, barbiturates, and other @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Example inhibitors include azole , , , doxycycline , , , , @DRUG$ protease inhibitors @DRUG$	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to @DRUG$ alone.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
on the of studies it concluded be @DRUG$ and	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
@DRUG$ including coumarin , indandione , aggregation inhibitors as nonsteroidal drugs @DRUG$ ) and the risk of when concomitantly with	DDI-false
glucocorticoids have been reduce effects including fever hyperbilirubinemia , and with PROLEUKIN may reduce the antitumor effectiveness thus should be 12 Beta-blockers antihypertensives may the with @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Imipramine mg/kg ) @DRUG$ 30 mg/kg , clonazepam ( 0.25 ) , @DRUG$ 20 ) ( 30 ) vehicle was	DDI-false
@DRUG$ has administered @DRUG$ , surfactant and high-frequency	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Tagamet , apparently on microsomal systems , been reported to metabolism warfarin-type , phenytoin , , chlordiazepoxide diazepam , @DRUG$ , @DRUG$ and elimination and increasing blood levels .	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving digoxin therapy, administration of oral @DRUG$ regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Although specific interactions with topical glaucoma drugs were identified in of % , of additive depressants @DRUG$ , barbiturates @DRUG$ , , anesthetics )	DDI-false
Example azole clarithromycin @DRUG$ , @DRUG$ , isoniazid , nefazodone inhibitors , , .	DDI-false
To impact of chemotherapy the clinical course patients systemic ( ) the authors compared retrospectively of 24 HIV-NHL were the @DRUG$ doxorubicin , vincristine and ) plus a group 80 were treated CHOP or a regimen , , teniposide , prednisone @DRUG$ bleomycin ) therapy	DDI-false
THERAPY were not performed clinical cerivastatin was used concomitantly with @DRUG$ @DRUG$ blockers diuretics , and nonsteroidal drugs ( ) without evidence of clinically	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Interactions Date not pharmacokinetic interactions captopril , @DRUG$ , felodipine warfarin isosorbide carvedilol or @DRUG$.	DDI-false
Benzthiazide interact with @DRUG$ @DRUG$s , sinus medicines , norepinephrine like Ibuprofen , and pressure	DDI-false
@DRUG$ been @DRUG$ requirements subjects ingesting agents .	DDI-mechanism
In addition, @DRUG$ neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ in receiving   or antagonists verapamil substrate , CYP3A4 inhibitor ) the possible , block	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
following eight drug/added combinations were @DRUG$/@DRUG$.	DDI-false
acetaminophen/@DRUG$ , , acid quinidine/lidocaine acid/phenobarbital .	DDI-false
drugs the thiazides @DRUG$ corticosteroids , thyroid estrogens , @DRUG$ , nicotinic , sympathomimet-ics , calcium and .	DDI-false
, uniformity and course of by , , @DRUG$ @DRUG$ systematically in patients receiving coumarin	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Haemodynamic effects of glucose and @DRUG$ were additive when @DRUG$ was co-administered but not under basal conditions.	DDI-false
pharmacokinetic were in studies ( phenytoin , @DRUG$ oral contraceptive , @DRUG$ , warfarin , ) and through screening in the placebo-controlled in .	DDI-false
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated @DRUG$ plus VIOXX 25 mg daily, as compared to those taking @DRUG$ 2400 mg daily alone.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In the case that you are taking @DRUG$ while taking aminosalicylic acid, higher doses of @DRUG$ may be needed.	DDI-false
may interact with blood @DRUG$ ( cold medicines ) , diabetic @DRUG$ Aleve Ibuprofen and high blood medications .	DDI-false
In performed with Fondaparinux the use anticoagulants ( , inhibitors ( acid , NSAIDs ( @DRUG$ ) and digoxin did not significantly affect the of @DRUG$.	DDI-false
In rats, simultaneous ingestion of @DRUG$ and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Potassium-sparing ( e.g. , , , or @DRUG$ supplements or salt may lead to	DDI-false
cyclophosphamide @DRUG$ @DRUG$ , and highly active antiretroviral therapy in with virus-related , non-Hodgkin lymphoma	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (efavirenz, @DRUG$ or @DRUG$).	DDI-false
The effects of @DRUG$ were very strong and completely depressed the @DRUG$-induced hyperlocomotion.	DDI-effect
Concomitant administration Mefloquine and other ( , , @DRUG$ and @DRUG$ abnormalities and increase risk of	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
Other concomitant therapy studies not performed , of 1 were studies acetaminophen acid , analgesics enzyme ( ACE , anticonvulsants @DRUG$ beta calcium-channel , @DRUG$ , HMG-CoA reductase inhibitors , inhibitors ( referred NSAIDs ) and of clinically adverse interactions .	DDI-false
drugs the @DRUG$ , @DRUG$ thyroid , estrogens , nicotinic blocking drugs and	DDI-false
no effects on warfarin levels prothrombin observed study involving concomitant administration of @DRUG$ @DRUG$.	DDI-false
Although @DRUG$ have been to including fever , administration of reduce of @DRUG$ thus be . 12 Beta-blockers antihypertensives may potentiate the hypotension PROLEUKIN	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
These drugs thiazides other , thyroid estrogens , oral contraceptives , @DRUG$ , nicotinic acid @DRUG$ calcium channel , isoniazid	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Drugs That Inhibit @DRUG$ Metabolism Via Cytochrome P450 3A: The initial step in @DRUG$ metabolism is hydroxylation catalyzed by cytochrome P450 3A (CYP 3A).	DDI-false
Potassium-sparing diuretics ( e.g. @DRUG$ , @DRUG$ supplements or potassium-containing salt may to increases serum	DDI-false
The pressor effects of @DRUG$ such as dopamine or norepinephrine are enhanced by @DRUG$.	DDI-effect
adverse blockade may when LEVSIN administered other , haloperidol , @DRUG$ , monoamine oxidase MAO inhibitors , @DRUG$ or some	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
There was no significant difference in the pharmacodynamic effect of @DRUG$ administered alone and warfarin administered with @DRUG$ as measured by prothrombin time.	DDI-false
Other Agents : Enalapril @DRUG$ IV been used concomitantly beta adrenergic-blocking , nitrates @DRUG$ prazosin without evidence clinically adverse interactions .	DDI-false
of @DRUG$ the @DRUG$.	DDI-mechanism
As with other , it be that HALDOL may potentiating @DRUG$ as @DRUG$ , opiates , and	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
tubular of @DRUG$ may inhibited by @DRUG$ to increased plasma of methotrexate .	DDI-mechanism
case that you are taking @DRUG$ acid higher of @DRUG$	DDI-false
Plasma valproate concentration should be monitored when isoniazid and @DRUG$ are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
The AUC @DRUG$ increased by of @DRUG$ potent inhibitor daily for 5	DDI-mechanism
In vitro studies have shown that precipitation occurs when eye drops containing @DRUG$ are mixed with @DRUG$.	DDI-false
@DRUG$ was @DRUG$ rifampin or H2antagonists , reduced were reported	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Use With @DRUG$ @DRUG$ is genotoxic and mutagenic	DDI-false
There is a significant increase in exposure to @DRUG$ when Gleevec is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/@DRUG$).	DDI-false
taken with @DRUG$ @DRUG$ serum by 33 % two	DDI-false
@DRUG$ may alcohol , allergy cold sinus , @DRUG$ norepinephrine NSAIDs like Ibuprofen high pressure medications	DDI-int
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ Isoniazid is known to the of carbamazepine increase serum levels levels determined prior concurrent isoniazid , signs and of @DRUG$ should monitored and appropriate dosage adjustment of be .	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Drugs that may concentrations that plasma Caution is recommended when @DRUG$ the , @DRUG$ clarithromycin )	DDI-advise
Multivalent : Concurrent a quinolone @DRUG$ with cation-containing products such as antacids , sucralfate tablets or containing calcium , @DRUG$ may substantially decrease ciprofloxacin resulting in considerably lower than .	DDI-mechanism
acetaminophen/theophylline , acid quinidine/lidocaine , theophylline/@DRUG$ ,	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, @DRUG$, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-effect
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Tagamet through effect on , has reported reduce the hepatic warfarin-type anticoagulants , @DRUG$ , , , certain @DRUG$ , metronidazole , thereby increasing levels these .	DDI-false
@DRUG$ : In volunteers administration of diflunisal @DRUG$ resulted in an approximate 50 increase in plasma acetaminophen .	DDI-false
Combination of amiodarone with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, @DRUG$, @DRUG$, or lamotrigine.	DDI-false
Therophylline: A recent study has shown that concomitan administration of isoniazid and @DRUG$ may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
The pharmacokinetics of @DRUG$ and 6-beta-naltrexol unaffected with	DDI-false
However, caution should be used when administering @DRUG$ with @DRUG$ since these patients are at increased risk of bleeding complications.	DDI-advise
This to be the only clinically this with Mefloquine , coadministration of other drugs alter cardiac ( eg @DRUG$ blocking , calcium channel blockers or H1-blocking agents , tricyclic @DRUG$ ) might to prolongation of	DDI-false
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
evaluate the impact the course of with , non-Hodgkin lymphoma ( retrospectively group with HIV-NHL with the doxorubicin , @DRUG$ , and ) regimen plus of who were treated with or regimen ( i.e. , doxorubicin , and prednisone with vincristine @DRUG$ ) without receiving antiretroviral	DDI-false
In of tolerance in dogs with @DRUG$ Innovar , the dosage of @DRUG$ needed to cause tachycardia was as the LD50 or with pentobarbital .	DDI-effect
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
@DRUG$: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Co-administration: Concomitant use of Argatroban with @DRUG$, thrombolytics, and other @DRUG$ may increase the risk of bleeding.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$: The anorectic and stimulatory effects of amphetamines may be inhibited by @DRUG$.	DDI-false
@DRUG$ (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Elevated serum levels of @DRUG$ have been reported with concomitant use of @DRUG$ with norfloxacin.	DDI-false
therefore well acquainted clinical paraclinical pattern of magnesium and to between magnesium deficiency due to only oral supplementation and @DRUG$ depletion of the mechanisms @DRUG$ status more less regulation its causal dysregulation	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
@DRUG$ will increase plasmaconcentration of CYP3A4 metabolized drugs ( , , @DRUG$ HMG-CoA ) .	DDI-mechanism
@DRUG$ : In a coadministration antacid ( hydroxide magnesium , serum urinary excretion of fosinoprilat as with fosinopril that @DRUG$ may impair of	DDI-false
HIV : Indinavir ( 800 co-administered @DRUG$ resulted in a increase in AUC , a 7-fold increase vardenafil Cmax 2-fold @DRUG$ .	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of diflunisal to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
, lidocaine phenobarbital , @DRUG$ , theophylline , and @DRUG$ added to pooled human serum at therapeutic .	DDI-false
: normal volunteers , concomitant administration of @DRUG$ and @DRUG$ resulted significantly increased plasma levels of	DDI-mechanism
: In conducted healthy mean steady-state @DRUG$ levels approximately subjects receiving BID mg subjects @DRUG$ .	DDI-false
@DRUG$ may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
@DRUG$ : pharmacology study an aluminum hydroxide magnesium hydroxide , ) fosinopril reduced and urinary as with @DRUG$ , antacids may of	DDI-false
In patients Nalfon a @DRUG$ , reduction @DRUG$ dosage be avoid possible complications of steroid .	DDI-false
of with @DRUG$ either discontinuing the or the of or @DRUG$.	DDI-false
, adversely suggesting that pyridoxine be with @DRUG$ and/or	DDI-false
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
azole antifungal @DRUG$ , the @DRUG$ , resulting elevated plasma of astemizole which may QT	DDI-mechanism
Clinical studies @DRUG$ and that of @DRUG$ with these drugs not result in drug	DDI-false
@DRUG$ and @DRUG$: a drug interaction.	DDI-int
@DRUG$ : of nonsteroial anti-inflammatory @DRUG$ been with in toxicity , due decreased synthesis renal	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
are drugs that have one or pharmacologic activities similar to @DRUG$ and @DRUG$ , .	DDI-false
@DRUG$ Coadministration 3 mg @DRUG$ 10 mg produced a scores	DDI-false
@DRUG$ : on the studied in group healthy subjects of 2 mg @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
lidocaine/quinidine , phenobarbital/valproic quinidine/lidocaine valproic acid/phenobarbital .	DDI-false
Both @DRUG$ have the PI @DRUG$ initial , with similar observed with nevirapine observed .	DDI-false
second study , of 12 @DRUG$ hour meal and 0.3 mg sodium 4 hours the evening in a in the @DRUG$ AUC 8 % a decrease of 30 % cerivastatin .	DDI-false
The pharmacokinetics of @DRUG$ and its major metabolite 6-beta-naltrexol were unaffected following co-administration with @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
In the presence of these @DRUG$, larger doses of @DRUG$ may be required or adenosine may not be effective.	DDI-advise
@DRUG$ Co-administration VIOXX with @DRUG$ 600 mg a potent inducer of hepatic , produced approximate in rofecoxib	DDI-false
Additive adverse resulting blockade is administered @DRUG$ amantadine , , @DRUG$ , oxidase ( MAO , or	DDI-false
These include @DRUG$ corticosteroids phe-nothiazines , @DRUG$ , , oral acid , calcium channel and isoniazid	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
drugs include the thiazides other , thyroid estrogens oral , phenytoin , nicotinic , , @DRUG$ , @DRUG$.	DDI-false
The @DRUG$ dosed subjects mg/day @DRUG$ = ) to 5 ) for 21 a course 100 mg five times/day .	DDI-false
@DRUG$: Simvastatin (CYP3A4 substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
is believed the have a previously unrecognized @DRUG$ and @DRUG$ a for this interaction been proposed	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Central System Depressants use DURAGESIC   system with other @DRUG$ to opioids , hypnotics tranquilizers , ) , @DRUG$ phenothiazines skeletal and alcohol , may respiratory depression , hypotension , , in coma or death .	DDI-false
Demonstrated to CYP on Basis of Clinical caution is during with alprazolam ): Coadministration @DRUG$ the plasma of @DRUG$ 46 , decreased by 21 , increased half-life by , psychomotor	DDI-false
may alcohol , ( allergy , and medicines ) , @DRUG$ NSAIDs like @DRUG$ or Ibuprofen , and high .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
- @DRUG$ , @DRUG$ ) or	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Based on the chemical resemblance of itraconazole and @DRUG$, coadministration of astemizole with @DRUG$ is contraindicated.	DDI-false
Example inhibitors include @DRUG$ clarithromycin , diclofenac , , erythromycin , , , @DRUG$ , quinidine , and verapamil .	DDI-false
@DRUG$ effects alcohol @DRUG$ other CNS depressants .	DDI-effect
@DRUG$-Concomitant intake @DRUG$ vitamin the absorption	DDI-false
The effects of @DRUG$ (RR) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
However , the @DRUG$-related deaths is far than of deaths in amphetamine or @DRUG$	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
- ( , ) Use @DRUG$ with @DRUG$ may increase chance side effects affecting liver and/or the effects of	DDI-effect
Other concomitant therapy Although studies not , finasteride of 1 mg or more concomitantly acetaminophen , a-blockers , , angiotensin-converting enzyme ( ACE @DRUG$ @DRUG$ , beta blockers , , diuretics H2 antagonists , HMG-CoA reductase , synthetase inhibitors also to as , anti-infectives without evidence adverse interactions .	DDI-false
In , that have pharmacologic activities similar including @DRUG$ procainamide , @DRUG$ and tricyclic anti-depressants	DDI-false
Important Interactions Date Levosimendan not clinically with captopril beta-blockers , , @DRUG$ @DRUG$ mononitrate carvedilol ethanol itraconazole	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as @DRUG$.	DDI-false
@DRUG$ , ketoconazole of elevated concentrations @DRUG$ its which may prolong QT	DDI-false
@DRUG$ ( but not @DRUG$ combination with very high of have shown provoke convulsions in studies .	DDI-false
specific have been coadministration that by CYP3A4 ( eg , calcium blockers , disopyramide , @DRUG$ , tacrolimus cyclosporine @DRUG$ carbamazepine , fentanyl alfentanyl , , ) coadministered with saquinavir ;	DDI-false
Cephalosporins-Cephalosporins side ( @DRUG$ , , @DRUG$ cefamandole latamoxef ) or ( cefazolin ) cause vitamin deficiency and .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
Potassium-sparing diuretics e.g. @DRUG$ , , potassium supplements , salt substitutes may	DDI-false
In vitro data suggest that @DRUG$, when compared to ketoconazole, has a less pronounced effect on the biotransformation system responsible for the metabolism of @DRUG$.	DDI-mechanism
Cardiovascular Agents @DRUG$ and enalapril been concomitantly with @DRUG$ , agents , digoxin of clinically adverse interactions .	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Analysis of the budesonide following that there is rapid equilibration of @DRUG$ the @DRUG$ and phase	DDI-false
Patients receiving high doses of salicylates concomitantly with @DRUG$, as in rheumatic disease, may experience @DRUG$ toxicity at lower doses because of competitive renal excretory sites.	DDI-false
In patients receiving Nalfon and a @DRUG$ concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-false
- K ( e.g. @DRUG$ , Synkayvite @DRUG$ with these may increase the chance effects the	DDI-false
drugs , like oxidase inhibitors MAOI @DRUG$ - Arecoline - - Ethanol : Ethanol cause additive CNS depression @DRUG$ : increases the Tricyclic antidepressants	DDI-false
and @DRUG$ can antagonize the antiviral of @DRUG$ and .	DDI-effect
: or pharmacodynamic drug-drug interactions been demonstrated between @DRUG$ and aspirin orally 26 2 hours prior initiation . ) or acetaminophen ( 1000 mg orally given 12 , 6 hours prior to , 6 12 to , of @DRUG$ 1.5   18 hours ) .	DDI-false
, apparently enzyme systems , been to reduce of warfarin-type nifedipine chlordiazepoxide , , certain @DRUG$ @DRUG$	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Example inhibitors @DRUG$ , ciprofloxacin , diclofenac doxycycline , imatinib isoniazid , nefazodone , nicardipine @DRUG$ , protease , quinidine , .	DDI-false
@DRUG$ serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and @DRUG$.	DDI-false
inhibitors @DRUG$ , @DRUG$ , imatinib nicardipine , propofol , protease , quinidine , .	DDI-false
@DRUG$ : normal volunteers , @DRUG$ doses of diflunisal and were	DDI-false
Here we show that a combination of @DRUG$ or 3,7-dihydroxyflavone with @DRUG$ may be used to sensitize resistant strains of Enterococcus faecalis and Enterococcus faecium to the level of vancomycin-sensitive strains.	DDI-false
Both ibogaine and 18-MC block @DRUG$-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-false
- steroids nandrolone , @DRUG$ , Anavar ] e.g. , @DRUG$ , Winstrol ] ) or	DDI-false
In in anesthetized with ketamine Vet , of significantly higher , as was the , @DRUG$ @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$, diltiazem, and @DRUG$.	DDI-false
@DRUG$ iodine excess may of Carbimazole , an @DRUG$ increase effect .	DDI-false
Other Although specific interaction not , of mg or concomitantly in clinical studies with acid a-blockers , angiotensin-converting ( , @DRUG$ , @DRUG$ calcium-channel , diuretics , antagonists , HMG-CoA inhibitors prostaglandin also NSAIDs and anti-infectives without clinically significant adverse interactions	DDI-false
The administration of other @DRUG$ with @DRUG$ has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function.	DDI-effect
Compounds that have been tested in man include @DRUG$, @DRUG$, propranolol, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
@DRUG$: Patients on @DRUG$, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium.	DDI-false
Inhibitors @DRUG$ t.i.d co-administered @DRUG$ a increase in vardenafil AUC a 7-fold vardenafil Cmax increase in half-life .	DDI-mechanism
@DRUG$, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$ tricyclic prolongation the @DRUG$.	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
additional @DRUG$ @DRUG$ not demonstrated any fluvastatin levels administration a patient population receiving resulted in no of bioavailability digoxin control data .	DDI-false
is efficacy of @DRUG$ future studies should chronic dosing of drugs in with @DRUG$.	DDI-false
Colestipol-Concomitant intake of colestipol @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
If treatment of CYP3A4 activity as ketoconazole , ritonavir , @DRUG$ , saquinavir , erythromycin , etc ) , reduction the @DRUG$ should be .	DDI-advise
a of digitalis tolerance ketamine , @DRUG$ of ouabain needed to ventricular tachycardia significantly higher as the of ouabain with ketamine or @DRUG$ .	DDI-false
Interaction on the antinociceptive effect between neurotensin and @DRUG$ or @DRUG$.	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-mechanism
Concurrent administration of @DRUG$ (for the treatment of hypotension related to obstetric blocks) and @DRUG$ may cause severe, persistent hypertension or cerebrovascular accidents.	DDI-effect
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
: pharmacology study , coadministration an ( @DRUG$ , simethicone ) with fosinopril of compared fosinopril alone suggesting antacids absorption of @DRUG$.	DDI-false
specific studies have been performed are mainly CYP3A4 eg , blockers , quinine amiodarone , quinidine , @DRUG$ , , pimozide @DRUG$ , , alfentanyl , alprazolam , triazolam may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Coadministration of phenytoin with 40 mg @DRUG$ tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
Drug Interactions Flupenthixol may some drugs , like @DRUG$ ( affect pharmacodynamics - Ethanol and @DRUG$ additive antidepressants Flupenthixol increases effect	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
and : be caution being treated with oxidase inhibitors @DRUG$ because of @DRUG$ the cardiovascular potentiated .	DDI-false
Plasma valproate concentration should be monitored when @DRUG$ and @DRUG$ are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-advise
Antihistamines: @DRUG$ may counteract the sedative effect of @DRUG$.	DDI-effect
@DRUG$ (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax.	DDI-mechanism
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Note: dissolution of aerosol particles of budesonide in @DRUG$, a model @DRUG$.	DDI-false
Because @DRUG$ been shown produce any additional effect beyond alone and because @DRUG$ increases rate of of , Nalfon and recommended .	DDI-false
@DRUG$: In an interaction study of rheumatoid arthritis patients taking methotrexate, @DRUG$ did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ doxorubicin , @DRUG$ and active antiretroviral with , non-Hodgkin .	DDI-false
Concomitant treatment @DRUG$ and tetracyclines should avoided Accutane use associated with a of cases of pseudotumor cerebri intracranial hypertension , of which involved concomitant @DRUG$	DDI-false
Other Agents : Enalapril and enalapril IV been adrenergic-blocking , nitrates agents @DRUG$ @DRUG$ and digoxin evidence of clinically	DDI-false
@DRUG$-Concomitant of oil and vitamin K may of	DDI-false
OTHER THERAPY : specific studies were not performed , in studies , @DRUG$ used with angiotensin- converting enzyme ( betablockers , blockers , , and nonsteroidal anti-inflammatory ( @DRUG$ ) without clinically significant adverse	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
- Anabolic steroids ( @DRUG$ [ Anabolin oxandrolone [ , Anavar , @DRUG$ e.g. Anadrol ] , stanozolol Winstrol ) or	DDI-false
To determine whether injection of thiosulfate would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
verapamil peritoneal of intestinal by @DRUG$ in rats	DDI-false
The hypoglycemic of be potentiated by @DRUG$ and other are highly protein bound , salicylates , , chloramphenicol , @DRUG$ , monoamine oxidase inhibitors and beta blocking agents	DDI-false
Methotrexate : In an study of rheumatoid arthritis taking @DRUG$ @DRUG$ did not a significant the methotrexate	DDI-false
Reciprocal interactions with concomitant of drugs that increase the cytochrome P450 , @DRUG$ , @DRUG$ , cimetidine , though this has studied	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of @DRUG$.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with @DRUG$, PEGASYS treatment did not affect @DRUG$ distribution or clearance.	DDI-false
: other quinolones concurrent of @DRUG$ with @DRUG$ may elevated serum concentrations theophylline and of its	DDI-mechanism
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Lithium @DRUG$ have produced lithium renal @DRUG$ .	DDI-false
may with @DRUG$ , ( allergy , drugs @DRUG$ , or high blood pressure .	DDI-false
Phenytoin @DRUG$ no apparent pharmacokinetic interaction when with	DDI-false
Potential pharmacokinetic interactions were in clinical ( phenytoin , contraceptive , @DRUG$ , @DRUG$ ) and through in the studies epilepsy	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
Although specific not , are by CYP3A4 , @DRUG$ , disopyramide , amiodarone , quinidine , tacrolimus cyclosporine @DRUG$ pimozide , fentanyl , alprazolam and triazolam have plasma concentrations coadministered ;	DDI-false
Elevated serum levels of @DRUG$ have been reported with concomitant use of cyclosporine with @DRUG$.	DDI-false
Stavudine and @DRUG$ @DRUG$ can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-effect
No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between @DRUG$ and @DRUG$.	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, @DRUG$.	DDI-false
@DRUG$: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
intensity , and time anticoagulant interference @DRUG$ glutethimide chloral and methaqualone investigated in patients @DRUG$ therapy .	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, @DRUG$, aminopyrine and antipyrine.	DDI-false
with , @DRUG$ @DRUG$ also been to produce adverse clinical effects	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the @DRUG$ benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
@DRUG$ used if @DRUG$ is administered with methotrexate .	DDI-false
@DRUG$ , lidocaine , @DRUG$ quinidine , and valproic were human concentrations	DDI-false
@DRUG$ including derivatives , indandione derivatives , and @DRUG$ drugs ( ) may when administered concomitantly	DDI-false
@DRUG$ Because relationship A , patients be advised against taking vitamin supplements containing @DRUG$ to avoid toxic effects	DDI-false
@DRUG$ reduce the renal clearance of lithium and add a high risk of @DRUG$ toxicity.	DDI-effect
Omeprazole : The and extent absorption bioequivalent @DRUG$ alone or when Proquin XR was 2 after @DRUG$ at that maximally suppresses secretion	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and @DRUG$.	DDI-false
Nevertheless clinical studies as well that @DRUG$ reduce the natriuretic effect @DRUG$ in some patients .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ be used with in taking @DRUG$ and renal should be monitored	DDI-advise
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
in benzodiazepines @DRUG$ suggest a for the , , @DRUG$ , nicardipine nifedipine .	DDI-int
Antidepressants , @DRUG$ Amphetamines may the or @DRUG$	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-effect
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, methotrexate, and increased toxicity.	DDI-mechanism
Olanzapine : @DRUG$ mg @DRUG$ mg a in scores .	DDI-effect
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (@DRUG$), erythromycin, azole antifungals.	DDI-false
of cholestyramine @DRUG$ the absorption	DDI-false
reported with amiodarone @DRUG$ substrate ) in @DRUG$ cause hypotension output	DDI-false
The possibility of hypotensive effects can be minimized by either discontinuing the @DRUG$ or increasing salt intake prior to initiation of treatment with @DRUG$.	DDI-effect
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ excretion amphetamines is , and reduced used in @DRUG$ therapy	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
Seizure, associated with increased @DRUG$ concentrations, has been reported with concomitant administration of intravenous @DRUG$.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent diuretics such as @DRUG$.	DDI-effect
@DRUG$ mg did interact with @DRUG$ ( AUC decreased by 15 %	DDI-false
Depressants The of DURAGESIC   ( fentanyl transdermal ) other @DRUG$ to other sedatives , hypnotics , @DRUG$ , general phenothiazines skeletal alcohol cause respiratory profound sedation , or potentially result death	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-mechanism
Concomitant administration of @DRUG$ doubled the AUC for @DRUG$.	DDI-mechanism
Methotrexate Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of @DRUG$.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$  may interact with drugs known to interact with the conventional formulation of @DRUG$.	DDI-false
Compounds tested in man include warfarin, theophylline, @DRUG$, @DRUG$, aminopyrine and antipyrine.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Antiarrhythmics : Other drugs , @DRUG$ @DRUG$ , disopyramide , and phenytoin been used with	DDI-false
The concomitant intake alcohol and @DRUG$ does affect the pharmacokinetics of or	DDI-false
reactions patients combination dose and @DRUG$ , specifically , , @DRUG$ interferon-alfa	DDI-false
: As with some other @DRUG$ ciprofloxacin @DRUG$ may lead to of theophylline prolongation its elimination half-life .	DDI-mechanism
If with inhibitors of ketoconazole intraconazole @DRUG$ @DRUG$ , saquinavir ) reduction of considered	DDI-false
Patients doses of @DRUG$ concomitantly with @DRUG$ rheumatic experience salicylate toxicity lower because renal excretory .	DDI-effect
Preparations Micro-dosed progesterone preparations do contain an @DRUG$ an method contraception during @DRUG$	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
@DRUG$ : Absorption @DRUG$ exchange resins	DDI-false
There have been reports of @DRUG$-related side effects in patients on concomitant therapy with @DRUG$ and theophylline.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
It is recommended not to exceed a single 2.5 mg @DRUG$ dose in a 24-hour period when used in combination with @DRUG$.	DDI-advise
has been with tolazoline , @DRUG$ , steroids , @DRUG$ , and high-frequency .	DDI-false
@DRUG$ has been administered with @DRUG$, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
Sulfapyridine may interact with any of the following: - @DRUG$ (e.g., @DRUG$) (with long-term, high-dose use) or	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Although no studies have been conducted, concomitant administration of @DRUG$ and @DRUG$ may alter the metabolism of phenytoin;	DDI-mechanism
Both ibogaine and @DRUG$ block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
@DRUG$, other, especially diazoxide, or pre@DRUG$ and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
inhibitors include azole antifungals ciprofloxacin imatinib , isoniazid , @DRUG$ , propofol , @DRUG$ , and verapamil	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane, propofol, @DRUG$, and @DRUG$.	DDI-false
Ergot Dihydroergotamine @DRUG$ ergotamine @DRUG$ CONTRAINDICATED to and life-threatening reactions acute toxicity characterized by peripheral and other	DDI-false
Like 18-MC mg/kg the intravenous of and @DRUG$ and the and @DRUG$ rats ;	DDI-false
: X : Use @DRUG$ CONTRAINDICATIONS Significant teratogenic effects in all animal species exposed to @DRUG$.	DDI-false
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
been performed coadministration drugs that are mainly CYP3A4 ( eg , , dapsone @DRUG$ amiodarone , quinidine , warfarin cyclosporine , derivatives alfentanyl , @DRUG$ and ) may have elevated concentrations when with	DDI-false
Specific studies have these effects with isoflurane , @DRUG$ , @DRUG$ .	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
However , a study in subjects @DRUG$ mg q.i.d . 800 . concomitantly a 300 b.i.d dosage of @DRUG$ , Inc. ) alteration steady-state theophylline serum 800 mg h.s regimen , 54 and .	DDI-mechanism
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, @DRUG$, clarithromycin).	DDI-false
After multiple dosing, @DRUG$ (AVONEX  30 mcg IM once weekly) reduced @DRUG$  clearance by approximately 30%.	DDI-mechanism
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Cyclosporine Administration @DRUG$ concomitantly cyclosporine has been with an increase @DRUG$-induced toxicity possibly due to decreased synthesis of renal	DDI-false
Compounds that have been tested in man include @DRUG$, digoxin, propranolol, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
Patients taking @DRUG$ @DRUG$ commonly weight gain weight , with patients either medication alone .	DDI-effect
Drugs Drugs as @DRUG$ , @DRUG$ , antihistamines , tricyclic antidepressants may be associated QT-interval and increased risk of	DDI-false
Cimetidine: @DRUG$ has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various @DRUG$.	DDI-mechanism
, ergonovine , @DRUG$ @DRUG$ due for serious and reactions toxicity peripheral vasospasm of and other tissues	DDI-false
studies have confirmed effects @DRUG$ , @DRUG$ propofol , alfentanil and midazolam	DDI-false
Intravenous @DRUG$ ) has been effectively the of cardioactive drugs , blocking agents , blocking agents and @DRUG$ , without any change in the adverse .	DDI-false
, , phenobarbital/valproic acid , and @DRUG$/phenobarbital .	DDI-false
that may alter plasma concentrations Drugs @DRUG$ concentrations : @DRUG$ with the family , erythromycin .	DDI-false
drugs include diuretics corticosteroids phenothiazines @DRUG$ , contraceptives , , sympathomimetics , @DRUG$ , and isoniazid	DDI-false
ANTACID (@DRUG$): @DRUG$ plasma concentrations were not affected by co-administration of antacid.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Careful observation is required when @DRUG$ is administered concurrently with @DRUG$.	DDI-advise
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, @DRUG$, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
: Lorazepam injection , like benzodiazepines produces the central system ethyl phenothiazines , barbiturates inhibitors other antidepressants . @DRUG$ is used with @DRUG$ , incidence sedation , hallucinations and observed .	DDI-effect
@DRUG$: Concomitant administration of low-dose @DRUG$ with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (@DRUG$), erythromycin, azole antifungals.	DDI-false
@DRUG$ : , concomitant @DRUG$ resulted in increased levels hydrochlorothiazide	DDI-false
Amiodarone should caution in receiving   agents ( e.g. , a CYP3A4 inhibitor ) calcium channel ( , @DRUG$ , a CYP3A4 , and , possible bradycardia arrest and AV	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
The effect of orally ingested @DRUG$ or @DRUG$ from breast milk on the nursing infant has not been evaluated.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
should caution patients @DRUG$ @DRUG$ Wyeth-Ayerst	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Reported examples the following @DRUG$ : @DRUG$ known inhibit CYP3A4 to varying .	DDI-false
@DRUG$   ( 1000 twice daily not the of @DRUG$.	DDI-false
administration of solutions or @DRUG$ @DRUG$ may produce severe , .	DDI-effect
The effects of ruthenium red (@DRUG$) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (TMP/SMX).	DDI-false
, there is a for with other drugs by CYP e.g. , @DRUG$ @DRUG$ zileuton	DDI-false
anticoagulant drug-drug between @DRUG$ @DRUG$ ( single dose not been demonstrated .	DDI-false
Potential interactions   and other , @DRUG$ , phenobarbital phenytoin , and were by serum concentrations of levetiracetam these @DRUG$ clinical	DDI-false
DIGOXIN: Plasma digoxin levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
Drug/Laboratory Test Interactions @DRUG$, including @DRUG$, are known to occasionally induce a positive direct Coombs test.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
However , administration @DRUG$ may ulceration complications , compared to use of @DRUG$ alone .	DDI-false
drug interactions Keppra and other @DRUG$ gabapentin @DRUG$ , phenobarbital , and ) evaluating the levetiracetam and these AEDs during clinical	DDI-false
Lithium generally should not be given with @DRUG$ because they reduce lithiums renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
Methylxanthines and @DRUG$ treatment with xanthine derivatives , , diuretics may effect   @DRUG$	DDI-false
adjustment is not . plasma carbamazepine , @DRUG$ , @DRUG$ .	DDI-false
treatment inhibitors CYP3A4 activity ( as intraconazole @DRUG$ , @DRUG$ , . ) indicated of be .	DDI-false
Other therapy Although specific interaction finasteride 1 concomitantly in clinical acetaminophen , acid , analgesics , @DRUG$ , anticonvulsants blockers cardiac nitrates , H2 HMG-CoA inhibitors @DRUG$ also to as ) and quinolone without evidence clinically significant interactions	DDI-false
Phenytoin : @DRUG$ may delay intestinal absorption of @DRUG$ ;	DDI-mechanism
These data indicate @DRUG$ not influence the plasma concentration of other @DRUG$ the levetiracetam	DDI-false
In clinical , concomitant use oral ) @DRUG$ ) , NSAIDs piroxicam , @DRUG$ did not affect pharmacokinetics/pharmacodynamics of sodium	DDI-false
include azole antifungals , clarithromycin @DRUG$ @DRUG$ , imatinib , isoniazid , nefazodone nicardipine , inhibitors , and verapamil	DDI-false
Results of multiple sclerosis taking   and concomitant interferon @DRUG$   30 IM once weekly glatiramer were inconclusive with regard for dose of the beta-interferon or	DDI-false
acetaminophen/theophylline , , phenobarbital/valproic acid , quinidine/@DRUG$ ,	DDI-false
Multivitamins, or other products containing @DRUG$ or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Other interactions: @DRUG$ had no effect on the pharmacodynamics of @DRUG$ (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters).	DDI-false
Therefore @DRUG$ serum @DRUG$ dosage made are .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In endoscopy study patients was in the cumulative incidence ulcers taking low-dose 81 mg enteric coated @DRUG$ plus 25 mg as to @DRUG$ mg daily alone .	DDI-false
@DRUG$ ( mg daily did not the and ECG ) of @DRUG$ given as a 0.25 mg dose day	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Anabolic steroids nandrolone [ e.g. , ] , [ e.g. , @DRUG$ , oxymetholone e.g. @DRUG$ ] [ e.g. , ] or	DDI-false
@DRUG$: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
evaluate impact plus HAART course of , lymphoma HIV-NHL the authors a group of with HIV-NHL who were treated with @DRUG$ , , and @DRUG$ ( ) regimen plus with a 80 patients treated with chemotherapy a regimen i.e. , cyclophosphamide teniposide and prednisone bleomycin ) without receiving therapy .	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or enalaprilat.	DDI-effect
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
include the , corticosteroids phenothiazines , oral contraceptives phenytoin , nicotinic , @DRUG$ , @DRUG$ ,	DDI-false
studies have not been performed , with drugs that are mainly by CYP3A4 ( eg calcium channel blockers @DRUG$ , disopyramide , , , quinidine , warfarin cyclosporine , carbamazepine @DRUG$ , , and may concentrations when	DDI-false
@DRUG$ : Dihydroergotamine @DRUG$ CONTRAINDICATED to life-threatening reactions toxicity vasospasm and ischemia other tissues	DDI-false
Specific studies have confirmed these effects with sevoflurane, @DRUG$, propofol, alfentanil, and @DRUG$.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
tested in warfarin theophylline @DRUG$ , @DRUG$ , antipyrine	DDI-false
drugs include the and diuretics phenothiazines , thyroid @DRUG$ , contraceptives @DRUG$ , channel , isoniazid	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
Injection : injection other benzodiazepines , produces depression of the when with ethyl @DRUG$ , barbiturates MAO inhibitors , other antidepressants . When is concomitantly @DRUG$ increased of sedation , behavior	DDI-false
interactions   AEDs ( carbamazepine gabapentin , phenytoin and valproate ) also evaluating the serum concentrations of @DRUG$ and @DRUG$ during placebo-controlled studies	DDI-false
specific interaction studies @DRUG$ of mg more concomitantly used studies with angiotensin-converting enzyme ACE ) beta blockers , diuretics , antagonists , @DRUG$ , referred as and anti-infectives without interactions .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Tagamet , an effect on certain , has been reported to metabolism of @DRUG$ , @DRUG$ propranolol , diazepam certain tricyclic , lidocaine , theophylline and elimination and levels of these .	DDI-false
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of neuroleptics after their prolonged administration.	DDI-false
Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as @DRUG$ and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
@DRUG$ (200 mg once daily) produced a 10-fold increase in @DRUG$ AUC and a 4-fold increase in Cmax when co-administered with Vardenafil (5 mg) in healthy volunteers.	DDI-mechanism
Antiarrhythmics: @DRUG$, bepridil, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
evaluate HAART on the course of patients with HIV-related non-Hodgkin lymphoma ( HIV-NHL the authors a who were treated the cyclophosphamide doxorubicin , vincristine ( CHOP HAART a group who were treated CHOP chemotherapy a ( i.e. @DRUG$ , , teniposide prednisone vincristine plus @DRUG$ antiretroviral	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Cholestyramine and colestipol @DRUG$: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
@DRUG$: Co- administration of warfarin and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Co-administration of @DRUG$ @DRUG$ produced 25 increase AUC and increase in Cmax of	DDI-mechanism
of @DRUG$ other @DRUG$ be for patients with life-threatening who are responsive to incompletely responsive to	DDI-false
of drugs ( e.g. , @DRUG$ , e.g. , @DRUG$ ) , cardiotoxic ( , doxorubicin hepatotoxic , methotrexate , with PROLEUKIN may increase toxicity in .	DDI-false
Antacids clinical pharmacology study of an antacid aluminum hydroxide @DRUG$ , and with fosinopril serum levels urinary excretion of administered alone suggesting that @DRUG$ may impair	DDI-false
interactions could occur concomitant of psychotropic drugs e.g. , @DRUG$ , antiemetics , sedatives @DRUG$	DDI-false
Cholestyramine and @DRUG$ resins: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
Vitamin K , AquaMEPHYTON @DRUG$ ) of @DRUG$ with these may increase the affecting the	DDI-false
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
may alter imatinib plasma concentrations that may imatinib Caution is recommended when administering of the CYP3A4 family e.g. , @DRUG$ , @DRUG$	DDI-false
Consequently, drugs with a low therapeutic margin, such as vitamin K antagonists, @DRUG$, and @DRUG$, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Poor metabolizers have higher than expected plasma concentrations of @DRUG$ (@DRUG$) when given usual doses.	DDI-false
Nalfon has not been to obtained with and @DRUG$ the rate @DRUG$ concomitant salicylates is	DDI-mechanism
@DRUG$ (Magnesium-Aluminum Hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of antacid.	DDI-false
Other substances: Grapefruit juice given to healthy volunteers increased @DRUG$ AUC by 50% and Cmax by 84%, resulting in increased plasma levels of @DRUG$.	DDI-false
@DRUG$ have reported to blunt effect of known whether agents in humans to interference the IOP effect	DDI-effect
Example include antifungals , , , diclofenac , @DRUG$ , propofol protease inhibitors @DRUG$ , and	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ (@DRUG$ substrate) given for local anesthesia.	DDI-false
Anti-inflammatory Drugs : some patients the anti-inflammatory reduce the , natriuretic , and antihypertensive of loop ,	DDI-false
Drug some , ( MAOI could @DRUG$ pharmacodynamics Arecoline - Eproxindine - Ethanol : and @DRUG$ cause depression antidepressants the of	DDI-false
Antidepressants , @DRUG$ activity @DRUG$ ;	DDI-effect
It has @DRUG$ the drugs	DDI-effect
Another oral @DRUG$, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
@DRUG$ @DRUG$ ( Heart Infarction)- In , 3020 ( 91 % ) patients receiving INSPRA 50 also inhibitors II .	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
@DRUG$ may augment the activity of other @DRUG$.	DDI-effect
These the other diuretics corticosteroids , thyroid products , @DRUG$ oral contraceptives @DRUG$ nicotinic acid , calcium blocking drugs , and	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Concomitant of aspirin with @DRUG$ result in increased rate of ulceration compared of @DRUG$ alone	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ have been reported the oral @DRUG$ its derivatives	DDI-false
@DRUG$ could the conduction with	DDI-effect
oral azole , inhibits @DRUG$ resulting in plasma @DRUG$ which may QT intervals .	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
, bepridil @DRUG$ propafenone , @DRUG$ CONTRAINDICATED to for serious and/or reactions	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Co-administration: Concomitant use of @DRUG$ with @DRUG$, thrombolytics, and other anticoagulants may increase the risk of bleeding.	DDI-effect
@DRUG$: Concomitant treatment with Accutane and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
In addition pharmacological interaction this a reaction between @DRUG$ ( @DRUG$ under acidic similar to those in a 3-ethoxylated product .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Vitamin A : @DRUG$ , patients against taking vitamin @DRUG$ to toxic effects	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ may enhance the effects of @DRUG$, barbiturates, and other CNS depressants.	DDI-effect
@DRUG$ has been shown to be antagonistic to @DRUG$, including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
effects red ( RR on @DRUG$ responses were in bone megakaryocytes with whole-cell technique in with microfluorometry	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
@DRUG$: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
intake @DRUG$ and vitamin may absorption @DRUG$.	DDI-false
blockers , as , @DRUG$ and @DRUG$ platelet activation in vitro , and platelet intravascularly .	DDI-false
@DRUG$ @DRUG$ not affect the	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Patients receiving high doses of @DRUG$ concomitantly with furosemide, as in rheumatic disease, may experience @DRUG$ toxicity at lower doses because of competitive renal excretory sites.	DDI-false
@DRUG$, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Injection : Lorazepam , injectable benzodiazepines produces central nervous when with ethyl , barbiturates @DRUG$ , and @DRUG$.When scopolamine is injectable increased of sedation , , observed .	DDI-false
, no deleterious were when @DRUG$ after narcotics @DRUG$ and muscle antagonists administered with anesthesia .	DDI-false
Betaseron administration patients dose of mg to mg dose-dependent @DRUG$ elimination.14 The effect of mg of @DRUG$ drug metabolism patients is unknown .	DDI-false
Drugs Narrow @DRUG$ A single pharmacokinetics of @DRUG$ measured at steady state of 0.5 day mg daily for next days .	DDI-false
These thiazides and diuretics corticosteroids , products @DRUG$ oral contraceptives phenytoin , sympathomimet-ics calcium channel blocking drugs @DRUG$.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (@DRUG$/SMX).	DDI-false
@DRUG$ Supplements @DRUG$ : Fosinopril loss caused by thiazide diuretics	DDI-false
studies multiple sclerosis patients taking TYSABRI and interferon beta-1a ( @DRUG$   IM once weekly ) or with the need dose adjustment of the @DRUG$ or glatiramer acetate	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
acetaminophen/@DRUG$ , lidocaine/quinidine , , theophylline/acetaminophen .	DDI-false
Phenothiazines and @DRUG$ may reduce or reverse the pressor effect of @DRUG$.	DDI-effect
and @DRUG$ : FORADIL should be administered with extreme treated monoamine inhibitors or @DRUG$ action of on the cardiovascular system may be by .	DDI-false
include @DRUG$ clarithromycin , , , imatinib , nefazodone nicardipine , propofol , protease inhibitors @DRUG$ , .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
include the other diuretics corticosteroids , @DRUG$ , products estrogens , contraceptives , @DRUG$ .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
MAO : not for use in have MAOI within days unpredictable potentiation by @DRUG$ has been reported with @DRUG$	DDI-advise
Potential interactions Keppra   and other AEDs ( carbamazepine @DRUG$ , lamotrigine phenobarbital , @DRUG$ also assessed serum concentrations of clinical studies .	DDI-false
vitro studies with human serum proteins indicate and does interact @DRUG$	DDI-false
@DRUG$ ( 40 mg/kg ) , @DRUG$ ) decreases the intravenous morphine and oral self-administration ethanol and ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Nonsteroidal drug an @DRUG$ been .	DDI-false
In a in ketamine @DRUG$ , or dosage of ouabain to was higher , as was the @DRUG$ with Innovar with pentobarbital .	DDI-false
@DRUG$ @DRUG$ levels and digoxin clearance at steady-state not affected co-administration of mg cerivastatin	DDI-false
As other antipsychotic should depressants @DRUG$ @DRUG$ , and alcohol	DDI-false
The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
to the only clinically relevant of kind , of other alter ( anti-arrhythmic or beta-adrenergic blocking @DRUG$ , antihistamines H1-blocking agents , tricyclic antidepressants @DRUG$ contribute a prolongation QTc interval .	DDI-false
@DRUG$ colestipol @DRUG$ Absorption hydrochlorothiazide in the presence of	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Anticoagulants coumarin derivatives , derivatives and @DRUG$ as @DRUG$ ( NSAIDs , and aspirin risk of bleeding when ardeparin	DDI-false
@DRUG$ : apparent pharmacokinetic when administered	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
The of solutions containing @DRUG$ @DRUG$ to patients monoamine or tricyclic may severe , hypertension	DDI-false
FLEXERIL may enhance the effects of alcohol, @DRUG$, and other @DRUG$.	DDI-false
Warfarin : Eszopiclone 3 administered daily days did pharmacokinetics or @DRUG$ any changes the profile prothrombin time following single dose @DRUG$	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and alcohol.	DDI-effect
@DRUG$ that NSAIDs may the antihypertensive effect of @DRUG$.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ diminished binding of @DRUG$ by a net change of 9.9% (percentage increase in FDF, 21.2%) at 1732 micromol/L.	DDI-mechanism
@DRUG$ @DRUG$ may antihypertensive Converting ( ACE inhibitors .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
A Narrow Therapeutic Index @DRUG$ single dose of @DRUG$ 3 did affect the digoxin state 0.5 one day and mg for the next days .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Potential between other AEDs ( , gabapentin , lamotrigine , phenobarbital @DRUG$ , @DRUG$ valproate also assessed evaluating the concentrations and these during clinical studies .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Injection @DRUG$ like injectable , produces nervous system when alcohol phenothiazines , barbiturates inhibitors , and other is used incidence , behavior has	DDI-effect
Monoamine and @DRUG$ : be with extreme being treated with monoamine inhibitors or tricyclic antidepressants because the of @DRUG$ on potentiated these	DDI-false
Other concomitant therapy Although specific were performed , finasteride doses 1 mg or concomitantly used in clinical with acetaminophen analgesics , angiotensin-converting ACE ) , anticonvulsants benzodiazepines , blockers @DRUG$ @DRUG$ HMG-CoA reductase inhibitors , inhibitors ( also referred as NSAIDs ) quinolone evidence significant interactions	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, @DRUG$ or itraconazole.	DDI-false
therapies : In clinical trials the @DRUG$ hypnotics and @DRUG$ ( including ) , or non-opioid analgesics was to that placebo with these concomitant medications .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
Interactions : Flupenthixol with , like Monoamine oxidase ): MAOI theoretically affect flupenthixol pharmacodynamics @DRUG$ - - : Flupenthixol Ethanol depression - Tricyclic @DRUG$ the of	DDI-false
No data are available for the coadministration of @DRUG$/@DRUG$ or FORTOVASE/ritonavir and garlic capsules.	DDI-false
, @DRUG$ : treatment or @DRUG$ may potentiate a possible hypokalemic effect of   .	DDI-false
@DRUG$ showed the most potent inhibition ( 66 % at microM , was more that @DRUG$.	DDI-false
This drug with @DRUG$ other CNS potentiate depressant effects of medications or antihistamines anticholinergics or other with activity potentiated when are used with antihistamines @DRUG$ ( concurrent use with may prolong intensify effects antihistamines	DDI-false
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of warfarin and @DRUG$.	DDI-false
Other : and enalapril concomitantly @DRUG$ , , calcium-blocking , and @DRUG$ without of adverse interactions .	DDI-false
Central Nervous Depressants : The concomitant ( transdermal system other @DRUG$ , but to opioids , @DRUG$ e.g. , ) , skeletal muscle alcohol cause depression , , in .	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
@DRUG$ has been dopamine , @DRUG$ ventilation .	DDI-false
of @DRUG$ theophylline with @DRUG$ , valproic acid phenobarbital at toxic concentrations of drug .	DDI-false
( nandrolone e.g. , ] , @DRUG$ , oxymetholone , Anadrol @DRUG$ ] )	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
: , other , depression of system when with , barbiturates inhibitors and @DRUG$ is concomitantly injectable lorazepam increased incidence of , , .	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
- Anabolic steroids @DRUG$ [ , Anabolin , [ Anavar ] oxymetholone [ e.g. , [ , @DRUG$ ] or	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and itraconazole) decrease gefitinib metabolism and increase @DRUG$ plasma concentrations.	DDI-mechanism
@DRUG$ , vincristine , chemotherapy @DRUG$ patients human non-Hodgkin lymphoma	DDI-false
: Lorazepam injection like , of central nervous system when administered ethyl alcohol phenothiazines @DRUG$ @DRUG$ other antidepressants scopolamine concomitantly with injectable lorazepam incidence , and irrational observed	DDI-false
the impact plus on course of , , non-Hodgkin lymphoma ( the authors compared group of patients with HIV-NHL who were the cyclophosphamide @DRUG$ @DRUG$ ( CHOP ) regimen plus a 80 chemotherapy CHOP-like regimen i.e. cyclophosphamide , , teniposide , prednisone bleomycin without receiving antiretroviral therapy	DDI-false
@DRUG$ : ergonovine , CONTRAINDICATED due to for serious and life-threatening reactions such as acute @DRUG$ toxicity by peripheral vasospasm and ischemia of the extremities tissues	DDI-false
Example inhibitors include ciprofloxacin diclofenac , @DRUG$ imatinib , , @DRUG$ , nicardipine , , and	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Central concomitant use system with other nervous system , including but not to opioids , tranquilizers e.g. @DRUG$ ) , muscle relaxants @DRUG$ may respiratory profound , or potentially or death .	DDI-false
Ketoconazole ( 200 daily ) produced a 10-fold @DRUG$ 4-fold increase Cmax @DRUG$ ( 5 ) volunteers .	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-effect
Hypersensitivity have been reported in patients containing high antineoplastic , , @DRUG$ , @DRUG$ , and	DDI-false
Plasma valproate concentration should be monitored when @DRUG$ and valproate are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
There is no pharmacokinetic interaction between @DRUG$ @DRUG$.	DDI-false
- @DRUG$ ( @DRUG$ Use of with these chance of side effects medicines	DDI-false
Although specific studies have not with that are ( eg calcium channel blockers , dapsone , , amiodarone , @DRUG$ tacrolimus , cyclosporine ergot derivatives @DRUG$ , , alfentanyl and ) may elevated when with	DDI-false
Potential drug other ( carbamazepine , @DRUG$ , , @DRUG$ valproate were by evaluating concentrations of levetiracetam these during placebo-controlled studies .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ ( ' @DRUG$ is newly introduced antipsychotic with in treatment of	DDI-false
Cardiac glycosides In digoxin , of @DRUG$ results an serum @DRUG$ may toxic levels with toxicity .	DDI-false
Aspirin: Concurrent administration of @DRUG$ may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-mechanism
In addition influenced the of @DRUG$ , piroxicam digoxin the pharmacokinetics @DRUG$ at .	DDI-false
The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or @DRUG$.	DDI-false
- steroids e.g. , oxandrolone e.g. @DRUG$ [ e.g. Anadrol stanozolol e.g. , @DRUG$ ) or	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$ : @DRUG$ adrenergic of	DDI-false
@DRUG$ may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
@DRUG$ and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
antihypertensive @DRUG$ and @DRUG$ IV augmented antihypertensive renin ( e.g. ) .	DDI-false
@DRUG$ - prior ingestion of @DRUG$ may decrease the emetic response to apomorphine in the treatment of poisoning.	DDI-false
Potential were assessed in pharmacokinetic studies ( @DRUG$ , valproate contraceptive , , @DRUG$ ) and through screening in the studies in epilepsy patients	DDI-false
been effects including fever insufficiency , hyperbilirubinemia confusion , dyspnea , concomitant @DRUG$ reduce PROLEUKIN and should be avoided 12 and potentiate	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
, Methylxanthines Diuretics Concomitant treatment , @DRUG$ @DRUG$ may potentiate possible hypokalemic of   beta2-agonists .	DDI-false
@DRUG$ including phenelzine sulfate , and pargyline : @DRUG$ MAO may cause	DDI-false
Example antifungals , , diclofenac doxycycline erythromycin , imatinib isoniazid @DRUG$ nicardipine , inhibitors ,	DDI-false
Concurrent administration of @DRUG$ @DRUG$ may result in elevated serum levels .	DDI-mechanism
: Pharmacokinetic or pharmacodynamic drug-drug interactions been demonstrated Argatroban administered ( orally 26 and 2 hours prior to @DRUG$ 1   . or @DRUG$ mg orally 6 and hours prior to and 6 and 12 subsequent , of 1.5   18 hours ) .	DDI-false
Concomitant administration of @DRUG$ and other related compounds (eg, quinine, @DRUG$ and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
This to be clinically relevant interaction of this kind theoretically , coadministration drugs known to cardiac conduction blocking agents calcium blockers @DRUG$ or agents tricyclic and @DRUG$ might to a prolongation the QTc	DDI-false
Two groups ( were hydroalcoholic containing @DRUG$ , methanol , @DRUG$ in the same as in and alcoholic beverages ;	DDI-false
The aim of this paper was to study the interaction between neurotensin and both @DRUG$ or its synthetic analogue @DRUG$, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
In patients receiving @DRUG$ and a @DRUG$ concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-advise
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and cyclosporine (INN, @DRUG$) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
Haloperidol: @DRUG$ blocks dopamine receptors, thus inhibiting the central stimulant effects of @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antihistamines: @DRUG$*, @DRUG$* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
Lithium generally should not be given with @DRUG$ because they reduce @DRUG$s renal clearance and add a high risk of lithium toxicity.	DDI-false
@DRUG$: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Example include antifungals ciprofloxacin , @DRUG$ , , @DRUG$ , , , , nefazodone nicardipine , , , and	DDI-false
Fluoxetine and @DRUG$ blood @DRUG$ at times glucose overload .	DDI-false
Tagamet , an effect on enzyme , reported hepatic of warfarin-type , phenytoin @DRUG$ @DRUG$ , , tricyclic antidepressants , lidocaine theophylline and , thereby and increasing blood levels drugs .	DDI-false
Benzthiazide may with @DRUG$ ( allergy cold , and sinus , diabetic drugs norepinephrine , like Aleve or Ibuprofen , high pressure .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
vitro studies of @DRUG$ suggest the : ergotamine , , @DRUG$ and nifedipine	DDI-int
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of @DRUG$ (7.4 mg/kg body weight) and subcutaneous injections of @DRUG$ (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of verapamil (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
@DRUG$: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of furosemide and thiazides in some patients.	DDI-false
Warfarin : The @DRUG$ on the anti-coagulant effect of @DRUG$ a group healthy subjects 2 - 5 mg .	DDI-false
Injection: @DRUG$ injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Agents Affecting Cytochrome P450 3A4 Isoenzyme System @DRUG$ is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when @DRUG$  is given concurrently with agents that affect CYP3A4 activity.	DDI-false
@DRUG$ : Anticoagulant monitored , in first days after or changing VIOXX therapy receiving @DRUG$ or agents , these bleeding .	DDI-false
Example inhibitors include ciprofloxacin , , @DRUG$ doxycycline erythromycin , nefazodone , @DRUG$ , protease inhibitors , verapamil .	DDI-false
Potassium Supplements and Potassium-Sparing Diuretics: @DRUG$ can attenuate potassium loss caused by @DRUG$.	DDI-effect
@DRUG$: Concomitant administration of low-dose aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-false
@DRUG$ 18-MC block @DRUG$-induced release in the nucleus accumbens ;	DDI-effect
Potential drug interactions between @DRUG$  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$ : As @DRUG$ administration ciprofloxacin with lead elevated serum concentrations theophylline and prolongation half-life .	DDI-false
drug-drug the effect of use ACZONE % , with double 160 mg/800 @DRUG$/sulfamethoxazole .	DDI-false
drugs the corticosteroids , phe-nothiazines , products @DRUG$ , oral phenytoin @DRUG$ sympathomimet-ics , calcium drugs isoniazid	DDI-false
of @DRUG$ ( the treatment of related obstetric blocks @DRUG$ may severe , .	DDI-effect
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, @DRUG$, and increased toxicity.	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
drugs thiazides @DRUG$ @DRUG$ estrogens contraceptives phenytoin acid sympathomimet-ics calcium blocking and	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ In study male no pharmacokinetic interaction @DRUG$ and administered concomitantly for 6	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), @DRUG$ (10 ng/ml), and insulin (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-mechanism
Other Drug Oral @DRUG$ Keppra ( mg twice daily ) not influence the pharmacokinetics of oral 0.03 @DRUG$ and 0.15 mg levonorgestrel the luteinizing indicating impairment of is .	DDI-false
has antagonize skeletal relaxing effect @DRUG$ and may @DRUG$.	DDI-false
@DRUG$ @DRUG$ , decreases heart rate at high doses	DDI-false
Products Concurrent administration of a , including with multivalent products such @DRUG$ aluminum antacids sucralfate , VIDEX chewable/buffered tablets or pediatric , , @DRUG$ substantially decrease the , in serum levels	DDI-false
Antihypertensives should be caution -receptor blocking agents ( e.g. propranolol @DRUG$ inhibitor ) or channel antagonists @DRUG$ a CYP3A4 substrate diltiazem , a inhibitor possible bradycardia , sinus block	DDI-false
The hypoglycemic action of sulfonylureas may including nonsteroidal agents and other drugs that are bound @DRUG$ sulfonamides chloramphenicol , @DRUG$ monoamine oxidase inhibitors blocking agents .	DDI-false
Central System : The of @DRUG$ ( system other central system , including but not to other , sedatives hypnotics e.g. @DRUG$ , phenothiazines , skeletal , and alcohol depression hypotension sedation or result coma or death .	DDI-effect
: may interact some Monoamine oxidase MAOI ): could pharmacodynamics - Arecoline - Ethanol Flupenthixol @DRUG$ cause CNS depression - Tricyclic antidepressants increases @DRUG$	DDI-false
interactions in clinical pharmacokinetic studies phenytoin valproate @DRUG$ , , @DRUG$ , probenecid and pharmacokinetic screening the placebo-controlled studies epilepsy	DDI-false
When Itraconazole coadministered @DRUG$ @DRUG$ , or concentrations were .	DDI-false
Antacids : In clinical , coadministration of @DRUG$ hydroxide , magnesium ) fosinopril serum excretion fosinoprilat as with administered alone , suggesting @DRUG$ may absorption fosinopril .	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of amiodarone by stimulating the synthesis of @DRUG$ (enzyme induction).	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$ and @DRUG$ : interaction .	DDI-int
The pharmacokinetics of naltrexone and its major metabolite @DRUG$ were unaffected following co-administration with @DRUG$.	DDI-false
Probenecid @DRUG$ , a renal secretion blocking , dose times a day , pharmacokinetics @DRUG$ mg twice daily	DDI-false
@DRUG$: @DRUG$, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of levetiracetam 1000 mg twice daily.	DDI-false
@DRUG$ mg/kg ) , @DRUG$ ( 30 mg/kg , ( 0.25 , fluoxetine ( 20 sertraline ( 30 mg/kg or .	DDI-false
Therefore , @DRUG$ is a patient receiving @DRUG$ the dosage be reduced prevent excessive prolongation time .	DDI-advise
administration drugs nephrotoxic ( @DRUG$ , indomethacin ) , , cytotoxic chemotherapy ) , cardiotoxic e.g. doxorubicin or hepatotoxic e.g. , @DRUG$ , asparaginase ) PROLEUKIN increase these .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The of nitrofurantoin is recommended since @DRUG$ may antagonize antibacterial effect of @DRUG$ the tract	DDI-effect
Although interaction studies not , clinical , was ( ) , @DRUG$ , @DRUG$ anti-inflammatory drugs ) evidence of clinically .	DDI-false
effects with @DRUG$ or can be minimized the diuretic prior to initiation @DRUG$.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral @DRUG$, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Other the profile anxiolytics , hypnotics and @DRUG$ ( including @DRUG$ ) or non-opioid similar of these concomitant medications .	DDI-false
: of @DRUG$ @DRUG$ in volunteers resulted in of plasma levels the approximately	DDI-mechanism
Corticosteroids , and : treatment @DRUG$ , steroids @DRUG$ may potentiate effect of   beta2-agonists	DDI-false
- @DRUG$ (e.g., Mesantoin) Use of @DRUG$ with these medicines may increase the chance of side effects of these medicines	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
Administration of @DRUG$ during therapy with a @DRUG$ has been shown to produce a  stimulating  effect in some depressed patients.	DDI-effect
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
drugs the corticosteroids phenothiazines , thyroid , estrogens , contraceptives @DRUG$ nicotinic sympathomimetics channel blocking , and @DRUG$.	DDI-false
Patients receiving both @DRUG$ and @DRUG$ should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although specific have been performed that mainly by CYP3A4 ( eg , calcium channel , @DRUG$ @DRUG$ , warfarin tacrolimus ergot , fentanyl alprazolam elevated with	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
@DRUG$: Co-administration of @DRUG$ with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-false
In particular, convulsions have been reported when @DRUG$ is administered with @DRUG$ and special care should be taken when the treatment regimen includes both of these drugs.	DDI-effect
Warfarin @DRUG$ @DRUG$ bleeding are , users of both together have of GI than that of users drug	DDI-effect
Nitrates : @DRUG$ with @DRUG$ has safely tolerated patients with angina pectoris	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Primary and secondary @DRUG$ deficiencies the indication @DRUG$ therapy .	DDI-false
Drug Flupenthixol drugs , like ): MAOI could flupenthixol pharmacodynamics Ethanol Flupenthixol and Ethanol antidepressants @DRUG$ the effect @DRUG$	DDI-effect
interactions between other @DRUG$ ( lamotrigine , phenytoin and ) were assessed the serum concentrations of and @DRUG$ placebo-controlled .	DDI-false
Micro-dosed @DRUG$ Preparations: Micro-dosed progesterone preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
: @DRUG$ any important on @DRUG$.	DDI-false
@DRUG$ or iodine excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of Carbimazole.	DDI-effect
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with @DRUG$ for the following: sertraline and paroxetine.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
@DRUG$ : Plasma digoxin levels digoxin clearance at of mg	DDI-false
@DRUG$ may potentiate the adverse effects of other @DRUG$ administered concomitantly.	DDI-effect
clinical oral warfarin , @DRUG$ ) NSAIDs @DRUG$ , and did of fondaparinux sodium .	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
These the thiazides , phenothiazines thyroid products , @DRUG$ , acid @DRUG$ calcium .	DDI-false
Hypotension on Diuretic Therapy @DRUG$ in diuretic recently instituted as well as on severe salt restriction dialysis , of usually within the hour the initial dose @DRUG$.	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Since amiodarone a for @DRUG$ , the potential John Wort in receiving could result in reduced @DRUG$	DDI-false
metabolizers higher expected plasma @DRUG$ ( @DRUG$ ) when	DDI-false
@DRUG$: The concomitant administration of ciprofloxacin with the @DRUG$ glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
@DRUG$ concomitant of and @DRUG$ well in with	DDI-false
Alpha-blockers: When @DRUG$ 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of @DRUG$, significant hypotension developed in a substantial number of subjects.	DDI-effect
@DRUG$ are family and	DDI-false
Possible drug interactions of @DRUG$ with @DRUG$ or with other anticholinesterase agents.	DDI-int
There been reports of QTc , with or in taking @DRUG$ when @DRUG$ , macrolide antibiotics , or were administered concomitantly	DDI-false
@DRUG$ : The administration of volunteers no on of @DRUG$ decreased and its metabolite .	DDI-false
have been man , @DRUG$ , @DRUG$ , and warfarin no clinically interactions found .	DDI-false
@DRUG$: Reports suggest that @DRUG$ may diminish the antihypertensive effect of Angiotensin Converting Enzyme (ACE) inhibitors.	DDI-false
shown produce any additional effect that obtained with and aspirin increases excretion @DRUG$ concomitant @DRUG$ not	DDI-false
It is concluded that @DRUG$ and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
Coadministration of @DRUG$ with 40 mg SULAR tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Slow-channel calcium blockers, such as @DRUG$, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
studies not been performed , coadministration with that are metabolized by ( , calcium , @DRUG$ , quinine amiodarone quinidine , warfarin , , cyclosporine derivatives pimozide @DRUG$ , alfentanyl , ) may have elevated plasma when ;	DDI-false
Chloramphenicol has been shown to be antagonistic to @DRUG$, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-false
Probenecid: @DRUG$, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of @DRUG$ 1000 mg twice daily.	DDI-false
In general , are drugs that have more pharmacologic to , including @DRUG$ as quinidine and procainamide , cardiac glycosides and @DRUG$.	DDI-false
effects @DRUG$ are by caffeine	DDI-effect
: 20 mg , when co-administered @DRUG$ mg 60 mg once did the AUC or maximum concentration ( @DRUG$ that is metabolized via	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, @DRUG$, and increased toxicity.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
- prior ingestion of @DRUG$ @DRUG$ to in treatment of poisoning	DDI-false
@DRUG$ In a study of volunteers no significant when @DRUG$ administered concomitantly 6 days	DDI-false
The @DRUG$ containing to receiving monoamine oxidase , tricyclic antidepressants @DRUG$ , prolonged hypotension	DDI-effect
Although specific performed with drugs are eg , calcium channel dapsone , disopyramide , amiodarone quinidine @DRUG$ ergot derivatives pimozide , , @DRUG$ alfentanyl , plasma concentrations when coadministered with ;	DDI-false
- @DRUG$ e.g. @DRUG$ ] , oxymetholone [ ] , stanozolol [ , Winstrol ] or	DDI-false
Important Levosimendan does not interactions beta-blockers felodipine , digoxin warfarin , isosorbide mononitrate @DRUG$ @DRUG$	DDI-false
The action by drugs including nonsteroidal anti-inflammatory that are highly protein @DRUG$ , sulfonamides @DRUG$ , oxidase inhibitors blocking agents .	DDI-false
Cardiovascular Enalapril and @DRUG$ have been used with @DRUG$ , , agents , and evidence .	DDI-false
@DRUG$: @DRUG$ may counteract the sedative effect of antihistamines.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
therefore, close monitoring of prothrombin time is recommended, and adjustment of the @DRUG$ dose may be necessary when @DRUG$ is administered concomitantly.	DDI-advise
Other Although specific studies not finasteride doses of 1 or were used in clinical with acetaminophen @DRUG$ analgesics , angiotensin-converting enzyme ACE inhibitors , anticonvulsants benzodiazepines calcium-channel @DRUG$ , antagonists , HMG-CoA reductase inhibitors , inhibitors ( also referred to as NSAIDs ) , and anti-infectives without of significant adverse interactions .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
INOmax has been administered with tolazoline, @DRUG$, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
been coadministration drugs that are metabolized by CYP3A4 ( , dapsone @DRUG$ quinidine , warfarin , , cyclosporine , ergot , @DRUG$ , alfentanyl alprazolam and triazolam ) may elevated plasma concentrations coadministered with	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, @DRUG$, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
may interact with some drugs , like ( @DRUG$ ): MAOI theoretically pharmacodynamics Arecoline - - Ethanol : additive depression antidepressants : increases effect of @DRUG$	DDI-false
In binding with human serum indicate glipizide binds differently than @DRUG$ not with @DRUG$ or dicumarol	DDI-false
pharmacokinetic @DRUG$ isoflurane , , @DRUG$ have been	DDI-false
observed during of , @DRUG$ and @DRUG$ ;	DDI-false
with @DRUG$ @DRUG$ been studied	DDI-false
Observations from drug with @DRUG$ be for @DRUG$.	DDI-false
MAO Inhibitors :   is for patients who have received @DRUG$ within 14 because and potentiation @DRUG$ has been	DDI-false
@DRUG$: @DRUG$ may antagonize the hypotensive effects of antihypertensives.	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
specific studies coadministration with mainly metabolized by CYP3A4 eg calcium @DRUG$ , @DRUG$ , , amiodarone , quinidine tacrolimus , , alfentanyl , alprazolam , coadministered with	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
specific studies have with drugs by ( eg , calcium , , , amiodarone , quinidine , , tacrolimus @DRUG$ , @DRUG$ pimozide carbamazepine alfentanyl , triazolam may plasma when coadministered	DDI-false
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
@DRUG$ antiarrhythmic drugs , and @DRUG$ used concurrently with amiodarone .	DDI-false
@DRUG$ has been administered with tolazoline, @DRUG$, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
Corticosteroids @DRUG$ : Concomitant with @DRUG$ , steroids , or diuretics potentiate hypokalemic effect  	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, @DRUG$, cimetidine, ketoconazole), though this has not been studied	DDI-false
Multivitamins , other containing iron or @DRUG$ or @DRUG$ administered concomitantly within hours of administration of norfloxacin because interfere with resulting in serum urine of .	DDI-false
all the selective , , citalopram @DRUG$ , , @DRUG$ , and paroxetine , inhibit , they the inhibition	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
clinical performed @DRUG$ , concomitant of oral anticoagulants , inhibitors ( acetylsalicylic ) , NSAIDs ( @DRUG$ ) , the of .	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$: Cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various @DRUG$.	DDI-false
neostgmine @DRUG$ , @DRUG$ , toxicity cardio .	DDI-false
In studies @DRUG$ the of oral ( warfarin ) platelet inhibitors ( @DRUG$ ) and did not affect of fondaparinux .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
: other injectable benzodiazepines produces depression of system when administered @DRUG$ @DRUG$ , MAO inhibitors , and When lorazepam , an increased incidence of , and irrational has been .	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
The of catecholamines as @DRUG$ or enhanced	DDI-effect
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, digoxin, Maalox, and @DRUG$.	DDI-false
Anticoagulants including coumarin , indandione and platelet aggregation such as anti-inflammatory drugs @DRUG$ and of bleeding concomitantly with	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
In addition certain drugs by this , including @DRUG$ tricyclic @DRUG$ and others ) may activity of this , and make resemble poor metabolizers with regard drugs metabolized system interactions .	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
@DRUG$, barbiturates, or @DRUG$: potentiation of orthostatic hypotension may occur.	DDI-false
Concomitantly given @DRUG$ not with the absorption of @DRUG$.	DDI-false
@DRUG$ no of @DRUG$ , it significantly decreased tmax 44 % increased the intracellular to phosphorylated zidovudine 110 %	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Potential drug @DRUG$ and other AEDs carbamazepine , @DRUG$ lamotrigine , phenytoin primidone and evaluating serum of and these during placebo-controlled clinical studies .	DDI-false
Drug-Drug Interactions Keppra And Other Antiepileptic ( @DRUG$ @DRUG$ ( 3000 ) had effect on pharmacokinetic disposition of patients refractory epilepsy	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Ergot Derivatives @DRUG$ @DRUG$ potential for serious and life-threatening reactions such as toxicity by vasospasm and the and other tissues	DDI-false
The effects of DCG-IV and @DRUG$ upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
use of @DRUG$ that P450 may doses than prescribed for either @DRUG$ or drug	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
@DRUG$ effect antihypertensive drugs , ,	DDI-effect
In rats, simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-effect
@DRUG$ atorvastatin an oral increased AUC @DRUG$ by approximately % and 20 %	DDI-false
@DRUG$ @DRUG$ 10 or given to volunteers either or hours mg terazosin significant hypotension in a substantial of	DDI-false
containing chains of ( cefoperazone cefotetan , , ) or @DRUG$ can deficiency hypoprothrombinemia	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-effect
and concomitantly , reduction @DRUG$ gradual possible complications of @DRUG$ withdrawal .	DDI-false
Cation-Containing : quinolone , including with cation-containing products such @DRUG$ , sucralfate , @DRUG$ chewable/buffered tablets pediatric powder products containing iron , zinc may decrease absorption ciprofloxacin urine levels lower	DDI-false
Skeletal muscle relaxants, nondepolarizing (e.g., @DRUG$): possible increased responsiveness to the @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antihypertensives : Amiodarone caution in -receptor e.g. , CYP3A4 inhibitor or calcium channel ( e.g. , a @DRUG$ , and diltiazem @DRUG$ inhibitor because of bradycardia , sinus arrest , AV	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with @DRUG$.	DDI-false
appears to the only Mefloquine theoretically , of other drugs alter , beta-adrenergic , calcium @DRUG$ or agents , @DRUG$ might to prolongation the interval	DDI-false
The conversion of @DRUG$ to @DRUG$ is catalyzed by aldehyde oxidase.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ (but not aspirin): These drugs in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
interact blood decongestant drugs ( and , drugs norepinephrine , NSAIDs like @DRUG$ or @DRUG$ , high blood pressure .	DDI-false
impact chemotherapy plus course patients with , , non-Hodgkin ( HIV-NHL , retrospectively a patients HIV-NHL were treated with the @DRUG$ , , , and prednisone ) regimen HAART with a group 80 who CHOP chemotherapy regimen ( i.e. , cyclophosphamide doxorubicin , teniposide @DRUG$ with vincristine ) without receiving antiretroviral therapy .	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, digoxin, Maalox, and @DRUG$.	DDI-false
WARFARIN: Co- administration of @DRUG$ and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
BACKGROUND : effects of bombesin hydrochloride @DRUG$ ) , calcium channel blocker on of metastasis of intestinal azoxymethane ( @DRUG$ and the intestinal were investigated in Wistar .	DDI-false
- @DRUG$ ( nandrolone [ , Anabolin [ ] , oxymetholone [ e.g. ] @DRUG$ , Winstrol ] )	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and @DRUG$ with transdermal @DRUG$ may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-mechanism
Drugs that cause significant @DRUG$ such as @DRUG$ ) plasma concentrations of IRESSA therefore reduce efficacy	DDI-false
( INR ) have taking @DRUG$ on @DRUG$ therapy .	DDI-effect
effects from cholinergic blockade may occur when @DRUG$ with , @DRUG$ , phenothiazines ( ) inhibitors , tricyclic antidepressants or some antihistamines .	DDI-effect
is the @DRUG$ lovastatin , @DRUG$ , ) to unique	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-false
Antacids a pharmacology study , an antacid ( aluminum , @DRUG$ and simethicone reduced levels and urinary excretion of fosinoprilat compared with administered alone , impair absorption	DDI-false
lidocaine/quinidine , phenobarbital/acetaminophen phenobarbital/valproic , quinidine/@DRUG$ , , and valproic	DDI-false
Acetaminophen: A report of severe @DRUG$ toxicity was reported in a patient receiving @DRUG$.	DDI-effect
@DRUG$: Caution should be used if @DRUG$ is administered concomitantly with methotrexate.	DDI-false
Nitrates: The concomitant use of @DRUG$ with long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris.	DDI-false
Interactions Flupenthixol may interact some drugs , like Monoamine oxidase inhibitors ( MAOI could theoretically flupenthixol Arecoline Eproxindine - @DRUG$ cause additive CNS : @DRUG$ increases the effect Tricyclic antidepressants	DDI-false
Other reported interactions @DRUG$ : @DRUG$ CYP3A4 substrate in amiodarone hypotension , and .	DDI-false
Tagamet effect on , been reported to the hepatic of warfarin-type anticoagulants , propranolol , @DRUG$ @DRUG$ certain antidepressants , lidocaine , and , elimination increasing levels of .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
occurs @DRUG-DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
of ( @DRUG$ and @DRUG$ response is always seen in patients can in serious or .	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
specific been performed , drugs are mainly metabolized by eg , calcium blockers , quinine , , quinidine , @DRUG$ , cyclosporine , , , , and may have elevated when coadministered with @DRUG$ ;	DDI-mechanism
To evaluate impact HAART the clinical patients with HIV-related lymphoma ( , authors retrospectively a group patients HIV-NHL who treated cyclophosphamide vincristine and ( HAART with group of were treated or a ( , @DRUG$ , @DRUG$ with plus bleomycin ) antiretroviral .	DDI-false
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
This drug may interact with alcohol or depressants potentiate the depressant effects or antihistamines ) , @DRUG$ or other with activity may when with antihistamines ) and @DRUG$ ( concurrent use with antihistamines may prolong anticholinergic and CNS depressant of antihistamines	DDI-false
Colestipol concentrations of @DRUG$ decreased approximately 25 when @DRUG$ and atorvastatin coadministered	DDI-false
@DRUG$ had no effect on the @DRUG$ ( glucose and insulin ) and ( prothrombin time or other parameters ) .	DDI-false
Although have been performed coadministration drugs that mainly CYP3A4 eg , calcium channel blockers , quinine , , , warfarin tacrolimus , derivatives pimozide @DRUG$ , fentanyl , alprazolam , and @DRUG$ ) plasma coadministered saquinavir	DDI-false
There is significant in imatinib @DRUG$ @DRUG$ ( CYP3A4 .	DDI-mechanism
a ( in 48.59 /- 8.52 vs. /- 9.93 ( + 6.6 + 2.0 and tmax ( 1.1 0.6 ) levofloxacin @DRUG$/@DRUG$ regimens .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Quinolones including norfloxacin enhance the effects of oral @DRUG$ , including @DRUG$ derivatives or similar .	DDI-false
It is structurally distinct from the other currently available @DRUG$ (lovastatin, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
concomitant were , @DRUG$ doses of were concomitantly in clinical studies acetaminophen acetylsalicylic , a-blockers , angiotensin-converting ( ) , anticonvulsants , calcium-channel cardiac @DRUG$ H2 antagonists HMG-CoA reductase , synthetase ( also referred to , and anti-infectives of clinically	DDI-false
of @DRUG$ @DRUG$ were additive co-administered but not .	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
chemical resemblance @DRUG$ and ketoconazole of astemizole with @DRUG$ .	DDI-false
Central Nervous System : The concomitant use   ( @DRUG$ transdermal system other central system depressants , including but limited other opioids , hypnotics , tranquilizers e.g. , benzodiazepines general @DRUG$ , muscle , and alcohol , cause respiratory hypotension , , or in coma or death .	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Similarly dialyzed were phenobarbital, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
@DRUG$ The celecoxib on anti-coagulant effect of @DRUG$ in subjects daily doses of - 5 mg of	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
@DRUG$/quinidine , acid quinidine/lidocaine and valproic acid/phenobarbital .	DDI-false
Co-administration of @DRUG$ with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Vitamin A: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
@DRUG$: Simvastatin (@DRUG$ substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
These drugs thiazides other @DRUG$ corticosteroids , thyroid , oral contraceptives , @DRUG$ , sympathomimet-ics , drugs isoniazid	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
: @DRUG$ with some , like Monoamine inhibitors ( MAOI ): MAOI theoretically @DRUG$ - Arecoline - Ethanol Flupenthixol cause additive CNS Tricyclic antidepressants : Flupenthixol increases the effect Tricyclic antidepressants	DDI-false
@DRUG$ : @DRUG$ bepridil flecainide , CONTRAINDICATED due to for and/or life-threatening reactions .	DDI-false
@DRUG$ : @DRUG$ because Accutane has associated with a number cases of pseudotumor ( intracranial hypertension , of which use of tetracyclines	DDI-false
is co-administration @DRUG$ @DRUG$ also class to the	DDI-advise
Concurrent of e.g. , aminoglycosides @DRUG$ ) myelotoxic e.g. @DRUG$ ( doxorubicin or ) PROLEUKIN toxicity in organ .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with @DRUG$ or potent diuretics such as furosemide.	DDI-effect
Concomitant @DRUG$, @DRUG$, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
The of rifampin @DRUG$ requirement of patient days after the of @DRUG$ a of withdrawal .	DDI-false
Interactions Between @DRUG$ AEDs ) @DRUG$ daily ) had no effect pharmacokinetic disposition phenytoin in	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with aluminum hydroxide containing @DRUG$ for at least 4 hours following ethambutol administration.	DDI-false
@DRUG$, @DRUG$, phenobarbital, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
treatment of activity ( as ketoconazole , , @DRUG$ indinavir , @DRUG$ etc . reduction the budesonide dose be considered	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with nonsteroidal anti-inflammatory drugs, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-false
Drug/Laboratory urine of patients @DRUG$ can give a false-positive reaction for urinary bilirubin ( urobilin due to of phenolic metabolites of @DRUG$.	DDI-false
studies have shown of administered @DRUG$ enter CSF as 5-methyltetrahydro-folate in humans remain 1 to 3 orders magnitude @DRUG$ concentrations intrathecal administration .	DDI-false
Although there are no study evaluate possibility nitric oxide donor including @DRUG$ may have additive @DRUG$ on the developing methemoglobinemia .	DDI-effect
@DRUG$: Concomitant administration of @DRUG$ at 200 mg QD resulted in a two-fold increase in celecoxib plasma concentration.	DDI-false
Limited comparative with high viral loads treated with @DRUG$- or @DRUG$-based regimens	DDI-false
however, it adversely affected response duration suggesting that pyridoxine should not be administered with @DRUG$ and/or @DRUG$.1	DDI-false
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
No significant interactions were found between @DRUG$ and warfarin or @DRUG$.	DDI-false
The effects of @DRUG$ are antagonized such as @DRUG$ theophylline	DDI-effect
Central concomitant of DURAGESIC @DRUG$ system including but not limited to opioids , hypnotics @DRUG$ ( e.g. benzodiazepines , anesthetics , phenothiazines , and alcohol , cause profound sedation , potentially coma or death .	DDI-effect
Severe hypoglycemia has been reported in patients concomitantly receiving @DRUG$ and oral @DRUG$.	DDI-effect
@DRUG$ 400 . effect bioavailability ( and maximum ) of @DRUG$ when with mg healthy volunteers .	DDI-false
, @DRUG$ allergy , cold , and sinus ) diabetic @DRUG$ like Aleve Ibuprofen high .	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Therefore, @DRUG$ and @DRUG$ should not be used concomitantly.	DDI-advise
@DRUG$-@DRUG$ chains of N-methylthiotetrazole cefmenoxime , cefamandole , methylthiadiazole ( cefazolin can vitamin deficiency and .	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Although specific studies not been , coadministration that are mainly by ( eg calcium , dapsone , quinine , quinidine , , ergot , @DRUG$ , , alfentanyl @DRUG$ , triazolam may elevated concentrations when with	DDI-false
Prednisone/@DRUG$ : Rofecoxib did clinically effect the pharmacokinetics prednisolone or @DRUG$.	DDI-false
Single doses of either @DRUG$ @DRUG$ bind the hydrochlorothiazide and its from the up 85 and , .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Use with @DRUG$: The principal pathway for detoxification of @DRUG$ is inhibited by allopurinol.	DDI-false
There was no evidence of any pharmacokinetic interactions between @DRUG$ and @DRUG$.	DDI-false
@DRUG$ taken @DRUG$ for less than days plasma procainamide n-acetyl procainamide 55 and %	DDI-false
Limited clinical data in angina patients receiving concomitant @DRUG$ and @DRUG$ therapy indicate no discernible changes in serum digoxin levels.	DDI-false
Hypotension : on Therapy : Patients on @DRUG$ and those in diuretic was instituted excessive reduction of blood pressure initiation @DRUG$ .	DDI-effect
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, @DRUG$, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Other reported interactions with @DRUG$: @DRUG$ (CYP3A4 substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
acetaminophen/theophylline lidocaine/@DRUG$ , , acid , theophylline/acetaminophen acid/@DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, @DRUG$, reserpine.	DDI-false
In 12-week conducted in patients no difference in the ulcers taking mg enteric @DRUG$ plus @DRUG$ mg ibuprofen daily .	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
No pharmacokinetic interactions between @DRUG$ and isoflurane, propofol, @DRUG$, and midazolam have been demonstrated.	DDI-false
should used with in   blocking agents ( e.g. inhibitor ) calcium channel e.g. @DRUG$ , a @DRUG$ substrate , diltiazem , of possible potentiation of bradycardia , sinus arrest , and block	DDI-false
@DRUG$ is for both CYP2D6	DDI-false
azole antifungals @DRUG$ , , isoniazid , nicardipine , quinidine , and @DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Iodine or iodine the effect of @DRUG$ an @DRUG$ can increase Carbimazole .	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, @DRUG$, and @DRUG$.	DDI-false
MAO including sulfate , @DRUG$ and pargyline HC1 use of @DRUG$ and non-selective inhibitors hypertension	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-mechanism
Although @DRUG$ nor the proliferation of in containing @DRUG$ alone , modify of insulin	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
   Patients @DRUG$ Patients whom diuretic was instituted , well severe or may reduction of pressure usually within first hour after the initial of	DDI-false
Since amiodarone is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced amiodarone levels.	DDI-false
CONCOMITANT studies were performed , in clinical , @DRUG$ was used concomitantly with converting ( ACE inhibitors , , @DRUG$ , anti-inflammatory drugs ( ) without of adverse .	DDI-false
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
STRATTERA may necessary coadministered with CYP2D6 , @DRUG$	DDI-false
syndrome ( characterized by weakness , , tremulousness elevated enzymes and followed by irreversible brain damage in a patients treated @DRUG$ plus @DRUG$.	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Dosage adjustment of may be coadministered with CYP2D6 inhibitors , e.g. @DRUG$ , @DRUG$ , quinidine	DDI-false
chronic hepatitis treated combination with @DRUG$ , @DRUG$ did not or clearance	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$ , @DRUG$ , or sulfonylureas be observed activity drugs , signs of drugs .	DDI-false
, the @DRUG$ can the diuretic natriuretic and ,	DDI-effect
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as @DRUG$ and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
@DRUG$ levels and @DRUG$ clearance steady-state by mg .	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$ : flecainide , propafenone , @DRUG$ CONTRAINDICATED to potential for and/or .	DDI-false
The availability of potent @DRUG$ (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, methotrexate, and increased toxicity.	DDI-false
specific drug interactions topical glaucoma drugs systemic clinical of IOPIDINE % Solution , the or effect @DRUG$ ( alcohol , @DRUG$ ) considered	DDI-false
@DRUG$ especially diazoxide , and agents used @DRUG$ , nondepolarizing , used in	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
@DRUG$ 150 mg twice daily did not interact significantly with @DRUG$ (AUC was decreased by 15-20 %).	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: Concomitant treatment with Accutane and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Multivitamins, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
@DRUG$ have been reported to decrease the tubular secretion of @DRUG$ and to potentiate its toxicity.	DDI-mechanism
@DRUG$ were additive when @DRUG$ under basal conditions	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
@DRUG$ the effect of antihypertensive , e.g. , @DRUG$ , , reserpine .	DDI-effect
Use with Allopurinol: The principal pathway for detoxification of @DRUG$ is inhibited by @DRUG$.	DDI-mechanism
@DRUG$ @DRUG$ , , , to serious life-threatening as acute ergot toxicity characterized ischemia the extremities and other tissues	DDI-false
@DRUG$ may the antihypertensive action of @DRUG$ and .	DDI-effect
@DRUG$ is inhibited by @DRUG$.	DDI-mechanism
@DRUG$ : diuretics , those volume depletion , may experience an reduction initiation therapy with	DDI-false
@DRUG$ @DRUG$ additive ocular and on	DDI-false
Pregnancy: Category X: Use With @DRUG$ (see CONTRAINDICATIONS) Significant teratogenic and/or embryocidal effects have been demonstrated in all animal species exposed to @DRUG$.	DDI-false
Co-administration of warfarin and @DRUG$ did not alter @DRUG$.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Aspirin When Lodine with @DRUG$ , protein binding , although the clearance free @DRUG$ is .	DDI-false
@DRUG$, an anionic-binding resin, has a considerable effect in lowering the rate and extent of @DRUG$ bioavailability.	DDI-mechanism
Based on the chemical resemblance of @DRUG$ and ketoconazole, coadministration of @DRUG$ with itraconazole is contraindicated.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (@DRUG$), erythromycin, @DRUG$.	DDI-false
studies confirmed with sevoflurane isoflurane @DRUG$ , alfentanil , @DRUG$.	DDI-false
Like @DRUG$ (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-int
@DRUG$ (20 mg) did not potentiate the hypotensive effects of @DRUG$ during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight).	DDI-false
Concomitant @DRUG$ doxorubicin and @DRUG$ chemotherapy highly antiretroviral therapy in immunodeficiency virus-related , non-Hodgkin	DDI-false
@DRUG$-Concomitant intake of cholestyramine and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
@DRUG$: Quinolones have been reported to enhance the effects of the oral anticoagulant @DRUG$ or its derivatives.	DDI-false
Central Depressants : The of ( @DRUG$ transdermal ) system depressants , not to other sedatives hypnotics , e.g. , ) general anesthetics , , @DRUG$ and , , hypotension , profound result coma or death .	DDI-effect
Caution be if an inhibitor administered concomitantly with that may activity endogenous such as @DRUG$ , and	DDI-false
These drugs include the thiazides and other @DRUG$, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
CYP3A4 ( , @DRUG$ @DRUG$ , carbamazepine ,	DDI-false
cyclophosphamide , , @DRUG$ @DRUG$ therapy human , non-Hodgkin lymphoma	DDI-false
It not 2.5 @DRUG$ dose a 24-hour when used in	DDI-advise
Compounds tested in man include warfarin, @DRUG$, @DRUG$, diazepam, aminopyrine and antipyrine.	DDI-false
A potential interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported.	DDI-int
capsules should used taking @DRUG$ ) the @DRUG$ to the of decreased concentrations .	DDI-false
therefore, @DRUG$ or other nitrates (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting @DRUG$.	DDI-advise
Potassium Supplements @DRUG$ : Fosinopril can attenuate potassium	DDI-false
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., diuretics).	DDI-false
Folic acid in large amounts may counteract the antiepileptic effect of @DRUG$, phenytoin and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Diuretics: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$ or @DRUG$.	DDI-false
its major @DRUG$ unaffected with	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
administration nephrotoxic , indomethacin ) , cytotoxic ) e.g. , hepatotoxic e.g. , @DRUG$ , @DRUG$ PROLEUKIN in these organ systems .	DDI-false
However, concomitant administration of @DRUG$ with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of CELEBREX alone.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
ACE @DRUG$ (Hypertension)- In clinical of patients with , the addition INSPRA 50 to 100 mg to @DRUG$ II antagonists potassium slightly 0.13 mEq/L	DDI-false
Lithium-A drug interaction study of @DRUG$ with @DRUG$ has not been conducted.	DDI-false
of concomitantly with oral @DRUG$ has result in serum @DRUG$ and	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, valproate, @DRUG$, or lamotrigine.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, @DRUG$, and alcohol.	DDI-false
The aim of this paper was to study the interaction between neurotensin and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
@DRUG$ concentration should monitored isoniazid are co administered appropriate @DRUG$ should be made .	DDI-false
Products of a quinolone including @DRUG$ , multivalent cation-containing products as magnesium or , sucralfate VIDEX or pediatric powder , or products containing iron or may substantially @DRUG$ , resulting in serum and	DDI-mechanism
@DRUG$ and retinyl EGF- or @DRUG$-induced proliferation epithelium .	DDI-effect
Hemodynamic interactions have been after concomitant administration @DRUG$ , @DRUG$.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Vitamin A: Because of the relationship of @DRUG$ to @DRUG$, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although there are no study data to evaluate the possibility, @DRUG$, including @DRUG$ and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
In patients receiving @DRUG$ and a steroid concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue D-Ala2-metenkephalinamide, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Therophylline: A recent study has shown that concomitan administration of isoniazid and @DRUG$ may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of isoniazid.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ Supplements and Potassium-Sparing Diuretics: @DRUG$ can attenuate potassium loss caused by thiazide diuretics.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
of local @DRUG$ containing epinephrine @DRUG$ to patients monoamine inhibitors , prolonged .	DDI-false
, phenobarbital/acetaminophen acid @DRUG$/acetaminophen acid/phenobarbital	DDI-false
impact of plus on course patients systemic non-Hodgkin HIV-NHL , compared retrospectively group HIV-NHL who were the cyclophosphamide , , @DRUG$ CHOP chemotherapy regimen plus a group of with CHOP chemotherapy or CHOP-like ( , cyclophosphamide doxorubicin and prednisone with @DRUG$	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Concomitant administration of @DRUG$ ( eg , quinine , @DRUG$ chloroquine may produce electrocardiographic increase the risk of convulsions	DDI-effect
Ketoconazole : subjects @DRUG$ , inhibitor , at twice daily 7 days , systemic ) to @DRUG$ to approximately of and half-life to 1.7-fold	DDI-mechanism
@DRUG$/Acetaminophen or pharmacodynamic drug-drug interactions been demonstrated between @DRUG$ 162.5 mg orally given and 2 hours prior initiation of Argatroban   g/kg/min ) acetaminophen orally given , hours to 6 hours , of   over 18	DDI-false
treatment inhibitors of CYP3A4 ( such ketoconazole , @DRUG$ , ritonavir @DRUG$ , saquinavir etc ) is indicated , of budesonide dose be .	DDI-false
concluded @DRUG$ be safely coadministered zidovudine @DRUG$.	DDI-false
@DRUG$, tricyclic @DRUG$ may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
Dexamethasone @DRUG$ inhibit stimulate @DRUG$- of prostatic	DDI-effect
Lithium : In a study healthy subjects , mean steady-state @DRUG$ levels increased approximately subjects lithium mg BID with @DRUG$ 200 BID as to subjects .	DDI-false
In a comparison digitalis tolerance dogs anesthetized @DRUG$ Innovar or pentobarbital the needed as was LD50 of , with ketamine @DRUG$ .	DDI-false
@DRUG$ Angiotensin Receptor Antagonists Congestive Heart Failure Post-Myocardial In , ( 91 % ) receiving also @DRUG$ or angiotensin II receptor antagonists ( ACEI/ARB )	DDI-false
intensity , uniformity and time course of anticoagulant by phenobarbital , @DRUG$ @DRUG$ and were systematically in patients coumarin therapy .	DDI-false
Diuretic agents reduce the renal clearance of @DRUG$ and add a high risk of @DRUG$ toxicity.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
CYP2D6 inhibitors - @DRUG$ is primarily metabolized by the CYP2D6 pathway to @DRUG$.	DDI-false
Multivalent Products : Concurrent administration a quinolone , ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum @DRUG$ , tablets or pediatric , or products containing calcium , , or @DRUG$ absorption of resulting considerably lower desired .	DDI-false
Because the increased risk adverse reactions @DRUG$ a it important that benzodiazepine , @DRUG$ use as of the to any in which the of .	DDI-false
@DRUG$ absorption of when was given @DRUG$ was given 2 hours omeprazole at the that secretion .	DDI-false
@DRUG$: Concomitant administration of antacids may reduce plasma levels of @DRUG$.	DDI-false
As with other agents , be noted @DRUG$ capable @DRUG$ as anesthetics , opiates and alcohol	DDI-effect
Coingestion with theophylline phenobarbital with @DRUG$ , and @DRUG$ high concentrations the of target	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Although have not been , with metabolized CYP3A4 eg calcium channel blockers , quinine amiodarone quinidine , @DRUG$ , tacrolimus , cyclosporine ergot , pimozide , carbamazepine , @DRUG$ ) have when	DDI-false
containing chains N-methylthiotetrazole @DRUG$ cefoperazone , cefamandole @DRUG$ ) or cefazolin can cause vitamin K hypoprothrombinemia	DDI-false
chains of cefmenoxime , cefoperazone @DRUG$ cefamandole latamoxef or ( cefazolin can cause K deficiency hypoprothrombinemia .	DDI-false
There have been greater than 2-fold increases in previously stable plasma levels of other @DRUG$, including nortriptyline, when @DRUG$ has been administered in combination with these agents.	DDI-mechanism
An interaction study @DRUG$ showed no clinically @DRUG$ on warfarin pharmacokinetics or anticoagulant .	DDI-false
@DRUG$ of has been reported a diabetic @DRUG$ 1 ) days the addition ( mg/day .	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Other of e.g. , itraconazole , clarithromycin troleandomycin @DRUG$ @DRUG$ ) be to behave similarly	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Antiarrhythmics: Amiodarone, bepridil, @DRUG$, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Clinical studies with celecoxib have identified potentially significant interactions with @DRUG$ and @DRUG$.	DDI-false
Tricyclic have been to hypotensive effect of @DRUG$.It the use of these @DRUG$ humans lead resulting interference the lowering effect	DDI-false
drugs include @DRUG$ @DRUG$ phenothiazines , , oral contraceptives , phenytoin , sympathomimetics calcium drugs , isoniazid	DDI-false
@DRUG$ ( , spironolactone , triamterene , or @DRUG$ ) , potassium supplements , or potassium-containing salt lead to in serum .	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$, @DRUG$, and verapamil.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ @DRUG$ Amphetamines may antidepressants or ;	DDI-false
acidifying agents ( ammonium @DRUG$ , concentration the species the @DRUG$ increasing excretion	DDI-mechanism
Although not , drugs are metabolized by channel blockers , disopyramide , @DRUG$ @DRUG$ , quinidine warfarin , ergot pimozide , carbamazepine alfentanyl , alprazolam and have elevated plasma concentrations coadministered with	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
@DRUG$: @DRUG$, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, @DRUG$, ketoconazole), though this has not been studied	DDI-mechanism
an effect on certain microsomal systems reported to reduce metabolism @DRUG$ , propranolol , nifedipine chlordiazepoxide , @DRUG$ , tricyclic antidepressants lidocaine , metronidazole , thereby elimination and levels of these	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
appears to be the clinically interaction kind , , alter cardiac ( eg , @DRUG$ beta-adrenergic blocking , calcium channel blockers @DRUG$ or , tricyclic ) might the QTc interval .	DDI-false
specific studies have been coadministration with drugs that mainly CYP3A4 eg , @DRUG$ dapsone quinidine @DRUG$ , tacrolimus cyclosporine , ergot , , carbamazepine , alfentanyl alprazolam , elevated when coadministered with saquinavir	DDI-false
@DRUG$: @DRUG$ has no apparent pharmacokinetic interaction when administered with phenytoin.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, @DRUG$, alfentanil, and midazolam have been demonstrated.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
concomitant specific were not , doses 1 or @DRUG$ , , , analgesics , angiotensin-converting enzyme ( ACE , anticonvulsants @DRUG$ beta , calcium-channel H2 antagonists , HMG-CoA reductase inhibitors prostaglandin inhibitors ( also referred to as , quinolone without adverse	DDI-false
however, it adversely affected response duration suggesting that @DRUG$ should not be administered with @DRUG$ and/or cisplatin.1	DDI-advise
To evaluate the impact plus on clinical course of patients HIV-related lymphoma ( ) , authors compared a of 24 patients who with doxorubicin @DRUG$ prednisone ( plus with a of 80 patients who were treated CHOP chemotherapy a ( , doxorubicin and prednisone @DRUG$ ) receiving antiretroviral therapy	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
Atromid-S may displace acidic drugs such as @DRUG$ or @DRUG$ from their binding sites.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
Plasma @DRUG$ concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
Flupenthixol may interact with some Monoamine oxidase MAOI could theoretically affect Arecoline - - Ethanol : and @DRUG$ cause additive CNS Tricyclic : @DRUG$ increases effect of	DDI-false
relevant of this kind with Mefloquine , although , of known alter conduction ( , anti-arrhythmic @DRUG$ , @DRUG$ , antihistamines H1-blocking agents also to prolongation interval	DDI-false
Rifampin: Co-administration of @DRUG$ with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-mechanism
Carbamazepine known to slow the metabolism its levels @DRUG$ levels be prior to concurrent administration @DRUG$ symptoms carbamazepine toxicity monitored closely and appropriate adjustment of	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
may be potentiated by certain drugs including nonsteroidal agents drugs protein bound , sulfonamides , @DRUG$ probenecid coumarins @DRUG$ and adrenergic blocking .	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, methotrexate, and increased toxicity.	DDI-mechanism
Possible drug interactions of HUMORSOL with @DRUG$ or with other @DRUG$.	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, propofol, @DRUG$, and midazolam have been demonstrated.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
@DRUG$ : Fentanyl @DRUG$ in with amiodarone may , bradycardia ,	DDI-false
The pressor of as @DRUG$ or @DRUG$ .	DDI-false
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and @DRUG$ may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
A possible interaction between glyburide and ciprofloxacin, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
specific not performed , coadministration drugs that mainly blockers , dapsone @DRUG$ amiodarone quinidine , tacrolimus , , fentanyl @DRUG$ alprazolam , ) concentrations when coadministered with saquinavir	DDI-false
of myopathy during of this is concurrent administration of cyclosporine derivatives @DRUG$ ) @DRUG$ azole antifungals .	DDI-false
Although neither @DRUG$ retinyl proliferation epithelium in RPMI1640 containing alone they the effect @DRUG$ .	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
designed examine interactions have not done , it @DRUG$ @DRUG$ relapses up 28 been patients N=180 ) receiving Betaseron .	DDI-false
Since @DRUG$ is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, CYP2D6, and @DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, @DRUG$, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Therefore, when @DRUG$ and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.)	DDI-false
@DRUG$ (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
: Enalapril and IV have used with adrenergic-blocking @DRUG$ , nitrates , @DRUG$ hydralazine and digoxin without of clinically interactions .	DDI-false
@DRUG$, lidocaine, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
In second non-diabetic and streptozotocin-induced and same were for @DRUG$ tolerance 30 after @DRUG$ overload	DDI-false
Lack of an effect of @DRUG$ on the disposition of zidovudine and @DRUG$ in HIV-infected patients.	DDI-false
@DRUG$ suppress enzymes , CYP1A2 , @DRUG$ CYP3A4	DDI-false
Haemodynamic @DRUG$ and insulin additive when @DRUG$ was co-administered under basal conditions	DDI-false
therapy studies not finasteride doses of 1 or more concomitantly in studies with , acetylsalicylic a-blockers angiotensin-converting enzyme ( ACE ) anticonvulsants , @DRUG$ , @DRUG$ , cardiac nitrates , HMG-CoA inhibitors , prostaglandin ( also to ) , and evidence of clinically adverse interactions	DDI-false
Central System Depressants The use of   fentanyl system ) other @DRUG$ , including but not , @DRUG$ ( benzodiazepines phenothiazines , skeletal , and respiratory , and sedation or potentially in	DDI-false
@DRUG$ quinidine @DRUG$ and were to human serum concentrations	DDI-false
There have been reports of theophylline-related side effects in patients on concomitant therapy with @DRUG$ and @DRUG$.	DDI-effect
Multivalent : administration quinolone , @DRUG$ , cation-containing as magnesium aluminum , sucralfate , @DRUG$ pediatric products containing calcium , iron zinc substantially the ciprofloxacin resulting in serum considerably than	DDI-mechanism
However , concomitant @DRUG$ result in ulceration other @DRUG$ alone .	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking @DRUG$ when fluoroquinolones, @DRUG$, or azoles were administered concomitantly.	DDI-false
with activity such @DRUG$ intraconazole , ritonavir , indinavir , etc ) , of @DRUG$ considered .	DDI-advise
HMG-CoA Reductase Inhibitors: @DRUG$ (@DRUG$ substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
: or drug-drug have not been demonstrated concomitantly administered @DRUG$ ( 162.5 26 and hours prior of 1 g/kg/min . over 4 hours or mg 6 hours to 6 subsequent , initiation @DRUG$ . 18 hours .	DDI-false
Therophylline : A has shown that concomitan of @DRUG$ and theophylline cause elevated levels of theophylline in some decrease in elimination @DRUG$.	DDI-false
Benzthiazide may interact @DRUG$ thinners @DRUG$ ( , and sinus , diabetic drugs , like Aleve or Ibuprofen , high blood	DDI-false
Concomitant administration of other @DRUG$ undesirable @DRUG$.	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
concomitant therapy Although studies were performed , doses of 1 mg more used studies acetylsalicylic acid a-blockers , analgesics , enzyme ) , @DRUG$ , , , blockers cardiac @DRUG$ , HMG-CoA reductase inhibitors , synthetase ( also referred to NSAIDs and anti-infectives without evidence clinically interactions	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, @DRUG$, and beta adrenergic blocking agents.	DDI-false
To evaluate impact of plus HAART on clinical course of patients HIV-related systemic , lymphoma HIV-NHL the authors compared retrospectively a 24 patients with who were with , , vincristine CHOP chemotherapy with a of were treated with CHOP chemotherapy or a regimen ( cyclophosphamide , @DRUG$ , @DRUG$ vincristine plus bleomycin ) without receiving therapy	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
Diuretic agents renal of @DRUG$ and add risk of @DRUG$	DDI-false
Lorazepam injection , @DRUG$ , depression the administered with alcohol , phenothiazines barbiturates , other . When @DRUG$ used with lorazepam , an increased incidence of , irrational has been observed	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ (CYP3A4 substrate) given for local @DRUG$.	DDI-false
Example azole , , , doxycycline , erythromycin , nefazodone , @DRUG$ propofol inhibitors , quinidine	DDI-false
The administration local @DRUG$ to patients @DRUG$ antidepressants or phenothiazines may produce , prolonged hypotension or hypertension .	DDI-false
Close careful adjustment of the dosage @DRUG$ is @DRUG$ drugs	DDI-advise
@DRUG$ also increased rate of dissolution, in a manner similar to @DRUG$.	DDI-false
@DRUG$ administered , increased @DRUG$ are , and caution should be .	DDI-false
@DRUG$: Co- administration of @DRUG$ and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Cation-Containing : administration a quinolone , including ciprofloxacin multivalent cation-containing products as or antacids , sucralfate @DRUG$ chewable/buffered powder or products containing , , @DRUG$ may substantially the absorption of ciprofloxacin levels lower than desired .	DDI-false
colestipol @DRUG$ absorption K.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, CYP2D6, and @DRUG$.	DDI-false
ANTACID (@DRUG$): Cerivastatin plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
The effect of @DRUG$ on @DRUG$ requirement patient appeared to 5 to 7 days after the initiation after withdrawal	DDI-effect
@DRUG$ did not potentiate the increase time @DRUG$ two tablets ) .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
@DRUG$ increases 50 ) @DRUG$ , and	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Prednisone/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
Isoflurane potentiates the muscle relaxant effect of all @DRUG$, most notably @DRUG$, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
, reduction greater when @DRUG$ and @DRUG$ when either drug given	DDI-effect
It is interaction @DRUG$ and high affinity binding sites @DRUG$ on and underlies action of neuroleptics administration .	DDI-false
@DRUG$/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and @DRUG$ K.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although , been more 50 of use of antifibrinolytic therapies ( @DRUG$ and @DRUG$.	DDI-false
Because of increased of adverse reactions have been taking , it is particularly important that physicians or their carefully about @DRUG$ , @DRUG$ use as part of history to in which the use of ROMAZICON planned .	DDI-false
studies been performed , coadministration with that are eg @DRUG$ dapsone , , quinidine , , ergot derivatives @DRUG$ carbamazepine fentanyl alprazolam , and triazolam when with saquinavir	DDI-false
The @DRUG$ been to @DRUG$ is concurrently .	DDI-effect
Potential interactions other @DRUG$ ( , gabapentin phenobarbital , @DRUG$ , primidone and valproate also evaluating the concentrations of levetiracetam clinical	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
@DRUG$ and colestipol @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
The @DRUG$ and @DRUG$ tolerance dogs .	DDI-false
Cardiovasculars: @DRUG$: In patients receiving digoxin therapy, administration of oral amiodarone regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
@DRUG$ with Itraconazole has led elevated plasma concentrations of @DRUG$ , resulting cardiac one .	DDI-false
Other : In clinical safety profile treated with @DRUG$ concomitantly @DRUG$ hypnotics and sedatives including , non-opioid analgesics was similar that of with concomitant .	DDI-false
, or products or zinc , or @DRUG$ not be concomitantly with , or within 2 hours of , administration @DRUG$ may levels .	DDI-advise
Other Drug Interactions : observed following drugs : glyburide , @DRUG$ @DRUG$ .	DDI-false
INOmax administered with tolazoline , @DRUG$ , , steroids @DRUG$ , and ventilation	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
@DRUG$ any clinically important effect the @DRUG$ or	DDI-false
@DRUG$: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.	DDI-false
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
have reports of patients on concomitant therapy with norfloxacin and	DDI-false
@DRUG$/Acetaminophen : Pharmacokinetic or not and administered ( 162.5 mg orally given 26 and 2 hours of 1   g/kg/min . over 4 @DRUG$ ( 12 prior to and 6 and 12 hours , initiation of . over 18 hours .	DDI-false
of celecoxib the anti-coagulant of @DRUG$ studied in a of healthy of 2 mg @DRUG$.	DDI-false
@DRUG$ and @DRUG$ exert additive ocular and renal vasodilator effects on healthy humans.	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
@DRUG$ substrate @DRUG$	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other concomitant studies performed finasteride doses of mg or concomitantly acetylsalicylic acid , angiotensin-converting enzyme ACE ) inhibitors anticonvulsants , @DRUG$ blockers , diuretics , HMG-CoA reductase inhibitors , inhibitors ( referred to as @DRUG$ , quinolone anti-infectives evidence clinically adverse .	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
reported following concomitant @DRUG$ @DRUG$ or diuretics as	DDI-effect
@DRUG$ : concomitant use @DRUG$ been well with angina	DDI-false
@DRUG$ does not @DRUG$ .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
A concentrations above 2000 ng/mL with has led to an 80 increase in @DRUG$ exposure with a 38 in @DRUG$ alone .	DDI-false
Other concomitant therapy specific studies were not performed @DRUG$ 1 mg more were @DRUG$ , acetylsalicylic , a-blockers , , enzyme ( inhibitors , blockers , calcium-channel blockers , nitrates , diuretics H2 antagonists , reductase inhibitors prostaglandin synthetase inhibitors to and anti-infectives without evidence significant .	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-false
: In clinical pharmacology an antacid ( @DRUG$ @DRUG$ , with fosinopril reduced serum levels excretion fosinoprilat as compared fosinopril administered alone , suggesting that antacids may impair fosinopril	DDI-false
receiving @DRUG$ @DRUG$ concomitantly approximately 1/3 to 1/4 dose	DDI-advise
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , , quinidine/lidocaine , and @DRUG$/phenobarbital	DDI-false
Glyburide: @DRUG$ has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
mild of mg @DRUG$ @DRUG$ 40 mg weeks , was with an average increase mean pressure about 3 Hg compared to alone	DDI-false
@DRUG$ Urinary @DRUG$ increased , and efficacy is by acidifying agents in methenamine therapy	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
therefore, @DRUG$ or other @DRUG$ (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting captopril.	DDI-false
These drugs include thiazides other corticosteroids , , , estrogens , @DRUG$ @DRUG$ sympathomimet-ics calcium drugs and	DDI-false
and @DRUG$ Failure Post-Myocardial EPHESUS patients 25 to mg also @DRUG$ or II receptor .	DDI-false
, apparently through an microsomal enzyme to the metabolism of warfarin-type , phenytoin @DRUG$ , tricyclic antidepressants , , @DRUG$ metronidazole delaying elimination and increasing blood levels drugs	DDI-false
Chloral hydrate and @DRUG$ interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, opiates, and @DRUG$.	DDI-effect
should be with patients   ( e.g. , propranolol inhibitor channel ( e.g. , , substrate , @DRUG$ inhibitor ) possible , arrest AV block ;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
administration local containing epinephrine or @DRUG$ patients receiving monoamine oxidase inhibitors , @DRUG$ phenothiazines produce severe , hypotension hypertension	DDI-effect
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, @DRUG$, and nifedipine.	DDI-false
These drugs the and @DRUG$ corticosteroids , phe-nothiazines , thyroid oral @DRUG$ , , calcium drugs , and	DDI-false
@DRUG$ Simvastatin CYP3A4 @DRUG$ of .	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Caution be exercised @DRUG$ is administered with drugs that of steroid hormones such @DRUG$ , and cimetidine	DDI-advise
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
antiarrhythmic , such @DRUG$ , and @DRUG$ have used concurrently .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
To impact of chemotherapy plus HAART the clinical course patients HIV-related non-Hodgkin lymphoma HIV-NHL , the compared retrospectively group of 24 HIV-NHL who were cyclophosphamide , and prednisone CHOP plus HAART group of were CHOP chemotherapy regimen ( i.e. , doxorubicin , @DRUG$ @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
There was a significant p in ( 48.59 vs. 49.9 9.93 ( 7.73 /- 2.0 ) , and tmax 1.1 + /- + /- @DRUG$ regimens .	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
@DRUG$ may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, reserpine.	DDI-effect
@DRUG$: Atorvastatin plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
be used with caution patients   agents @DRUG$ inhibitor ) or calcium ( , verapamil CYP3A4 and @DRUG$ , possible of bradycardia , sinus arrest , and	DDI-false
side , cefotetan , @DRUG$ ) ( @DRUG$ vitamin K and .	DDI-false
@DRUG$ plasma Drugs that may imatinib concentrations recommended administering @DRUG$ inhibitors of CYP3A4 family ( , ketoconazole , erythromycin ,	DDI-false
@DRUG$ will increase other drugs channel , certain reductase , . )	DDI-mechanism
recommended to avoid of ethambutol with @DRUG$ 4 hours following @DRUG$ administration .	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
- @DRUG$ (e.g., @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects of these medicines	DDI-false
Intravenous @DRUG$ (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
To impact chemotherapy plus on the clinical course with HIV-related , systemic lymphoma ( HIV-NHL , the authors retrospectively a HIV-NHL treated with the cyclophosphamide doxorubicin , , and ( CHOP chemotherapy regimen plus HAART with a group of patients who were with CHOP-like regimen i.e. @DRUG$ , teniposide and prednisone vincristine bleomycin ) @DRUG$	DDI-false
Derivatives @DRUG$ , ergotamine , methylergonovine potential and life-threatening such as acute @DRUG$ toxicity vasospasm and the extremities and	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
an effect microsomal systems , has to reduce metabolism of warfarin-type anticoagulants , propranolol , , certain @DRUG$ , theophylline @DRUG$ elimination increasing blood levels of these drugs	DDI-false
These drugs the @DRUG$ , corticosteroids , thyroid products @DRUG$ , contraceptives , , , sympathomimetics , blocking and	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of Gleevec, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
Central System : The of DURAGESIC @DRUG$ transdermal with other system , including limited to @DRUG$ , hypnotics ( e.g. , muscle relaxants may cause depression , sedation in coma or .	DDI-effect
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
specific have not , drugs that are mainly metabolized by CYP3A4 ( eg calcium channel blockers disopyramide , @DRUG$ , warfarin , , cyclosporine , carbamazepine fentanyl , alfentanyl , ) may have plasma concentrations coadministered @DRUG$ ;	DDI-mechanism
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
: In study , coadministration of an , magnesium , simethicone ) serum levels and excretion of fosinoprilat with , suggesting @DRUG$ may absorption of @DRUG$.	DDI-mechanism
While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
ACE and @DRUG$ Failure , 3020 ( 91 ) receiving 25 to 50 also ACE or receptor ( @DRUG$/ARB )	DDI-false
@DRUG$ may suppress certain CYP450 enzymes @DRUG$ , CYP2C9 , and CYP3A4 .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning.	DDI-false
Effect of @DRUG$ in Pediatric Patients There was about a 22% increase of apparent total body clearance of levetiracetam when it was co-administered with enzyme-inducing @DRUG$.	DDI-false
Other Drugs as , @DRUG$ , @DRUG$ , phenothiazines antihistamines tricyclic be QT-interval prolongation and risk of .	DDI-false
Clinical studies with @DRUG$ have identified potentially significant interactions with @DRUG$ and lithium.	DDI-int
@DRUG$: Coadministration of single doses of eszopiclone 3 mg and @DRUG$ 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
safety and @DRUG$ combination @DRUG$ not established .	DDI-false
@DRUG$: Plasma digoxin levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
Acetaminophen, lidocaine, @DRUG$, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Antihypertensives should be used with in   -receptor agents ( , , inhibitor ) calcium channel ( , @DRUG$ , a @DRUG$ a inhibitor ) because possible , arrest and AV ;	DDI-false
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of @DRUG$.	DDI-false
, or products containing or , @DRUG$ sucralfate should not be concomitantly with , or within , of , they resulting and urine	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and @DRUG$ by approximately 30% and 20%.	DDI-false
Antihypertensive medications, other, especially @DRUG$, or preanesthetic and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
@DRUG$ and @DRUG$ not to receiving coumarin	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Single doses of either @DRUG$ or colestipol resins bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-mechanism
Other therapy specific interaction studies were not , finasteride or more concomitantly in acetaminophen acetylsalicylic , a-blockers , , enzyme inhibitors , anticonvulsants benzodiazepines , @DRUG$ , cardiac @DRUG$ , , antagonists HMG-CoA inhibitors , prostaglandin inhibitors ( as NSAIDs ) quinolone anti-infectives adverse	DDI-false
@DRUG$ will other CYP3A4 , , dihydropyridine channel blockers , @DRUG$ . ) .	DDI-mechanism
Some @DRUG$/substances are known to accelerate the metabolism of @DRUG$ by stimulating the synthesis of CYP3A4 (enzyme induction).	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
therapy interaction studies were 1 mg or were @DRUG$ acid , ) inhibitors benzodiazepines , , , diuretics H2 , reductase inhibitors , @DRUG$ also as , clinically significant adverse .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ mg/kg ) moclobemide 30 mg/kg , ( mg/kg ) 20 ) @DRUG$ 30 mg/kg ) or vehicle	DDI-false
However, if @DRUG$ is to be initiated after cessation of heparin therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of @DRUG$ therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
been performed , drugs that are metabolized blockers , disopyramide , , @DRUG$ , , warfarin , , cyclosporine ergot derivatives carbamazepine , @DRUG$ and triazolam ) have elevated concentrations when coadministered with ;	DDI-false
therefore concomitant administration of @DRUG$ with @DRUG$ is contraindicated.	DDI-advise
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Since chronic dosing is required for therapeutic efficacy of @DRUG$, future studies should focus on investigation of chronic dosing effects of these drugs in combination with @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Methotrexate ( , Mexate ) of @DRUG$ may increase the effects liver and/or side of @DRUG$	DDI-false
These include the thiazides @DRUG$ corticosteroids , , products , estrogens oral , @DRUG$ , nicotinic sympathomimetics , calcium and isoniazid	DDI-false
@DRUG$ may reduce the of K.	DDI-false
In the case that you are taking digoxin while taking @DRUG$, higher doses of @DRUG$ may be needed.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with @DRUG$.	DDI-false
The similarity adverse profile ( AVONEX ) 2 with co-administered @DRUG$ indicates this alteration in clearance not necessitate reduction of @DRUG$ , )	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-advise
steroidal agent can reduce diuretic , natriuretic ,	DDI-false
@DRUG$ ( Magnesium-Aluminum Hydroxide plasma concentrations were not affected	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-false
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
Rifampin Co-administration VIOXX with @DRUG$ , a potent metabolism an approximate 50 % in @DRUG$ concentrations .	DDI-false
To evaluate chemotherapy plus on course of patients HIV-related , ( HIV-NHL retrospectively a with were the cyclophosphamide @DRUG$ vincristine , prednisone ( ) regimen HAART with of who were with CHOP chemotherapy regimen ( i.e. , cyclophosphamide doxorubicin , , and @DRUG$ plus ) without receiving antiretroviral therapy	DDI-false
, lidocaine phenobarbital , quinidine , @DRUG$ , and @DRUG$ added human serum at therapeutic concentrations .	DDI-false
, since there is bleeding with @DRUG$ caution should employed @DRUG$ is used that affect hemostasis .	DDI-false
Carbamazepine: In healthy subjects receiving the CYP3A4 inducer, @DRUG$, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to @DRUG$ was decreased approximately 72%.	DDI-mechanism
of antidepressants of inhibitor class may cause severe hypotension.@DRUG$ drug , and model .	DDI-mechanism
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-effect
that have man @DRUG$ , , , theophylline , and @DRUG$ and clinically interactions were found	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
@DRUG$ study of young subjects a direct pharmacokinetic @DRUG$-digoxin found	DDI-false
Folic in may the of @DRUG$ @DRUG$ , and increase the of susceptible pediatric .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
acetaminophen/theophylline , phenobarbital/valproic acid , , and .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Drugs that significant elevation in gastric pH ( histamine H2-receptor antagonists such as @DRUG$ reduce concentrations of @DRUG$ therefore potentially .	DDI-mechanism
In of in anesthetized with @DRUG$ @DRUG$ or pentobarbital , the needed to tachycardia significantly higher , was LD50 ouabain ketamine Innovar than with .	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Multivalent Products administration of a quinolone , , multivalent such as magnesium aluminum @DRUG$ , @DRUG$ pediatric powder or products containing calcium iron , or decrease the absorption , in serum and urine considerably desired	DDI-false
specific have not been coadministration are mainly metabolized ( , blockers dapsone , @DRUG$ , amiodarone , quinidine , warfarin , pimozide fentanyl , alfentanyl alprazolam , @DRUG$ may elevated concentrations when with	DDI-false
MAO well a @DRUG$ slow @DRUG$ metabolism .	DDI-mechanism
Although data , @DRUG$ , including @DRUG$ and nitroglycerin , an additive INOmax the developing	DDI-false
Chemotherapy Agents In a separate study , of @DRUG$ @DRUG$ alter the pharmacokinetics either agent or the of	DDI-false
- @DRUG$ (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Ritonavir @DRUG$ concomitant of 5 of @DRUG$ BID and AUC of reduced by approximately 20 %	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
CONCOMITANT THERAPY : Although interaction studies were performed studies , @DRUG$ was used enzyme ( inhibitors , betablockers calcium-channel diuretics @DRUG$ NSAIDs ) of interactions .	DDI-false
@DRUG$ report of was reported in patient @DRUG$.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent diuretics such as @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
@DRUG$ and may its	DDI-false
Treatment with @DRUG$ can directly interfere with blood glucose levels or may interact with @DRUG$.	DDI-int
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
of @DRUG$ eg @DRUG$ quinidine and ) may produce electrocardiographic and the risk	DDI-effect
@DRUG$ Lithium patients receiving @DRUG$ concomitantly cause elimination , inhibitors .	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ cause severe persistent accidents	DDI-false
These include other @DRUG$ @DRUG$ , products contraceptives , phenytoin , nicotinic , drugs , and isoniazid .	DDI-false
only @DRUG$ enhances @DRUG$-induced increases in accumbal dopamine.	DDI-effect
When @DRUG$ coadministered with phenytoin @DRUG$ or , reduced plasma concentrations .	DDI-mechanism
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Both @DRUG$ and 18-MC block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
@DRUG$ Administration of @DRUG$ concomitantly with associated with an in cyclosporine-induced , to decreased synthesis of renal .	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of enalapril may result in a further deterioration of renal function.	DDI-false
Although interaction studies were not performed finasteride doses 1 mg or concomitantly clinical studies with , acid , @DRUG$ angiotensin-converting ( ACE , anticonvulsants , benzodiazepines , blockers , cardiac , diuretics , H2 antagonists , @DRUG$ prostaglandin as NSAIDs , and quinolone anti-infectives of clinically significant interactions	DDI-false
Potential drug interactions   and ( @DRUG$ gabapentin lamotrigine phenobarbital , @DRUG$ and were assessed by evaluating concentrations of levetiracetam and clinical studies .	DDI-false
Furosemide: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ and @DRUG$ in some patients.	DDI-false
Dose adjustment not recommended no @DRUG$ , topiramate ,	DDI-false
of sclerosis concomitant AVONEX   30 weekly or @DRUG$ inconclusive with regard the dose adjustment @DRUG$ or glatiramer .	DDI-false
interactions between   AEDs @DRUG$ gabapentin , lamotrigine phenobarbital , phenytoin were also assessed evaluating concentrations these @DRUG$ during clinical	DDI-false
ACE and @DRUG$ In clinical studies patients hypertension addition of INSPRA 100 mg inhibitors @DRUG$ mean potassium slightly about 0.09 - .	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
@DRUG$ : astemizole * , @DRUG$ * serious and/or .	DDI-false
Benzthiazide @DRUG$ , blood thinners , drugs allergy , cold , and ) , diabetic drugs , lithium , norepinephrine @DRUG$ or Ibuprofen , high blood pressure .	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
Nervous : concomitant @DRUG$ transdermal with nervous not other opioids , sedatives , ( ) , , skeletal muscle relaxants @DRUG$ may cause , hypotension profound or or	DDI-effect
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, cimetidine, @DRUG$), though this has not been studied	DDI-false
This effect may be mediated by the ability of @DRUG$ to induce microsomal enzymes and, thus, the catabolism of @DRUG$.	DDI-mechanism
inhibitors include antifungals , @DRUG$ clarithromycin , , erythromycin , imatinib , @DRUG$ nicardipine protease verapamil	DDI-false
, derivatives , aggregation inhibitors NSAIDs ) , and @DRUG$ risk bleeding concomitantly @DRUG$.	DDI-effect
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
CYP3A4 Racemic @DRUG$ exposure was 80 % by useof @DRUG$ , inducer of CYP3A4	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
@DRUG$ inhibited by @DRUG$.	DDI-effect
Multivalent Cation-Containing Concurrent a with cation-containing products as magnesium @DRUG$ , chewable/buffered tablets pediatric , or products calcium , iron @DRUG$ may of ciprofloxacin , in serum urine levels considerably .	DDI-false
interaction were not , clinical studies sodium was used with angiotensin- ( ) , @DRUG$ , nonsteroidal anti-inflammatory ( @DRUG$ ) without significant adverse	DDI-false
These results suggest that @DRUG$ and , and other @DRUG$ retinoids , regulate the proliferation of prostate dose-dependent modification of the of insulin and EGF	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
include thiazides and diuretics , @DRUG$ , thyroid products , estrogens oral contraceptives , @DRUG$ acid , sympathomimetics blocking drugs , isoniazid	DDI-false
Because has not additional beyond that obtained with because aspirin the of excretion the concomitant use @DRUG$ @DRUG$ not recommended	DDI-advise
@DRUG$ : Haloperidol dopamine thus central	DDI-false
therapies not be @DRUG$ as pharmacologic .	DDI-advise
The of during treatment with this is increased with @DRUG$ niacin ( erythromycin	DDI-false
@DRUG$: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on tolazamide (1 gm/day) 11 days after the addition of @DRUG$ (75 mg/day).	DDI-false
Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, @DRUG$ and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as @DRUG$ or cimetidine) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
@DRUG$ of may be inhibited concomitant administration of , leading to plasma levels of @DRUG$.	DDI-false
Therefore, when @DRUG$ is given to a patient receiving warfarin, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Amiodarone, bepridil, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
@DRUG$: In diabetic patients receiving @DRUG$ and tolbutamide, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
The pharmacokinetics of @DRUG$ are unaltered in the presence of @DRUG$ and vice versa.	DDI-false
@DRUG$ had a similar effect in the presence of @DRUG$.	DDI-false
@DRUG$: @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of cimetidine.	DDI-false
@DRUG$: The effect of @DRUG$ on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
The possibility or @DRUG$ be minimized by either discontinuing the @DRUG$ or the intake prior with enalapril or .	DDI-effect
@DRUG$ : Concomitant treatment with Accutane and avoided because @DRUG$ has been associated a number of of pseudotumor intracranial ) of which involved	DDI-false
@DRUG$ inhibits @DRUG$.	DDI-false
The intensity uniformity and course of anticoagulant interference phenobarbital , @DRUG$ , @DRUG$ and were 16 patients receiving	DDI-false
intensity , uniformity and course of @DRUG$ phenobarbital secobarbital , chloral hydrate and methaqualone systematically investigated in receiving @DRUG$ therapy .	DDI-false
@DRUG$ and @DRUG$ similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.	DDI-false
Non-steroidal Agents : In patients with compromised renal function @DRUG$ the co-administration @DRUG$ may in a of renal	DDI-effect
- Anabolic steroids (@DRUG$ [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of @DRUG$, dextromethorphan, and methotrexate.	DDI-false
The pharmacokinetics of @DRUG$ are the presence of @DRUG$ .	DDI-false
Antiarrhythmics @DRUG$ bepridil , @DRUG$ , propafenone CONTRAINDICATED due to for serious and/or reactions .	DDI-false
Similarly dialyzed , @DRUG$ and @DRUG$ , both at in at three	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
The @DRUG$ are a family of @DRUG$ and hypnotic drugs.	DDI-false
Example inhibitors include azole antifungals , @DRUG$ imatinib , isoniazid , , @DRUG$ protease inhibitors quinidine ,	DDI-false
, @DRUG$ Diuretics Concomitant treatment xanthine @DRUG$ or diuretics potentiate possible	DDI-false
, , , and	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
Anticoagulants Potentiation of warfarin-type ( @DRUG$ substrate ) response always seen patients receiving @DRUG$ result in serious fatal bleeding	DDI-false
studies performed with , the concomitant of ( , platelet acid , @DRUG$ piroxicam , and @DRUG$ did significantly affect fondaparinux sodium	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
: concomitant use of DURAGESIC   ) with other central nervous depressants , not to other opioids , @DRUG$ tranquilizers ( e.g. @DRUG$ ) , general , skeletal muscle relaxants , and , may cause respiratory hypotension , and potentially result coma or death	DDI-false
Patients both and @DRUG$ be to determine if desired diuretic antihypertensive of @DRUG$ achieved	DDI-false
no specific drug topical drugs medications were identified in of @DRUG$ Ophthalmic , the possibility an effect with CNS depressants ( , @DRUG$ , , should be considered .	DDI-advise
Other Although interaction studies not , doses of were concomitantly used in clinical with acetaminophen , acetylsalicylic acid , enzyme ACE , @DRUG$ , , beta , blockers cardiac , H2 antagonists HMG-CoA @DRUG$ ( also as NSAIDs , and without evidence adverse .	DDI-false
@DRUG$: May decrease renal tubular secretion of @DRUG$ resulting in increased blood levels and/or ampicillin toxicity.	DDI-mechanism
Central Nervous System : The use DURAGESIC ( fentanyl ) other central system depressants not opioids , @DRUG$ tranquilizers , benzodiazepines ) , @DRUG$ phenothiazines , skeletal relaxants and alcohol may depression hypotension and sedation potentially result or death .	DDI-false
Lithium: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal @DRUG$ clearance.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$ and Zidovudine @DRUG$ can antagonize the activity and zidovudine against .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The effects of nonbenzodiazepine agonists at benzodiazepine receptors, such as @DRUG$, triazolopyridazines and others, are also blocked by @DRUG$.	DDI-effect
Central System : concomitant of ( fentanyl system ) central nervous depressants including but limited to other @DRUG$ sedatives , tranquilizers ( e.g. benzodiazepines ) general , @DRUG$ skeletal muscle and , may cause depression , , potentially coma	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Multivalent Cation-Containing administration quinolone ciprofloxacin such as @DRUG$ or aluminum chewable/buffered tablets powder , products @DRUG$ , or substantially the of resulting serum levels considerably lower than desired	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Aspirin: @DRUG$ (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by @DRUG$ (two 81 mg tablets).	DDI-false
mild administration 25 of VIOXX the @DRUG$ @DRUG$ , 10 to associated with increase mean 3 compared to alone	DDI-false
Drug Interactions : Flupenthixol may with some like @DRUG$ ( MAOI ): could pharmacodynamics - : : Flupenthixol the @DRUG$	DDI-false
Several drug interaction studies have been completed with both @DRUG$ and @DRUG$.	DDI-false
studies been performed , with drugs mainly eg , calcium blockers dapsone quinine , , , cyclosporine ergot derivatives , @DRUG$ carbamazepine fentanyl , alfentanyl , , concentrations when coadministered with @DRUG$ ;	DDI-mechanism
Potential pharmacokinetic were in studies @DRUG$ valproate , oral @DRUG$ , digoxin , ) screening in placebo-controlled in epilepsy patients	DDI-false
@DRUG$: When multiple doses of @DRUG$ and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
drugs include the , estrogens @DRUG$ , @DRUG$ sympathomimet-ics , channel .	DDI-false
Cephalosporins-@DRUG$ containing side of ( , cefotetan @DRUG$ , or methylthiadiazole ) can cause hypoprothrombinemia .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, troleandomycin, @DRUG$, @DRUG$) would be expected to behave similarly.	DDI-false
OTHER THERAPY : specific were performed studies sodium used concomitantly @DRUG$ betablockers blockers @DRUG$ and anti-inflammatory drugs evidence of clinically interactions	DDI-false
Dose adjustment had effect on plasma @DRUG$ , valproate , or lamotrigine .	DDI-false
Warfarin: @DRUG$ enhances the effect of @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
of @DRUG$ Acamprosate not the of	DDI-false
concomitant specific interaction were not performed finasteride of mg or were in clinical acetylsalicylic acid , a-blockers ( ) inhibitors , anticonvulsants benzodiazepines beta blockers blockers , nitrates @DRUG$ @DRUG$ , HMG-CoA inhibitors synthetase inhibitors ( also to as NSAIDs , without of clinically significant interactions	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these @DRUG$ do not influence the pharmacokinetics of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although neither @DRUG$ the of epithelium RPMI1640 containing alone , modify the effect of @DRUG$ insulin	DDI-effect
The risk myopathy drugs this class is with @DRUG$ , @DRUG$ azole	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
disopyramide , @DRUG$ , phenothiazines , , and @DRUG$ may associated QT-interval prolongation an increased risk of arrhythmia .	DDI-false
@DRUG$ 20 , when co-administered with @DRUG$ mg 60 mg once daily the bioavailability AUC ) concentration nifedipine drug that metabolized CYP3A4	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Suppression by @DRUG$ of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and @DRUG$.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/@DRUG$).	DDI-false
( ( mg/kg ) decreases intravenous of @DRUG$ and @DRUG$ the oral self-administration ethanol ;	DDI-false
lithium should be monitored if @DRUG$ administered	DDI-advise
Since @DRUG$ a , there the the use St. s Wort in patients receiving @DRUG$ in reduced	DDI-false
have metabolized CYP3A4 eg , , @DRUG$ , cyclosporine ergot derivatives , , carbamazepine , fentanyl , and @DRUG$ ) elevated plasma concentrations when saquinavir ;	DDI-false
therapy Although interaction studies of 1 more were used in with acetaminophen , acetylsalicylic , enzyme ACE anticonvulsants , , calcium-channel blockers , cardiac nitrates , , @DRUG$ , inhibitors , synthetase ( also referred to and @DRUG$ evidence of	DDI-false
studies with @DRUG$ have @DRUG$.	DDI-int
Therefore @DRUG$ and nonsteroidal agents are used , the patient should be observed closely to determine desired of @DRUG$	DDI-false
HIV Protease co-administered Vardenafil mg in 16-fold in @DRUG$ , 7-fold increase in a @DRUG$ half-life .	DDI-false
a median follow-up 33 months the @DRUG$ @DRUG$ did demonstrate any tamoxifen in patients as in hormone .	DDI-false
@DRUG$ : Amphetamines may sedative	DDI-false
INOmax has been administered with @DRUG$, dopamine, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
Cation-Containing : Concurrent including ciprofloxacin , with multivalent products as @DRUG$ @DRUG$ , sucralfate , chewable/buffered tablets powder containing calcium , , zinc may substantially resulting in and urine levels considerably desired .	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ and @DRUG$ similarly and EGF- or insulin-induced prostatic .	DDI-false
The successive application of 5 or 10 mg/kg ( e.w ) and @DRUG$ . 10 min motility of chick embryos effect @DRUG$ .	DDI-false
Although neither @DRUG$ nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
- @DRUG$ (e.g., @DRUG$, Synkayvite) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
@DRUG$: Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine.	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or @DRUG$.	DDI-false
@DRUG$ Potentiation of and ) anticoagulant is almost seen in patients amiodarone and result in bleeding	DDI-false
Colestipol: Plasma concentrations of @DRUG$ decreased approximately 25% when @DRUG$ and atorvastatin were coadministered.	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Previous reduction in the oral bioavailability @DRUG$ concomitantly with an intravenous such @DRUG$.	DDI-mechanism
@DRUG$-Vitamin K can the @DRUG$	DDI-false
Sedatives/@DRUG$: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Both @DRUG$ block dopamine release in accumbens ;	DDI-effect
use of @DRUG$ other @DRUG$ not recommended due the increased possibility little increase .	DDI-effect
Drug/Laboratory Test Interaction @DRUG$ may cause a false low measurement of serum @DRUG$ levels with the Digi- Tab  RIA Kit for Digoxin.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
of @DRUG$ and antidepressants of the may cause severe orthostatic , inhibitor microsomal metabolism , increased half-life in a rat model .	DDI-false
This interact with other @DRUG$ ( may potentiate the of or @DRUG$ ) other medications with activity may be , and ) use antihistamines may prolong intensify the and depressant effects of antihistamines	DDI-false
@DRUG$, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Vitamin : of the relationship of @DRUG$ , should be advised against @DRUG$ containing A to avoid additive toxic	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Benzthiazide interact thinners drugs , and sinus ) diabetic drugs @DRUG$ norepinephrine @DRUG$ Aleve , and high	DDI-false
Potential differences in @DRUG$ dosing and pharmacokinetics at different levels of @DRUG$ exposure were assessed in the context of ANOVA.	DDI-false
Although have not been , with drugs that are mainly CYP3A4 ( calcium blockers dapsone , disopyramide , amiodarone , quinidine , warfarin , , cyclosporine , ergot derivatives pimozide , carbamazepine , fentanyl , , @DRUG$ ) may plasma concentrations when with @DRUG$ ;	DDI-mechanism
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)-A drug interaction study of @DRUG$ with an @DRUG$ has not been conducted.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Central Nervous System : The use DURAGESIC ( fentanyl transdermal system ) with central nervous , but not limited to other sedatives , hypnotics , ( e.g. , benzodiazepines , general @DRUG$ , @DRUG$ cause , and profound sedation , potentially result death .	DDI-false
@DRUG$/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, @DRUG$, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Oral @DRUG$ ( birth control pills ) @DRUG$ or	DDI-false
Patients receiving @DRUG$ and @DRUG$ concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose.	DDI-advise
For information on the pharmacokinetics of @DRUG$ and @DRUG$ in combination, see Drug Interactions under CLINICAL PHARMACOLOGY section.	DDI-false
@DRUG$: Caution should be used if diflunisal is administered concomitantly with @DRUG$.	DDI-false
Bacteriostatic Chloramphenicol , erythromycins or @DRUG$ interfere bactericidal of	DDI-effect
azole @DRUG$ diclofenac , doxycycline imatinib @DRUG$ propofol , , quinidine , verapamil	DDI-false
the selective reuptake inhibitors @DRUG$ e.g. , , , , sertraline , @DRUG$ , P450 2D6 , they may vary in of .	DDI-false
Micro-dosed @DRUG$ Preparations: Micro-dosed progesterone preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during Accutane therapy.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Naproxen : The of @DRUG$ normal plasma levels @DRUG$ , the urinary excretion and its glucuronide metabolite .	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Central : concomitant DURAGESIC   fentanyl ) other central nervous limited other sedatives , , tranquilizers e.g. , benzodiazepines , @DRUG$ , phenothiazines , muscle relaxants and @DRUG$ may respiratory , hypotension , result or death	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-false
The conversion @DRUG$ to @DRUG$ by aldehyde oxidase .	DDI-false
@DRUG$ such norepinephrine enhanced by	DDI-effect
injection of @DRUG$ ( @DRUG$ ) were observed measuring locomotor and stereotyped behavior .	DDI-false
containing side chains of ( cefmenoxime , cefoperazone , @DRUG$ @DRUG$ or methylthiadiazole ( ) cause vitamin K hypoprothrombinemia	DDI-false
Drug Interactions interact some , Monoamine ( @DRUG$ ): affect @DRUG$ pharmacodynamics Arecoline - - and additive CNS depression - Tricyclic antidepressants : increases effect Tricyclic	DDI-false
@DRUG$: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Alcohol, @DRUG$, or @DRUG$: potentiation of orthostatic hypotension may occur.	DDI-false
Depressants The use DURAGESIC   fentanyl ) with other system , limited to other opioids tranquilizers ( , @DRUG$ general phenothiazines @DRUG$ cause depression hypotension , sedation or or	DDI-false
ACE and Angiotensin Receptor ( Congestive Post-Myocardial EPHESUS ( 91 % receiving INSPRA 50 mg @DRUG$ or angiotensin II receptor antagonists	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
It is that increased interaction between @DRUG$ sites apomorphine on the action of @DRUG$ their administration	DDI-false
@DRUG$-Concomitant of cholestyramine and vitamin the	DDI-false
Imipramine ( mg/kg , @DRUG$ ( 30 ) clonazepam ) fluoxetine ( 20 mg/kg @DRUG$ ( ) vehicle was administered .	DDI-false
Benzthiazide may alcohol @DRUG$s , , sinus medicines ) , , @DRUG$ like or Ibuprofen and blood pressure	DDI-false
ANTACID Magnesium-Aluminum @DRUG$ concentrations not affected by of	DDI-false
Cardiovascular Agents @DRUG$ and concomitantly with beta adrenergic-blocking , nitrates hydralazine , @DRUG$ without of clinically interactions .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Mineral Oil-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$/@DRUG$ Rofecoxib did clinically effect pharmacokinetics of prednisone .	DDI-false
However crossover in Tagamet mg . or 800 mg a 300 mg b.i.d of theophylline @DRUG$ Key Inc. ) demonstrated alteration steady-state @DRUG$ mg h.s . , particularly subjects 54 years and older	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
action sulfonylureas be potentiated by including are highly , sulfonamides , , @DRUG$ , @DRUG$ and blocking agents	DDI-false
Antihypertensives : Amiodarone should caution patients receiving   blocking e.g. , @DRUG$ calcium channel e.g. , verapamil a @DRUG$ and diltiazem , a CYP3A4 inhibitor because the possible of , , and ;	DDI-false
, in the second study , administration cholestyramine 1 evening 0.3 @DRUG$ approximately 4 hours the resulted in the AUC less and decrease in when @DRUG$ .	DDI-false
with compounds that are potent of CYP3A4 ( , @DRUG$ , @DRUG$ , dexamethasone , carbamazepine ) may in decreased levels saquinavir	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
EM with @DRUG$ @DRUG$ , is 6- 8-fold , 3- 4-fold than alone .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
: In coadministration of an ( hydroxide , , simethicone levels urinary excretion fosinoprilat with @DRUG$ administered alone , suggesting that @DRUG$ may absorption fosinopril	DDI-false
: Flupenthixol may interact drugs , Monoamine @DRUG$ theoretically - @DRUG$ - Eproxindine - Ethanol : Ethanol cause - Tricyclic antidepressants : Flupenthixol increases the of Tricyclic	DDI-false
A possible interaction between @DRUG$ and ciprofloxacin, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-false
have been , with are metabolized by , blockers , , disopyramide @DRUG$ , quinidine @DRUG$ tacrolimus ergot derivatives , , alfentanyl , alprazolam triazolam have when with saquinavir	DDI-false
drug may interact CNS depressants potentiate the of these medications or antihistamines anticholinergics anticholinergic effects may be these medications are used concurrently with @DRUG$ monoamine oxidase ( ( with intensify and @DRUG$ )	DDI-false
of @DRUG$ as @DRUG$ or norepinephrine are enhanced Tosylate .	DDI-false
biologic half-life @DRUG$ in metabolic that in @DRUG$ .	DDI-false
In clinical studies with @DRUG$ (@DRUG$, 1 mg) in men 18-41 years of age, the mean value of serum prostate-specific antigen (PSA) decreased from 0.7 ng/mL at baseline to 0.5 ng/mL at Month 12.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
The hypoglycemic effect of @DRUG$ has been reported to increase when @DRUG$ is given concurrently.	DDI-effect
These drugs the and @DRUG$ , @DRUG$ phenothiazines , thyroid , oral , nicotinic , , channel , isoniazid	DDI-false
Particular necessary cases of mixed drug overdosage since the ( convulsions and ) of other ( emerge the @DRUG$ by	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
- @DRUG$ @DRUG$ or	DDI-false
Antihypertensive , especially , or or @DRUG$ used surgery	DDI-false
- @DRUG$ ( , @DRUG$ ) or	DDI-false
Pretreatment of megakaryocytes with extracellular @DRUG$ (50 microM) also inhibited @DRUG$-induced responses.	DDI-effect
may increase antihypertensive , e.g. guanethidine @DRUG$	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of phenytoin, @DRUG$, and @DRUG$.	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
acetaminophen/@DRUG$ lidocaine/quinidine phenobarbital/acetaminophen phenobarbital/valproic acid , @DRUG$/phenobarbital	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
It is not known if @DRUG$ differ in their effectiveness when used with @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Notably, systemic exposure (AUC0-12) of @DRUG$ (@DRUG$) was more than doubled in the presence of TMP/SMX.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
digitalis tolerance with Vet , @DRUG$ the dosage ouabain needed cause ventricular tachycardia significantly higher , as was LD50 @DRUG$ with ketamine or than pentobarbital .	DDI-false
@DRUG$ may decrease the amount of @DRUG$ (Lanoxin, Lanoxicaps) that gets absorbed into your body.	DDI-mechanism
While @DRUG$ ( SSRIs , , citalopram @DRUG$ , sertraline , and paroxetine , inhibit P450 2D6 may vary in .	DDI-false
Cardiovasculars : @DRUG$ : receiving @DRUG$ , of amiodarone regularly results an increase in concentration clinical toxicity	DDI-false
drugs include the thiazides and phenothiazines thyroid products , oral @DRUG$ nicotinic acid , , @DRUG$ .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
In mild to moderate , mg VIOXX @DRUG$ 40 was associated with average increase about 3 compared to @DRUG$ alone .	DDI-false
Anticoagulants : of ( CYP2C9 substrate ) anticoagulant @DRUG$ result serious or .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with @DRUG$.	DDI-false
Nalfon been to produce any additional effect with aspirin alone and @DRUG$ increases the rate Nalfon use of @DRUG$ .	DDI-false
doses or @DRUG$ @DRUG$ and its absorption gastrointestinal by up and ,	DDI-false
@DRUG$ : Probenecid of ciprofloxacin and produces an level of @DRUG$ serum .	DDI-false
@DRUG$ drugs quinidine procainamide , @DRUG$ , phenytoin , have	DDI-false
Adequate monitoring of @DRUG$ plasma concentrations should be considered when therapy with VIOXX is initiated or changed in patients receiving @DRUG$.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
The of other @DRUG$ with @DRUG$ has been shown to the effect and in severe in impaired .	DDI-effect
possibility hypotensive with enalapril or be either discontinuing @DRUG$ the salt prior to of @DRUG$ enalaprilat	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
amiodarone for @DRUG$ , that use of John in patients receiving @DRUG$ levels	DDI-false
Example azole antifungals , ciprofloxacin clarithromycin , @DRUG$ , erythromycin , , , , inhibitors , quinidine @DRUG$.	DDI-false
Antacids In clinical pharmacology study antacid , @DRUG$ , @DRUG$ fosinopril reduced serum excretion of fosinoprilat fosinopril administered alone absorption of	DDI-false
Preliminary animal and human studies have shown that small quantities of systemically administered @DRUG$ enter the CSF primarily as 5-methyltetrahydro-folate and, in humans, remain 1 to 3 orders of magnitude lower than the usual @DRUG$ concentrations following intrathecal administration.	DDI-false
Like @DRUG$ 40 18-MC the intravenous of @DRUG$ and the self-administration of and nicotine in ;	DDI-false
@DRUG$ and retinyl acetate similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
@DRUG$ : healthy @DRUG$ CYP3A4 inhibitor , 200 mg twice for 7 systemic exposure ) was increased to approximately half-life control	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
inhibitors azole antifungals , , , , doxycycline erythromycin imatinib , nefazodone , , @DRUG$ @DRUG$ verapamil .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
Antacids a clinical study @DRUG$ ( hydroxide magnesium hydroxide , simethicone ) with @DRUG$ reduced serum urinary of with fosinopril suggesting that antacids impair absorption fosinopril	DDI-mechanism
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
selective serotonin inhibitors ) , @DRUG$ , escitalopram , @DRUG$ , sertraline , and paroxetine 2D6 they may the extent	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
Compounds that have been tested in man include antipyrine, digoxin, propranolol, @DRUG$, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
In patients receiving Nalfon and a @DRUG$ concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
drugs and other diuretics , corticosteroids thyroid products , @DRUG$ , contraceptives , , @DRUG$ , sympathomimetics , channel blocking	DDI-false
Anticholinesterases (neostgmine, physostigmine), @DRUG$, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Note: dissolution of aerosol particles of @DRUG$ in Survanta, a model @DRUG$.	DDI-false
Other specific interaction were not performed , were concomitantly studies , acetylsalicylic , analgesics angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ beta blockers @DRUG$ , nitrates , H2 antagonists , HMG-CoA reductase synthetase referred to as NSAIDs without of clinically adverse .	DDI-false
that tested , digoxin @DRUG$ , @DRUG$ , and warfarin clinically	DDI-false
Although specific studies have not been , coadministration mainly metabolized by CYP3A4 , channel blockers , disopyramide , amiodarone , quinidine warfarin , @DRUG$ , , derivatives @DRUG$ , carbamazepine fentanyl , , and ) plasma concentrations when coadministered saquinavir	DDI-false
Drugs The of diflunisal to normal @DRUG$ renal clearance increased the	DDI-false
, , @DRUG$/acetaminophen phenobarbital/valproic acid , @DRUG$/acetaminophen valproic .	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, @DRUG$, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
: administration with the @DRUG$ @DRUG$ has , on occasions , in hypoglycemia	DDI-false
containing of N-methylthiotetrazole ( @DRUG$ @DRUG$ cefotetan , latamoxef ) or methylthiadiazole cefazolin cause K	DDI-false
Cephalosporins-@DRUG$ containing side of N-methylthiotetrazole ( @DRUG$ , , latamoxef or methylthiadiazole ( cefazolin ) can vitamin K hypoprothrombinemia	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Because the for from drugs nursing infants , decision must made whether to nursing discontinue @DRUG$ and @DRUG$	DDI-false
BACKGROUND : The effects of of hydrochloride ( ) , a @DRUG$ incidence of peritoneal of adenocarcinomas by @DRUG$ and index intestinal were investigated Wistar .	DDI-false
results suggest @DRUG$ in alcoholic interaction with its and @DRUG$	DDI-effect
@DRUG$ , oral ( medicine you take with sulfapyridine increase of effects the and/or side or oral @DRUG$	DDI-false
@DRUG$ MAOI , as a metabolite @DRUG$ , metabolism .	DDI-false
is necessary using @DRUG$ in mixed drug overdosage effects ( such convulsions dysrhythmias other drugs taken overdose @DRUG$ may the reversal benzodiazepine by flumazenil .	DDI-effect
reported interactions with @DRUG$ CYP3A4 ) @DRUG$ may hypotension , , decreased cardiac output	DDI-false
Drugs that Inhibit or Induce Cytochrome P450 3A4 Enzymes @DRUG$ undergoes extensive metabolism by CYP3A4, and concomitant administration of strong inhibitors or inducers of CYP3A4 alter @DRUG$ concentrations significantly.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-effect
International Normalized Ratio (INR) elevations and/or bleeding events have been reported in some patients taking @DRUG$ while on @DRUG$ therapy.	DDI-effect
While inhibitors ( SSRIs , @DRUG$ , @DRUG$ fluoxetine , and , may vary in the .	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on @DRUG$ than in patients on no other antihypertensive therapy.	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Ritonavir and : administration 5 @DRUG$ 600 mg @DRUG$ Cmax ritonavir reduced by 20 .	DDI-mechanism
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both @DRUG$ and @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
QTc prolongation with , in taking amiodarone when @DRUG$ @DRUG$ azoles were administered concomitantly .	DDI-false
Patients receiving these drugs who are given @DRUG$, or any other @DRUG$, and particularly those patients with altered renal function, should be observed for the development of the specific toxicities of these drugs.	DDI-false
@DRUG$ been used concomitantly @DRUG$	DDI-false
@DRUG$ , , flecainide , @DRUG$ CONTRAINDICATED to potential for life-threatening	DDI-false
Other therapy Although interaction studies were not finasteride doses of 1 more were concomitantly used clinical with @DRUG$ , acid , a-blockers , analgesics , angiotensin-converting ( inhibitors , @DRUG$ , calcium-channel blockers , , diuretics , , HMG-CoA reductase , prostaglandin synthetase inhibitors also referred NSAIDs ) and anti-infectives without evidence clinically significant .	DDI-false
@DRUG$ MAOI antidepressants, as well as a metabolite of @DRUG$, slow amphetamine metabolism.	DDI-false
@DRUG$: Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Mothers It not @DRUG$ @DRUG$ or components	DDI-false
patients mild administration of of VIOXX @DRUG$ , to mg for 4 weeks , an average in mean Hg @DRUG$ .	DDI-false
In @DRUG$ does not the in vitro	DDI-false
@DRUG$ and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
glucocorticoids have reduce effects fever , renal , and of these agents @DRUG$ may antitumor effectiveness PROLEUKIN . and other @DRUG$ may with .	DDI-false
: @DRUG$ injection like , of the nervous system when with ethyl , , @DRUG$ , inhibitors other antidepressants When scopolamine with increased incidence sedation hallucinations , behavior has been	DDI-effect
@DRUG$ @DRUG$ quinidine 33 after two .	DDI-false
Other therapy Although specific interaction were , doses of mg or more were used in studies acetaminophen , a-blockers , analgesics , @DRUG$ , benzodiazepines , , @DRUG$ , nitrates , diuretics , antagonists , reductase synthetase inhibitors ( also as NSAIDs and quinolone anti-infectives evidence clinically interactions .	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Multivalent Products : Concurrent of a quinolone including ciprofloxacin , cation-containing @DRUG$ or aluminum sucralfate tablets or , zinc may the absorption @DRUG$ , resulting lower desired	DDI-false
The of @DRUG$ anesthesia @DRUG$ dogs	DDI-false
If treatment with activity as @DRUG$ , intraconazole , , , saquinavir @DRUG$ , . indicated reduction of dose be .	DDI-false
to 3A Inhibitors Basis Studies Involving @DRUG$ caution is recommended coadministration Coadministration of fluoxetine maximum plasma concentration of @DRUG$ by 46 % 21 % half-life by % , and decreased measured psychomotor .	DDI-false
Compounds that have been tested in man include antipyrine, digoxin, @DRUG$, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and ciprofloxacin when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
Data from in studies of other alprazolam suggest a possible interaction for the @DRUG$ , @DRUG$ , ,	DDI-false
Drug : Flupenthixol interact drugs , @DRUG$ ( could flupenthixol - Arecoline - Ethanol : Flupenthixol Ethanol cause CNS - @DRUG$ : the effect of Tricyclic	DDI-false
Antiarrhythmics : antiarrhythmic drugs as quinidine , @DRUG$ , @DRUG$ and have been .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
interactions Keppra and AEDs gabapentin , phenobarbital @DRUG$ and @DRUG$ ) assessed by the levetiracetam AEDs placebo-controlled clinical studies .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
No Levosimendan not with @DRUG$ felodipine , @DRUG$ , warfarin isosorbide mononitrate , or itraconazole	DDI-false
@DRUG$ Concomitant Accutane be because Accutane use been associated with a number of cases pseudotumor ( hypertension ) , some of which involved concomitant @DRUG$	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Quetiapine fumarate ('@DRUG$') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Stavudine and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-effect
Patients receiving @DRUG$ sulfonamides , or @DRUG$ be observed for activity drugs and , therefore , signs from these drugs .	DDI-false
@DRUG$ interact orally administered @DRUG$ the effect not significant	DDI-int
WARFARIN: Co- administration of warfarin and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
may and decrease the @DRUG$ contribution to the body by intestinal microflora	DDI-false
risk a potential interaction between @DRUG$ and @DRUG$ has preclinical or	DDI-false
@DRUG$ as @DRUG$ , inhibit activation vitro , intravascularly	DDI-false
Since the concomitant administration of @DRUG$ with amiodarone increases the prothrombin time by 100% after 3 to 4 days, the dose of the @DRUG$ should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Tagamet , an certain reported reduce warfarin-type anticoagulants propranolol , nifedipine , @DRUG$ , @DRUG$ , , lidocaine , theophylline , blood levels of these drugs	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, @DRUG$, or @DRUG$.	DDI-false
Injection : Lorazepam like injectable benzodiazepines , the nervous system when administered with , @DRUG$ @DRUG$ other antidepressants When scopolamine is concomitantly with injectable lorazepam an increased incidence of irrational behavior observed .	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
The , uniformity time of interference , secobarbital @DRUG$ , methaqualone were systematically 16 patients receiving @DRUG$ therapy	DDI-false
The possibility hypotensive effects can by either @DRUG$ salt of treatment with	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Similarly dialyzed were @DRUG$, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
These increases should be considered when selecting an oral @DRUG$ for a woman taking @DRUG$.	DDI-advise
@DRUG$ (NSAIDs)-A drug interaction study of eplerenone with an @DRUG$ has not been conducted.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
If a @DRUG$ is also used, it may increase the risk of @DRUG$ toxicity.	DDI-effect
Effect of @DRUG$ on the pharmacokinetics of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ ( AquaMEPHYTON @DRUG$ of with these may side effects affecting the	DDI-false
( 5 , moclobemide ( , @DRUG$ mg/kg @DRUG$ 20 vehicle .	DDI-false
not been to additional effect beyond with @DRUG$ alone and @DRUG$ increases Nalfon , of Nalfon salicylates is not recommended	DDI-false
@DRUG$: Rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of @DRUG$ after a single 0.5 mg oral dose.	DDI-false
because of this, the dosage of @DRUG$ should be adjusted when these @DRUG$ are administered concomitantly.	DDI-false
These drugs include the @DRUG$ and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Other Although interaction were not , finasteride of 1 mg in , , enzyme anticonvulsants benzodiazepines beta blockers , , cardiac nitrates , diuretics @DRUG$ reductase @DRUG$ ( also referred to as ) anti-infectives without evidence significant adverse interactions .	DDI-false
Example inhibitors include @DRUG$ ciprofloxacin , clarithromycin , erythromycin , imatinib , @DRUG$ , , , protease inhibitors , , and .	DDI-false
12 ) @DRUG$ ( @DRUG$ ) was doubled in presence of TMP/SMX .	DDI-false
@DRUG$ and @DRUG$ use may be rarely associated with ventricular fibrillation when combined with Adenocard.	DDI-false
Combination of @DRUG$ with other antiarrhythmic therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
Amiodarone suppress certain CYP450 enzymes including @DRUG$ @DRUG$ , .	DDI-false
specific topical systemic medications were identified clinical studies of % Ophthalmic possibility of an additive depressants ( alcohol barbiturates , @DRUG$ @DRUG$ ) be considered .	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
example @DRUG$ , @DRUG$ renin-angiotensin-aldosterone	DDI-false
to dictate against the clinical use methotrexate @DRUG$ the period following @DRUG$ when asparagine levels are	DDI-false
@DRUG$ : In subjects inducer , twice for and 200 twice exposure ( @DRUG$ was 72 %	DDI-false
A potential interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported.	DDI-effect
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
this was interaction @DRUG$ and both or its analogue @DRUG$ , or peptides mice after intracisternal injection	DDI-false
However , crossover study in healthy subjects receiving @DRUG$ mg . or 800 mg h.s concomitantly with b.i.d dosage theophylline @DRUG$ , Key Inc. ) demonstrated less in levels the mg h.s , subjects aged 54 and .	DDI-mechanism
In , certain drugs that metabolized by this , many @DRUG$ @DRUG$ , reuptake , others may inhibit of isoenzyme normal poor metabolizers with to concomitant therapy other by system drug interactions	DDI-false
the @DRUG$ after @DRUG$ administration 56.9 % range : 81 ) .	DDI-mechanism
@DRUG$: Because of the relationship of Accutane to vitamin A, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
INOmax has been administered with tolazoline, @DRUG$, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
Coadministration oral @DRUG$ not influence the of @DRUG$.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration @DRUG$ including , products as magnesium or aluminum @DRUG$ , sucralfate VIDEX chewable/buffered or pediatric powder , or containing , , zinc decrease absorption of , in serum and levels considerably lower than .	DDI-mechanism
@DRUG$-Cephalosporins of cefotetan , @DRUG$ methylthiadiazole cefazolin ) can vitamin K deficiency hypoprothrombinemia .	DDI-false
@DRUG$ Methylxanthines Diuretics Concomitant xanthine derivatives , @DRUG$ potentiate .	DDI-false
Oral Contraceptives : of @DRUG$ an AUC for @DRUG$ ethinyl by approximately 30 % 20 .	DDI-mechanism
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
After multiple dosing , beta-1a ( @DRUG$ IM weekly ) reduced @DRUG$ by .	DDI-mechanism
@DRUG$ a antagonize the skeletal relaxing @DRUG$ and potentiate action succinylcholine	DDI-effect
a 25 @DRUG$ considered for the treatment when @DRUG$ co-administered with potent inducers	DDI-false
There is a significant increase in exposure to imatinib when @DRUG$ is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-mechanism
No Interactions not interactions captopril , , , warfarin , @DRUG$ , carvedilol @DRUG$	DDI-false
THE OF THESE TWO LEAD PHENYTOIN INTOXICATION , TO @DRUG$ TO PATIENT ON @DRUG$ A SERUM LEVEL BE OBTAINED .	DDI-effect
In the , @DRUG$ @DRUG$ active dose in drug mixed signalled-unsignalled DRL ) procedures .	DDI-false
The blood pressure effect @DRUG$ tended be in than @DRUG$ .	DDI-false
Example inhibitors azole , ciprofloxacin , , diclofenac , , @DRUG$ @DRUG$ , , , propofol inhibitors , and .	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
may certain CYP450 enzymes , including @DRUG$ , @DRUG$	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
The of sulfonylureas potentiated by certain drugs including and other that highly protein bound salicylates , @DRUG$ @DRUG$ , monoamine and blocking agents .	DDI-false
However, since there is an increased risk of bleeding with @DRUG$, caution should be employed when @DRUG$ is used with other drugs that affect hemostasis.	DDI-false
@DRUG$ @DRUG$ and NSAIDs on are synergistic users both have risk serious bleeding that of either alone	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, antiemetics, @DRUG$, @DRUG$).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and @DRUG$.	DDI-false
Derivatives Dihydroergotamine , @DRUG$ for serious reactions as @DRUG$ toxicity characterized by vasospasm and of the other .	DDI-false
@DRUG$: The concomitant use of Bepridil with long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris.	DDI-false
@DRUG$ may displace acidic drugs such as phenytoin or @DRUG$ from their binding sites.	DDI-mechanism
indinavir mg of Vardenafil with 600 mg BID @DRUG$ the AUC @DRUG$ were reduced by .	DDI-false
In a of digitalis tolerance dogs anesthetized Innovar or pentobarbital , the dosage ouabain needed to was higher as the @DRUG$ , with @DRUG$ or Innovar than	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue @DRUG$, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
combined of @DRUG$ with @DRUG$ .	DDI-advise
has been reported @DRUG$ or such as @DRUG$.	DDI-effect
@DRUG$ patients the administration of a non-steroidal agent can diuretic antihypertensive	DDI-false
Digoxin Methotrexate like NSAIDs , through on renal prostaglandins , cause the of serum levels @DRUG$ , @DRUG$ methotrexate , toxicity	DDI-false
@DRUG$ : @DRUG$ appear on ciprofloxacin .	DDI-false
The effects of @DRUG$ are antagonized by methylxanthines such as @DRUG$ and theophylline.	DDI-effect
@DRUG$ @DRUG$ narcotics of .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
No prospective currently comparing 3 approved ( @DRUG$ , @DRUG$ .	DDI-false
Since the therapeutic range of @DRUG$ is narrow @DRUG$ serum levels should be monitored closely, and appropriate dosage adjustments of theophylline should be made.	DDI-false
@DRUG$ : @DRUG$   in patients MAOI days severe potentiation by MAO inhibitors been reported with opioid	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ resulting in above ng/mL administered with oral @DRUG$ to an % etoposide exposure with 38 % of compared to etoposide alone	DDI-mechanism
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the @DRUG$ effect by flumazenil.	DDI-false
Antipyrine: Because atorvastatin does not affect the pharmacokinetics of @DRUG$, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
Drug Interactions @DRUG$ drugs , like @DRUG$ ): MAOI could affect pharmacodynamics - Arecoline Eproxindine Ethanol cause additive - Tricyclic : increases the effect of Tricyclic	DDI-int
Antiarrhythmics : @DRUG$ as quinidine procainamide , @DRUG$ , and phenytoin , used with amiodarone .	DDI-false
WARFARIN Co- administration and @DRUG$ any changes prothrombin clotting compared co-administration of @DRUG$ placebo	DDI-false
all the selective serotonin reuptake inhibitors ( @DRUG$ ) , e.g. , citalopram escitalopram , @DRUG$ sertraline , paroxetine they vary in the of .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antacids : In a clinical pharmacology , of an @DRUG$ ( aluminum @DRUG$ , simethicone with reduced serum levels and excretion of fosinoprilat as with administered alone , suggesting that antacids may absorption of fosinopril	DDI-false
Digoxin When multiple doses @DRUG$ and @DRUG$ were steady-state concentrations approximately % .	DDI-mechanism
Co-medications that induce CYP3A4 (e.g., @DRUG$, @DRUG$, carbamazepine, rifampin, phenobarbital or St.	DDI-false
Other therapies In subjects with @DRUG$ concomitantly , hypnotics sedatives ( including @DRUG$ ) , or non-opioid was similar to that taking with these concomitant medications .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Coadministration with are CYP3A4 ( eg , @DRUG$ , , dexamethasone , @DRUG$ ) may in plasma levels of	DDI-false
@DRUG$    @DRUG$ antagonism	DDI-false
Other interactions: Vardenafil had no effect on the pharmacodynamics of @DRUG$ (glucose and insulin concentrations) and @DRUG$ (prothrombin time or other pharmacodynamic parameters).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
: Pharmacokinetic or drug-drug interactions been demonstrated between Argatroban aspirin ( given 26 2 hours initiation @DRUG$ g/kg/min over 4 or ( orally given 12 6 and 0 prior , and and to , Argatroban 1.5   over 18 )	DDI-false
Hypersensitivity reactions have patients regimens containing @DRUG$ and cis-platinum , tamoxifen and	DDI-effect
Although specific studies been , by CYP3A4 ( calcium channel blockers , dapsone , disopyramide , , quinidine , , @DRUG$ pimozide , , @DRUG$ , alprazolam triazolam elevated plasma coadministered with saquinavir	DDI-false
Ketoconazole: In healthy subjects receiving @DRUG$, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-mechanism
@DRUG$-@DRUG$ may the and the .	DDI-false
Therefore , prothrombin be carefully receiving @DRUG$ @DRUG$-like .	DDI-advise
No Interactions To Date not clinically important interactions with @DRUG$ , @DRUG$ , warfarin , isosorbide , carvedilol , ethanol or	DDI-false
have been shown PROLEUKIN-induced effects including , insufficiency , hyperbilirubinemia confusion dyspnea , concomitant administration reduce the effectiveness PROLEUKIN thus should be avoided 12 @DRUG$ other @DRUG$ may the hypotension PROLEUKIN .	DDI-false
Lorazepam like other injectable benzodiazepines produces depression of when administered ethyl alcohol , @DRUG$ inhibitors other . When scopolamine @DRUG$ , an increased , irrational behavior has been observed	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
A interaction between @DRUG$ ciprofloxacin , a @DRUG$ , has reported , a the hypoglycemic glyburide	DDI-false
Non-steroidal patients , non-steroidal anti-inflammatory the and antihypertensive effects @DRUG-DRUG$.	DDI-false
FLEXERIL may enhance the effects of @DRUG$, @DRUG$, and other CNS depressants.	DDI-false
It therefore to acquainted with clinical and paraclinical magnesium deficit and to magnesium deficiency due an @DRUG$ requires oral physiological supplementation and @DRUG$ depletion related a control which specific its causal .	DDI-false
Plasma @DRUG$ concentration should be monitored when @DRUG$ and valproate are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the ACE inhibitor @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
: From beginning of the , rats 10 weekly @DRUG$ weight ) and subcutaneous ( 40 body other , and from week intraperitoneal @DRUG$ ( mg/kg body weight ) other day until the	DDI-false
Certain endocrine and liver function tests may be affected by @DRUG$-containing oral @DRUG$.	DDI-false
Benzthiazide may interact alcohol , , cold and medicines ) , lithium , norepinephrine , @DRUG$ Ibuprofen and blood pressure .	DDI-false
While 18-MC @DRUG$ have similar for kappa and receptors , has affinities than @DRUG$ for NMDA and receptors , sodium channels , the 5-HT transporter	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Urinary acidifying agents These agents (ammonium chloride, @DRUG$, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
@DRUG$ : known slow the and increase serum Carbamazepine levels should be determined to administration with , signs and should closely , and dosage of @DRUG$ should .	DDI-false
@DRUG$ : In individuals , concentrations increased approximately % atorvastatin and @DRUG$ a inhibitor cytochrome .	DDI-false
Concurrent administration of HEXALEN and @DRUG$ may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-false
clinical studies performed use oral @DRUG$ ( @DRUG$ ) , acetylsalicylic acid ( piroxicam ) did affect the pharmacokinetics/pharmacodynamics of sodium .	DDI-false
Data in vitro studies of @DRUG$ other than suggest possible drug interaction the , cyclosporine amiodarone @DRUG$ and nifedipine .	DDI-int
Drug Interactions : with drugs like oxidase ( @DRUG$ - Eproxindine @DRUG$ Flupenthixol and additive : effect of antidepressants	DDI-false
Interaction between @DRUG$ and @DRUG$ in the development of spontaneous motility in chick embryos.	DDI-effect
@DRUG$: The concomitant administration of ciprofloxacin with the sulfonylurea @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of methotrexate.	DDI-false
@DRUG$: In healthy subjects receiving the CYP3A4 inducer, @DRUG$, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to lapatinib was decreased approximately 72%.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
therefore acquainted clinical pattern @DRUG$ to between deficiency due intake which physiological supplementation magnesium depletion to of control @DRUG$ status which more or less specific its .	DDI-false
Human pharmacokinetics that @DRUG$ potently inhibits eight-fold in @DRUG$.	DDI-false
SINCE THE OF TWO DRUGS LEAD @DRUG$ INTOXICATION , DISULFIRAM PATIENT @DRUG$ THERAPY PHENYTOIN LEVEL SHOULD .	DDI-false
Cation-Containing Products Concurrent of quinolone , including with multivalent products such antacids , @DRUG$ @DRUG$ chewable/buffered tablets or pediatric powder , or containing , iron , or zinc substantially the absorption ciprofloxacin in serum urine than .	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Alpha-blockers : When @DRUG$ or 20 was given to simultaneously or after a mg @DRUG$ , significant hypotension in a substantial number	DDI-effect
Other Cardiovascular : and @DRUG$ IV been concomitantly with beta adrenergic-blocking agents @DRUG$ , , prazosin digoxin without of adverse .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
However, the absolute number of @DRUG$-related deaths is far greater than the number of deaths in @DRUG$ or heroin users.	DDI-false
Because of its lack of platelet effects, @DRUG$ is not a substitute for @DRUG$ for cardiovascular prophylaxis.	DDI-false
concomitant therapy were performed , finasteride doses of 1 mg or were concomitantly in acetaminophen acetylsalicylic , , analgesics , @DRUG$ @DRUG$ , benzodiazepines , , H2 antagonists reductase inhibitors inhibitors ( to ) , quinolone without evidence of clinically significant adverse interactions	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
No data are available @DRUG$/ritonavir or @DRUG$/ritonavir and garlic capsules .	DDI-false
@DRUG$ indinavir : Upon administration of mg mg the and of @DRUG$ were approximately	DDI-false
Other and @DRUG$ IV used concomitantly beta adrenergic-blocking , nitrates , agents @DRUG$ and without of significant .	DDI-false
epithelium a defined consisting RPMI1640 transferrin ( ) , @DRUG$ ( 10 ng/ml ) and @DRUG$ ( 3.7 0.1	DDI-false
Caution exercised an HMG-CoA administered with the levels of steroid such @DRUG$ , spironolactone , and @DRUG$.	DDI-false
phenobarbital/acetaminophen quinidine/lidocaine , theophylline/@DRUG$ valproic acid/phenobarbital .	DDI-false
@DRUG$ has tolazoline , , @DRUG$ , surfactant , ventilation	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
of of azithromycin the @DRUG$ @DRUG$	DDI-false
groups SH/FA to daily with ethanol , @DRUG$ , alcohols @DRUG$ same proportions those found common and alcoholic beverages ;	DDI-false
, apparently through certain , has reported to of @DRUG$ , phenytoin , , nifedipine , tricyclic , @DRUG$ , blood levels drugs .	DDI-false
toxicity measurement of @DRUG$ serum concentration concomitant @DRUG$ therapy be	DDI-advise
, crossover @DRUG$ . h.s . a 300 mg b.i.d . dosage Theo-Dur , Key Pharmaceuticals , ) demonstrated steady-state @DRUG$ peak serum levels with the mg . particularly aged and older	DDI-false
Although specific have not drugs that are @DRUG$ , disopyramide amiodarone warfarin tacrolimus cyclosporine , derivatives , , @DRUG$ , and triazolam may elevated when	DDI-false
Injection : Lorazepam injection like when alcohol , @DRUG$ , MAO inhibitors , and other scopolamine used with lorazepam , an increased of sedation hallucinations .	DDI-false
@DRUG$ clinical study , coadministration of an antacid ( @DRUG$ and with of as fosinopril administered suggesting that antacids absorption .	DDI-false
The AUC and Cmax of both the (R) and (S) isomers of @DRUG$ were unaffected by concurrent dosing of 0.3 mg @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$: Because of the relationship of Accutane to vitamin A, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
all the reuptake inhibitors ( @DRUG$ ) , citalopram , @DRUG$ fluoxetine , paroxetine P450 2D6 , they vary the extent inhibition .	DDI-false
Although specific studies have not been , with that mainly by eg , blockers dapsone , @DRUG$ , quinine , @DRUG$ , quinidine , tacrolimus cyclosporine , derivatives , carbamazepine fentanyl alfentanyl , , and have elevated concentrations when coadministered with saquinavir	DDI-false
@DRUG$ @DRUG$ counteract effect of	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-false
inhibitors include azole antifungals , @DRUG$ diclofenac doxycycline , , nefazodone , protease inhibitors , , @DRUG$.	DDI-false
@DRUG$ : @DRUG$ and cerivastatin volunteers not any in clotting factor when and placebo .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ may result in elevated serum levels of oxyphenbutazone.	DDI-mechanism
(@DRUG$)-A drug @DRUG$ an NSAID has	DDI-false
@DRUG$ : Anticoagulant be monitored in initiating changing @DRUG$ therapy in receiving or agents , since these patients of complications	DDI-false
Therefore, when hydroflumethiazide and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.)	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
These include and , , thyroid products , estrogens , @DRUG$ phenytoin , @DRUG$ , channel drugs ,	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Single doses of either @DRUG$ colestipol the @DRUG$ and its absorption from the gastrointestinal tract by up and 43 percent respectively .	DDI-mechanism
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of @DRUG$ and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-mechanism
No Important Interactions To Date does not have pharmacokinetic interactions with captopril , @DRUG$ , warfarin @DRUG$ carvedilol , ethanol or .	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as @DRUG$, opiates, and alcohol.	DDI-false
In some patients @DRUG$ can the diuretic natriuretic , effects of potassium and @DRUG$.	DDI-effect
the other @DRUG$ , , products @DRUG$ , phenytoin , acid drugs and	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, quinine, @DRUG$ and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
Tolbutamide: In diabetic patients receiving @DRUG$ and tolbutamide, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-effect
In and multiple dose healthy receiving both @DRUG$ @DRUG$ , prothrombin time ( INR increased approximately % to 11 % .	DDI-effect
clinical performed with @DRUG$ , use of oral anticoagulants ( , acetylsalicylic acid , NSAIDs ( ) and @DRUG$ not pharmacokinetics/pharmacodynamics sodium	DDI-false
@DRUG$ may alcohol , blood thinners decongestant ( allergy , cold sinus ) drugs NSAIDs like @DRUG$ or Ibuprofen , pressure medications .	DDI-int
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
were not performed , doses of mg more concomitantly used clinical studies @DRUG$ , acid , a-blockers analgesics @DRUG$ anticonvulsants , benzodiazepines beta cardiac diuretics , H2 HMG-CoA inhibitors , ( also to as ) , anti-infectives without of significant adverse	DDI-false
Studies in rats have shown that @DRUG$ administration attenuates certain types of adrenocortical steroid dependent hypertension, including @DRUG$ hypertension.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
- @DRUG$ (e.g., Mexate) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
While all the @DRUG$ (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
including derivatives , indandione derivatives such anti-inflammatory @DRUG$ ) , and @DRUG$ increase the risk of with ardeparin	DDI-false
Because @DRUG$ to effect beyond that obtained and increases the rate excretion the concomitant use of @DRUG$ and salicylates is	DDI-false
Use with @DRUG$: The principal pathway for detoxification of azathioprine is inhibited by @DRUG$.	DDI-false
@DRUG$ : with some other quinolones , of ciprofloxacin with @DRUG$ elevated serum concentrations of theophylline its elimination half-life .	DDI-false
Consequently, drugs with a low therapeutic margin, such as @DRUG$, @DRUG$, and theophylline, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
@DRUG$ interact with the following Acetaminophen ( e.g. @DRUG$ ) ( high-dose use ) or	DDI-int
Antidiabetic drugs : ( oral agents and @DRUG$ ) - @DRUG$ may .	DDI-false
However, high doses of @DRUG$ may reduce the efficacy of intrathecally administered @DRUG$.	DDI-effect
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
Warfarin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of R and @DRUG$.	DDI-false
Drugs That Induce CYP3A4 (@DRUG$) Racemic @DRUG$ exposure was decreased 80% by concomitant useof rifampicin, a potent inducer of CYP3A4.	DDI-false
The effects of @DRUG$ and L-CCG-1 upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
OBJECTIVE Our was characterize of @DRUG$ ( INN @DRUG$ coadministered de novo recipients during the first after	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a benzodiazepine) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Multivalent Cation-Containing : Concurrent of ciprofloxacin , with multivalent cation-containing products as @DRUG$ @DRUG$ antacids , sucralfate VIDEX chewable/buffered , containing zinc may of resulting in and urine levels lower than .	DDI-false
Analysis of the concentration @DRUG$ ultracentrifugation indicated there is equilibration budesonide between @DRUG$ phase .	DDI-false
Chlorpromazine norepinephrine thus inhibiting the central stimulant effects of @DRUG$ and can used to @DRUG$	DDI-false
Short-term have demonstrated that concomitant administration of @DRUG$ and and tablets ) results in reduced protein of @DRUG$ but was no in free warfarin .	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and procainamide, cardiac glycosides and @DRUG$.	DDI-false
The concomitant use other inhibitors with @DRUG$ may also result an in @DRUG$ , could or prolong and may serious depression .	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-int
Standard monitoring of @DRUG$-related toxicity should be continued if VIOXX and @DRUG$ are administered concomitantly.	DDI-false
: Concurrent administration @DRUG$ may lower @DRUG$ possibly by sites .	DDI-mechanism
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
drugs @DRUG$ @DRUG$ phe-nothiazines products , estrogens contraceptives , , nicotinic acid sympathomimet-ics calcium and .	DDI-false
Therefore , when and @DRUG$ are used the effect @DRUG$ obtained	DDI-false
The @DRUG$ be certain drugs including anti-inflammatory and other that highly bound , , sulfonamides , chloramphenicol @DRUG$ , oxidase inhibitors , beta	DDI-effect
drug other AEDs ( gabapentin lamotrigine @DRUG$ phenytoin and @DRUG$ were assessed by evaluating the of levetiracetam and AEDs placebo-controlled clinical	DDI-false
@DRUG$/theophylline lidocaine/quinidine , @DRUG$/acetaminophen valproic acid/phenobarbital .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
If with activity ( @DRUG$ intraconazole ritonavir , @DRUG$ , erythromycin , . reduction the budesonide dose should	DDI-false
No Important Interactions Date @DRUG$ does not clinically pharmacokinetic with @DRUG$ , , , mononitrate carvedilol , ethanol	DDI-false
Sedatives/Hypnotics: @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , acid , , theophylline/acetaminophen valproic	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-int
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the chemotherapy plus clinical course of HIV-related systemic non-Hodgkin lymphoma HIV-NHL the retrospectively patients HIV-NHL were with cyclophosphamide , @DRUG$ , and ( ) chemotherapy regimen HAART 80 were treated with CHOP chemotherapy a CHOP-like , cyclophosphamide doxorubicin , prednisone @DRUG$ bleomycin ) without antiretroviral .	DDI-false
Other were observed between vardenafil and following : , , , @DRUG$ @DRUG$.	DDI-false
Antacids In a clinical pharmacology , an @DRUG$ @DRUG$ hydroxide , and simethicone ) reduced urinary excretion of fosinoprilat with fosinopril administered , that antacids	DDI-false
Imipramine , 30 , clonazepam mg/kg , @DRUG$ 20 @DRUG$ ( 30 mg/kg ) was administered .	DDI-false
of @DRUG$ aqueous @DRUG$ solutions	DDI-mechanism
@DRUG$ (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
In post-marketing experience, bleeding events have been reported, predominantly in the elderly, in association with increases in prothrombin time in patients receiving @DRUG$ concurrently with @DRUG$.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
When @DRUG$ was phenytoin , reduced of @DRUG$ were reported .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Therefore following concomitant of psychotropic drugs ( @DRUG$ , analgesics antiemetics , @DRUG$ )	DDI-false
@DRUG$ : @DRUG$ intestinal phenytoin ;	DDI-false
@DRUG$ @DRUG$ plasma were not by .	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
In a similar study with tamsulosin in healthy volunteers, 1 of 24 subjects dosed with @DRUG$ 20 mg and @DRUG$ 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-effect
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, @DRUG$, CYP2D6, and CYP3A4.	DDI-false
The @DRUG$   @DRUG$ was studied .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, @DRUG$).	DDI-false
, lidocaine/@DRUG$ phenobarbital/valproic acid , , , and @DRUG$/phenobarbital .	DDI-false
concomitant therapy Although specific studies performed , finasteride of mg or more were used clinical studies with @DRUG$ acetylsalicylic a-blockers , ) inhibitors , anticonvulsants benzodiazepines , blockers , blockers cardiac nitrates diuretics , antagonists , reductase inhibitors , prostaglandin synthetase inhibitors ( to NSAIDs ) @DRUG$ without clinically adverse .	DDI-false
@DRUG$     @DRUG$ antagonism	DDI-false
The steady state plasma concentrations of imipramine and @DRUG$ have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of @DRUG$ tablets in doses up to 4 mg/day.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
interactions between dexmedetomidine isoflurane @DRUG$ , @DRUG$ have been demonstrated	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
@DRUG$ allopurinol should have dose reduction of @DRUG$ , to 1/3 usual	DDI-false
The hypoglycemic of may by drugs @DRUG$ drugs highly protein bound , salicylates , sulfonamides chloramphenicol @DRUG$ , coumarins monoamine oxidase inhibitors , and blocking agents .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
injury , myocardial myocarditis , ventricular , severe rhabdomyolysis appear to be in @DRUG$ and @DRUG$	DDI-effect
@DRUG$ have been reported increase in of oral @DRUG$ ;	DDI-false
Although interaction studies not performed , doses of mg or more used with @DRUG$ , acetylsalicylic a-blockers , analgesics angiotensin-converting enzyme ( ACE ) anticonvulsants benzodiazepines beta blockers , @DRUG$ diuretics antagonists HMG-CoA reductase inhibitors , prostaglandin synthetase ( to as NSAIDs anti-infectives without evidence significant	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
may certain , @DRUG$ , ,	DDI-false
concomitant administration @DRUG$ the prothrombin 100 % after 3 4 the @DRUG$ be reduced by one-third to , times be monitored	DDI-false
In a 12-week in OA there difference incidence gastroduodenal in patients taking low-dose mg enteric coated aspirin plus @DRUG$ mg to taking @DRUG$ 2400 mg .	DDI-false
of myopathy treatment of class concurrent of @DRUG$ @DRUG$ nicotinic acid ) erythromycin azole antifungals .	DDI-false
Lithium carbonate: The anorectic and stimulatory effects of @DRUG$ may be inhibited by @DRUG$.	DDI-effect
@DRUG$ and glutethimide should not be administered to patients receiving @DRUG$.	DDI-advise
Tagamet apparently through an certain enzyme , has been reduce the @DRUG$ , , @DRUG$ diazepam certain lidocaine theophylline and metronidazole , thereby delaying elimination and increasing of drugs .	DDI-false
Similarly, @DRUG$ decreased the rate of elimination of @DRUG$ (by approximately 50%) by the same mechanism.	DDI-mechanism
Beta-blocking Agents: The concomitant use of @DRUG$ and @DRUG$ has been well tolerated in patients with stable angina.	DDI-false
Myocardial injury, including myocardial infarction, myocarditis, ventricular hypokinesia, and severe rhabdomyolysis appear to be increased in patients receiving @DRUG$ and @DRUG$ concurrently.	DDI-effect
Oral @DRUG$ : of atorvastatin and an contraceptive values for @DRUG$ and estradiol 30 %	DDI-false
and @DRUG$ ( Heart Post-Myocardial Infarction)- % @DRUG$ 25 50 or angiotensin antagonists ACEI/ARB	DDI-false
Other concomitant Although studies not finasteride of in clinical studies acetaminophen a-blockers , angiotensin-converting enzyme ( ACE inhibitors , anticonvulsants , blockers , calcium-channel cardiac @DRUG$ , , @DRUG$ HMG-CoA reductase inhibitors , prostaglandin synthetase ( referred to NSAIDs , and quinolone without evidence significant adverse interactions	DDI-false
@DRUG$ or iodine may the can increase of @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Other specific interaction studies were not , @DRUG$ doses mg more were concomitantly in acetaminophen , , , , angiotensin-converting ( ACE inhibitors , anticonvulsants benzodiazepines , beta blockers blockers , cardiac , H2 , , @DRUG$ as NSAIDs and quinolone anti-infectives evidence clinically adverse	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Both @DRUG$ and its major metabolite, @DRUG$, are inhibitors of the cytochrome P450 3A4 enzyme system.	DDI-false
oral ketoconazole inhibits metabolism of @DRUG$ resulting in increase in mean	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
In study @DRUG$ healthy , 1 of dosed 20 and @DRUG$ 0.4 separated hours experienced a standing systolic blood pressure Hg .	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
INOmax has been administered with tolazoline, @DRUG$, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-int
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
It is structurally distinct from the other currently available @DRUG$ (@DRUG$, simvastatin, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
concentrations that increase imatinib concentrations : Caution when with CYP3A4 family e.g. , @DRUG$ erythromycin , @DRUG$	DDI-false
Central Nervous Depressants use DURAGESIC fentanyl transdermal system central system , including but @DRUG$ , hypnotics , ( , benzodiazepines ) general @DRUG$ , , skeletal relaxants , , may , hypotension , and profound sedation or potentially in coma or death	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
in vitro studies alprazolam suggest a possible interaction with @DRUG$ the sertraline	DDI-int
@DRUG$ is known to slow of @DRUG$ increase prior concurrent administration symptoms should be monitored closely , and be made .	DDI-mechanism
This window different than for of @DRUG$ are administered @DRUG$.	DDI-advise
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-mechanism
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
effects combined of @DRUG$ and @DRUG$ verapamil calcium channel , of peritoneal metastasis intestinal by azoxymethane ( AOM ) the labeling index intestinal cancers investigated in male Wistar rats	DDI-false
Antacids , of an aluminum , magnesium and @DRUG$ levels and urinary @DRUG$ as compared administered may impair of fosinopril .	DDI-false
Interactions @DRUG$   And Other @DRUG$ ) Phenytoin   3000 mg no on the pharmacokinetic phenytoin in patients with epilepsy	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
of @DRUG$ and may the	DDI-false
Multivalent Products Concurrent of a @DRUG$ , , with cation-containing such as or antacids , sucralfate VIDEX , or containing , or @DRUG$ decrease the absorption ciprofloxacin in and lower than desired .	DDI-mechanism
In a similar study with @DRUG$ in healthy volunteers, 1 of 24 subjects dosed with Vardenafil 20 mg and @DRUG$ 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-false
Prednisone/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
, close is of the @DRUG$ may @DRUG$ concomitantly	DDI-advise
acetaminophen/theophylline , , @DRUG$/acetaminophen , phenobarbital/valproic @DRUG$/lidocaine , and acid/phenobarbital	DDI-false
Chronic administration of @DRUG$, a known enzyme inducer, may be associated with a decrease in the plasma half-life of @DRUG$.	DDI-mechanism
@DRUG$ ( nandrolone Anabolin ] oxandrolone [ e.g. Anavar ] stanozolol , @DRUG$ )	DDI-false
drugs other diuretics @DRUG$ , estrogens @DRUG$ phenytoin , nicotinic , calcium drugs , and isoniazid	DDI-false
we show a @DRUG$ 3,7-dihydroxyflavone @DRUG$ be to of Enterococcus Enterococcus faecium to the level	DDI-false
Example inhibitors include ciprofloxacin clarithromycin , diclofenac , , nefazodone , nicardipine propofol protease inhibitors , @DRUG$ , @DRUG$.	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-mechanism
with alcohol blood thinners @DRUG$ , , and medicines ) drugs lithium , NSAIDs @DRUG$ , and pressure .	DDI-false
Interaction During : @DRUG$ @DRUG$ were subcutaneous pregnant	DDI-false
@DRUG$ @DRUG$ ): Cerivastatin plasma were by of	DDI-false
@DRUG$ of other	DDI-effect
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Tolbutamide: In diabetic patients receiving @DRUG$ and @DRUG$, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, @DRUG$.	DDI-false
Potential Keppra and AEDs ( gabapentin @DRUG$ , phenytoin primidone and were assessed evaluating the serum concentrations @DRUG$ these during placebo-controlled clinical	DDI-false
of hypotensive effects with @DRUG$ be discontinuing the @DRUG$ or salt to initiation treatment with enalaprilat	DDI-effect
drug with alcohol or CNS ( may the depressant either these or antihistamines , @DRUG$ or other with ( anticholinergic effects be potentiated when medications used concurrently with , oxidase antihistamines and intensify and CNS depressant effects @DRUG$ ) .	DDI-false
@DRUG$: In healthy subjects receiving the CYP3A4 inducer, carbamazepine, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to @DRUG$ was decreased approximately 72%.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
As other antipsychotic agents should be noted that @DRUG$ capable @DRUG$ , opiates alcohol	DDI-effect
of this to @DRUG$ or its @DRUG$ , on effect peptides mice injection	DDI-false
The administration of local @DRUG$ or norepinephrine monoamine oxidase inhibitors , @DRUG$ or may severe .	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
caution using ROMAZICON cases of overdosage since toxic effects such cardiac ) other in especially @DRUG$ may emerge the of effect @DRUG$.	DDI-false
@DRUG$ therapy Urinary excretion of @DRUG$ is increased, and efficacy is reduced by acidifying agents used in methenamine therapy.	DDI-false
In clinical performed with @DRUG$ the of @DRUG$ ( warfarin inhibitors ( ) , ( ) did significantly the pharmacokinetics/pharmacodynamics of fondaparinux .	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
@DRUG$: @DRUG$*, terfenadine* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Dosage @DRUG$ may when coadministered CYP2D6 inhibitors , e.g. , @DRUG$ .	DDI-advise
@DRUG$: Vardenafil (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by @DRUG$ (two 81 mg tablets).	DDI-false
@DRUG$/theophylline lidocaine/quinidine , phenobarbital/valproic acid , quinidine/lidocaine theophylline/@DRUG$ and acid/phenobarbital	DDI-false
Data suggest that coadministration of oral @DRUG$ and @DRUG$ can result in prolongation of the QT interval on the ECG.	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
FLEXERIL may enhance the effects of @DRUG$, barbiturates, and other @DRUG$.	DDI-false
inhibitors include azole antifungals , , erythromycin , imatinib , isoniazid @DRUG$ , nicardipine , propofol protease @DRUG$ , .	DDI-false
@DRUG$ vitamin may the absorption @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
In Fondaparinux , the concomitant use oral @DRUG$ ) platelet , ( piroxicam ) and digoxin not pharmacokinetics/pharmacodynamics of	DDI-false
Both and compared triple with PI @DRUG$ weeks initial therapy , responses observed with @DRUG$ regimens superiority observed with .	DDI-false
Multivalent Concurrent administration , @DRUG$ , cation-containing as magnesium or @DRUG$ , sucralfate VIDEX tablets or pediatric powder or or zinc may substantially decrease of ciprofloxacin resulting and considerably lower desired	DDI-mechanism
acetaminophen/theophylline lidocaine/quinidine , phenobarbital/acetaminophen , , quinidine/@DRUG$ ,	DDI-false
Quinolones , @DRUG$ , may enhance the of oral anticoagulants including @DRUG$ or or similar .	DDI-effect
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
In the presence of these @DRUG$, larger doses of adenosine may be required or @DRUG$ may not be effective.	DDI-advise
The effects of administration @DRUG$ @DRUG$ ) , a calcium , the incidence of peritoneal metastasis of intestinal adenocarcinomas AOM ) and the index cancers in male Wistar rats .	DDI-false
results seem the clinical use @DRUG$ @DRUG$ or during period ELSPAR when plasma .	DDI-advise
The hypoglycemic @DRUG$ potentiated by certain nonsteroidal anti-inflammatory agents and drugs protein , @DRUG$ , coumarins , monoamine inhibitors , beta agents	DDI-effect
This is the inhibition of @DRUG$ metabolism @DRUG$ ( CLINICAL - Pharmacokinetics : ) .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
addition , @DRUG$ the pharmacodynamics of warfarin , piroxicam , @DRUG$ , nor the of at	DDI-false
In a clinical pharmacology study, @DRUG$ or sulindac was administered to hypertensive patients receiving @DRUG$.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Although studies not been performed , coadministration that are metabolized by CYP3A4 eg calcium blockers , @DRUG$ amiodarone , , , cyclosporine , , , fentanyl , , @DRUG$ ) may plasma with saquinavir ;	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
Tagamet through effect on certain systems , has been reported to hepatic of anticoagulants , propranolol , , chlordiazepoxide @DRUG$ , @DRUG$ metronidazole thereby elimination of these drugs	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
@DRUG$ Potassium-Sparing Diuretics Fosinopril can potassium loss caused @DRUG$.	DDI-false
The successive application of @DRUG$ (5 or 10 mg/kg egg weight (e.w.) and glutamate (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of @DRUG$ alone.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Central Nervous System The @DRUG$   other system depressants , not limited to opioids sedatives , hypnotics tranquilizers general , @DRUG$ , and alcohol , may depression , hypotension , and profound sedation , result coma or death	DDI-effect
( In some , the steroidal can the diuretic antihypertensive @DRUG-DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ Supplements and Potassium-Sparing Diuretics: Fosinopril sodium can attenuate potassium loss caused by @DRUG$.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous @DRUG$ such as morphine.	DDI-mechanism
Rifampin @DRUG$ @DRUG$ mg daily potent , produced approximate % decrease rofecoxib concentrations .	DDI-mechanism
These drugs thiazides and other @DRUG$ corticosteroids , phenothiazines thyroid , contraceptives phenytoin , @DRUG$ blocking .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/@DRUG$.	DDI-false
Additional drugs that are not recommended for coadministration with @DRUG$ and @DRUG$ are included below.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
Multivitamins, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
@DRUG$     @DRUG$ antagonism	DDI-false
that @DRUG$ retinyl acetate , glucocorticoids and , regulate of epithelium by of activity @DRUG$ EGF	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or @DRUG$.	DDI-false
Specific have these effects , @DRUG$ @DRUG$ , midazolam	DDI-false
Because not shown effect beyond with @DRUG$ because increases the of of @DRUG$ , the of salicylates recommended	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
interact alcohol , decongestant , and sinus , diabetic drugs , lithium norepinephrine , @DRUG$ like or @DRUG$ high .	DDI-false
@DRUG$ has been shown to have neuromuscular blocking properties that may enhance the action of other @DRUG$.	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/valproic acid valproic acid/phenobarbital	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ may the absorption of @DRUG$ to a deficiency .	DDI-mechanism
@DRUG$ of warfarin and @DRUG$ to did not result in any changes in prothrombin time clotting VII when compared to and placebo	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
@DRUG$ to three cancer a range 0.025 mg to led to a inhibition elimination.14 alternate-day mg @DRUG$ on metabolism MS patients .	DDI-false
Gleevec will increase plasmaconcentration of CYP3A4 drugs ( triazolo-@DRUG$ , dihydropyridine calcium blockers , @DRUG$ )	DDI-false
Although been performed , drugs are by channel blockers , amiodarone quinidine @DRUG$ , tacrolimus , ergot derivatives @DRUG$ , , alprazolam triazolam ) may elevated coadministered with ;	DDI-false
@DRUG$ : the of to @DRUG$ advised against vitamin supplements containing to additive toxic effects	DDI-false
: Clinical , as marketing , that @DRUG$ can the @DRUG$ and some patients	DDI-effect
Other : such as @DRUG$ @DRUG$ , procainamide , phenothiazines , tricyclic antidepressants may with QT-interval prolongation and arrhythmia .	DDI-false
Acetaminophen In volunteers administration diflunisal @DRUG$ resulted in levels of	DDI-false
The results raise the possibility that the ethanolysis reaction may occur in the stomach of people who consume @DRUG$ and @DRUG$ on a regular basis.	DDI-mechanism
Example @DRUG$ ciprofloxacin , diclofenac , @DRUG$ , isoniazid , nefazodone , nicardipine , protease inhibitors quinidine and verapamil	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
@DRUG$ , , , , theophylline , and @DRUG$ were added at concentrations	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
These results suggest that both @DRUG$ and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Since the concomitant administration of @DRUG$ with @DRUG$ increases the prothrombin time by 100% after 3 to 4 days, the dose of the anticoagulant should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
@DRUG$, such as @DRUG$, diltiazem and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
, lidocaine/quinidine , quinidine/@DRUG$ theophylline/acetaminophen and valproic acid/@DRUG$.	DDI-false
between @DRUG$   and other @DRUG$ gabapentin lamotrigine , phenytoin and valproate ) also of and clinical .	DDI-false
Glycosides a young healthy male evidence of a pharmacokinetic @DRUG$-@DRUG$ interaction found	DDI-false
